data_1big_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1big _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 . . . . . 0 C--O 1.216 -0.659 0 CA-C-O 120.95 0.405 . . . . 1.0 110.373 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.4 p -130.54 172.56 11.78 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.826 -1.079 . . . . 1.0 110.105 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -126.3 28.3 6.04 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.245 0.965 . . . . 1.0 109.061 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 p -115.79 155.11 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 115.152 -0.931 . . . . 1.0 109.895 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -70.8 131.95 44.59 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.508 -0.769 . . . . 1.0 112.83 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.3 p -123.55 160.31 27.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.944 0.777 . . . . 1.0 109.018 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 81.4 p -132.77 40.09 3.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.608 0.718 . . . . 1.0 110.15 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.3 163.17 13.86 Favored Glycine 0 N--CA 1.494 2.534 0 CA-C-N 114.092 -1.413 . . . . 1.0 109.8 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.4 p -43.71 -49.9 7.74 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 114.385 -0.907 . . . . 1.0 113.332 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -45.95 -50.09 15.07 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 115.102 -0.954 . . . . 1.0 113.002 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -70.99 -29.3 65.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.056 0.848 . . . . 1.0 110.692 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 26.3 t -73.97 -23.15 59.44 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.777 -1.101 . . . . 1.0 112.678 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.408 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 7.1 m0 -62.89 -58.83 14.57 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-O 118.591 -0.718 . . . . 1.0 111.949 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 90.5 Cg_endo -64.01 -41.4 23.02 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 123.121 2.548 . . . . 1.0 109.801 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.12 -45.63 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 123.96 0.788 . . . . 1.0 110.26 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.53 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 42.4 t -70.0 -43.8 70.65 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.841 -1.17 . . . . 1.0 107.841 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -48.38 -43.44 33.82 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 122.415 1.103 . . . . 1.0 108.405 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -70.82 -52.62 19.32 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 113.048 -1.887 . . . . 1.0 113.902 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 84.0 mtp -64.6 -55.97 16.92 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 115.015 1.487 . . . . 1.0 115.015 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -108.86 -57.38 2.15 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.403 1.064 . . . . 1.0 113.034 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.3 35.49 0.66 Allowed Glycine 0 N--CA 1.495 2.587 0 O-C-N 123.857 0.723 . . . . 1.0 111.332 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.53 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 13.1 mptt -122.28 90.84 49.22 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 104.484 -2.413 . . . . 1.0 104.484 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.09 -3.47 7.28 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 123.227 2.618 . . . . 1.0 113.366 -160.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -105.09 -175.93 2.93 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.032 -1.47 . . . . 1.0 107.032 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.66 -178.74 19.14 Favored Glycine 0 N--CA 1.489 2.174 0 CA-C-N 114.0 -1.454 . . . . 1.0 113.224 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -139.66 167.58 21.78 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.751 -1.225 . . . . 1.0 111.281 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 39.0 t -108.61 147.78 31.33 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.807 -0.812 . . . . 1.0 108.807 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.9 ptm -136.54 108.47 7.13 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 123.786 0.679 . . . . 1.0 110.314 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.2 t30 31.2 46.13 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.188 -1.824 . . . . 1.0 113.027 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.34 -30.42 6.02 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 119.29 2.476 . . . . 1.0 119.29 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -118.2 146.89 43.89 Favored 'General case' 0 C--O 1.205 -1.247 0 CA-C-N 120.56 2.18 . . . . 1.0 112.911 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.3 t -72.52 156.47 38.98 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 112.853 -1.976 . . . . 1.0 112.728 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.46 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 10.0 tpt180 -133.1 142.66 48.83 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 112.175 -2.284 . . . . 1.0 105.516 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.0 m -109.42 166.31 10.97 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 124.231 0.957 . . . . 1.0 109.669 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -118.37 -178.57 3.55 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 114.386 -1.279 . . . . 1.0 108.923 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 117.537 -1.22 . . . . 1.0 111.127 179.946 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.7 p90 . . . . . 0 C--O 1.217 -0.638 0 N-CA-C 112.965 0.728 . . . . 1.0 112.965 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 59.4 p -132.25 166.3 22.18 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 113.872 -1.513 . . . . 1.0 108.416 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -123.62 45.75 2.38 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.885 0.85 . . . . 1.0 109.161 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -104.78 153.17 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 114.411 -1.268 . . . . 1.0 108.975 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -70.63 117.92 12.76 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.248 1.944 . . . . 1.0 116.248 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.8 p -127.33 172.93 10.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 124.156 0.91 . . . . 1.0 109.098 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.4 m -124.11 -44.93 2.01 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 112.961 -1.927 . . . . 1.0 106.956 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.57 169.76 32.88 Favored Glycine 0 N--CA 1.494 2.555 0 CA-C-N 114.831 -1.077 . . . . 1.0 111.73 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.5 t -43.75 -57.4 3.25 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.195 -1.002 . . . . 1.0 112.076 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -41.88 -42.27 2.67 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 114.284 -1.326 . . . . 1.0 113.704 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -70.51 -41.11 73.03 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.658 1.218 . . . . 1.0 111.419 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 41.3 t -71.35 -23.53 61.93 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 113.137 -1.847 . . . . 1.0 112.309 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.439 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.2 m0 -59.15 -60.62 9.97 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 123.918 0.761 . . . . 1.0 111.876 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -63.77 -43.09 17.53 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.152 2.568 . . . . 1.0 109.738 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.77 -42.73 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 123.864 0.728 . . . . 1.0 109.966 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 51.4 m -70.27 -43.86 69.6 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -50.36 -42.24 52.85 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.333 1.063 . . . . 1.0 108.544 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -70.89 -56.39 6.36 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 113.539 -1.664 . . . . 1.0 113.42 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.7 ttm -59.19 -56.15 25.87 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 115.075 1.509 . . . . 1.0 115.075 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -106.36 -58.98 1.85 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 113.461 -1.699 . . . . 1.0 114.011 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.59 45.88 0.26 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 106.383 -2.687 . . . . 1.0 106.383 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -128.72 88.66 51.41 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 106.132 -1.803 . . . . 1.0 106.132 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -62.16 2.39 0.65 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.318 2.012 . . . . 1.0 113.67 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.439 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 8.0 m120 -113.49 -174.74 2.52 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.96 -179.08 18.38 Favored Glycine 0 N--CA 1.489 2.216 0 CA-C-N 113.659 -1.609 . . . . 1.0 110.734 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -140.96 167.92 21.04 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.863 -0.668 . . . . 1.0 110.539 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.5 t -107.75 157.49 18.08 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.52 -0.918 . . . . 1.0 108.52 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.7 mtp -132.05 81.91 1.99 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.783 -1.191 . . . . 1.0 107.783 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.1 t30 29.34 53.94 0.11 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 125.534 1.771 . . . . 1.0 111.519 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.36 -38.04 2.3 Favored Glycine 0 N--CA 1.479 1.543 0 CA-C-N 113.145 -1.843 . . . . 1.0 115.737 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -114.98 135.2 54.48 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-N 119.37 1.585 . . . . 1.0 112.711 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 15.2 t -72.07 157.61 37.47 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.796 -2.911 . . . . 1.0 114.828 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.532 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.4 tpt180 -138.11 143.49 40.41 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 112.365 -2.198 . . . . 1.0 105.938 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.6 m -119.4 160.71 21.8 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.718 -1.586 . . . . 1.0 106.718 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -110.88 -172.15 1.97 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.7 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 116.109 -1.9 . . . . 1.0 109.493 -179.702 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.2 p90 . . . . . 0 C--O 1.215 -0.759 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.404 HG23 ' SG ' ' A' ' 33' ' ' CYS . 72.8 p -128.47 177.55 6.91 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 122.132 0.968 . . . . 1.0 113.146 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -112.98 -5.93 13.77 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 112.596 -2.093 . . . . 1.0 109.319 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.2 t -112.81 140.65 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.327 -0.99 . . . . 1.0 108.327 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 25.2 pttm -71.05 167.44 19.24 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.751 1.76 . . . . 1.0 115.751 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.9 p -138.54 176.04 9.04 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 124.61 1.194 . . . . 1.0 110.716 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.3 m -125.36 -49.31 1.68 Allowed 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.256 -2.247 . . . . 1.0 105.345 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.82 170.13 29.26 Favored Glycine 0 N--CA 1.493 2.495 0 CA-C-N 114.004 -1.453 . . . . 1.0 109.764 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.0 m -51.23 -54.94 20.92 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.382 0.611 . . . . 1.0 110.661 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -49.1 -39.95 30.19 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.659 -1.155 . . . . 1.0 113.161 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -70.39 -30.71 67.67 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.255 1.026 . . . . 1.0 110.849 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.578 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 6.0 t -76.98 -10.65 59.51 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 113.568 -1.651 . . . . 1.0 112.833 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 9.9 m0 -66.86 -58.48 9.49 Favored Pre-proline 0 N--CA 1.485 1.29 0 CA-C-O 118.873 -0.584 . . . . 1.0 109.523 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.09 -48.0 9.2 Favored 'Trans proline' 0 N--CA 1.486 1.081 0 C-N-CA 122.369 2.046 . . . . 1.0 110.096 173.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.5 t -51.33 -40.8 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 119.997 -0.681 . . . . 1.0 110.315 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 42.8 t -70.35 -49.43 49.35 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.775 -1.17 . . . . 1.0 107.999 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -47.77 -38.23 15.18 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.205 1.002 . . . . 1.0 109.425 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -70.24 -53.99 14.65 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.309 -1.769 . . . . 1.0 111.956 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 35.7 mmt -69.82 -55.31 10.15 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 115.98 1.844 . . . . 1.0 115.98 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -102.86 -53.58 2.82 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 123.77 0.669 . . . . 1.0 112.666 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.07 35.28 0.55 Allowed Glycine 0 N--CA 1.492 2.381 0 O-C-N 123.662 0.601 . . . . 1.0 113.281 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.493 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 2.9 mptp? -127.45 131.67 23.95 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -87.3 14.36 2.43 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 122.43 2.087 . . . . 1.0 110.511 -175.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -119.54 -177.56 3.4 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.557 -1.275 . . . . 1.0 107.557 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.24 172.76 12.76 Favored Glycine 0 N--CA 1.488 2.135 0 CA-C-N 114.13 -1.395 . . . . 1.0 114.747 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.478 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 50.4 mtpt -130.35 177.81 7.06 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 112.158 -2.021 . . . . 1.0 110.719 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 t -116.35 151.79 35.21 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.375 -1.343 . . . . 1.0 107.375 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 70.8 mtm -130.69 83.75 2.14 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.114 -1.069 . . . . 1.0 108.114 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 27.84 50.35 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 125.54 1.775 . . . . 1.0 112.851 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 126.44 -31.4 4.01 Favored Glycine 0 N--CA 1.484 1.838 0 CA-C-O 116.012 -2.549 . . . . 1.0 117.532 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -116.94 145.98 43.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 121.356 2.578 . . . . 1.0 109.491 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.404 ' SG ' HG23 ' A' ' 3' ' ' THR . 16.7 t -71.7 157.98 36.96 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.581 -1.645 . . . . 1.0 113.791 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.578 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 17.8 tpt85 -128.96 140.18 51.77 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.366 -2.197 . . . . 1.0 105.692 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.8 m -111.6 163.49 14.04 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.146 -1.057 . . . . 1.0 108.146 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.411 ' OH ' ' HG3' ' A' ' 27' ' ' LYS . 12.7 m-30 -114.26 -176.86 2.99 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 113.717 -1.583 . . . . 1.0 108.201 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 116.162 -1.875 . . . . 1.0 108.893 -179.921 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 43.9 p90 . . . . . 0 C--O 1.216 -0.687 0 CA-C-O 121.824 0.821 . . . . 1.0 113.143 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.7 p -132.18 163.47 28.48 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 113.045 -1.889 . . . . 1.0 108.158 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -126.65 52.26 1.77 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 124.003 0.814 . . . . 1.0 110.459 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -111.58 151.58 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 C-N-CA 120.001 -0.68 . . . . 1.0 109.352 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -70.21 103.17 2.27 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 114.968 1.47 . . . . 1.0 114.968 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.3 p -120.58 172.3 7.95 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.082 0.944 . . . . 1.0 109.909 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.6 t -126.22 -42.22 1.86 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 112.578 -2.101 . . . . 1.0 107.898 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.79 165.29 26.91 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 124.268 0.98 . . . . 1.0 111.542 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.0 m -47.88 -53.33 16.07 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.384 -0.908 . . . . 1.0 111.719 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.441 ' HZ1' HE22 ' A' ' 12' ' ' GLN . 10.4 mtmp? -45.19 -43.37 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.075 -1.42 . . . . 1.0 114.063 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.441 HE22 ' HZ1' ' A' ' 11' ' ' LYS . 14.4 mp0 -70.24 -32.52 70.41 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.893 0.854 . . . . 1.0 111.346 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 8.5 t -77.55 -11.5 59.86 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 113.742 -1.572 . . . . 1.0 112.331 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.431 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.0 m0 -67.6 -59.7 6.56 Favored Pre-proline 0 N--CA 1.49 1.57 0 CA-C-O 118.655 -0.688 . . . . 1.0 110.434 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -63.73 -46.98 7.82 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.59 2.194 . . . . 1.0 109.287 174.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.1 t -51.62 -42.08 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 123.802 0.689 . . . . 1.0 109.928 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 41.7 t -70.09 -46.05 65.69 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.31 -0.996 . . . . 1.0 108.31 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -46.76 -42.76 17.37 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.731 1.253 . . . . 1.0 108.188 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -70.62 -52.21 22.88 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 112.831 -1.986 . . . . 1.0 113.206 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -55.95 26.96 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 114.728 1.381 . . . . 1.0 114.728 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -110.82 -56.35 2.37 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.321 -1.309 . . . . 1.0 113.712 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.05 34.95 0.53 Allowed Glycine 0 N--CA 1.492 2.383 0 O-C-N 124.032 0.832 . . . . 1.0 111.132 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 13.1 mptt -124.84 99.18 35.51 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 104.292 -2.485 . . . . 1.0 104.292 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.6 14.16 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.737 2.291 . . . . 1.0 113.322 -169.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.431 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 17.9 p30 -117.03 -179.95 3.85 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.56 168.39 12.59 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.362 -1.399 . . . . 1.0 116.365 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.453 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 35.4 mtpt -123.83 171.03 9.96 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 112.55 -1.825 . . . . 1.0 109.531 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.1 t -118.42 158.57 25.06 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.539 -1.282 . . . . 1.0 107.539 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.7 mtp -134.91 79.11 1.77 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.38 -1.341 . . . . 1.0 107.38 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.6 p30 28.2 51.96 0.05 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 125.598 1.811 . . . . 1.0 112.573 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.11 -37.93 2.01 Favored Glycine 0 N--CA 1.484 1.856 0 CA-C-N 112.471 -2.149 . . . . 1.0 115.258 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -114.47 139.77 49.27 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 119.46 1.63 . . . . 1.0 112.143 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 36.0 t -71.92 159.98 33.32 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 111.721 -2.49 . . . . 1.0 115.027 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.561 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 14.2 tpt180 -135.94 145.37 46.16 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 112.543 -2.117 . . . . 1.0 105.543 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.0 m -124.04 163.02 22.27 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.086 -1.82 . . . . 1.0 106.086 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.453 ' OH ' ' HG3' ' A' ' 27' ' ' LYS . 4.5 m-85 -116.57 168.27 10.33 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 105.472 -2.047 . . . . 1.0 105.472 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 N--CA 1.507 2.42 0 N-CA-C 115.34 1.607 . . . . 1.0 115.34 -179.813 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 122.101 0.953 . . . . 1.0 111.57 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.5 p -133.2 163.77 28.56 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 112.525 -2.125 . . . . 1.0 109.038 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -104.05 40.59 1.42 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.558 -0.746 . . . . 1.0 111.326 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -121.35 142.57 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 107.743 -1.206 . . . . 1.0 107.743 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -70.72 146.44 49.86 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.412 1.634 . . . . 1.0 115.412 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.5 p -140.15 174.17 10.78 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.575 1.172 . . . . 1.0 109.807 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.5 p -122.86 -46.3 2.11 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.917 -1.947 . . . . 1.0 106.572 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.86 173.17 33.9 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.562 -1.415 . . . . 1.0 109.562 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.6 t -40.04 -59.36 1.24 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 124.521 0.777 . . . . 1.0 111.005 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -42.32 -42.32 3.1 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.061 -1.427 . . . . 1.0 113.973 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.36 -37.92 74.68 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.419 1.104 . . . . 1.0 110.005 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.612 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 10.1 t -71.51 -23.33 61.77 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.228 -1.351 . . . . 1.0 113.48 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.457 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.6 m0 -57.99 -60.62 9.46 Favored Pre-proline 0 CA--C 1.56 1.33 0 O-C-N 123.768 0.668 . . . . 1.0 111.324 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -62.38 -42.86 25.45 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 C-N-CA 122.738 2.292 . . . . 1.0 109.491 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.1 t -53.15 -44.44 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 123.803 0.689 . . . . 1.0 110.963 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 48.6 t -70.16 -44.76 68.16 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.948 -1.13 . . . . 1.0 107.948 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -48.49 -43.29 34.85 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.355 1.074 . . . . 1.0 108.494 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -70.86 -47.87 56.98 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 113.065 -1.879 . . . . 1.0 113.235 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 80.9 mmm -65.59 -60.2 3.16 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 114.879 1.436 . . . . 1.0 114.879 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -107.91 -56.27 2.26 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.246 -1.343 . . . . 1.0 112.855 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.18 34.83 0.61 Allowed Glycine 0 N--CA 1.493 2.485 0 O-C-N 123.92 0.762 . . . . 1.0 111.278 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 0.9 OUTLIER -121.05 86.69 42.68 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 104.563 -2.384 . . . . 1.0 104.563 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -64.49 3.18 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.141 2.561 . . . . 1.0 113.961 -163.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.457 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 66.8 m-80 -111.48 -177.53 3.22 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.898 -1.89 . . . . 1.0 105.898 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.23 -172.6 24.14 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.214 -1.47 . . . . 1.0 114.222 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.521 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 60.8 mtpt -132.56 171.7 13.46 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 113.421 -1.389 . . . . 1.0 112.219 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.8 t -111.23 156.12 21.94 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 105.619 -1.993 . . . . 1.0 105.619 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 59.5 mtp -134.25 83.53 2.04 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.825 -1.176 . . . . 1.0 107.825 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 27.99 54.21 0.07 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 125.815 1.947 . . . . 1.0 110.583 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.34 -40.48 1.8 Allowed Glycine 0 N--CA 1.484 1.849 0 CA-C-N 112.591 -2.095 . . . . 1.0 116.441 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -116.58 147.75 41.55 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 120.554 2.177 . . . . 1.0 112.656 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 35.0 t -71.84 155.46 40.39 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.853 -2.885 . . . . 1.0 116.223 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.612 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.2 tpt180 -130.14 144.47 51.37 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 111.099 -2.773 . . . . 1.0 105.54 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.9 m -115.24 163.89 15.01 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.563 -1.643 . . . . 1.0 106.563 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.521 ' CZ ' ' HG3' ' A' ' 27' ' ' LYS . 15.3 m-85 -113.19 -179.41 3.64 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.153 -1.055 . . . . 1.0 108.153 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.8 p . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 115.928 -1.987 . . . . 1.0 110.018 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.3 p90 . . . . . 0 C--O 1.217 -0.646 0 N-CA-C 114.373 1.249 . . . . 1.0 114.373 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.3 p -132.63 171.9 13.23 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 112.901 -1.954 . . . . 1.0 109.045 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -122.99 51.54 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.992 -1.114 . . . . 1.0 107.992 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.2 t -112.67 128.72 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 115.126 -0.943 . . . . 1.0 111.418 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -39.76 102.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 118.478 2.77 . . . . 1.0 118.478 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.6 p -125.58 170.17 11.75 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.805 0.812 . . . . 1.0 109.672 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.9 t -121.98 -43.01 2.36 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 113.105 -1.861 . . . . 1.0 106.923 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.17 165.03 31.65 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.908 -1.277 . . . . 1.0 109.908 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.8 t -40.64 -59.52 1.35 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 124.727 0.898 . . . . 1.0 111.94 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -43.44 -43.39 5.26 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 113.819 -1.537 . . . . 1.0 114.618 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -70.59 -34.11 71.8 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.883 0.849 . . . . 1.0 111.121 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 7.3 t -76.24 -11.92 60.0 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.303 -1.317 . . . . 1.0 112.675 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.425 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 5.0 m0 -67.64 -58.21 8.77 Favored Pre-proline 0 N--CA 1.489 1.497 0 CA-C-O 118.605 -0.712 . . . . 1.0 110.166 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 77.0 Cg_endo -63.05 -43.1 20.52 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.936 2.424 . . . . 1.0 109.95 174.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.0 t -54.55 -45.05 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 119.835 -0.746 . . . . 1.0 109.829 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 54.1 t -70.13 -39.71 75.27 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.203 -1.036 . . . . 1.0 108.203 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -51.35 -43.94 61.93 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.51 1.148 . . . . 1.0 108.04 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -70.69 -57.18 4.95 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 113.663 -1.608 . . . . 1.0 113.122 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -55.25 -50.87 68.36 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 114.282 1.216 . . . . 1.0 114.282 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -112.06 -62.99 1.48 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.585 -1.643 . . . . 1.0 114.924 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.89 43.73 0.36 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 107.31 -2.316 . . . . 1.0 107.31 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.454 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 98.1 mttt -130.62 86.66 52.21 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 104.79 -2.3 . . . . 1.0 104.79 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.09 -2.66 5.98 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.55 2.833 . . . . 1.0 113.254 -160.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.425 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 71.9 m-80 -104.24 -176.77 3.17 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.152 -1.425 . . . . 1.0 107.152 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.26 -176.04 21.94 Favored Glycine 0 N--CA 1.493 2.44 0 CA-C-N 114.298 -1.319 . . . . 1.0 113.259 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 53.2 mtpt -135.58 179.28 6.43 Favored 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 113.903 -1.148 . . . . 1.0 112.001 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 t -121.68 157.51 30.74 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 63.5 mtm -135.01 73.51 1.48 Allowed 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.312 -1.366 . . . . 1.0 107.312 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.1 t30 28.22 55.36 0.09 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 125.669 1.856 . . . . 1.0 111.215 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.89 -37.57 2.13 Favored Glycine 0 N--CA 1.484 1.878 0 CA-C-N 112.308 -2.224 . . . . 1.0 114.687 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -111.91 137.64 49.61 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-N 118.985 1.393 . . . . 1.0 111.607 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 45.1 t -72.13 159.6 33.86 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 112.127 -2.306 . . . . 1.0 113.449 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.563 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.6 tpt180 -135.85 147.44 48.24 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.426 -2.065 . . . . 1.0 105.426 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.9 m -122.3 162.36 21.63 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.059 -1.46 . . . . 1.0 107.059 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 16.2 m-30 -115.8 -179.03 3.53 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.4 -2.074 . . . . 1.0 105.4 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.501 2.113 0 N-CA-C 115.639 1.718 . . . . 1.0 115.639 -179.639 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--O 1.216 -0.681 0 CA-C-O 122.899 1.333 . . . . 1.0 113.313 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.3 p -133.11 160.6 36.75 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 110.902 -2.863 . . . . 1.0 107.776 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -116.06 50.4 1.04 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.063 0.852 . . . . 1.0 109.207 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.9 t -108.17 145.82 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 105.268 -2.123 . . . . 1.0 105.268 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -70.2 135.72 49.34 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.254 0.835 . . . . 1.0 113.254 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.548 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 6.0 p -130.15 160.0 35.12 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 124.887 1.367 . . . . 1.0 113.083 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.8 t -136.62 44.13 2.39 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.912 -1.494 . . . . 1.0 108.429 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.9 167.27 13.06 Favored Glycine 0 N--CA 1.495 2.606 0 CA-C-N 113.589 -1.641 . . . . 1.0 110.454 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.2 t -47.12 -62.78 1.26 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.421 0.897 . . . . 1.0 113.421 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.463 ' C ' ' HZ1' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -39.49 -29.18 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.262 1.949 . . . . 1.0 116.262 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.454 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 3.5 tm0? -70.62 -40.14 73.32 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 122.658 1.218 . . . . 1.0 111.398 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 70.5 m -78.4 -7.55 57.48 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.393 -1.73 . . . . 1.0 113.583 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.404 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 8.1 m95 -70.18 -57.96 5.51 Favored Pre-proline 0 C--N 1.305 -1.34 0 O-C-N 124.147 0.905 . . . . 1.0 109.34 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 98.8 Cg_endo -64.44 -45.27 9.6 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 C-N-CA 122.793 2.329 . . . . 1.0 110.343 174.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.6 t -55.84 -46.05 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 119.371 -0.932 . . . . 1.0 110.775 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 52.8 t -68.51 -43.26 77.2 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.938 -1.105 . . . . 1.0 109.252 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -50.36 -42.36 53.03 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -70.83 -49.23 48.56 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 113.635 -1.621 . . . . 1.0 112.971 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.2 mmm -62.93 -56.5 16.68 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.979 1.103 . . . . 1.0 113.979 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -110.82 -59.78 1.91 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.725 -1.125 . . . . 1.0 112.492 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.51 43.99 0.44 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 106.486 -2.646 . . . . 1.0 106.486 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 94.4 mttt -126.73 78.22 73.31 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 105.265 -2.124 . . . . 1.0 105.265 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -62.18 -3.48 4.04 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 123.487 2.791 . . . . 1.0 114.92 -154.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -107.11 121.25 44.11 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 104.183 -2.525 . . . . 1.0 104.183 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.16 161.7 27.88 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.788 -1.725 . . . . 1.0 108.788 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HE2' ' CE2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -127.74 176.61 7.41 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.204 -1.776 . . . . 1.0 106.204 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -109.68 161.64 15.2 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.399 -0.521 . . . . 1.0 111.027 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 64.1 mtp -136.2 88.2 2.37 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.214 -1.772 . . . . 1.0 106.214 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.1 p30 30.99 48.64 0.07 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 125.121 1.513 . . . . 1.0 113.501 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.78 -35.86 3.16 Favored Glycine 0 N--CA 1.491 2.312 0 CA-C-N 113.302 -1.772 . . . . 1.0 116.504 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.67 147.65 40.6 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-N 120.108 1.954 . . . . 1.0 110.885 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.548 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 33.8 m -72.03 154.58 41.06 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 110.722 -2.944 . . . . 1.0 118.817 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.525 ' HG3' ' HZ3' ' A' ' 27' ' ' LYS . 8.1 tpt180 -137.6 153.67 49.88 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 111.944 -2.389 . . . . 1.0 105.653 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 89.4 m -118.68 157.27 27.77 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 124.178 0.924 . . . . 1.0 110.678 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.53 ' CE2' ' HE2' ' A' ' 27' ' ' LYS . 49.7 m-85 -110.1 -175.86 2.84 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.042 -1.89 . . . . 1.0 108.08 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 t . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 115.852 -2.023 . . . . 1.0 108.944 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.1 t80 . . . . . 0 C--O 1.216 -0.693 0 CA-C-O 122.613 1.197 . . . . 1.0 111.598 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.3 p -147.16 166.01 28.26 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 111.702 -2.499 . . . . 1.0 109.42 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -123.57 52.47 1.42 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.447 HG23 ' SD ' ' A' ' 20' ' ' MET . 62.4 t -108.09 141.17 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-N 114.614 -1.176 . . . . 1.0 108.64 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -70.27 105.45 2.98 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 114.161 -1.382 . . . . 1.0 113.889 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.9 p -119.72 170.87 8.82 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.587 -1.188 . . . . 1.0 111.513 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -128.19 -40.81 1.63 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 112.46 -2.155 . . . . 1.0 109.064 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.1 171.3 23.16 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 124.375 1.047 . . . . 1.0 112.368 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.7 m -70.14 -58.2 4.07 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.193 -1.003 . . . . 1.0 112.355 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -44.12 -33.14 1.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.341 1.237 . . . . 1.0 114.341 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -70.19 -34.81 73.4 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.269 1.033 . . . . 1.0 111.646 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.5 t -77.72 -6.21 53.19 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.413 -1.721 . . . . 1.0 112.014 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -69.03 -59.96 4.76 Favored Pre-proline 0 N--CA 1.484 1.25 0 CA-C-O 118.757 -0.639 . . . . 1.0 109.456 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -64.22 -46.51 7.76 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 C-N-CA 122.325 2.017 . . . . 1.0 110.421 174.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.0 t -54.29 -44.1 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.965 -0.694 . . . . 1.0 110.758 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 47.2 t -69.9 -46.22 65.9 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.381 -1.328 . . . . 1.0 107.768 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -48.92 -39.79 27.54 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 122.116 0.96 . . . . 1.0 108.987 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.15 -50.74 37.46 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.676 -1.602 . . . . 1.0 112.007 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.447 ' SD ' HG23 ' A' ' 5' ' ' VAL . 66.0 mtm -66.38 -57.45 7.41 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 115.57 1.692 . . . . 1.0 115.57 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -103.52 -55.31 2.42 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.787 -1.097 . . . . 1.0 113.76 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.14 41.14 0.31 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 75.1 mmtt -125.83 121.08 24.32 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 105.008 -2.219 . . . . 1.0 105.008 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -82.41 11.83 3.06 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.114 1.876 . . . . 1.0 110.685 -173.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -117.29 -176.86 3.09 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.385 -1.339 . . . . 1.0 107.385 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.04 143.45 3.99 Favored Glycine 0 N--CA 1.486 1.985 0 CA-C-N 113.605 -1.634 . . . . 1.0 111.47 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.417 ' CG ' ' HB3' ' A' ' 34' ' ' ARG . 19.0 ptmt -123.73 172.75 8.61 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 113.569 -1.316 . . . . 1.0 107.774 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.7 t -115.61 159.72 20.93 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.699 -0.8 . . . . 1.0 110.83 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 73.2 mtm -131.01 78.47 1.84 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.41 -1.723 . . . . 1.0 107.42 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 28.48 55.63 0.1 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 125.875 1.985 . . . . 1.0 110.743 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.32 -37.14 2.52 Favored Glycine 0 N--CA 1.485 1.956 0 CA-C-N 112.586 -2.097 . . . . 1.0 115.951 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -110.66 139.65 45.75 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 119.729 1.765 . . . . 1.0 111.793 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.64 157.13 38.51 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.473 -2.148 . . . . 1.0 113.845 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.417 ' HB3' ' CG ' ' A' ' 27' ' ' LYS . 18.7 tpt85 -138.32 145.91 41.76 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 102.753 -3.054 . . . . 1.0 102.753 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -120.19 167.51 12.18 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.251 -1.018 . . . . 1.0 108.251 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -118.69 -179.0 3.67 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.096 -1.411 . . . . 1.0 108.353 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 116.389 -1.767 . . . . 1.0 109.503 -179.776 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 . . . . . 0 C--O 1.215 -0.745 0 CA-C-O 120.903 0.382 . . . . 1.0 111.114 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 p -138.31 171.97 13.59 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 114.743 -1.117 . . . . 1.0 110.137 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -131.64 40.33 3.4 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.4 -1.333 . . . . 1.0 107.4 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.9 p -114.72 155.93 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 115.122 -0.945 . . . . 1.0 110.298 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.612 ' H ' ' HZ1' ' A' ' 6' ' ' LYS . 0.2 OUTLIER -71.32 131.18 43.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 123.587 0.554 . . . . 1.0 110.207 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.449 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 30.8 p -127.6 157.33 40.5 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 120.219 -0.593 . . . . 1.0 110.741 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -137.06 42.0 2.44 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.613 -1.176 . . . . 1.0 109.646 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.75 159.88 11.24 Favored Glycine 0 N--CA 1.496 2.685 0 CA-C-N 114.293 -1.322 . . . . 1.0 111.442 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.7 p -47.35 -56.73 6.3 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.515 1.302 . . . . 1.0 114.515 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -39.69 -41.27 1.05 Allowed 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 114.291 1.219 . . . . 1.0 114.291 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -36.43 74.73 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.163 0.914 . . . . 1.0 111.394 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 73.0 m -73.26 -20.17 60.9 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.07 -0.968 . . . . 1.0 112.779 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.45 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 9.4 m0 -58.95 -62.47 5.73 Favored Pre-proline 0 CA--C 1.562 1.428 0 C-N-CA 120.321 -0.552 . . . . 1.0 110.911 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -66.39 -49.84 1.65 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.883 2.389 . . . . 1.0 110.728 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 71.8 t -50.29 -42.52 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 123.648 0.593 . . . . 1.0 110.081 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 50.3 t -70.16 -47.76 60.25 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.575 -1.269 . . . . 1.0 107.575 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -46.88 -40.54 14.23 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 122.196 0.998 . . . . 1.0 108.542 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -70.4 -50.94 33.38 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 113.335 -1.757 . . . . 1.0 112.107 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 56.0 mtm -70.81 -57.84 4.23 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 115.452 1.649 . . . . 1.0 115.452 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -100.6 -56.02 2.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 123.916 0.76 . . . . 1.0 112.025 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.9 39.48 0.52 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.836 -1.305 . . . . 1.0 109.836 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.546 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 38.5 mmtm -122.5 105.69 35.86 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 104.922 -2.251 . . . . 1.0 104.922 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.94 0.65 5.47 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.258 1.972 . . . . 1.0 111.811 -171.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.45 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 5.9 m120 -119.19 -174.5 2.73 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.63 179.39 18.71 Favored Glycine 0 N--CA 1.488 2.112 0 CA-C-N 113.522 -1.672 . . . . 1.0 111.243 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -138.31 172.51 12.79 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 114.356 -0.922 . . . . 1.0 111.197 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.9 t -107.76 160.14 15.95 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 71.5 mtm -138.96 84.8 2.03 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 108.812 -0.81 . . . . 1.0 108.812 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 25.17 55.89 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 125.975 2.047 . . . . 1.0 110.903 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.74 -42.83 1.36 Allowed Glycine 0 N--CA 1.483 1.81 0 CA-C-N 111.806 -2.452 . . . . 1.0 116.145 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -121.64 149.41 43.23 Favored 'General case' 0 C--O 1.205 -1.279 0 CA-C-O 124.46 2.076 . . . . 1.0 112.584 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 10.9 m -72.33 157.95 36.72 Favored 'General case' 0 C--N 1.285 -2.205 1 CA-C-N 108.347 -4.024 . . . . 1.0 115.199 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -137.73 146.34 43.58 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 111.935 -2.393 . . . . 1.0 105.35 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.2 m -117.58 163.68 16.07 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.898 -1.519 . . . . 1.0 106.898 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -116.69 175.19 5.69 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.7 m . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 C--O 1.216 -0.666 0 CA-C-O 121.538 0.685 . . . . 1.0 109.515 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.0 p -138.86 170.46 15.95 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 113.53 -1.668 . . . . 1.0 111.4 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -124.87 51.12 1.67 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.444 -1.317 . . . . 1.0 107.444 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.28 147.26 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 114.628 -1.169 . . . . 1.0 109.042 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.55 127.08 31.48 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.401 -0.818 . . . . 1.0 111.201 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.22 161.72 27.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 124.007 0.817 . . . . 1.0 111.227 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 t -135.61 42.06 2.69 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.612 -1.177 . . . . 1.0 109.403 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.66 166.52 13.34 Favored Glycine 0 N--CA 1.496 2.678 0 CA-C-N 114.061 -1.427 . . . . 1.0 111.605 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.6 t -53.71 -66.49 0.38 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 114.595 1.331 . . . . 1.0 114.595 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -39.14 -31.96 0.09 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.244 1.572 . . . . 1.0 115.244 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -70.4 -42.3 71.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 124.125 0.891 . . . . 1.0 112.439 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.401 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 4.4 t -89.38 7.79 34.04 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 117.923 -1.511 . . . . 1.0 112.978 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.459 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 2.5 m95 -70.3 -58.33 5.02 Favored Pre-proline 0 N--CA 1.482 1.171 0 N-CA-C 103.441 -2.8 . . . . 1.0 103.441 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 86.8 Cg_endo -65.37 -44.65 8.54 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 123.119 2.546 . . . . 1.0 112.429 172.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.401 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 90.7 t -58.73 -46.86 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 C-N-CA 117.633 -1.627 . . . . 1.0 110.041 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.42 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 53.2 t -64.76 -44.36 90.33 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.048 -1.061 . . . . 1.0 108.139 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -50.86 -40.17 55.55 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.287 1.042 . . . . 1.0 109.025 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -70.52 -45.78 64.88 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.894 -1.503 . . . . 1.0 111.446 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.4 mtp -61.44 -56.04 24.65 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 114.261 1.208 . . . . 1.0 114.261 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -113.39 -56.87 2.36 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.395 -1.275 . . . . 1.0 113.96 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.25 45.59 0.27 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 106.757 -2.537 . . . . 1.0 106.757 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 34.6 mmtp -125.85 89.69 51.89 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 106.053 -1.832 . . . . 1.0 106.053 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -65.57 -4.51 9.77 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.594 2.196 . . . . 1.0 113.246 -162.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -105.34 129.8 53.6 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 105.166 -2.161 . . . . 1.0 105.166 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.95 132.12 3.98 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.497 -1.841 . . . . 1.0 108.497 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -117.05 157.37 25.95 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 106.519 -1.66 . . . . 1.0 106.519 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -102.44 161.47 13.69 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.923 -0.711 . . . . 1.0 112.345 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.9 mtm -133.72 82.87 2.01 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.429 -1.714 . . . . 1.0 107.039 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 28.9 55.08 0.1 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 125.562 1.789 . . . . 1.0 111.197 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.91 -38.56 2.3 Favored Glycine 0 N--CA 1.481 1.648 0 CA-C-N 113.011 -1.904 . . . . 1.0 116.067 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -114.72 140.55 48.78 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 119.792 1.796 . . . . 1.0 112.909 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.483 ' SG ' ' N ' ' A' ' 34' ' ' ARG . 25.5 t -72.11 156.91 38.67 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 110.558 -3.019 . . . . 1.0 115.92 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.483 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 47.8 ttt-85 -136.83 146.12 45.27 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 104.106 -2.553 . . . . 1.0 104.106 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.9 m -119.22 168.58 10.75 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 123.974 0.796 . . . . 1.0 110.223 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -126.75 -165.53 1.47 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 114.421 -1.263 . . . . 1.0 111.596 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.468 -1.253 . . . . 1.0 110.278 -179.762 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 65.0 m-85 . . . . . 0 C--O 1.216 -0.664 0 CA-C-O 121.013 0.435 . . . . 1.0 110.815 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 50.2 p -134.01 169.32 17.3 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 114.491 -1.231 . . . . 1.0 109.8 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -123.59 41.36 3.49 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.369 1.081 . . . . 1.0 109.045 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.96 148.11 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.402 -1.703 . . . . 1.0 106.402 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -70.39 153.63 42.78 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.81 168.19 14.77 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 124.522 1.139 . . . . 1.0 110.553 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.5 t -142.96 32.08 1.39 Allowed 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 105.672 -1.973 . . . . 1.0 105.672 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.77 154.19 9.13 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.643 -2.183 . . . . 1.0 107.643 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.5 m -39.71 -53.08 2.24 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.182 1.178 . . . . 1.0 114.182 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -44.71 -41.26 6.66 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.442 1.645 . . . . 1.0 115.442 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -61.87 -27.69 68.98 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 119.431 -0.908 . . . . 1.0 112.687 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.1 m -77.42 -6.26 52.77 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.006 -0.997 . . . . 1.0 112.127 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.457 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 11.2 m0 -69.37 -62.57 2.51 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 108.724 -0.843 . . . . 1.0 108.724 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.457 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 94.0 Cg_endo -66.62 -42.45 9.29 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.886 2.39 . . . . 1.0 110.969 176.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.23 -45.37 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 123.962 0.789 . . . . 1.0 110.198 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 46.6 t -70.2 -44.76 68.0 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.483 -1.287 . . . . 1.0 107.765 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -47.74 -41.3 22.71 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 122.37 1.081 . . . . 1.0 108.93 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -70.86 -57.7 4.34 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 113.091 -1.868 . . . . 1.0 113.107 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.5 mmm -62.59 -54.92 32.47 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 115.928 1.825 . . . . 1.0 115.928 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -106.85 -55.91 2.26 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 114.532 -1.213 . . . . 1.0 112.998 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.84 41.05 0.27 Allowed Glycine 0 N--CA 1.492 2.426 0 O-C-N 123.467 0.48 . . . . 1.0 113.422 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.476 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 33.7 mmtp -133.58 109.55 12.24 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 107.897 -1.149 . . . . 1.0 107.897 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.27 6.79 2.05 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.989 2.459 . . . . 1.0 112.055 -175.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.1 115.19 20.75 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.588 -1.264 . . . . 1.0 107.588 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -139.41 155.25 23.98 Favored Glycine 0 N--CA 1.493 2.495 0 CA-C-N 114.195 -1.366 . . . . 1.0 114.628 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -116.46 179.7 3.93 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-N 113.882 -1.159 . . . . 1.0 108.965 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.3 t -120.29 164.28 16.54 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' LYS . 84.3 mtp -141.05 82.2 1.82 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.089 -1.819 . . . . 1.0 106.089 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.4 t30 31.79 51.77 0.19 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 125.088 1.493 . . . . 1.0 111.688 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.45 -36.42 3.16 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-O 117.463 -1.743 . . . . 1.0 115.782 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 29' ' ' MET . 35.6 mmtp -111.23 150.51 29.47 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-N 120.468 2.134 . . . . 1.0 110.811 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.5 m -71.79 163.43 27.82 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 118.72 2.859 . . . . 1.0 118.72 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.1 tpt85 -136.2 153.26 51.29 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 110.882 -2.872 . . . . 1.0 104.69 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.7 m -121.86 169.98 10.24 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.835 -1.543 . . . . 1.0 106.835 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -115.67 -172.54 2.17 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.418 -0.81 . . . . 1.0 109.63 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.2 p . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 115.89 -2.005 . . . . 1.0 110.173 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 . . . . . 0 C--O 1.215 -0.716 0 CA-C-O 121.909 0.861 . . . . 1.0 110.973 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.9 p -143.72 163.03 34.44 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 112.806 -1.997 . . . . 1.0 107.751 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -127.06 48.56 2.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 123.681 0.613 . . . . 1.0 111.086 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.29 156.68 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.641 -1.244 . . . . 1.0 107.641 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -70.31 109.99 5.02 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.133 0.79 . . . . 1.0 113.133 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.9 p -114.29 152.52 31.24 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 123.813 0.696 . . . . 1.0 110.401 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -145.72 48.52 1.24 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.57 -1.65 . . . . 1.0 108.2 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.37 125.47 2.52 Favored Glycine 0 N--CA 1.498 2.802 0 CA-C-N 114.123 -1.399 . . . . 1.0 111.472 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.3 m -39.72 -52.57 2.28 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.967 1.84 . . . . 1.0 115.967 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -40.55 -37.46 0.72 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.826 1.417 . . . . 1.0 114.826 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -61.07 -35.35 76.73 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.804 -1.089 . . . . 1.0 113.771 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.0 m -77.26 -10.95 59.74 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.338 -1.301 . . . . 1.0 112.511 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.426 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 11.3 m0 -65.7 -61.83 5.23 Favored Pre-proline 0 C--N 1.307 -1.246 0 C-N-CA 119.636 -0.825 . . . . 1.0 109.171 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 83.1 Cg_endo -67.93 -43.58 4.91 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 123.015 2.477 . . . . 1.0 111.548 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.3 t -58.35 -47.59 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 123.787 0.679 . . . . 1.0 110.733 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.54 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 46.8 t -70.32 -42.83 71.43 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.19 -1.404 . . . . 1.0 107.951 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -48.41 -41.12 28.21 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.399 1.095 . . . . 1.0 108.161 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -70.65 -51.4 28.15 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.455 -1.702 . . . . 1.0 112.107 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 32.2 ttm -58.69 -59.15 5.86 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 114.513 1.301 . . . . 1.0 114.513 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -110.63 -55.8 2.43 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.531 -1.668 . . . . 1.0 114.056 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.39 45.09 0.25 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.124 -1.99 . . . . 1.0 108.124 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.54 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 40.5 mmtm -123.74 94.68 45.71 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 105.276 -2.12 . . . . 1.0 105.276 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -64.99 -1.88 4.86 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.577 2.185 . . . . 1.0 112.489 -168.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -115.9 142.78 46.32 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 105.589 -2.004 . . . . 1.0 105.589 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.43 153.7 24.76 Favored Glycine 0 N--CA 1.489 2.17 0 CA-C-N 113.849 -1.523 . . . . 1.0 110.701 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.413 ' CG ' ' HB3' ' A' ' 34' ' ' ARG . 20.6 ptmt -131.27 176.64 8.11 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 119.253 -0.979 . . . . 1.0 109.243 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.5 t -114.16 162.3 16.7 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.108 0.48 . . . . 1.0 110.433 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.2 mtp -135.23 75.84 1.59 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.595 -1.631 . . . . 1.0 106.595 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 29.67 55.74 0.15 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 125.599 1.812 . . . . 1.0 110.89 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.18 -36.39 2.83 Favored Glycine 0 N--CA 1.483 1.806 0 CA-C-N 112.971 -1.922 . . . . 1.0 115.602 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -111.93 139.61 47.28 Favored 'General case' 0 C--O 1.206 -1.229 0 CA-C-N 119.286 1.543 . . . . 1.0 110.856 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 52.2 t -71.74 161.67 30.62 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 112.878 -1.965 . . . . 1.0 114.704 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.413 ' HB3' ' CG ' ' A' ' 27' ' ' LYS . 18.3 tpt85 -141.26 152.71 44.75 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.973 -1.467 . . . . 1.0 107.221 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.0 m -116.39 169.57 9.21 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 124.545 1.153 . . . . 1.0 109.4 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -120.07 -171.25 2.11 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.321 -1.309 . . . . 1.0 109.01 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.7 m . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 116.275 -1.821 . . . . 1.0 108.99 -179.611 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 C--O 1.216 -0.705 0 CA-C-O 121.198 0.523 . . . . 1.0 109.86 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 82.4 p -133.71 176.02 8.93 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 114.171 -1.377 . . . . 1.0 109.028 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -124.67 30.04 6.07 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 123.98 0.8 . . . . 1.0 109.382 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.48 153.37 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 115.255 -0.884 . . . . 1.0 109.311 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -71.1 155.26 40.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.988 0.805 . . . . 1.0 111.808 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.8 p -134.71 157.29 47.05 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.043 -0.663 . . . . 1.0 110.881 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.8 p -136.56 43.85 2.42 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.469 -1.241 . . . . 1.0 108.815 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.53 167.63 13.45 Favored Glycine 0 N--CA 1.494 2.564 0 CA-C-N 113.926 -1.488 . . . . 1.0 110.191 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.9 m -65.21 -59.39 4.13 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 114.46 1.282 . . . . 1.0 114.46 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -40.49 -39.23 0.97 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 114.692 1.368 . . . . 1.0 114.692 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -33.84 70.49 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 122.077 0.941 . . . . 1.0 112.806 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 60.6 m -78.36 -7.91 57.84 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.218 -1.355 . . . . 1.0 113.578 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.407 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 11.3 m95 -69.57 -60.56 3.8 Favored Pre-proline 0 C--N 1.304 -1.373 0 C-N-CA 119.554 -0.858 . . . . 1.0 108.877 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.407 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 97.6 Cg_endo -66.99 -42.92 7.37 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.891 2.394 . . . . 1.0 111.185 176.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.67 -47.9 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 123.91 0.756 . . . . 1.0 110.572 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.561 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 49.3 t -70.01 -40.61 75.14 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.702 -1.199 . . . . 1.0 108.438 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -51.41 -42.17 61.26 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.422 -0.955 . . . . 1.0 108.422 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 -70.56 -50.01 41.96 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 113.971 -1.468 . . . . 1.0 111.997 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.4 ttm -54.02 -54.59 37.04 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -122.51 -55.69 1.82 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 113.62 -1.627 . . . . 1.0 112.808 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.43 42.6 0.21 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.561 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 6.1 mptp? -120.22 92.3 47.03 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 106.409 -1.7 . . . . 1.0 106.409 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -64.82 -5.01 9.67 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.963 2.442 . . . . 1.0 113.555 -164.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -115.48 143.17 45.7 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 105.95 -1.87 . . . . 1.0 105.95 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.96 154.56 25.61 Favored Glycine 0 N--CA 1.488 2.117 0 CA-C-N 113.382 -1.735 . . . . 1.0 111.281 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.404 ' CG ' ' HB3' ' A' ' 34' ' ' ARG . 20.7 ptmt -128.23 178.81 5.99 Favored 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 119.388 -0.925 . . . . 1.0 109.064 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.0 t -116.45 157.68 24.76 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 73.2 mtm -133.71 82.93 2.01 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.254 -1.758 . . . . 1.0 106.254 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 29.46 50.7 0.07 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 125.307 1.629 . . . . 1.0 112.919 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.96 -34.04 3.53 Favored Glycine 0 N--CA 1.483 1.777 0 CA-C-O 117.152 -1.916 . . . . 1.0 116.539 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -111.43 140.93 45.62 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 120.588 2.194 . . . . 1.0 109.817 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.1 t -71.86 158.11 36.66 Favored 'General case' 0 C--N 1.292 -1.891 0 CA-C-N 112.187 -2.279 . . . . 1.0 115.468 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.404 ' HB3' ' CG ' ' A' ' 27' ' ' LYS . 5.1 tpt180 -139.25 155.5 47.72 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.31 -1.768 . . . . 1.0 107.748 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.2 m -118.75 168.25 10.92 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 124.929 1.393 . . . . 1.0 108.338 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -118.62 -179.48 3.81 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.392 -0.822 . . . . 1.0 110.822 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.5 m . . . . . 0 N--CA 1.504 2.237 0 O-C-N 125.701 1.876 . . . . 1.0 115.684 -179.917 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 . . . . . 0 C--O 1.216 -0.671 0 CA-C-O 121.822 0.82 . . . . 1.0 110.096 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 p -141.13 165.07 28.55 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.211 -1.813 . . . . 1.0 109.825 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -125.85 55.72 1.44 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.831 -1.077 . . . . 1.0 108.776 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.68 148.32 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-N 114.672 -1.149 . . . . 1.0 108.437 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -70.1 102.57 2.09 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.853 -1.067 . . . . 1.0 110.557 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.7 p -116.24 158.61 23.07 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 124.407 1.067 . . . . 1.0 111.842 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 t -137.72 45.78 2.14 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.931 -1.486 . . . . 1.0 107.147 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.07 157.43 9.68 Favored Glycine 0 N--CA 1.494 2.522 0 CA-C-N 113.243 -1.799 . . . . 1.0 110.084 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.2 m -40.31 -49.68 2.76 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 116.148 1.906 . . . . 1.0 116.148 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -39.69 -31.2 0.09 Allowed 'General case' 0 C--O 1.205 -1.25 0 C-N-CA 125.577 1.551 . . . . 1.0 114.905 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -70.15 -40.39 74.79 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.789 0.804 . . . . 1.0 113.047 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 96.1 m -70.72 -26.21 63.29 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.023 -1.444 . . . . 1.0 113.058 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -57.19 -65.79 1.57 Allowed Pre-proline 0 C--N 1.3 -1.57 0 C-N-CA 118.999 -1.08 . . . . 1.0 110.775 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -64.37 -45.84 8.7 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 122.835 2.357 . . . . 1.0 111.591 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 88.8 t -62.33 -49.01 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 124.082 0.864 . . . . 1.0 112.455 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 24.8 t -70.28 -31.94 69.51 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.973 -1.091 . . . . 1.0 108.414 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -61.52 -49.24 77.5 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.617 -0.883 . . . . 1.0 108.617 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -70.79 -38.82 73.39 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.164 -1.014 . . . . 1.0 113.236 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.0 mtp -69.64 -56.35 7.5 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 115.267 1.58 . . . . 1.0 115.267 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -106.52 -58.19 1.96 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.793 0.683 . . . . 1.0 112.091 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.55 37.62 0.58 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.821 -1.712 . . . . 1.0 108.821 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 5.0 mptp? -122.85 79.37 49.69 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 105.483 -2.043 . . . . 1.0 105.483 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -66.43 10.96 0.18 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 123.042 2.494 . . . . 1.0 113.751 -170.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.404 ' H ' ' C ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -128.51 109.72 11.64 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.826 -1.175 . . . . 1.0 107.826 179.626 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.05 174.41 23.22 Favored Glycine 0 N--CA 1.492 2.384 0 CA-C-N 112.546 -2.115 . . . . 1.0 111.291 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.432 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 18.6 ptmt -132.95 171.71 13.59 Favored 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 108.891 -0.781 . . . . 1.0 108.891 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.2 t -109.27 160.23 16.3 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 120.181 -0.608 . . . . 1.0 110.019 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 56.9 mtp -132.61 76.93 1.72 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.098 -1.815 . . . . 1.0 106.098 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 30.87 55.36 0.2 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 125.606 1.816 . . . . 1.0 110.954 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.96 -35.43 3.39 Favored Glycine 0 N--CA 1.483 1.804 0 CA-C-N 113.353 -1.749 . . . . 1.0 115.815 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -112.01 137.55 49.88 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 119.315 1.557 . . . . 1.0 110.698 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 34' ' ' ARG . 39.1 t -72.18 158.31 36.13 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 117.696 2.48 . . . . 1.0 117.696 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.516 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 10.3 tpt180 -138.95 149.26 44.55 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 106.409 -1.7 . . . . 1.0 106.409 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.3 m -123.93 163.55 21.1 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 104.906 -2.257 . . . . 1.0 104.906 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -112.88 170.08 8.46 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.656 -1.609 . . . . 1.0 106.656 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.507 2.377 0 N-CA-C 116.225 1.935 . . . . 1.0 116.225 -179.902 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 . . . . . 0 C--O 1.216 -0.661 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.4 p -135.1 169.66 17.09 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 123.891 0.745 . . . . 1.0 110.894 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.59 24.0 11.16 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.085 -1.416 . . . . 1.0 107.659 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.31 145.73 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.494 ' HZ1' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -71.04 163.24 27.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.277 0.985 . . . . 1.0 112.516 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.494 ' N ' ' HZ1' ' A' ' 6' ' ' LYS . 8.4 p -142.61 159.55 42.01 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 124.148 0.905 . . . . 1.0 111.353 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 p -131.89 41.02 3.31 Favored 'General case' 0 C--N 1.31 -1.116 0 O-C-N 124.465 1.103 . . . . 1.0 108.188 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.45 171.22 17.73 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.115 -1.594 . . . . 1.0 109.115 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.5 p -48.8 -60.35 2.82 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.816 0.672 . . . . 1.0 112.816 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -40.06 -39.43 0.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -70.45 -36.2 73.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.287 0.992 . . . . 1.0 112.104 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.462 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 49.0 t -76.01 -13.94 60.23 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.643 -1.617 . . . . 1.0 112.326 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.424 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 7.5 m0 -69.14 -56.2 9.09 Favored Pre-proline 0 N--CA 1.485 1.289 0 CA-C-O 118.193 -0.908 . . . . 1.0 110.695 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 90.3 Cg_endo -65.34 -42.17 13.93 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.906 2.404 . . . . 1.0 110.643 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.48 -48.45 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 123.925 0.766 . . . . 1.0 110.823 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.4 t -68.57 -44.61 74.05 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.146 -1.022 . . . . 1.0 108.915 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -52.43 -39.41 60.99 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.951 0.881 . . . . 1.0 109.081 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -70.46 -52.88 18.96 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 114.21 -1.359 . . . . 1.0 111.141 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 34.4 ttm -56.07 -56.96 14.51 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.537 0.94 . . . . 1.0 113.537 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -113.07 -61.16 1.78 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 113.098 -1.864 . . . . 1.0 113.915 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.07 41.25 0.45 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 107.885 -2.086 . . . . 1.0 107.885 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -123.42 81.83 53.17 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 105.904 -1.887 . . . . 1.0 105.904 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -65.13 1.35 2.0 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 123.092 2.528 . . . . 1.0 114.94 -157.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -100.22 121.81 42.04 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 100.698 -3.816 . . . . 1.0 100.698 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.15 143.88 12.42 Favored Glycine 0 C--N 1.294 -1.761 0 CA-C-N 113.786 -1.552 . . . . 1.0 110.726 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -125.77 160.3 30.13 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 106.517 -1.66 . . . . 1.0 106.517 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.9 t -101.05 157.49 16.72 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.969 -0.693 . . . . 1.0 112.629 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.4 mtm -132.3 89.88 2.72 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.527 -1.657 . . . . 1.0 106.527 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 30.34 48.31 0.05 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 125.097 1.498 . . . . 1.0 113.414 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.84 -31.54 4.93 Favored Glycine 0 N--CA 1.487 2.036 0 CA-C-O 117.112 -1.938 . . . . 1.0 117.912 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.451 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -113.01 142.68 45.43 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 120.719 2.259 . . . . 1.0 110.028 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 13.3 t -71.6 157.61 37.67 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.362 -1.745 . . . . 1.0 114.057 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.462 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 27.7 ttt85 -133.37 140.32 47.3 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 112.519 -2.128 . . . . 1.0 106.362 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.412 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 65.2 m -109.85 166.52 10.86 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 123.969 0.793 . . . . 1.0 112.23 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 35' ' ' CYS . 47.4 m-85 -127.56 -165.0 1.42 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.42 -1.718 . . . . 1.0 110.774 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.4 t . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.512 -1.233 . . . . 1.0 110.004 -179.723 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.7 p90 . . . . . 0 C--O 1.218 -0.593 0 N-CA-C 109.473 -0.565 . . . . 1.0 109.473 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -124.3 173.39 8.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 124.034 0.833 . . . . 1.0 111.739 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.2 23.34 11.91 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.267 -1.788 . . . . 1.0 107.161 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -124.02 151.87 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 115.323 -0.853 . . . . 1.0 109.074 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -71.11 159.71 34.21 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.536 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.528 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 28.8 p -136.82 150.42 48.31 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.769 -0.772 . . . . 1.0 111.392 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.5 p -137.04 45.09 2.27 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.152 -1.385 . . . . 1.0 107.755 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.58 159.84 11.27 Favored Glycine 0 N--CA 1.494 2.548 0 CA-C-N 113.466 -1.697 . . . . 1.0 110.112 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.8 m -50.71 -54.47 22.95 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 113.896 1.073 . . . . 1.0 113.896 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -40.33 -36.91 0.59 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.204 1.557 . . . . 1.0 115.204 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -70.41 -34.82 72.96 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.233 -0.894 . . . . 1.0 112.432 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.5 m -73.6 -18.1 61.09 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.332 -1.304 . . . . 1.0 112.464 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.439 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 9.7 m0 -63.08 -60.88 8.51 Favored Pre-proline 0 N--CA 1.483 1.2 0 CA-C-O 118.364 -0.827 . . . . 1.0 110.887 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -65.74 -45.71 6.12 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 123.024 2.482 . . . . 1.0 111.344 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.26 -45.47 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 123.948 0.78 . . . . 1.0 111.097 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 52.7 t -70.0 -48.52 57.79 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.596 -1.261 . . . . 1.0 107.596 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -47.63 -38.87 15.63 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 122.136 0.97 . . . . 1.0 108.89 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -70.67 -58.49 3.61 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.36 -1.745 . . . . 1.0 112.433 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 70.7 mtm -68.7 -53.83 19.83 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 116.808 2.151 . . . . 1.0 116.808 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -99.01 -57.52 2.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 124.057 0.848 . . . . 1.0 112.715 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.59 34.45 0.86 Allowed Glycine 0 N--CA 1.495 2.606 0 O-C-N 123.837 0.711 . . . . 1.0 111.743 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.468 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 12.9 mptt -122.97 107.07 33.48 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 104.905 -2.257 . . . . 1.0 104.905 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.21 -4.53 13.84 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.913 2.409 . . . . 1.0 112.527 -163.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.439 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 29.3 m-80 -107.17 -171.91 1.97 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.143 -1.429 . . . . 1.0 107.143 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.35 163.94 10.44 Favored Glycine 0 N--CA 1.483 1.8 0 CA-C-N 112.302 -2.226 . . . . 1.0 110.376 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.533 ' HE2' ' CE2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -132.59 177.14 7.85 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 113.896 -1.152 . . . . 1.0 108.57 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.5 t -105.6 155.61 19.05 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.737 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 70.6 mtm -131.04 82.3 2.04 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 107.204 -1.406 . . . . 1.0 107.204 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 m120 29.49 51.38 0.08 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 125.463 1.727 . . . . 1.0 112.442 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.29 -33.84 3.53 Favored Glycine 0 N--CA 1.486 2.016 0 CA-C-N 113.082 -1.872 . . . . 1.0 116.864 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 6.2 mptt -117.43 141.34 48.46 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 120.228 2.014 . . . . 1.0 110.272 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 3.0 m -72.32 156.13 39.43 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 113.805 -1.543 . . . . 1.0 114.616 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.523 ' HG3' ' HZ3' ' A' ' 27' ' ' LYS . 9.1 tpt180 -135.1 152.71 51.91 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.76 -1.941 . . . . 1.0 105.76 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.5 m -117.23 156.89 26.96 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 124.672 1.232 . . . . 1.0 110.794 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.533 ' CE2' ' HE2' ' A' ' 27' ' ' LYS . 58.1 m-85 -111.62 -179.12 3.62 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.35 -1.722 . . . . 1.0 106.35 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.2 m . . . . . 0 N--CA 1.505 2.325 0 N-CA-C 115.487 1.662 . . . . 1.0 115.487 179.837 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 . . . . . 0 C--O 1.217 -0.645 0 N-CA-C 109.818 -0.438 . . . . 1.0 109.818 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.7 p -137.05 173.37 11.77 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 115.033 -0.985 . . . . 1.0 110.395 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -131.86 34.34 3.87 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 114.72 -1.127 . . . . 1.0 108.155 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.6 p -111.08 150.86 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-N 115.053 -0.976 . . . . 1.0 110.518 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -71.13 127.46 32.64 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.096 1.147 . . . . 1.0 114.096 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.429 ' SG ' ' C ' ' A' ' 32' ' ' LYS . 30.3 p -134.9 159.37 41.63 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.837 -0.62 . . . . 1.0 109.917 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -148.02 48.64 1.06 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.621 -1.251 . . . . 1.0 107.621 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.26 153.09 7.04 Favored Glycine 0 N--CA 1.498 2.83 0 CA-C-N 113.489 -1.687 . . . . 1.0 112.145 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.473 ' HG ' ' H ' ' A' ' 11' ' ' LYS . 65.4 p -53.62 -57.71 9.8 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 116.038 1.866 . . . . 1.0 116.038 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.473 ' H ' ' HG ' ' A' ' 10' ' ' SER . 19.6 ttpp -39.76 -41.8 1.16 Allowed 'General case' 0 C--O 1.204 -1.298 0 C-N-CA 124.63 1.172 . . . . 1.0 113.78 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -70.69 -38.37 73.69 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.598 -1.183 . . . . 1.0 111.7 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 13.3 t -72.19 -18.1 61.88 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 113.546 -1.661 . . . . 1.0 111.369 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -64.03 -61.29 7.06 Favored Pre-proline 0 N--CA 1.486 1.341 0 CA-C-O 118.449 -0.786 . . . . 1.0 111.331 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -64.83 -42.96 13.46 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 123.054 2.503 . . . . 1.0 110.499 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 66.6 t -56.85 -45.91 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 123.928 0.767 . . . . 1.0 110.057 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 38.2 t -67.76 -45.0 76.16 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -49.31 -42.73 42.23 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.433 1.111 . . . . 1.0 108.82 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -70.48 -49.25 50.42 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 113.168 -1.833 . . . . 1.0 112.208 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.0 ttp -57.01 -57.89 10.56 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 124.265 0.978 . . . . 1.0 113.007 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -116.82 -58.61 2.05 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 113.334 -1.757 . . . . 1.0 114.073 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.04 45.71 0.21 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.033 -1.627 . . . . 1.0 109.033 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.567 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 75.0 mmtt -127.01 72.22 76.13 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 105.852 -1.907 . . . . 1.0 105.852 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -60.89 -3.47 2.86 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.738 2.959 . . . . 1.0 114.359 -163.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.4 108.09 16.42 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.616 -1.624 . . . . 1.0 106.616 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.89 172.76 23.93 Favored Glycine 0 N--CA 1.486 2.011 0 CA-C-N 111.756 -2.475 . . . . 1.0 113.454 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -131.45 169.33 16.2 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 107.979 -1.119 . . . . 1.0 107.979 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.5 t -105.69 159.7 15.78 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 120.084 -0.647 . . . . 1.0 109.505 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.1 mtm -133.68 80.66 1.88 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.712 -1.131 . . . . 1.0 107.962 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 24.96 55.84 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 126.079 2.112 . . . . 1.0 110.632 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.5 -40.87 1.58 Allowed Glycine 0 N--CA 1.483 1.827 0 CA-C-N 111.858 -2.428 . . . . 1.0 116.205 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.429 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 48.1 mtmt -118.2 144.21 45.92 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 119.598 1.699 . . . . 1.0 113.584 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.1 t -71.86 157.97 36.9 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 112.487 -2.142 . . . . 1.0 112.813 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.432 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 12.9 tpt180 -136.78 144.74 43.9 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 112.699 -2.046 . . . . 1.0 105.862 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.9 m -118.5 163.79 16.24 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 105.557 -2.016 . . . . 1.0 105.557 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -113.55 169.22 9.13 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.601 -0.888 . . . . 1.0 108.601 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.506 2.371 0 CA-C-O 116.154 -1.879 . . . . 1.0 115.788 179.992 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 . . . . . 0 C--O 1.216 -0.688 0 CA-C-O 121.837 0.827 . . . . 1.0 109.677 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.426 ' HG1' ' CB ' ' A' ' 33' ' ' CYS . 31.4 p -148.12 171.3 16.1 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 112.946 -1.934 . . . . 1.0 109.808 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -127.79 51.39 1.95 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.825 -1.08 . . . . 1.0 108.586 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.2 t -111.96 126.38 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.856 0.836 . . . . 1.0 110.355 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -39.36 110.86 0.15 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 117.438 2.384 . . . . 1.0 117.438 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.3 p -125.97 172.36 9.99 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.025 0.917 . . . . 1.0 110.409 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.0 m -123.86 -47.04 1.95 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 112.431 -2.168 . . . . 1.0 106.482 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.82 168.69 31.78 Favored Glycine 0 N--CA 1.492 2.433 0 CA-C-N 114.218 -1.355 . . . . 1.0 110.081 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -48.13 -63.72 0.99 Allowed 'General case' 0 N--CA 1.482 1.128 0 O-C-N 124.097 0.528 . . . . 1.0 111.816 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -41.09 -37.4 0.86 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.902 1.376 . . . . 1.0 114.615 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -70.59 -34.42 72.15 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 122.975 1.369 . . . . 1.0 110.51 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 14.5 t -80.83 0.96 32.65 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.35 -1.75 . . . . 1.0 111.352 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.426 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 5.5 m95 -70.05 -60.59 3.43 Favored Pre-proline 0 N--CA 1.482 1.147 0 N-CA-C 106.069 -1.826 . . . . 1.0 106.069 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 14' ' ' TRP . 73.9 Cg_endo -61.22 -43.98 26.12 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 122.422 2.081 . . . . 1.0 110.551 174.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.3 t -58.2 -45.3 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 C-N-CA 118.136 -1.425 . . . . 1.0 110.677 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 40.6 t -70.29 -31.03 68.21 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.308 -0.957 . . . . 1.0 109.047 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -59.47 -50.4 74.05 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -71.14 -48.22 53.25 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 119.348 -0.941 . . . . 1.0 113.373 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -50.28 73.98 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 114.1 1.148 . . . . 1.0 114.1 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -113.16 -61.57 1.72 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.7 1.37 . . . . 1.0 114.7 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.26 41.46 0.4 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.386 -1.885 . . . . 1.0 108.386 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.405 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 63.0 mmtt -130.38 81.52 67.92 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 104.645 -2.354 . . . . 1.0 104.645 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -62.1 -0.69 1.83 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.787 2.325 . . . . 1.0 114.222 -161.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.426 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 3.8 m120 -111.97 116.4 30.53 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 101.682 -3.451 . . . . 1.0 101.682 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.88 164.98 16.87 Favored Glycine 0 N--CA 1.486 1.979 0 CA-C-N 113.32 -1.763 . . . . 1.0 111.176 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.579 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . 73.6 tttt -128.33 170.78 12.67 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.826 -1.916 . . . . 1.0 105.826 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.5 t -123.06 159.7 27.91 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.219 0.533 . . . . 1.0 109.95 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.9 mtp -133.62 71.59 1.46 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.441 -1.689 . . . . 1.0 106.441 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 30.82 53.36 0.16 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 125.311 1.632 . . . . 1.0 111.981 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.72 -31.87 4.02 Favored Glycine 0 N--CA 1.48 1.575 0 CA-C-N 113.317 -1.765 . . . . 1.0 115.158 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.454 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 8.3 mptt -111.12 144.16 40.7 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-N 119.299 1.55 . . . . 1.0 108.755 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.426 ' CB ' ' HG1' ' A' ' 3' ' ' THR . 0.5 OUTLIER -71.82 160.63 32.25 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 114.919 1.451 . . . . 1.0 114.919 -179.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.3 tpt85 -142.72 159.23 42.64 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 104.022 -2.585 . . . . 1.0 104.022 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.9 m -128.03 169.81 13.61 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.204 0.526 . . . . 1.0 110.036 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.579 ' CZ ' ' HB2' ' A' ' 27' ' ' LYS . 11.7 m-85 -122.72 -174.3 2.89 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 109.533 -0.543 . . . . 1.0 109.533 -179.762 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.9 p90 . . . . . 0 C--O 1.216 -0.661 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.8 p -133.44 169.07 17.49 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 123.826 0.704 . . . . 1.0 110.552 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -114.86 23.79 12.3 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.361 -1.29 . . . . 1.0 107.729 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -124.29 143.18 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.347 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -71.13 161.71 30.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.192 0.932 . . . . 1.0 112.131 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.485 ' SG ' ' C ' ' A' ' 32' ' ' LYS . 11.0 p -142.12 158.76 43.37 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.955 0.784 . . . . 1.0 111.617 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.479 ' HG1' HE21 ' A' ' 12' ' ' GLN . 74.6 p -136.58 43.98 2.41 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.492 -1.231 . . . . 1.0 108.138 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.63 161.08 11.92 Favored Glycine 0 N--CA 1.494 2.56 0 CA-C-N 113.902 -1.499 . . . . 1.0 110.889 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.8 t -45.59 -58.86 3.09 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.164 -1.018 . . . . 1.0 113.594 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -40.83 -41.52 1.6 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 115.122 1.527 . . . . 1.0 115.122 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.479 HE21 ' HG1' ' A' ' 8' ' ' THR . 0.7 OUTLIER -70.75 -33.1 70.45 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.306 1.004 . . . . 1.0 111.995 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 41.4 t -76.55 -12.73 60.07 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 113.633 -1.621 . . . . 1.0 112.059 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.42 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 8.3 m0 -69.8 -59.38 4.6 Favored Pre-proline 0 N--CA 1.483 1.215 0 CA-C-O 118.497 -0.763 . . . . 1.0 109.645 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 72.4 Cg_endo -62.51 -43.84 20.46 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 122.826 2.351 . . . . 1.0 109.732 177.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.9 t -59.34 -46.72 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 123.946 0.779 . . . . 1.0 110.633 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 41.6 t -70.26 -31.58 69.02 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.625 -1.23 . . . . 1.0 109.724 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -63.42 -48.1 79.17 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -70.74 -44.26 67.16 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.525 -0.87 . . . . 1.0 111.843 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.4 mmm -63.93 -52.76 58.27 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 113.935 1.087 . . . . 1.0 113.935 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -110.12 -62.19 1.55 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 124.179 0.924 . . . . 1.0 112.656 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.99 42.24 0.45 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.615 -2.194 . . . . 1.0 107.615 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.41 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 48.9 mmtm -130.86 82.64 63.7 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 106.821 -1.548 . . . . 1.0 106.821 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -62.55 0.24 1.55 Allowed 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.873 2.382 . . . . 1.0 114.609 -163.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -103.08 117.06 33.73 Favored 'General case' 0 C--N 1.308 -1.224 1 N-CA-C 99.485 -4.265 . . . . 1.0 99.485 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.11 144.1 13.36 Favored Glycine 0 C--N 1.292 -1.916 0 CA-C-N 113.604 -1.635 . . . . 1.0 110.534 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -126.08 165.32 19.07 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 107.08 -1.452 . . . . 1.0 107.08 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.2 t -104.59 148.97 25.92 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 113.206 0.817 . . . . 1.0 113.206 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.3 ptp -128.97 98.53 4.97 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.354 -1.294 . . . . 1.0 108.743 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.0 t30 32.4 47.06 0.08 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 113.02 -1.9 . . . . 1.0 113.124 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.49 -26.59 8.04 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 118.686 2.234 . . . . 1.0 118.686 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.485 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 93.2 mttt -114.26 149.95 35.11 Favored 'General case' 0 C--O 1.204 -1.291 0 CA-C-N 121.167 2.483 . . . . 1.0 109.96 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.1 t -72.28 159.03 34.75 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.814 -1.085 . . . . 1.0 111.946 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.448 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 26.4 ttt85 -133.05 141.22 48.11 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 112.956 -1.929 . . . . 1.0 106.057 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -111.99 166.19 11.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 124.172 0.92 . . . . 1.0 111.743 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -126.36 -166.25 1.55 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.175 -1.829 . . . . 1.0 110.472 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.246 -1.359 . . . . 1.0 111.232 -179.772 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.5 p90 . . . . . 0 C--O 1.217 -0.639 0 CA-C-O 120.921 0.391 . . . . 1.0 111.377 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.7 p -132.3 179.13 6.3 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.612 -1.176 . . . . 1.0 110.962 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.22 26.3 9.72 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.405 -1.27 . . . . 1.0 109.398 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.8 t -123.98 141.9 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 31.0 mmmt -71.36 148.51 46.94 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.866 1.432 . . . . 1.0 114.866 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.7 p -140.42 173.08 11.86 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.35 1.071 . . . . 1.0 112.041 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.5 ' H ' HE22 ' A' ' 12' ' ' GLN . 10.1 t -136.38 -38.35 0.68 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 111.997 -2.365 . . . . 1.0 108.986 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.74 163.48 23.76 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 123.747 0.654 . . . . 1.0 112.78 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.52 ' HG ' ' H ' ' A' ' 11' ' ' LYS . 54.5 p -70.29 -54.51 12.37 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.341 0.867 . . . . 1.0 113.341 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.52 ' H ' ' HG ' ' A' ' 10' ' ' SER . 98.8 mttt -58.44 -20.15 42.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 124.322 1.014 . . . . 1.0 111.459 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.5 HE22 ' H ' ' A' ' 8' ' ' THR . 4.9 tt0 -70.07 -31.0 68.38 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.219 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 3.9 t -80.11 -1.57 40.7 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.465 -1.243 . . . . 1.0 113.207 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.421 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 10.5 m0 -70.27 -60.4 3.42 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.406 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 87.7 Cg_endo -64.95 -44.35 10.12 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.794 2.329 . . . . 1.0 111.747 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.8 t -58.26 -45.21 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 119.736 -0.786 . . . . 1.0 110.892 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.4 t -69.98 -44.3 69.71 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -48.24 -42.06 29.31 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 122.355 1.074 . . . . 1.0 108.365 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -70.73 -47.64 58.71 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 113.114 -1.857 . . . . 1.0 112.792 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 94.9 mtp -69.19 -58.24 4.31 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 116.312 1.968 . . . . 1.0 116.312 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -102.66 -55.23 2.48 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.905 -1.043 . . . . 1.0 112.641 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.47 37.3 0.38 Allowed Glycine 0 N--CA 1.489 2.218 0 O-C-N 124.08 0.863 . . . . 1.0 111.331 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.54 115.07 22.98 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 106.548 -1.649 . . . . 1.0 106.548 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -74.46 15.36 0.67 Allowed 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.734 2.289 . . . . 1.0 112.66 -174.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.504 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 5.5 m120 -123.65 -177.13 3.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.76 0.791 . . . . 1.0 109.065 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.86 169.73 12.16 Favored Glycine 0 N--CA 1.49 2.293 0 CA-C-N 114.029 -1.441 . . . . 1.0 114.072 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 49.0 mtpt -132.21 -167.82 1.95 Allowed 'General case' 0 N--CA 1.504 2.25 0 CA-C-N 113.005 -1.597 . . . . 1.0 111.296 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.5 t -126.37 154.45 43.53 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.035 -1.839 . . . . 1.0 106.035 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.6 mtm -132.37 78.42 1.8 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.637 -1.246 . . . . 1.0 107.637 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.0 t30 28.76 52.64 0.07 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 125.835 1.959 . . . . 1.0 111.143 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 127.11 -35.49 2.83 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-O 117.019 -1.99 . . . . 1.0 116.273 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -109.23 146.01 34.93 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-N 120.853 2.326 . . . . 1.0 109.607 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -70.97 159.97 33.75 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.896 -1.047 . . . . 1.0 111.499 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.481 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 4.6 tpt180 -134.51 146.77 50.03 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 106.237 -1.764 . . . . 1.0 106.237 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.7 m -120.38 163.04 18.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.48 -1.674 . . . . 1.0 106.48 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.504 ' CD2' ' HB3' ' A' ' 25' ' ' ASN . 11.1 m-30 -114.38 178.11 4.4 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.393 -1.706 . . . . 1.0 106.393 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.506 2.35 0 O-C-N 125.117 1.511 . . . . 1.0 114.451 -179.73 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.0 p90 . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 112.965 0.728 . . . . 1.0 112.965 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.439 HG23 ' SG ' ' A' ' 33' ' ' CYS . 68.4 p -131.12 -179.95 5.64 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.078 -0.964 . . . . 1.0 112.316 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.37 -4.41 11.83 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.117 -1.856 . . . . 1.0 109.168 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.07 141.82 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 107.104 -1.443 . . . . 1.0 107.104 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -71.17 167.39 19.46 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.341 1.978 . . . . 1.0 116.341 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.2 p -139.15 177.52 7.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 124.819 1.324 . . . . 1.0 110.613 179.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.8 m -123.18 -50.11 1.92 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 104.889 -2.263 . . . . 1.0 104.889 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.05 167.85 31.79 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.581 -1.807 . . . . 1.0 108.581 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 65.4 m -46.49 -56.34 6.11 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.403 0.621 . . . . 1.0 110.19 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -48.7 -39.81 26.0 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.329 -1.305 . . . . 1.0 112.848 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -70.69 -35.21 72.67 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.846 1.308 . . . . 1.0 109.751 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 4.0 t -74.46 -12.33 60.47 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 113.653 -1.612 . . . . 1.0 113.015 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.484 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 5.0 m0 -65.9 -58.73 10.46 Favored Pre-proline 0 C--N 1.306 -1.285 0 CA-C-O 118.752 -0.642 . . . . 1.0 109.603 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -61.3 -42.86 31.89 Favored 'Trans proline' 0 N--CA 1.488 1.158 0 C-N-CA 122.567 2.178 . . . . 1.0 110.44 173.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.9 t -55.04 -44.08 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 119.335 -0.946 . . . . 1.0 110.906 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.428 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 41.2 t -70.31 -41.53 73.19 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -50.16 -43.98 52.43 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.306 -0.998 . . . . 1.0 108.306 179.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -70.85 -53.02 16.75 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 113.354 -1.748 . . . . 1.0 113.238 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.419 ' SD ' ' HB ' ' A' ' 3' ' ' THR . 20.3 ttp -55.67 -55.77 28.3 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 115.309 1.596 . . . . 1.0 115.309 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -116.13 -56.86 2.27 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 113.474 -1.693 . . . . 1.0 113.033 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.73 39.88 0.28 Allowed Glycine 0 N--CA 1.491 2.322 0 O-C-N 123.812 0.695 . . . . 1.0 111.623 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 5.5 mppt? -129.29 91.37 41.97 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 105.551 -2.018 . . . . 1.0 105.551 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -64.63 3.58 0.84 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 123.045 2.497 . . . . 1.0 113.981 -165.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.484 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 55.4 m-80 -111.62 -178.05 3.34 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.499 -1.667 . . . . 1.0 106.499 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.61 -176.03 23.98 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.269 -1.443 . . . . 1.0 114.745 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.543 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 28.5 mtpp -131.64 177.1 7.77 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 113.138 -1.531 . . . . 1.0 111.927 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.0 t -119.26 152.28 36.95 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 179.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.8 mtm -131.76 80.11 1.91 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.079 -0.964 . . . . 1.0 108.627 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.2 t30 28.73 52.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 125.586 1.804 . . . . 1.0 111.919 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.59 -31.4 4.18 Favored Glycine 0 N--CA 1.485 1.965 0 CA-C-O 116.405 -2.33 . . . . 1.0 116.912 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -115.88 141.17 48.46 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 120.795 2.297 . . . . 1.0 109.32 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.439 ' SG ' HG23 ' A' ' 3' ' ' THR . 33.1 t -71.87 160.64 32.22 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.652 -1.613 . . . . 1.0 113.517 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.557 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.2 tpt180 -133.61 146.75 51.23 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.431 -2.063 . . . . 1.0 105.431 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.3 m -117.61 164.82 14.37 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.248 -1.019 . . . . 1.0 108.248 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.529 ' CZ ' ' HG3' ' A' ' 27' ' ' LYS . 13.8 m-85 -117.63 -178.01 3.38 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.295 -1.32 . . . . 1.0 107.572 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.496 1.86 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 -179.962 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.4 p90 . . . . . 0 C--O 1.216 -0.692 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.441 HG23 ' SG ' ' A' ' 33' ' ' CYS . 79.7 p -127.89 -173.46 2.94 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.052 0.845 . . . . 1.0 112.297 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -124.17 -7.45 7.68 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 113.403 -1.726 . . . . 1.0 110.273 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.4 t -111.54 145.34 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.498 -0.927 . . . . 1.0 108.498 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 171.02 11.68 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 116.923 2.194 . . . . 1.0 116.923 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 p -141.2 173.11 11.8 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.175 -1.375 . . . . 1.0 110.478 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.2 m -121.49 -49.49 2.14 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.854 -2.276 . . . . 1.0 104.854 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.19 169.59 33.22 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.542 -1.823 . . . . 1.0 108.542 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.6 t -43.54 -58.78 2.46 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.51 0.671 . . . . 1.0 110.521 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.26 -39.4 14.28 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 113.859 -1.519 . . . . 1.0 114.219 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -70.23 -32.66 70.62 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.066 0.936 . . . . 1.0 111.175 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 15.3 t -76.44 -12.32 60.03 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.949 -1.478 . . . . 1.0 113.111 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.407 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 6.9 m0 -66.78 -58.99 8.59 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 123.822 0.701 . . . . 1.0 109.462 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 85.3 Cg_endo -63.31 -42.88 20.32 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.883 2.389 . . . . 1.0 110.681 175.316 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.9 t -55.78 -46.45 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 C-N-CA 120.104 -0.638 . . . . 1.0 110.398 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.8 t -68.97 -42.55 76.46 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -50.48 -42.69 54.86 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.252 1.025 . . . . 1.0 108.534 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -70.65 -51.37 28.3 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.691 -1.595 . . . . 1.0 112.741 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.4 ttp -58.31 -52.41 65.7 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.026 1.121 . . . . 1.0 114.026 -179.258 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -116.86 -58.03 2.11 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.484 -1.235 . . . . 1.0 114.083 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.93 40.67 0.19 Allowed Glycine 0 N--CA 1.488 2.125 0 O-C-N 123.774 0.671 . . . . 1.0 112.501 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -127.79 103.31 21.67 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 105.694 -1.965 . . . . 1.0 105.694 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.71 10.08 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.993 2.462 . . . . 1.0 113.002 -168.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.404 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 73.5 m-80 -116.03 -176.3 2.92 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.954 -1.498 . . . . 1.0 106.954 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.406 ' HA2' ' CD1' ' A' ' 36' ' ' TYR . . . 143.44 175.98 17.05 Favored Glycine 0 N--CA 1.489 2.175 0 CA-C-N 113.994 -1.457 . . . . 1.0 113.069 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.474 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 51.8 mtpt -133.0 178.73 6.66 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 113.061 -1.57 . . . . 1.0 109.466 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -114.77 155.55 26.5 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.961 -1.496 . . . . 1.0 106.961 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 48.4 mtp -132.5 74.96 1.6 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.292 -1.373 . . . . 1.0 107.292 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 31.13 54.52 0.21 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 125.375 1.672 . . . . 1.0 110.995 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.88 -29.8 5.7 Favored Glycine 0 N--CA 1.487 2.07 0 CA-C-O 116.829 -2.095 . . . . 1.0 116.469 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.449 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 7.1 mptt -113.73 142.5 45.96 Favored 'General case' 0 C--O 1.206 -1.207 0 CA-C-N 120.387 2.093 . . . . 1.0 108.446 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.441 ' SG ' HG23 ' A' ' 3' ' ' THR . 36.4 t -71.55 160.82 32.02 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.574 -1.194 . . . . 1.0 113.216 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.581 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 5.3 tpt180 -131.6 140.12 49.34 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.274 -2.121 . . . . 1.0 105.274 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.7 m -111.74 161.55 16.18 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.116 0.96 . . . . 1.0 110.13 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.406 ' CD1' ' HA2' ' A' ' 26' ' ' GLY . 7.2 m-30 -115.88 -168.99 1.51 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 111.939 -2.391 . . . . 1.0 106.816 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 107.509 -1.293 . . . . 1.0 107.509 -179.816 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 C--O 1.216 -0.693 0 N-CA-C 107.188 -1.412 . . . . 1.0 107.188 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.6 p -131.47 174.01 10.52 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 123.641 0.588 . . . . 1.0 110.72 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -125.3 32.51 5.35 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.571 -1.27 . . . . 1.0 107.571 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.1 p -111.29 134.95 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.151 -1.425 . . . . 1.0 107.151 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -70.67 140.7 51.58 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 113.454 0.909 . . . . 1.0 113.454 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.426 ' SG ' ' C ' ' A' ' 32' ' ' LYS . 2.5 p -136.21 170.41 16.06 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.063 0.935 . . . . 1.0 111.909 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.4 m -130.25 -43.19 1.18 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 112.384 -2.189 . . . . 1.0 108.516 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.19 172.08 21.59 Favored Glycine 0 N--CA 1.497 2.742 0 O-C-N 124.431 1.082 . . . . 1.0 112.411 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.1 p -70.1 -57.66 4.7 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.461 -0.869 . . . . 1.0 112.838 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -39.86 -32.79 0.17 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.82 -36.64 73.02 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 122.228 1.013 . . . . 1.0 111.031 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 41.8 t -73.6 -10.13 59.39 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.467 -1.242 . . . . 1.0 111.574 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.408 ' CD1' ' O ' ' A' ' 26' ' ' GLY . 9.8 m95 -69.94 -61.04 3.16 Favored Pre-proline 0 N--CA 1.484 1.231 0 CA-C-O 118.462 -0.78 . . . . 1.0 110.104 179.366 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -63.04 -40.42 34.05 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.771 2.314 . . . . 1.0 109.752 177.088 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.8 t -58.83 -49.77 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 123.837 0.71 . . . . 1.0 110.356 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.9 t -68.96 -34.63 75.64 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 118.946 -1.102 . . . . 1.0 109.295 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.08 -38.74 89.98 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -70.44 -52.36 22.76 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.642 -1.163 . . . . 1.0 111.035 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 73.1 mtm -61.35 -52.11 66.01 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.629 0.974 . . . . 1.0 113.629 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -111.26 -62.48 1.54 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 113.93 1.085 . . . . 1.0 113.93 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.41 43.68 0.42 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 106.922 -2.471 . . . . 1.0 106.922 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -127.82 81.94 69.33 Favored Pre-proline 0 N--CA 1.493 1.718 0 CA-C-N 113.496 -1.352 . . . . 1.0 107.584 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.7 0.18 3.23 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 123.684 2.923 . . . . 1.0 116.266 -150.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 47.0 m-80 -103.94 129.25 51.47 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 104.771 -2.307 . . . . 1.0 104.771 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 14' ' ' TRP . . . -146.82 145.86 15.14 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-N 113.958 -1.474 . . . . 1.0 110.815 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -131.46 170.51 14.59 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 106.869 -1.53 . . . . 1.0 106.869 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.3 t -107.09 150.61 26.37 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.898 -0.721 . . . . 1.0 110.691 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.3 ptm -129.18 102.77 6.61 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.916 -1.493 . . . . 1.0 108.566 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.7 p30 31.69 44.34 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 113.641 -1.618 . . . . 1.0 114.194 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.94 -28.57 6.34 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 118.592 2.197 . . . . 1.0 118.592 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 35.3 mmtp -114.99 156.64 24.72 Favored 'General case' 0 C--O 1.202 -1.419 0 CA-C-N 120.87 2.335 . . . . 1.0 111.44 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.8 t -71.87 160.27 32.86 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.155 0.978 . . . . 1.0 111.0 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.447 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.3 tpt180 -136.26 140.45 43.45 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 105.93 -1.878 . . . . 1.0 105.93 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.9 m -109.39 164.01 12.88 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.437 1.113 . . . . 1.0 113.242 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.408 ' HB2' ' HB2' ' A' ' 25' ' ' ASN . 42.9 m-85 -128.16 -160.45 1.02 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 111.931 -2.395 . . . . 1.0 108.287 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.487 1.414 0 O-C-N 125.029 1.456 . . . . 1.0 107.756 179.898 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.2 p90 . . . . . 0 C--O 1.216 -0.7 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.495 HG22 ' SG ' ' A' ' 33' ' ' CYS . 58.9 p -127.3 -175.41 3.43 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.71 0.767 . . . . 1.0 112.803 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -124.22 -7.21 7.66 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.05 -1.886 . . . . 1.0 110.153 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.7 t -111.64 144.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.35 170.99 11.99 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 116.515 2.042 . . . . 1.0 116.515 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.3 p -141.23 173.03 11.88 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.225 -1.352 . . . . 1.0 110.493 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.9 m -121.3 -49.51 2.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 104.758 -2.312 . . . . 1.0 104.758 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.13 169.51 33.18 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 108.625 -1.79 . . . . 1.0 108.625 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.1 t -43.29 -58.58 2.47 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.541 0.686 . . . . 1.0 110.51 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.93 -39.24 11.91 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 113.958 -1.474 . . . . 1.0 114.447 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -70.3 -33.1 71.13 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.233 1.016 . . . . 1.0 111.174 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.573 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 19.2 t -76.56 -11.55 59.89 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 113.747 -1.57 . . . . 1.0 113.075 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.408 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 7.0 m0 -67.49 -58.53 8.44 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 123.75 0.656 . . . . 1.0 109.52 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 84.6 Cg_endo -63.38 -43.07 19.23 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.816 2.344 . . . . 1.0 110.686 174.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -55.49 -47.27 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 119.844 -0.742 . . . . 1.0 110.216 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.0 t -67.75 -42.45 81.76 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.372 -0.931 . . . . 1.0 108.805 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -50.13 -42.85 51.41 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.342 1.067 . . . . 1.0 108.347 179.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -70.54 -46.25 63.93 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 113.648 -1.614 . . . . 1.0 111.151 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.4 ttp -54.03 -56.7 15.49 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 123.957 0.785 . . . . 1.0 112.641 -179.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -121.87 -57.02 1.82 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 113.385 -1.734 . . . . 1.0 114.021 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.95 43.41 0.11 Allowed Glycine 0 N--CA 1.488 2.122 0 O-C-N 124.045 0.841 . . . . 1.0 111.517 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -126.22 98.93 31.83 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 105.065 -2.198 . . . . 1.0 105.065 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.09 11.96 0.4 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 123.091 2.528 . . . . 1.0 113.218 -167.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.401 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 73.4 m-80 -116.36 -176.2 2.91 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.73 -1.581 . . . . 1.0 106.73 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.424 ' HA2' ' CD1' ' A' ' 36' ' ' TYR . . . 144.75 175.92 18.31 Favored Glycine 0 N--CA 1.49 2.254 0 CA-C-N 113.991 -1.459 . . . . 1.0 112.734 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.461 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 52.0 mtpt -133.33 177.81 7.4 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 113.165 -1.517 . . . . 1.0 109.001 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.3 t -114.89 155.99 25.83 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.769 -1.567 . . . . 1.0 106.769 179.446 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 48.8 mtp -133.01 75.17 1.61 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.29 -1.374 . . . . 1.0 107.29 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 30.95 54.44 0.19 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 125.321 1.638 . . . . 1.0 111.202 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.11 -29.69 5.68 Favored Glycine 0 N--CA 1.483 1.833 0 CA-C-O 116.916 -2.046 . . . . 1.0 116.438 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 7.1 mptt -113.97 142.49 46.09 Favored 'General case' 0 C--O 1.206 -1.218 0 CA-C-N 120.331 2.066 . . . . 1.0 108.194 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.495 ' SG ' HG22 ' A' ' 3' ' ' THR . 35.5 t -71.65 161.74 30.53 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.482 -1.236 . . . . 1.0 113.137 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.573 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 5.9 tpt180 -132.69 139.96 47.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.555 -2.017 . . . . 1.0 105.555 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.5 m -111.18 161.02 16.4 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.426 1.108 . . . . 1.0 110.778 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.424 ' CD1' ' HA2' ' A' ' 26' ' ' GLY . 6.2 m-30 -116.66 -169.0 1.55 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 111.318 -2.674 . . . . 1.0 106.722 -179.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 107.624 -1.25 . . . . 1.0 107.624 -179.863 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 35.6 p90 . . . . . 0 C--O 1.216 -0.678 0 CA-C-O 121.421 0.629 . . . . 1.0 111.088 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.9 p -132.45 171.35 13.88 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.639 -1.619 . . . . 1.0 110.687 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.58 48.79 1.03 Allowed 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.6 t -111.04 119.42 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.063 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -39.65 113.13 0.31 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.655 -1.611 . . . . 1.0 115.272 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.4 p -123.24 171.48 9.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.257 0.973 . . . . 1.0 111.149 179.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.1 p -126.18 -43.17 1.81 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 112.595 -2.093 . . . . 1.0 108.495 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.49 169.17 29.76 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 124.44 1.087 . . . . 1.0 112.29 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.9 t -54.67 -62.63 1.53 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.454 -0.873 . . . . 1.0 111.576 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -42.7 -40.13 2.67 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 115.126 1.528 . . . . 1.0 115.126 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -57.88 -31.23 66.52 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.156 0.979 . . . . 1.0 112.974 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.9 m -81.21 -3.84 53.56 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.04 -1.437 . . . . 1.0 113.553 -179.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.497 ' CG ' ' HA ' ' A' ' 25' ' ' ASN . 11.5 m0 -70.31 -59.0 4.4 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 107.826 -1.176 . . . . 1.0 107.826 179.262 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.408 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 83.6 Cg_endo -65.69 -46.45 5.15 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 122.735 2.29 . . . . 1.0 111.515 174.115 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.8 t -56.87 -44.69 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 119.276 -0.969 . . . . 1.0 110.306 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.438 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 51.8 t -68.45 -45.01 73.61 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.692 -1.203 . . . . 1.0 108.627 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -46.89 -43.18 18.61 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 107.591 -1.263 . . . . 1.0 107.591 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -70.76 -45.33 64.97 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 112.941 -1.936 . . . . 1.0 112.719 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.9 mtm -63.45 -57.96 8.59 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.678 1.362 . . . . 1.0 114.678 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -111.88 -56.34 2.4 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.387 -1.279 . . . . 1.0 113.252 -179.408 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.16 39.47 0.38 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.438 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 14.0 mptt -119.01 97.0 50.62 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 102.691 -3.078 . . . . 1.0 102.691 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -64.91 -3.48 7.07 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 123.367 2.711 . . . . 1.0 113.346 -156.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.539 ' ND2' ' H ' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -122.25 165.68 15.81 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 124.438 1.086 . . . . 1.0 109.079 179.923 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.0 168.72 41.43 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.336 -0.935 . . . . 1.0 112.444 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.571 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 27.8 mtpp -121.85 -176.64 3.38 Favored 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 115.014 -0.593 . . . . 1.0 109.575 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.8 t -127.26 156.32 42.09 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 106.263 -1.754 . . . . 1.0 106.263 179.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 71.4 mtm -136.15 77.18 1.64 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.016 -1.476 . . . . 1.0 107.016 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.1 t30 30.36 53.43 0.14 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 125.271 1.607 . . . . 1.0 111.341 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.13 -35.52 3.08 Favored Glycine 0 N--CA 1.486 2.03 0 CA-C-N 113.159 -1.837 . . . . 1.0 115.637 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' A' ' 32' ' ' LYS . 1.7 mppt? -109.48 139.78 44.04 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 119.948 1.874 . . . . 1.0 109.907 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 46.1 t -71.94 160.56 32.32 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 112.917 -1.947 . . . . 1.0 116.013 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -139.29 155.41 47.75 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.017 -1.447 . . . . 1.0 107.773 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.9 m -126.71 166.14 17.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.992 -2.225 . . . . 1.0 104.992 179.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.571 ' CZ ' ' HG3' ' A' ' 27' ' ' LYS . 89.4 m-85 -113.26 177.37 4.65 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.752 -1.203 . . . . 1.0 107.752 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.9 m . . . . . 0 N--CA 1.501 2.077 0 CA-C-O 117.404 -1.284 . . . . 1.0 111.342 179.942 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.209 -1.063 0 N-CA-C 113.348 0.87 . . . . 1.0 113.348 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -99.31 168.5 9.98 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.624 -1.171 . . . . 1.0 110.373 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.4 p -130.54 172.56 11.78 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.826 -1.079 . . . . 1.0 110.105 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -126.3 28.3 6.04 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.245 0.965 . . . . 1.0 109.061 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 p -115.79 155.11 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 115.152 -0.931 . . . . 1.0 109.895 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -70.8 131.95 44.59 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.508 -0.769 . . . . 1.0 112.83 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.3 p -123.55 160.31 27.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.944 0.777 . . . . 1.0 109.018 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 81.4 p -132.77 40.09 3.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.608 0.718 . . . . 1.0 110.15 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.3 163.17 13.86 Favored Glycine 0 N--CA 1.494 2.534 0 CA-C-N 114.092 -1.413 . . . . 1.0 109.8 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.4 p -43.71 -49.9 7.74 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 114.385 -0.907 . . . . 1.0 113.332 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -45.95 -50.09 15.07 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 115.102 -0.954 . . . . 1.0 113.002 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -70.99 -29.3 65.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.056 0.848 . . . . 1.0 110.692 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 26.3 t -73.97 -23.15 59.44 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.777 -1.101 . . . . 1.0 112.678 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.408 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 7.1 m0 -62.89 -58.83 14.57 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-O 118.591 -0.718 . . . . 1.0 111.949 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 90.5 Cg_endo -64.01 -41.4 23.02 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 123.121 2.548 . . . . 1.0 109.801 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.12 -45.63 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 123.96 0.788 . . . . 1.0 110.26 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.53 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 42.4 t -70.0 -43.8 70.65 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.841 -1.17 . . . . 1.0 107.841 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -48.38 -43.44 33.82 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 122.415 1.103 . . . . 1.0 108.405 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -70.82 -52.62 19.32 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 113.048 -1.887 . . . . 1.0 113.902 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 84.0 mtp -64.6 -55.97 16.92 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 115.015 1.487 . . . . 1.0 115.015 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -108.86 -57.38 2.15 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.403 1.064 . . . . 1.0 113.034 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.3 35.49 0.66 Allowed Glycine 0 N--CA 1.495 2.587 0 O-C-N 123.857 0.723 . . . . 1.0 111.332 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.53 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 13.1 mptt -122.28 90.84 49.22 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 104.484 -2.413 . . . . 1.0 104.484 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.09 -3.47 7.28 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 123.227 2.618 . . . . 1.0 113.366 -160.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -105.09 -175.93 2.93 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.032 -1.47 . . . . 1.0 107.032 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.66 -178.74 19.14 Favored Glycine 0 N--CA 1.489 2.174 0 CA-C-N 114.0 -1.454 . . . . 1.0 113.224 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -139.66 167.58 21.78 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.751 -1.225 . . . . 1.0 111.281 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 39.0 t -108.61 147.78 31.33 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.807 -0.812 . . . . 1.0 108.807 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.9 ptm -136.54 108.47 7.13 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 123.786 0.679 . . . . 1.0 110.314 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.2 t30 31.2 46.13 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.188 -1.824 . . . . 1.0 113.027 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.34 -30.42 6.02 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 119.29 2.476 . . . . 1.0 119.29 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -118.2 146.89 43.89 Favored 'General case' 0 C--O 1.205 -1.247 0 CA-C-N 120.56 2.18 . . . . 1.0 112.911 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.3 t -72.52 156.47 38.98 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 112.853 -1.976 . . . . 1.0 112.728 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.46 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 10.0 tpt180 -133.1 142.66 48.83 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 112.175 -2.284 . . . . 1.0 105.516 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.0 m -109.42 166.31 10.97 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 124.231 0.957 . . . . 1.0 109.669 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -118.37 -178.57 3.55 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 114.386 -1.279 . . . . 1.0 108.923 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 117.537 -1.22 . . . . 1.0 111.127 179.946 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -94.19 156.51 16.51 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.965 0.728 . . . . 1.0 112.965 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 59.4 p -132.25 166.3 22.18 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 113.872 -1.513 . . . . 1.0 108.416 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -123.62 45.75 2.38 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.885 0.85 . . . . 1.0 109.161 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -104.78 153.17 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 114.411 -1.268 . . . . 1.0 108.975 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -70.63 117.92 12.76 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.248 1.944 . . . . 1.0 116.248 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.8 p -127.33 172.93 10.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 124.156 0.91 . . . . 1.0 109.098 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.4 m -124.11 -44.93 2.01 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 112.961 -1.927 . . . . 1.0 106.956 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.57 169.76 32.88 Favored Glycine 0 N--CA 1.494 2.555 0 CA-C-N 114.831 -1.077 . . . . 1.0 111.73 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.5 t -43.75 -57.4 3.25 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.195 -1.002 . . . . 1.0 112.076 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -41.88 -42.27 2.67 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 114.284 -1.326 . . . . 1.0 113.704 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -70.51 -41.11 73.03 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.658 1.218 . . . . 1.0 111.419 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 41.3 t -71.35 -23.53 61.93 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 113.137 -1.847 . . . . 1.0 112.309 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.439 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.2 m0 -59.15 -60.62 9.97 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 123.918 0.761 . . . . 1.0 111.876 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -63.77 -43.09 17.53 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.152 2.568 . . . . 1.0 109.738 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.77 -42.73 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 123.864 0.728 . . . . 1.0 109.966 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 51.4 m -70.27 -43.86 69.6 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -50.36 -42.24 52.85 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.333 1.063 . . . . 1.0 108.544 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -70.89 -56.39 6.36 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 113.539 -1.664 . . . . 1.0 113.42 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.7 ttm -59.19 -56.15 25.87 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 115.075 1.509 . . . . 1.0 115.075 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -106.36 -58.98 1.85 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 113.461 -1.699 . . . . 1.0 114.011 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.59 45.88 0.26 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 106.383 -2.687 . . . . 1.0 106.383 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -128.72 88.66 51.41 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 106.132 -1.803 . . . . 1.0 106.132 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -62.16 2.39 0.65 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.318 2.012 . . . . 1.0 113.67 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.439 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 8.0 m120 -113.49 -174.74 2.52 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.96 -179.08 18.38 Favored Glycine 0 N--CA 1.489 2.216 0 CA-C-N 113.659 -1.609 . . . . 1.0 110.734 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -140.96 167.92 21.04 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.863 -0.668 . . . . 1.0 110.539 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.5 t -107.75 157.49 18.08 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.52 -0.918 . . . . 1.0 108.52 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.7 mtp -132.05 81.91 1.99 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.783 -1.191 . . . . 1.0 107.783 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.1 t30 29.34 53.94 0.11 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 125.534 1.771 . . . . 1.0 111.519 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.36 -38.04 2.3 Favored Glycine 0 N--CA 1.479 1.543 0 CA-C-N 113.145 -1.843 . . . . 1.0 115.737 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -114.98 135.2 54.48 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-N 119.37 1.585 . . . . 1.0 112.711 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 15.2 t -72.07 157.61 37.47 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.796 -2.911 . . . . 1.0 114.828 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.532 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.4 tpt180 -138.11 143.49 40.41 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 112.365 -2.198 . . . . 1.0 105.938 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.6 m -119.4 160.71 21.8 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.718 -1.586 . . . . 1.0 106.718 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -110.88 -172.15 1.97 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.7 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 116.109 -1.9 . . . . 1.0 109.493 -179.702 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.907 0.384 . . . . 1.0 109.975 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -97.54 168.76 10.17 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.404 HG23 ' SG ' ' A' ' 33' ' ' CYS . 72.8 p -128.47 177.55 6.91 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 122.132 0.968 . . . . 1.0 113.146 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -112.98 -5.93 13.77 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 112.596 -2.093 . . . . 1.0 109.319 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.2 t -112.81 140.65 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.327 -0.99 . . . . 1.0 108.327 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 25.2 pttm -71.05 167.44 19.24 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.751 1.76 . . . . 1.0 115.751 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.9 p -138.54 176.04 9.04 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 124.61 1.194 . . . . 1.0 110.716 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.3 m -125.36 -49.31 1.68 Allowed 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.256 -2.247 . . . . 1.0 105.345 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.82 170.13 29.26 Favored Glycine 0 N--CA 1.493 2.495 0 CA-C-N 114.004 -1.453 . . . . 1.0 109.764 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.0 m -51.23 -54.94 20.92 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.382 0.611 . . . . 1.0 110.661 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -49.1 -39.95 30.19 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.659 -1.155 . . . . 1.0 113.161 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -70.39 -30.71 67.67 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.255 1.026 . . . . 1.0 110.849 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.578 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 6.0 t -76.98 -10.65 59.51 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 113.568 -1.651 . . . . 1.0 112.833 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 9.9 m0 -66.86 -58.48 9.49 Favored Pre-proline 0 N--CA 1.485 1.29 0 CA-C-O 118.873 -0.584 . . . . 1.0 109.523 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.09 -48.0 9.2 Favored 'Trans proline' 0 N--CA 1.486 1.081 0 C-N-CA 122.369 2.046 . . . . 1.0 110.096 173.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.5 t -51.33 -40.8 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 119.997 -0.681 . . . . 1.0 110.315 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 42.8 t -70.35 -49.43 49.35 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.775 -1.17 . . . . 1.0 107.999 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -47.77 -38.23 15.18 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.205 1.002 . . . . 1.0 109.425 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -70.24 -53.99 14.65 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.309 -1.769 . . . . 1.0 111.956 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 35.7 mmt -69.82 -55.31 10.15 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 115.98 1.844 . . . . 1.0 115.98 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -102.86 -53.58 2.82 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 123.77 0.669 . . . . 1.0 112.666 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.07 35.28 0.55 Allowed Glycine 0 N--CA 1.492 2.381 0 O-C-N 123.662 0.601 . . . . 1.0 113.281 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.493 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 2.9 mptp? -127.45 131.67 23.95 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -87.3 14.36 2.43 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 122.43 2.087 . . . . 1.0 110.511 -175.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -119.54 -177.56 3.4 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.557 -1.275 . . . . 1.0 107.557 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.24 172.76 12.76 Favored Glycine 0 N--CA 1.488 2.135 0 CA-C-N 114.13 -1.395 . . . . 1.0 114.747 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.478 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 50.4 mtpt -130.35 177.81 7.06 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 112.158 -2.021 . . . . 1.0 110.719 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 t -116.35 151.79 35.21 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.375 -1.343 . . . . 1.0 107.375 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 70.8 mtm -130.69 83.75 2.14 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.114 -1.069 . . . . 1.0 108.114 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 27.84 50.35 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 125.54 1.775 . . . . 1.0 112.851 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 126.44 -31.4 4.01 Favored Glycine 0 N--CA 1.484 1.838 0 CA-C-O 116.012 -2.549 . . . . 1.0 117.532 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -116.94 145.98 43.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 121.356 2.578 . . . . 1.0 109.491 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.404 ' SG ' HG23 ' A' ' 3' ' ' THR . 16.7 t -71.7 157.98 36.96 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.581 -1.645 . . . . 1.0 113.791 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.578 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 17.8 tpt85 -128.96 140.18 51.77 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.366 -2.197 . . . . 1.0 105.692 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.8 m -111.6 163.49 14.04 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.146 -1.057 . . . . 1.0 108.146 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.411 ' OH ' ' HG3' ' A' ' 27' ' ' LYS . 12.7 m-30 -114.26 -176.86 2.99 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 113.717 -1.583 . . . . 1.0 108.201 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 116.162 -1.875 . . . . 1.0 108.893 -179.921 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . 0.447 ' CD ' ' HB2' ' A' ' 35' ' ' CYS . . . . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 112.29 0.478 . . . . 1.0 112.29 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -95.27 145.19 25.25 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.824 0.821 . . . . 1.0 113.143 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.7 p -132.18 163.47 28.48 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 113.045 -1.889 . . . . 1.0 108.158 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -126.65 52.26 1.77 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 124.003 0.814 . . . . 1.0 110.459 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -111.58 151.58 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 C-N-CA 120.001 -0.68 . . . . 1.0 109.352 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -70.21 103.17 2.27 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 114.968 1.47 . . . . 1.0 114.968 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.3 p -120.58 172.3 7.95 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.082 0.944 . . . . 1.0 109.909 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.6 t -126.22 -42.22 1.86 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 112.578 -2.101 . . . . 1.0 107.898 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.79 165.29 26.91 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 124.268 0.98 . . . . 1.0 111.542 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.0 m -47.88 -53.33 16.07 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.384 -0.908 . . . . 1.0 111.719 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.441 ' HZ1' HE22 ' A' ' 12' ' ' GLN . 10.4 mtmp? -45.19 -43.37 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.075 -1.42 . . . . 1.0 114.063 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.441 HE22 ' HZ1' ' A' ' 11' ' ' LYS . 14.4 mp0 -70.24 -32.52 70.41 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.893 0.854 . . . . 1.0 111.346 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 8.5 t -77.55 -11.5 59.86 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 113.742 -1.572 . . . . 1.0 112.331 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.431 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.0 m0 -67.6 -59.7 6.56 Favored Pre-proline 0 N--CA 1.49 1.57 0 CA-C-O 118.655 -0.688 . . . . 1.0 110.434 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -63.73 -46.98 7.82 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.59 2.194 . . . . 1.0 109.287 174.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.1 t -51.62 -42.08 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 123.802 0.689 . . . . 1.0 109.928 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 41.7 t -70.09 -46.05 65.69 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.31 -0.996 . . . . 1.0 108.31 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -46.76 -42.76 17.37 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.731 1.253 . . . . 1.0 108.188 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -70.62 -52.21 22.88 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 112.831 -1.986 . . . . 1.0 113.206 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -55.95 26.96 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 114.728 1.381 . . . . 1.0 114.728 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -110.82 -56.35 2.37 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.321 -1.309 . . . . 1.0 113.712 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.05 34.95 0.53 Allowed Glycine 0 N--CA 1.492 2.383 0 O-C-N 124.032 0.832 . . . . 1.0 111.132 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 13.1 mptt -124.84 99.18 35.51 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 104.292 -2.485 . . . . 1.0 104.292 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.6 14.16 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.737 2.291 . . . . 1.0 113.322 -169.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.431 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 17.9 p30 -117.03 -179.95 3.85 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.56 168.39 12.59 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.362 -1.399 . . . . 1.0 116.365 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.453 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 35.4 mtpt -123.83 171.03 9.96 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 112.55 -1.825 . . . . 1.0 109.531 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.1 t -118.42 158.57 25.06 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.539 -1.282 . . . . 1.0 107.539 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.7 mtp -134.91 79.11 1.77 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.38 -1.341 . . . . 1.0 107.38 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.6 p30 28.2 51.96 0.05 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 125.598 1.811 . . . . 1.0 112.573 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.11 -37.93 2.01 Favored Glycine 0 N--CA 1.484 1.856 0 CA-C-N 112.471 -2.149 . . . . 1.0 115.258 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -114.47 139.77 49.27 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 119.46 1.63 . . . . 1.0 112.143 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 36.0 t -71.92 159.98 33.32 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 111.721 -2.49 . . . . 1.0 115.027 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.561 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 14.2 tpt180 -135.94 145.37 46.16 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 112.543 -2.117 . . . . 1.0 105.543 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.447 ' HB2' ' CD ' ' A' ' 1' ' ' PCA . 71.0 m -124.04 163.02 22.27 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.086 -1.82 . . . . 1.0 106.086 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.453 ' OH ' ' HG3' ' A' ' 27' ' ' LYS . 4.5 m-85 -116.57 168.27 10.33 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 105.472 -2.047 . . . . 1.0 105.472 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 N--CA 1.507 2.42 0 N-CA-C 115.34 1.607 . . . . 1.0 115.34 -179.813 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.205 -1.267 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.86 162.09 14.52 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.101 0.953 . . . . 1.0 111.57 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.5 p -133.2 163.77 28.56 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 112.525 -2.125 . . . . 1.0 109.038 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -104.05 40.59 1.42 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.558 -0.746 . . . . 1.0 111.326 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -121.35 142.57 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 107.743 -1.206 . . . . 1.0 107.743 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -70.72 146.44 49.86 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.412 1.634 . . . . 1.0 115.412 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.5 p -140.15 174.17 10.78 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.575 1.172 . . . . 1.0 109.807 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.5 p -122.86 -46.3 2.11 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.917 -1.947 . . . . 1.0 106.572 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.86 173.17 33.9 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.562 -1.415 . . . . 1.0 109.562 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.6 t -40.04 -59.36 1.24 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 124.521 0.777 . . . . 1.0 111.005 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -42.32 -42.32 3.1 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.061 -1.427 . . . . 1.0 113.973 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.36 -37.92 74.68 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.419 1.104 . . . . 1.0 110.005 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.612 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 10.1 t -71.51 -23.33 61.77 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.228 -1.351 . . . . 1.0 113.48 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.457 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.6 m0 -57.99 -60.62 9.46 Favored Pre-proline 0 CA--C 1.56 1.33 0 O-C-N 123.768 0.668 . . . . 1.0 111.324 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -62.38 -42.86 25.45 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 C-N-CA 122.738 2.292 . . . . 1.0 109.491 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.1 t -53.15 -44.44 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 123.803 0.689 . . . . 1.0 110.963 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 48.6 t -70.16 -44.76 68.16 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.948 -1.13 . . . . 1.0 107.948 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -48.49 -43.29 34.85 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.355 1.074 . . . . 1.0 108.494 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -70.86 -47.87 56.98 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 113.065 -1.879 . . . . 1.0 113.235 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 80.9 mmm -65.59 -60.2 3.16 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 114.879 1.436 . . . . 1.0 114.879 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -107.91 -56.27 2.26 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.246 -1.343 . . . . 1.0 112.855 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.18 34.83 0.61 Allowed Glycine 0 N--CA 1.493 2.485 0 O-C-N 123.92 0.762 . . . . 1.0 111.278 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 0.9 OUTLIER -121.05 86.69 42.68 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 104.563 -2.384 . . . . 1.0 104.563 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -64.49 3.18 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.141 2.561 . . . . 1.0 113.961 -163.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.457 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 66.8 m-80 -111.48 -177.53 3.22 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.898 -1.89 . . . . 1.0 105.898 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.23 -172.6 24.14 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.214 -1.47 . . . . 1.0 114.222 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.521 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 60.8 mtpt -132.56 171.7 13.46 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 113.421 -1.389 . . . . 1.0 112.219 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.8 t -111.23 156.12 21.94 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 105.619 -1.993 . . . . 1.0 105.619 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 59.5 mtp -134.25 83.53 2.04 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.825 -1.176 . . . . 1.0 107.825 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 27.99 54.21 0.07 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 125.815 1.947 . . . . 1.0 110.583 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.34 -40.48 1.8 Allowed Glycine 0 N--CA 1.484 1.849 0 CA-C-N 112.591 -2.095 . . . . 1.0 116.441 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -116.58 147.75 41.55 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 120.554 2.177 . . . . 1.0 112.656 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 35.0 t -71.84 155.46 40.39 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.853 -2.885 . . . . 1.0 116.223 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.612 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.2 tpt180 -130.14 144.47 51.37 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 111.099 -2.773 . . . . 1.0 105.54 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.9 m -115.24 163.89 15.01 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.563 -1.643 . . . . 1.0 106.563 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.521 ' CZ ' ' HG3' ' A' ' 27' ' ' LYS . 15.3 m-85 -113.19 -179.41 3.64 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.153 -1.055 . . . . 1.0 108.153 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.8 p . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 115.928 -1.987 . . . . 1.0 110.018 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 N-CA-C 112.036 0.384 . . . . 1.0 112.036 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -85.61 146.28 26.94 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 114.373 1.249 . . . . 1.0 114.373 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.3 p -132.63 171.9 13.23 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 112.901 -1.954 . . . . 1.0 109.045 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -122.99 51.54 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.992 -1.114 . . . . 1.0 107.992 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.2 t -112.67 128.72 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 115.126 -0.943 . . . . 1.0 111.418 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -39.76 102.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 118.478 2.77 . . . . 1.0 118.478 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.6 p -125.58 170.17 11.75 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.805 0.812 . . . . 1.0 109.672 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.9 t -121.98 -43.01 2.36 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 113.105 -1.861 . . . . 1.0 106.923 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.17 165.03 31.65 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.908 -1.277 . . . . 1.0 109.908 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.8 t -40.64 -59.52 1.35 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 124.727 0.898 . . . . 1.0 111.94 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -43.44 -43.39 5.26 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 113.819 -1.537 . . . . 1.0 114.618 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -70.59 -34.11 71.8 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.883 0.849 . . . . 1.0 111.121 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 7.3 t -76.24 -11.92 60.0 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.303 -1.317 . . . . 1.0 112.675 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.425 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 5.0 m0 -67.64 -58.21 8.77 Favored Pre-proline 0 N--CA 1.489 1.497 0 CA-C-O 118.605 -0.712 . . . . 1.0 110.166 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 77.0 Cg_endo -63.05 -43.1 20.52 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.936 2.424 . . . . 1.0 109.95 174.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.0 t -54.55 -45.05 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 119.835 -0.746 . . . . 1.0 109.829 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 54.1 t -70.13 -39.71 75.27 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.203 -1.036 . . . . 1.0 108.203 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -51.35 -43.94 61.93 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.51 1.148 . . . . 1.0 108.04 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -70.69 -57.18 4.95 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 113.663 -1.608 . . . . 1.0 113.122 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -55.25 -50.87 68.36 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 114.282 1.216 . . . . 1.0 114.282 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -112.06 -62.99 1.48 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.585 -1.643 . . . . 1.0 114.924 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.89 43.73 0.36 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 107.31 -2.316 . . . . 1.0 107.31 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.454 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 98.1 mttt -130.62 86.66 52.21 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 104.79 -2.3 . . . . 1.0 104.79 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.09 -2.66 5.98 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.55 2.833 . . . . 1.0 113.254 -160.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.425 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 71.9 m-80 -104.24 -176.77 3.17 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.152 -1.425 . . . . 1.0 107.152 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.26 -176.04 21.94 Favored Glycine 0 N--CA 1.493 2.44 0 CA-C-N 114.298 -1.319 . . . . 1.0 113.259 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 53.2 mtpt -135.58 179.28 6.43 Favored 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 113.903 -1.148 . . . . 1.0 112.001 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 t -121.68 157.51 30.74 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 63.5 mtm -135.01 73.51 1.48 Allowed 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.312 -1.366 . . . . 1.0 107.312 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.1 t30 28.22 55.36 0.09 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 125.669 1.856 . . . . 1.0 111.215 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.89 -37.57 2.13 Favored Glycine 0 N--CA 1.484 1.878 0 CA-C-N 112.308 -2.224 . . . . 1.0 114.687 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -111.91 137.64 49.61 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-N 118.985 1.393 . . . . 1.0 111.607 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 45.1 t -72.13 159.6 33.86 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 112.127 -2.306 . . . . 1.0 113.449 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.563 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.6 tpt180 -135.85 147.44 48.24 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.426 -2.065 . . . . 1.0 105.426 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.9 m -122.3 162.36 21.63 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.059 -1.46 . . . . 1.0 107.059 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 16.2 m-30 -115.8 -179.03 3.53 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.4 -2.074 . . . . 1.0 105.4 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.501 2.113 0 N-CA-C 115.639 1.718 . . . . 1.0 115.639 -179.639 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.205 -1.276 0 CA-C-O 120.502 0.191 . . . . 1.0 111.314 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -104.05 157.2 17.27 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 122.899 1.333 . . . . 1.0 113.313 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.3 p -133.11 160.6 36.75 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 110.902 -2.863 . . . . 1.0 107.776 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -116.06 50.4 1.04 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.063 0.852 . . . . 1.0 109.207 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.9 t -108.17 145.82 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 105.268 -2.123 . . . . 1.0 105.268 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -70.2 135.72 49.34 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.254 0.835 . . . . 1.0 113.254 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.548 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 6.0 p -130.15 160.0 35.12 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 124.887 1.367 . . . . 1.0 113.083 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.8 t -136.62 44.13 2.39 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.912 -1.494 . . . . 1.0 108.429 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.9 167.27 13.06 Favored Glycine 0 N--CA 1.495 2.606 0 CA-C-N 113.589 -1.641 . . . . 1.0 110.454 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.2 t -47.12 -62.78 1.26 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.421 0.897 . . . . 1.0 113.421 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.463 ' C ' ' HZ1' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -39.49 -29.18 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.262 1.949 . . . . 1.0 116.262 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.454 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 3.5 tm0? -70.62 -40.14 73.32 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 122.658 1.218 . . . . 1.0 111.398 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 70.5 m -78.4 -7.55 57.48 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.393 -1.73 . . . . 1.0 113.583 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.404 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 8.1 m95 -70.18 -57.96 5.51 Favored Pre-proline 0 C--N 1.305 -1.34 0 O-C-N 124.147 0.905 . . . . 1.0 109.34 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 98.8 Cg_endo -64.44 -45.27 9.6 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 C-N-CA 122.793 2.329 . . . . 1.0 110.343 174.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.6 t -55.84 -46.05 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 119.371 -0.932 . . . . 1.0 110.775 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 52.8 t -68.51 -43.26 77.2 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.938 -1.105 . . . . 1.0 109.252 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -50.36 -42.36 53.03 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -70.83 -49.23 48.56 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 113.635 -1.621 . . . . 1.0 112.971 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.2 mmm -62.93 -56.5 16.68 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.979 1.103 . . . . 1.0 113.979 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -110.82 -59.78 1.91 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.725 -1.125 . . . . 1.0 112.492 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.51 43.99 0.44 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 106.486 -2.646 . . . . 1.0 106.486 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 94.4 mttt -126.73 78.22 73.31 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 105.265 -2.124 . . . . 1.0 105.265 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -62.18 -3.48 4.04 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 123.487 2.791 . . . . 1.0 114.92 -154.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -107.11 121.25 44.11 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 104.183 -2.525 . . . . 1.0 104.183 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.16 161.7 27.88 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.788 -1.725 . . . . 1.0 108.788 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HE2' ' CE2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -127.74 176.61 7.41 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.204 -1.776 . . . . 1.0 106.204 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -109.68 161.64 15.2 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.399 -0.521 . . . . 1.0 111.027 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 64.1 mtp -136.2 88.2 2.37 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.214 -1.772 . . . . 1.0 106.214 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.1 p30 30.99 48.64 0.07 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 125.121 1.513 . . . . 1.0 113.501 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.78 -35.86 3.16 Favored Glycine 0 N--CA 1.491 2.312 0 CA-C-N 113.302 -1.772 . . . . 1.0 116.504 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.67 147.65 40.6 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-N 120.108 1.954 . . . . 1.0 110.885 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.548 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 33.8 m -72.03 154.58 41.06 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 110.722 -2.944 . . . . 1.0 118.817 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.525 ' HG3' ' HZ3' ' A' ' 27' ' ' LYS . 8.1 tpt180 -137.6 153.67 49.88 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 111.944 -2.389 . . . . 1.0 105.653 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 89.4 m -118.68 157.27 27.77 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 124.178 0.924 . . . . 1.0 110.678 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.53 ' CE2' ' HE2' ' A' ' 27' ' ' LYS . 49.7 m-85 -110.1 -175.86 2.84 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.042 -1.89 . . . . 1.0 108.08 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 t . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 115.852 -2.023 . . . . 1.0 108.944 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.187 0 N-CA-C 112.209 0.448 . . . . 1.0 112.209 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -101.81 157.46 16.83 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 122.613 1.197 . . . . 1.0 111.598 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.3 p -147.16 166.01 28.26 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 111.702 -2.499 . . . . 1.0 109.42 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -123.57 52.47 1.42 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.447 HG23 ' SD ' ' A' ' 20' ' ' MET . 62.4 t -108.09 141.17 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-N 114.614 -1.176 . . . . 1.0 108.64 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -70.27 105.45 2.98 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 114.161 -1.382 . . . . 1.0 113.889 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.9 p -119.72 170.87 8.82 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.587 -1.188 . . . . 1.0 111.513 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -128.19 -40.81 1.63 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 112.46 -2.155 . . . . 1.0 109.064 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.1 171.3 23.16 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 124.375 1.047 . . . . 1.0 112.368 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.7 m -70.14 -58.2 4.07 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.193 -1.003 . . . . 1.0 112.355 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -44.12 -33.14 1.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.341 1.237 . . . . 1.0 114.341 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -70.19 -34.81 73.4 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.269 1.033 . . . . 1.0 111.646 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.5 t -77.72 -6.21 53.19 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.413 -1.721 . . . . 1.0 112.014 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -69.03 -59.96 4.76 Favored Pre-proline 0 N--CA 1.484 1.25 0 CA-C-O 118.757 -0.639 . . . . 1.0 109.456 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -64.22 -46.51 7.76 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 C-N-CA 122.325 2.017 . . . . 1.0 110.421 174.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.0 t -54.29 -44.1 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.965 -0.694 . . . . 1.0 110.758 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 47.2 t -69.9 -46.22 65.9 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.381 -1.328 . . . . 1.0 107.768 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -48.92 -39.79 27.54 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 122.116 0.96 . . . . 1.0 108.987 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.15 -50.74 37.46 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.676 -1.602 . . . . 1.0 112.007 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.447 ' SD ' HG23 ' A' ' 5' ' ' VAL . 66.0 mtm -66.38 -57.45 7.41 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 115.57 1.692 . . . . 1.0 115.57 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -103.52 -55.31 2.42 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.787 -1.097 . . . . 1.0 113.76 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.14 41.14 0.31 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 75.1 mmtt -125.83 121.08 24.32 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 105.008 -2.219 . . . . 1.0 105.008 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -82.41 11.83 3.06 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.114 1.876 . . . . 1.0 110.685 -173.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -117.29 -176.86 3.09 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.385 -1.339 . . . . 1.0 107.385 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.04 143.45 3.99 Favored Glycine 0 N--CA 1.486 1.985 0 CA-C-N 113.605 -1.634 . . . . 1.0 111.47 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.417 ' CG ' ' HB3' ' A' ' 34' ' ' ARG . 19.0 ptmt -123.73 172.75 8.61 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 113.569 -1.316 . . . . 1.0 107.774 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.7 t -115.61 159.72 20.93 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.699 -0.8 . . . . 1.0 110.83 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 73.2 mtm -131.01 78.47 1.84 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.41 -1.723 . . . . 1.0 107.42 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 28.48 55.63 0.1 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 125.875 1.985 . . . . 1.0 110.743 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.32 -37.14 2.52 Favored Glycine 0 N--CA 1.485 1.956 0 CA-C-N 112.586 -2.097 . . . . 1.0 115.951 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -110.66 139.65 45.75 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 119.729 1.765 . . . . 1.0 111.793 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.64 157.13 38.51 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.473 -2.148 . . . . 1.0 113.845 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.417 ' HB3' ' CG ' ' A' ' 27' ' ' LYS . 18.7 tpt85 -138.32 145.91 41.76 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 102.753 -3.054 . . . . 1.0 102.753 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -120.19 167.51 12.18 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.251 -1.018 . . . . 1.0 108.251 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -118.69 -179.0 3.67 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.096 -1.411 . . . . 1.0 108.353 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 116.389 -1.767 . . . . 1.0 109.503 -179.776 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.642 0.258 . . . . 1.0 110.925 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -106.66 160.43 15.46 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 123.032 0.533 . . . . 1.0 111.114 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 p -138.31 171.97 13.59 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 114.743 -1.117 . . . . 1.0 110.137 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -131.64 40.33 3.4 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.4 -1.333 . . . . 1.0 107.4 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.9 p -114.72 155.93 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 115.122 -0.945 . . . . 1.0 110.298 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.612 ' H ' ' HZ1' ' A' ' 6' ' ' LYS . 0.2 OUTLIER -71.32 131.18 43.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 123.587 0.554 . . . . 1.0 110.207 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.449 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 30.8 p -127.6 157.33 40.5 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 120.219 -0.593 . . . . 1.0 110.741 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -137.06 42.0 2.44 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.613 -1.176 . . . . 1.0 109.646 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.75 159.88 11.24 Favored Glycine 0 N--CA 1.496 2.685 0 CA-C-N 114.293 -1.322 . . . . 1.0 111.442 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.7 p -47.35 -56.73 6.3 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.515 1.302 . . . . 1.0 114.515 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -39.69 -41.27 1.05 Allowed 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 114.291 1.219 . . . . 1.0 114.291 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -36.43 74.73 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.163 0.914 . . . . 1.0 111.394 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 73.0 m -73.26 -20.17 60.9 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.07 -0.968 . . . . 1.0 112.779 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.45 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 9.4 m0 -58.95 -62.47 5.73 Favored Pre-proline 0 CA--C 1.562 1.428 0 C-N-CA 120.321 -0.552 . . . . 1.0 110.911 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -66.39 -49.84 1.65 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.883 2.389 . . . . 1.0 110.728 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 71.8 t -50.29 -42.52 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 123.648 0.593 . . . . 1.0 110.081 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 50.3 t -70.16 -47.76 60.25 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.575 -1.269 . . . . 1.0 107.575 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -46.88 -40.54 14.23 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 122.196 0.998 . . . . 1.0 108.542 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -70.4 -50.94 33.38 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 113.335 -1.757 . . . . 1.0 112.107 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 56.0 mtm -70.81 -57.84 4.23 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 115.452 1.649 . . . . 1.0 115.452 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -100.6 -56.02 2.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 123.916 0.76 . . . . 1.0 112.025 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.9 39.48 0.52 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.836 -1.305 . . . . 1.0 109.836 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.546 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 38.5 mmtm -122.5 105.69 35.86 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 104.922 -2.251 . . . . 1.0 104.922 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.94 0.65 5.47 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.258 1.972 . . . . 1.0 111.811 -171.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.45 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 5.9 m120 -119.19 -174.5 2.73 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.63 179.39 18.71 Favored Glycine 0 N--CA 1.488 2.112 0 CA-C-N 113.522 -1.672 . . . . 1.0 111.243 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -138.31 172.51 12.79 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 114.356 -0.922 . . . . 1.0 111.197 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.9 t -107.76 160.14 15.95 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 71.5 mtm -138.96 84.8 2.03 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 108.812 -0.81 . . . . 1.0 108.812 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 25.17 55.89 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 125.975 2.047 . . . . 1.0 110.903 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.74 -42.83 1.36 Allowed Glycine 0 N--CA 1.483 1.81 0 CA-C-N 111.806 -2.452 . . . . 1.0 116.145 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -121.64 149.41 43.23 Favored 'General case' 0 C--O 1.205 -1.279 0 CA-C-O 124.46 2.076 . . . . 1.0 112.584 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 10.9 m -72.33 157.95 36.72 Favored 'General case' 0 C--N 1.285 -2.205 1 CA-C-N 108.347 -4.024 . . . . 1.0 115.199 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -137.73 146.34 43.58 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 111.935 -2.393 . . . . 1.0 105.35 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.2 m -117.58 163.68 16.07 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.898 -1.519 . . . . 1.0 106.898 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -116.69 175.19 5.69 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.7 m . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.223 0 N-CA-C 110.82 -0.067 . . . . 1.0 110.82 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -107.79 159.12 16.75 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.538 0.685 . . . . 1.0 109.515 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.0 p -138.86 170.46 15.95 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 113.53 -1.668 . . . . 1.0 111.4 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -124.87 51.12 1.67 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.444 -1.317 . . . . 1.0 107.444 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.28 147.26 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 114.628 -1.169 . . . . 1.0 109.042 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.55 127.08 31.48 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.401 -0.818 . . . . 1.0 111.201 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.22 161.72 27.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 124.007 0.817 . . . . 1.0 111.227 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 t -135.61 42.06 2.69 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.612 -1.177 . . . . 1.0 109.403 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.66 166.52 13.34 Favored Glycine 0 N--CA 1.496 2.678 0 CA-C-N 114.061 -1.427 . . . . 1.0 111.605 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.6 t -53.71 -66.49 0.38 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 114.595 1.331 . . . . 1.0 114.595 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -39.14 -31.96 0.09 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.244 1.572 . . . . 1.0 115.244 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -70.4 -42.3 71.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 124.125 0.891 . . . . 1.0 112.439 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.401 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 4.4 t -89.38 7.79 34.04 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 117.923 -1.511 . . . . 1.0 112.978 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.459 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 2.5 m95 -70.3 -58.33 5.02 Favored Pre-proline 0 N--CA 1.482 1.171 0 N-CA-C 103.441 -2.8 . . . . 1.0 103.441 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 86.8 Cg_endo -65.37 -44.65 8.54 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 123.119 2.546 . . . . 1.0 112.429 172.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.401 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 90.7 t -58.73 -46.86 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 C-N-CA 117.633 -1.627 . . . . 1.0 110.041 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.42 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 53.2 t -64.76 -44.36 90.33 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.048 -1.061 . . . . 1.0 108.139 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -50.86 -40.17 55.55 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.287 1.042 . . . . 1.0 109.025 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -70.52 -45.78 64.88 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.894 -1.503 . . . . 1.0 111.446 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.4 mtp -61.44 -56.04 24.65 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 114.261 1.208 . . . . 1.0 114.261 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -113.39 -56.87 2.36 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.395 -1.275 . . . . 1.0 113.96 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.25 45.59 0.27 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 106.757 -2.537 . . . . 1.0 106.757 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 34.6 mmtp -125.85 89.69 51.89 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 106.053 -1.832 . . . . 1.0 106.053 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -65.57 -4.51 9.77 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.594 2.196 . . . . 1.0 113.246 -162.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -105.34 129.8 53.6 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 105.166 -2.161 . . . . 1.0 105.166 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.95 132.12 3.98 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.497 -1.841 . . . . 1.0 108.497 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -117.05 157.37 25.95 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 106.519 -1.66 . . . . 1.0 106.519 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -102.44 161.47 13.69 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.923 -0.711 . . . . 1.0 112.345 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.9 mtm -133.72 82.87 2.01 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.429 -1.714 . . . . 1.0 107.039 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 28.9 55.08 0.1 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 125.562 1.789 . . . . 1.0 111.197 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.91 -38.56 2.3 Favored Glycine 0 N--CA 1.481 1.648 0 CA-C-N 113.011 -1.904 . . . . 1.0 116.067 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -114.72 140.55 48.78 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 119.792 1.796 . . . . 1.0 112.909 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.483 ' SG ' ' N ' ' A' ' 34' ' ' ARG . 25.5 t -72.11 156.91 38.67 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 110.558 -3.019 . . . . 1.0 115.92 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.483 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 47.8 ttt-85 -136.83 146.12 45.27 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 104.106 -2.553 . . . . 1.0 104.106 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.9 m -119.22 168.58 10.75 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 123.974 0.796 . . . . 1.0 110.223 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -126.75 -165.53 1.47 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 114.421 -1.263 . . . . 1.0 111.596 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.468 -1.253 . . . . 1.0 110.278 -179.762 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . 0.409 ' CD ' ' HB2' ' A' ' 35' ' ' CYS . . . . . . . . 0 C--O 1.209 -1.034 0 N-CA-C 112.684 0.624 . . . . 1.0 112.684 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 65.0 m-85 -100.36 153.16 19.54 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.661 -0.7 . . . . 1.0 110.815 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 50.2 p -134.01 169.32 17.3 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 114.491 -1.231 . . . . 1.0 109.8 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -123.59 41.36 3.49 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.369 1.081 . . . . 1.0 109.045 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.96 148.11 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.402 -1.703 . . . . 1.0 106.402 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -70.39 153.63 42.78 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.81 168.19 14.77 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 124.522 1.139 . . . . 1.0 110.553 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.5 t -142.96 32.08 1.39 Allowed 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 105.672 -1.973 . . . . 1.0 105.672 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.77 154.19 9.13 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.643 -2.183 . . . . 1.0 107.643 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.5 m -39.71 -53.08 2.24 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.182 1.178 . . . . 1.0 114.182 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -44.71 -41.26 6.66 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.442 1.645 . . . . 1.0 115.442 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -61.87 -27.69 68.98 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 119.431 -0.908 . . . . 1.0 112.687 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.1 m -77.42 -6.26 52.77 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.006 -0.997 . . . . 1.0 112.127 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.457 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 11.2 m0 -69.37 -62.57 2.51 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 108.724 -0.843 . . . . 1.0 108.724 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.457 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 94.0 Cg_endo -66.62 -42.45 9.29 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.886 2.39 . . . . 1.0 110.969 176.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.23 -45.37 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 123.962 0.789 . . . . 1.0 110.198 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 46.6 t -70.2 -44.76 68.0 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.483 -1.287 . . . . 1.0 107.765 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -47.74 -41.3 22.71 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 122.37 1.081 . . . . 1.0 108.93 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -70.86 -57.7 4.34 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 113.091 -1.868 . . . . 1.0 113.107 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.5 mmm -62.59 -54.92 32.47 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 115.928 1.825 . . . . 1.0 115.928 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -106.85 -55.91 2.26 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 114.532 -1.213 . . . . 1.0 112.998 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.84 41.05 0.27 Allowed Glycine 0 N--CA 1.492 2.426 0 O-C-N 123.467 0.48 . . . . 1.0 113.422 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.476 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 33.7 mmtp -133.58 109.55 12.24 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 107.897 -1.149 . . . . 1.0 107.897 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.27 6.79 2.05 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.989 2.459 . . . . 1.0 112.055 -175.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.1 115.19 20.75 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.588 -1.264 . . . . 1.0 107.588 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -139.41 155.25 23.98 Favored Glycine 0 N--CA 1.493 2.495 0 CA-C-N 114.195 -1.366 . . . . 1.0 114.628 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -116.46 179.7 3.93 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-N 113.882 -1.159 . . . . 1.0 108.965 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.3 t -120.29 164.28 16.54 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' LYS . 84.3 mtp -141.05 82.2 1.82 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.089 -1.819 . . . . 1.0 106.089 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.4 t30 31.79 51.77 0.19 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 125.088 1.493 . . . . 1.0 111.688 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.45 -36.42 3.16 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-O 117.463 -1.743 . . . . 1.0 115.782 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 29' ' ' MET . 35.6 mmtp -111.23 150.51 29.47 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-N 120.468 2.134 . . . . 1.0 110.811 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.5 m -71.79 163.43 27.82 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 118.72 2.859 . . . . 1.0 118.72 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.1 tpt85 -136.2 153.26 51.29 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 110.882 -2.872 . . . . 1.0 104.69 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.409 ' HB2' ' CD ' ' A' ' 1' ' ' PCA . 69.7 m -121.86 169.98 10.24 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.835 -1.543 . . . . 1.0 106.835 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -115.67 -172.54 2.17 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.418 -0.81 . . . . 1.0 109.63 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.2 p . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 115.89 -2.005 . . . . 1.0 110.173 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . 0.418 ' N ' ' HB2' ' A' ' 35' ' ' CYS . . . . . . . . 0 C--O 1.209 -1.04 0 N-CA-C 112.819 0.674 . . . . 1.0 112.819 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -101.62 151.4 22.04 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.909 0.861 . . . . 1.0 110.973 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.9 p -143.72 163.03 34.44 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 112.806 -1.997 . . . . 1.0 107.751 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -127.06 48.56 2.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 123.681 0.613 . . . . 1.0 111.086 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.29 156.68 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.641 -1.244 . . . . 1.0 107.641 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -70.31 109.99 5.02 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.133 0.79 . . . . 1.0 113.133 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.9 p -114.29 152.52 31.24 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 123.813 0.696 . . . . 1.0 110.401 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -145.72 48.52 1.24 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.57 -1.65 . . . . 1.0 108.2 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.37 125.47 2.52 Favored Glycine 0 N--CA 1.498 2.802 0 CA-C-N 114.123 -1.399 . . . . 1.0 111.472 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.3 m -39.72 -52.57 2.28 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.967 1.84 . . . . 1.0 115.967 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -40.55 -37.46 0.72 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.826 1.417 . . . . 1.0 114.826 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -61.07 -35.35 76.73 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.804 -1.089 . . . . 1.0 113.771 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.0 m -77.26 -10.95 59.74 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.338 -1.301 . . . . 1.0 112.511 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.426 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 11.3 m0 -65.7 -61.83 5.23 Favored Pre-proline 0 C--N 1.307 -1.246 0 C-N-CA 119.636 -0.825 . . . . 1.0 109.171 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 83.1 Cg_endo -67.93 -43.58 4.91 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 123.015 2.477 . . . . 1.0 111.548 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.3 t -58.35 -47.59 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 123.787 0.679 . . . . 1.0 110.733 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.54 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 46.8 t -70.32 -42.83 71.43 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.19 -1.404 . . . . 1.0 107.951 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -48.41 -41.12 28.21 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.399 1.095 . . . . 1.0 108.161 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -70.65 -51.4 28.15 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.455 -1.702 . . . . 1.0 112.107 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 32.2 ttm -58.69 -59.15 5.86 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 114.513 1.301 . . . . 1.0 114.513 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -110.63 -55.8 2.43 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.531 -1.668 . . . . 1.0 114.056 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.39 45.09 0.25 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.124 -1.99 . . . . 1.0 108.124 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.54 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 40.5 mmtm -123.74 94.68 45.71 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 105.276 -2.12 . . . . 1.0 105.276 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -64.99 -1.88 4.86 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.577 2.185 . . . . 1.0 112.489 -168.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -115.9 142.78 46.32 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 105.589 -2.004 . . . . 1.0 105.589 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.43 153.7 24.76 Favored Glycine 0 N--CA 1.489 2.17 0 CA-C-N 113.849 -1.523 . . . . 1.0 110.701 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.413 ' CG ' ' HB3' ' A' ' 34' ' ' ARG . 20.6 ptmt -131.27 176.64 8.11 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 119.253 -0.979 . . . . 1.0 109.243 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.5 t -114.16 162.3 16.7 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.108 0.48 . . . . 1.0 110.433 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.2 mtp -135.23 75.84 1.59 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.595 -1.631 . . . . 1.0 106.595 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 29.67 55.74 0.15 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 125.599 1.812 . . . . 1.0 110.89 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.18 -36.39 2.83 Favored Glycine 0 N--CA 1.483 1.806 0 CA-C-N 112.971 -1.922 . . . . 1.0 115.602 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -111.93 139.61 47.28 Favored 'General case' 0 C--O 1.206 -1.229 0 CA-C-N 119.286 1.543 . . . . 1.0 110.856 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 52.2 t -71.74 161.67 30.62 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 112.878 -1.965 . . . . 1.0 114.704 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.413 ' HB3' ' CG ' ' A' ' 27' ' ' LYS . 18.3 tpt85 -141.26 152.71 44.75 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.973 -1.467 . . . . 1.0 107.221 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.418 ' HB2' ' N ' ' A' ' 1' ' ' PCA . 49.0 m -116.39 169.57 9.21 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 124.545 1.153 . . . . 1.0 109.4 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -120.07 -171.25 2.11 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.321 -1.309 . . . . 1.0 109.01 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.7 m . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 116.275 -1.821 . . . . 1.0 108.99 -179.611 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 111.941 0.348 . . . . 1.0 111.941 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -100.2 159.33 15.2 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.198 0.523 . . . . 1.0 109.86 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 82.4 p -133.71 176.02 8.93 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 114.171 -1.377 . . . . 1.0 109.028 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -124.67 30.04 6.07 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 123.98 0.8 . . . . 1.0 109.382 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.48 153.37 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 115.255 -0.884 . . . . 1.0 109.311 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -71.1 155.26 40.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.988 0.805 . . . . 1.0 111.808 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.8 p -134.71 157.29 47.05 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.043 -0.663 . . . . 1.0 110.881 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.8 p -136.56 43.85 2.42 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.469 -1.241 . . . . 1.0 108.815 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.53 167.63 13.45 Favored Glycine 0 N--CA 1.494 2.564 0 CA-C-N 113.926 -1.488 . . . . 1.0 110.191 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.9 m -65.21 -59.39 4.13 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 114.46 1.282 . . . . 1.0 114.46 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -40.49 -39.23 0.97 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 114.692 1.368 . . . . 1.0 114.692 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -33.84 70.49 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 122.077 0.941 . . . . 1.0 112.806 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 60.6 m -78.36 -7.91 57.84 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.218 -1.355 . . . . 1.0 113.578 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.407 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 11.3 m95 -69.57 -60.56 3.8 Favored Pre-proline 0 C--N 1.304 -1.373 0 C-N-CA 119.554 -0.858 . . . . 1.0 108.877 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.407 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 97.6 Cg_endo -66.99 -42.92 7.37 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.891 2.394 . . . . 1.0 111.185 176.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.67 -47.9 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 123.91 0.756 . . . . 1.0 110.572 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.561 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 49.3 t -70.01 -40.61 75.14 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.702 -1.199 . . . . 1.0 108.438 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -51.41 -42.17 61.26 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.422 -0.955 . . . . 1.0 108.422 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 -70.56 -50.01 41.96 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 113.971 -1.468 . . . . 1.0 111.997 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.4 ttm -54.02 -54.59 37.04 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -122.51 -55.69 1.82 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 113.62 -1.627 . . . . 1.0 112.808 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.43 42.6 0.21 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.561 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 6.1 mptp? -120.22 92.3 47.03 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 106.409 -1.7 . . . . 1.0 106.409 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -64.82 -5.01 9.67 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.963 2.442 . . . . 1.0 113.555 -164.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -115.48 143.17 45.7 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 105.95 -1.87 . . . . 1.0 105.95 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.96 154.56 25.61 Favored Glycine 0 N--CA 1.488 2.117 0 CA-C-N 113.382 -1.735 . . . . 1.0 111.281 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.404 ' CG ' ' HB3' ' A' ' 34' ' ' ARG . 20.7 ptmt -128.23 178.81 5.99 Favored 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 119.388 -0.925 . . . . 1.0 109.064 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.0 t -116.45 157.68 24.76 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 73.2 mtm -133.71 82.93 2.01 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.254 -1.758 . . . . 1.0 106.254 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 29.46 50.7 0.07 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 125.307 1.629 . . . . 1.0 112.919 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.96 -34.04 3.53 Favored Glycine 0 N--CA 1.483 1.777 0 CA-C-O 117.152 -1.916 . . . . 1.0 116.539 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -111.43 140.93 45.62 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 120.588 2.194 . . . . 1.0 109.817 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.1 t -71.86 158.11 36.66 Favored 'General case' 0 C--N 1.292 -1.891 0 CA-C-N 112.187 -2.279 . . . . 1.0 115.468 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.404 ' HB3' ' CG ' ' A' ' 27' ' ' LYS . 5.1 tpt180 -139.25 155.5 47.72 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.31 -1.768 . . . . 1.0 107.748 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.2 m -118.75 168.25 10.92 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 124.929 1.393 . . . . 1.0 108.338 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -118.62 -179.48 3.81 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.392 -0.822 . . . . 1.0 110.822 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.5 m . . . . . 0 N--CA 1.504 2.237 0 O-C-N 125.701 1.876 . . . . 1.0 115.684 -179.917 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 111.848 0.314 . . . . 1.0 111.848 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -102.56 153.73 19.8 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.822 0.82 . . . . 1.0 110.096 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 p -141.13 165.07 28.55 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.211 -1.813 . . . . 1.0 109.825 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -125.85 55.72 1.44 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.831 -1.077 . . . . 1.0 108.776 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.68 148.32 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-N 114.672 -1.149 . . . . 1.0 108.437 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -70.1 102.57 2.09 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.853 -1.067 . . . . 1.0 110.557 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.7 p -116.24 158.61 23.07 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 124.407 1.067 . . . . 1.0 111.842 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 t -137.72 45.78 2.14 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.931 -1.486 . . . . 1.0 107.147 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.07 157.43 9.68 Favored Glycine 0 N--CA 1.494 2.522 0 CA-C-N 113.243 -1.799 . . . . 1.0 110.084 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.2 m -40.31 -49.68 2.76 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 116.148 1.906 . . . . 1.0 116.148 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -39.69 -31.2 0.09 Allowed 'General case' 0 C--O 1.205 -1.25 0 C-N-CA 125.577 1.551 . . . . 1.0 114.905 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -70.15 -40.39 74.79 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.789 0.804 . . . . 1.0 113.047 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 96.1 m -70.72 -26.21 63.29 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.023 -1.444 . . . . 1.0 113.058 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -57.19 -65.79 1.57 Allowed Pre-proline 0 C--N 1.3 -1.57 0 C-N-CA 118.999 -1.08 . . . . 1.0 110.775 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -64.37 -45.84 8.7 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 122.835 2.357 . . . . 1.0 111.591 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 88.8 t -62.33 -49.01 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 124.082 0.864 . . . . 1.0 112.455 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 24.8 t -70.28 -31.94 69.51 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.973 -1.091 . . . . 1.0 108.414 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -61.52 -49.24 77.5 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.617 -0.883 . . . . 1.0 108.617 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -70.79 -38.82 73.39 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.164 -1.014 . . . . 1.0 113.236 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.0 mtp -69.64 -56.35 7.5 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 115.267 1.58 . . . . 1.0 115.267 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -106.52 -58.19 1.96 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.793 0.683 . . . . 1.0 112.091 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.55 37.62 0.58 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.821 -1.712 . . . . 1.0 108.821 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 5.0 mptp? -122.85 79.37 49.69 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 105.483 -2.043 . . . . 1.0 105.483 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -66.43 10.96 0.18 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 123.042 2.494 . . . . 1.0 113.751 -170.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.404 ' H ' ' C ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -128.51 109.72 11.64 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.826 -1.175 . . . . 1.0 107.826 179.626 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.05 174.41 23.22 Favored Glycine 0 N--CA 1.492 2.384 0 CA-C-N 112.546 -2.115 . . . . 1.0 111.291 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.432 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 18.6 ptmt -132.95 171.71 13.59 Favored 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 108.891 -0.781 . . . . 1.0 108.891 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.2 t -109.27 160.23 16.3 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 120.181 -0.608 . . . . 1.0 110.019 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 56.9 mtp -132.61 76.93 1.72 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.098 -1.815 . . . . 1.0 106.098 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 30.87 55.36 0.2 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 125.606 1.816 . . . . 1.0 110.954 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.96 -35.43 3.39 Favored Glycine 0 N--CA 1.483 1.804 0 CA-C-N 113.353 -1.749 . . . . 1.0 115.815 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -112.01 137.55 49.88 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 119.315 1.557 . . . . 1.0 110.698 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 34' ' ' ARG . 39.1 t -72.18 158.31 36.13 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 117.696 2.48 . . . . 1.0 117.696 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.516 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 10.3 tpt180 -138.95 149.26 44.55 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 106.409 -1.7 . . . . 1.0 106.409 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.3 m -123.93 163.55 21.1 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 104.906 -2.257 . . . . 1.0 104.906 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -112.88 170.08 8.46 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.656 -1.609 . . . . 1.0 106.656 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.507 2.377 0 N-CA-C 116.225 1.935 . . . . 1.0 116.225 -179.902 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 121.292 0.568 . . . . 1.0 111.735 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -114.61 163.81 14.89 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.4 p -135.1 169.66 17.09 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 123.891 0.745 . . . . 1.0 110.894 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.59 24.0 11.16 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.085 -1.416 . . . . 1.0 107.659 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.31 145.73 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.494 ' HZ1' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -71.04 163.24 27.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.277 0.985 . . . . 1.0 112.516 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.494 ' N ' ' HZ1' ' A' ' 6' ' ' LYS . 8.4 p -142.61 159.55 42.01 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 124.148 0.905 . . . . 1.0 111.353 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 p -131.89 41.02 3.31 Favored 'General case' 0 C--N 1.31 -1.116 0 O-C-N 124.465 1.103 . . . . 1.0 108.188 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.45 171.22 17.73 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.115 -1.594 . . . . 1.0 109.115 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.5 p -48.8 -60.35 2.82 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.816 0.672 . . . . 1.0 112.816 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -40.06 -39.43 0.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -70.45 -36.2 73.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.287 0.992 . . . . 1.0 112.104 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.462 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 49.0 t -76.01 -13.94 60.23 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.643 -1.617 . . . . 1.0 112.326 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.424 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 7.5 m0 -69.14 -56.2 9.09 Favored Pre-proline 0 N--CA 1.485 1.289 0 CA-C-O 118.193 -0.908 . . . . 1.0 110.695 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 90.3 Cg_endo -65.34 -42.17 13.93 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.906 2.404 . . . . 1.0 110.643 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.48 -48.45 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 123.925 0.766 . . . . 1.0 110.823 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.4 t -68.57 -44.61 74.05 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.146 -1.022 . . . . 1.0 108.915 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -52.43 -39.41 60.99 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.951 0.881 . . . . 1.0 109.081 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -70.46 -52.88 18.96 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 114.21 -1.359 . . . . 1.0 111.141 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 34.4 ttm -56.07 -56.96 14.51 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.537 0.94 . . . . 1.0 113.537 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -113.07 -61.16 1.78 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 113.098 -1.864 . . . . 1.0 113.915 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.07 41.25 0.45 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 107.885 -2.086 . . . . 1.0 107.885 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -123.42 81.83 53.17 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 105.904 -1.887 . . . . 1.0 105.904 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -65.13 1.35 2.0 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 123.092 2.528 . . . . 1.0 114.94 -157.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -100.22 121.81 42.04 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 100.698 -3.816 . . . . 1.0 100.698 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.15 143.88 12.42 Favored Glycine 0 C--N 1.294 -1.761 0 CA-C-N 113.786 -1.552 . . . . 1.0 110.726 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -125.77 160.3 30.13 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 106.517 -1.66 . . . . 1.0 106.517 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.9 t -101.05 157.49 16.72 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.969 -0.693 . . . . 1.0 112.629 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.4 mtm -132.3 89.88 2.72 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.527 -1.657 . . . . 1.0 106.527 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 30.34 48.31 0.05 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 125.097 1.498 . . . . 1.0 113.414 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.84 -31.54 4.93 Favored Glycine 0 N--CA 1.487 2.036 0 CA-C-O 117.112 -1.938 . . . . 1.0 117.912 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.451 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -113.01 142.68 45.43 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 120.719 2.259 . . . . 1.0 110.028 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 13.3 t -71.6 157.61 37.67 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.362 -1.745 . . . . 1.0 114.057 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.462 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 27.7 ttt85 -133.37 140.32 47.3 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 112.519 -2.128 . . . . 1.0 106.362 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.412 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 65.2 m -109.85 166.52 10.86 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 123.969 0.793 . . . . 1.0 112.23 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 35' ' ' CYS . 47.4 m-85 -127.56 -165.0 1.42 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.42 -1.718 . . . . 1.0 110.774 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.4 t . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.512 -1.233 . . . . 1.0 110.004 -179.723 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.17 0 CA-C-O 121.606 0.717 . . . . 1.0 112.552 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -84.84 171.45 12.22 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.524 -1.216 . . . . 1.0 109.473 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -124.3 173.39 8.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 124.034 0.833 . . . . 1.0 111.739 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.2 23.34 11.91 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.267 -1.788 . . . . 1.0 107.161 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -124.02 151.87 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 115.323 -0.853 . . . . 1.0 109.074 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -71.11 159.71 34.21 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.536 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.528 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 28.8 p -136.82 150.42 48.31 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.769 -0.772 . . . . 1.0 111.392 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.5 p -137.04 45.09 2.27 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.152 -1.385 . . . . 1.0 107.755 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.58 159.84 11.27 Favored Glycine 0 N--CA 1.494 2.548 0 CA-C-N 113.466 -1.697 . . . . 1.0 110.112 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.8 m -50.71 -54.47 22.95 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 113.896 1.073 . . . . 1.0 113.896 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -40.33 -36.91 0.59 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.204 1.557 . . . . 1.0 115.204 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -70.41 -34.82 72.96 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.233 -0.894 . . . . 1.0 112.432 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.5 m -73.6 -18.1 61.09 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.332 -1.304 . . . . 1.0 112.464 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.439 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 9.7 m0 -63.08 -60.88 8.51 Favored Pre-proline 0 N--CA 1.483 1.2 0 CA-C-O 118.364 -0.827 . . . . 1.0 110.887 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -65.74 -45.71 6.12 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 123.024 2.482 . . . . 1.0 111.344 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.26 -45.47 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 123.948 0.78 . . . . 1.0 111.097 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 52.7 t -70.0 -48.52 57.79 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.596 -1.261 . . . . 1.0 107.596 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -47.63 -38.87 15.63 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 122.136 0.97 . . . . 1.0 108.89 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -70.67 -58.49 3.61 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.36 -1.745 . . . . 1.0 112.433 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 70.7 mtm -68.7 -53.83 19.83 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 116.808 2.151 . . . . 1.0 116.808 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -99.01 -57.52 2.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 124.057 0.848 . . . . 1.0 112.715 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.59 34.45 0.86 Allowed Glycine 0 N--CA 1.495 2.606 0 O-C-N 123.837 0.711 . . . . 1.0 111.743 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.468 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 12.9 mptt -122.97 107.07 33.48 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 104.905 -2.257 . . . . 1.0 104.905 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.21 -4.53 13.84 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.913 2.409 . . . . 1.0 112.527 -163.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.439 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 29.3 m-80 -107.17 -171.91 1.97 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.143 -1.429 . . . . 1.0 107.143 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.35 163.94 10.44 Favored Glycine 0 N--CA 1.483 1.8 0 CA-C-N 112.302 -2.226 . . . . 1.0 110.376 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.533 ' HE2' ' CE2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -132.59 177.14 7.85 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 113.896 -1.152 . . . . 1.0 108.57 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.5 t -105.6 155.61 19.05 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.737 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 70.6 mtm -131.04 82.3 2.04 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 107.204 -1.406 . . . . 1.0 107.204 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 m120 29.49 51.38 0.08 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 125.463 1.727 . . . . 1.0 112.442 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.29 -33.84 3.53 Favored Glycine 0 N--CA 1.486 2.016 0 CA-C-N 113.082 -1.872 . . . . 1.0 116.864 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 6.2 mptt -117.43 141.34 48.46 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 120.228 2.014 . . . . 1.0 110.272 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 3.0 m -72.32 156.13 39.43 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 113.805 -1.543 . . . . 1.0 114.616 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.523 ' HG3' ' HZ3' ' A' ' 27' ' ' LYS . 9.1 tpt180 -135.1 152.71 51.91 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.76 -1.941 . . . . 1.0 105.76 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.5 m -117.23 156.89 26.96 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 124.672 1.232 . . . . 1.0 110.794 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.533 ' CE2' ' HE2' ' A' ' 27' ' ' LYS . 58.1 m-85 -111.62 -179.12 3.62 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.35 -1.722 . . . . 1.0 106.35 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.2 m . . . . . 0 N--CA 1.505 2.325 0 N-CA-C 115.487 1.662 . . . . 1.0 115.487 179.837 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.444 0.64 . . . . 1.0 112.681 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -106.8 160.65 15.33 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.285 -0.87 . . . . 1.0 109.818 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.7 p -137.05 173.37 11.77 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 115.033 -0.985 . . . . 1.0 110.395 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -131.86 34.34 3.87 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 114.72 -1.127 . . . . 1.0 108.155 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.6 p -111.08 150.86 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-N 115.053 -0.976 . . . . 1.0 110.518 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -71.13 127.46 32.64 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.096 1.147 . . . . 1.0 114.096 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.429 ' SG ' ' C ' ' A' ' 32' ' ' LYS . 30.3 p -134.9 159.37 41.63 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.837 -0.62 . . . . 1.0 109.917 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -148.02 48.64 1.06 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.621 -1.251 . . . . 1.0 107.621 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.26 153.09 7.04 Favored Glycine 0 N--CA 1.498 2.83 0 CA-C-N 113.489 -1.687 . . . . 1.0 112.145 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.473 ' HG ' ' H ' ' A' ' 11' ' ' LYS . 65.4 p -53.62 -57.71 9.8 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 116.038 1.866 . . . . 1.0 116.038 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.473 ' H ' ' HG ' ' A' ' 10' ' ' SER . 19.6 ttpp -39.76 -41.8 1.16 Allowed 'General case' 0 C--O 1.204 -1.298 0 C-N-CA 124.63 1.172 . . . . 1.0 113.78 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -70.69 -38.37 73.69 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.598 -1.183 . . . . 1.0 111.7 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 13.3 t -72.19 -18.1 61.88 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 113.546 -1.661 . . . . 1.0 111.369 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -64.03 -61.29 7.06 Favored Pre-proline 0 N--CA 1.486 1.341 0 CA-C-O 118.449 -0.786 . . . . 1.0 111.331 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -64.83 -42.96 13.46 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 123.054 2.503 . . . . 1.0 110.499 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 66.6 t -56.85 -45.91 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 123.928 0.767 . . . . 1.0 110.057 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 38.2 t -67.76 -45.0 76.16 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -49.31 -42.73 42.23 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.433 1.111 . . . . 1.0 108.82 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -70.48 -49.25 50.42 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 113.168 -1.833 . . . . 1.0 112.208 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.0 ttp -57.01 -57.89 10.56 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 124.265 0.978 . . . . 1.0 113.007 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -116.82 -58.61 2.05 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 113.334 -1.757 . . . . 1.0 114.073 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.04 45.71 0.21 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.033 -1.627 . . . . 1.0 109.033 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.567 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 75.0 mmtt -127.01 72.22 76.13 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 105.852 -1.907 . . . . 1.0 105.852 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -60.89 -3.47 2.86 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.738 2.959 . . . . 1.0 114.359 -163.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.4 108.09 16.42 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.616 -1.624 . . . . 1.0 106.616 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.89 172.76 23.93 Favored Glycine 0 N--CA 1.486 2.011 0 CA-C-N 111.756 -2.475 . . . . 1.0 113.454 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -131.45 169.33 16.2 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 107.979 -1.119 . . . . 1.0 107.979 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.5 t -105.69 159.7 15.78 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 120.084 -0.647 . . . . 1.0 109.505 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.1 mtm -133.68 80.66 1.88 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.712 -1.131 . . . . 1.0 107.962 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 24.96 55.84 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 126.079 2.112 . . . . 1.0 110.632 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.5 -40.87 1.58 Allowed Glycine 0 N--CA 1.483 1.827 0 CA-C-N 111.858 -2.428 . . . . 1.0 116.205 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.429 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 48.1 mtmt -118.2 144.21 45.92 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 119.598 1.699 . . . . 1.0 113.584 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.1 t -71.86 157.97 36.9 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 112.487 -2.142 . . . . 1.0 112.813 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.432 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 12.9 tpt180 -136.78 144.74 43.9 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 112.699 -2.046 . . . . 1.0 105.862 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.9 m -118.5 163.79 16.24 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 105.557 -2.016 . . . . 1.0 105.557 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -113.55 169.22 9.13 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.601 -0.888 . . . . 1.0 108.601 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.506 2.371 0 CA-C-O 116.154 -1.879 . . . . 1.0 115.788 179.992 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 121.013 0.435 . . . . 1.0 111.449 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -96.01 148.72 22.36 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.837 0.827 . . . . 1.0 109.677 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.426 ' HG1' ' CB ' ' A' ' 33' ' ' CYS . 31.4 p -148.12 171.3 16.1 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 112.946 -1.934 . . . . 1.0 109.808 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -127.79 51.39 1.95 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.825 -1.08 . . . . 1.0 108.586 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.2 t -111.96 126.38 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.856 0.836 . . . . 1.0 110.355 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -39.36 110.86 0.15 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 117.438 2.384 . . . . 1.0 117.438 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.3 p -125.97 172.36 9.99 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.025 0.917 . . . . 1.0 110.409 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.0 m -123.86 -47.04 1.95 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 112.431 -2.168 . . . . 1.0 106.482 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.82 168.69 31.78 Favored Glycine 0 N--CA 1.492 2.433 0 CA-C-N 114.218 -1.355 . . . . 1.0 110.081 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -48.13 -63.72 0.99 Allowed 'General case' 0 N--CA 1.482 1.128 0 O-C-N 124.097 0.528 . . . . 1.0 111.816 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -41.09 -37.4 0.86 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.902 1.376 . . . . 1.0 114.615 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -70.59 -34.42 72.15 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 122.975 1.369 . . . . 1.0 110.51 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 14.5 t -80.83 0.96 32.65 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.35 -1.75 . . . . 1.0 111.352 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.426 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 5.5 m95 -70.05 -60.59 3.43 Favored Pre-proline 0 N--CA 1.482 1.147 0 N-CA-C 106.069 -1.826 . . . . 1.0 106.069 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 14' ' ' TRP . 73.9 Cg_endo -61.22 -43.98 26.12 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 122.422 2.081 . . . . 1.0 110.551 174.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.3 t -58.2 -45.3 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 C-N-CA 118.136 -1.425 . . . . 1.0 110.677 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 40.6 t -70.29 -31.03 68.21 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.308 -0.957 . . . . 1.0 109.047 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -59.47 -50.4 74.05 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -71.14 -48.22 53.25 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 119.348 -0.941 . . . . 1.0 113.373 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -50.28 73.98 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 114.1 1.148 . . . . 1.0 114.1 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -113.16 -61.57 1.72 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.7 1.37 . . . . 1.0 114.7 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.26 41.46 0.4 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.386 -1.885 . . . . 1.0 108.386 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.405 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 63.0 mmtt -130.38 81.52 67.92 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 104.645 -2.354 . . . . 1.0 104.645 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -62.1 -0.69 1.83 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.787 2.325 . . . . 1.0 114.222 -161.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.426 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 3.8 m120 -111.97 116.4 30.53 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 101.682 -3.451 . . . . 1.0 101.682 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.88 164.98 16.87 Favored Glycine 0 N--CA 1.486 1.979 0 CA-C-N 113.32 -1.763 . . . . 1.0 111.176 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.579 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . 73.6 tttt -128.33 170.78 12.67 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.826 -1.916 . . . . 1.0 105.826 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.5 t -123.06 159.7 27.91 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.219 0.533 . . . . 1.0 109.95 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.9 mtp -133.62 71.59 1.46 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.441 -1.689 . . . . 1.0 106.441 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 30.82 53.36 0.16 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 125.311 1.632 . . . . 1.0 111.981 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.72 -31.87 4.02 Favored Glycine 0 N--CA 1.48 1.575 0 CA-C-N 113.317 -1.765 . . . . 1.0 115.158 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.454 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 8.3 mptt -111.12 144.16 40.7 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-N 119.299 1.55 . . . . 1.0 108.755 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.426 ' CB ' ' HG1' ' A' ' 3' ' ' THR . 0.5 OUTLIER -71.82 160.63 32.25 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 114.919 1.451 . . . . 1.0 114.919 -179.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.3 tpt85 -142.72 159.23 42.64 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 104.022 -2.585 . . . . 1.0 104.022 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.9 m -128.03 169.81 13.61 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.204 0.526 . . . . 1.0 110.036 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.579 ' CZ ' ' HB2' ' A' ' 27' ' ' LYS . 11.7 m-85 -122.72 -174.3 2.89 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 109.533 -0.543 . . . . 1.0 109.533 -179.762 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.167 0 CA-C-O 121.112 0.482 . . . . 1.0 111.509 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -103.62 164.71 11.49 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.8 p -133.44 169.07 17.49 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 123.826 0.704 . . . . 1.0 110.552 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -114.86 23.79 12.3 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.361 -1.29 . . . . 1.0 107.729 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -124.29 143.18 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.347 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -71.13 161.71 30.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.192 0.932 . . . . 1.0 112.131 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.485 ' SG ' ' C ' ' A' ' 32' ' ' LYS . 11.0 p -142.12 158.76 43.37 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.955 0.784 . . . . 1.0 111.617 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.479 ' HG1' HE21 ' A' ' 12' ' ' GLN . 74.6 p -136.58 43.98 2.41 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.492 -1.231 . . . . 1.0 108.138 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.63 161.08 11.92 Favored Glycine 0 N--CA 1.494 2.56 0 CA-C-N 113.902 -1.499 . . . . 1.0 110.889 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.8 t -45.59 -58.86 3.09 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.164 -1.018 . . . . 1.0 113.594 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -40.83 -41.52 1.6 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 115.122 1.527 . . . . 1.0 115.122 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.479 HE21 ' HG1' ' A' ' 8' ' ' THR . 0.7 OUTLIER -70.75 -33.1 70.45 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.306 1.004 . . . . 1.0 111.995 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 41.4 t -76.55 -12.73 60.07 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 113.633 -1.621 . . . . 1.0 112.059 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.42 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 8.3 m0 -69.8 -59.38 4.6 Favored Pre-proline 0 N--CA 1.483 1.215 0 CA-C-O 118.497 -0.763 . . . . 1.0 109.645 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 72.4 Cg_endo -62.51 -43.84 20.46 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 122.826 2.351 . . . . 1.0 109.732 177.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.9 t -59.34 -46.72 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 123.946 0.779 . . . . 1.0 110.633 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 41.6 t -70.26 -31.58 69.02 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.625 -1.23 . . . . 1.0 109.724 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -63.42 -48.1 79.17 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -70.74 -44.26 67.16 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.525 -0.87 . . . . 1.0 111.843 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.4 mmm -63.93 -52.76 58.27 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 113.935 1.087 . . . . 1.0 113.935 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -110.12 -62.19 1.55 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 124.179 0.924 . . . . 1.0 112.656 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.99 42.24 0.45 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.615 -2.194 . . . . 1.0 107.615 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.41 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 48.9 mmtm -130.86 82.64 63.7 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 106.821 -1.548 . . . . 1.0 106.821 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -62.55 0.24 1.55 Allowed 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.873 2.382 . . . . 1.0 114.609 -163.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -103.08 117.06 33.73 Favored 'General case' 0 C--N 1.308 -1.224 1 N-CA-C 99.485 -4.265 . . . . 1.0 99.485 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.11 144.1 13.36 Favored Glycine 0 C--N 1.292 -1.916 0 CA-C-N 113.604 -1.635 . . . . 1.0 110.534 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -126.08 165.32 19.07 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 107.08 -1.452 . . . . 1.0 107.08 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.2 t -104.59 148.97 25.92 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 113.206 0.817 . . . . 1.0 113.206 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.3 ptp -128.97 98.53 4.97 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.354 -1.294 . . . . 1.0 108.743 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.0 t30 32.4 47.06 0.08 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 113.02 -1.9 . . . . 1.0 113.124 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.49 -26.59 8.04 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 118.686 2.234 . . . . 1.0 118.686 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.485 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 93.2 mttt -114.26 149.95 35.11 Favored 'General case' 0 C--O 1.204 -1.291 0 CA-C-N 121.167 2.483 . . . . 1.0 109.96 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.1 t -72.28 159.03 34.75 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.814 -1.085 . . . . 1.0 111.946 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.448 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 26.4 ttt85 -133.05 141.22 48.11 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 112.956 -1.929 . . . . 1.0 106.057 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -111.99 166.19 11.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 124.172 0.92 . . . . 1.0 111.743 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -126.36 -166.25 1.55 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.175 -1.829 . . . . 1.0 110.472 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.246 -1.359 . . . . 1.0 111.232 -179.772 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 121.529 0.681 . . . . 1.0 112.837 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -92.93 165.23 12.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.901 -1.045 . . . . 1.0 111.377 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.7 p -132.3 179.13 6.3 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.612 -1.176 . . . . 1.0 110.962 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.22 26.3 9.72 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.405 -1.27 . . . . 1.0 109.398 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.8 t -123.98 141.9 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 31.0 mmmt -71.36 148.51 46.94 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.866 1.432 . . . . 1.0 114.866 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.7 p -140.42 173.08 11.86 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.35 1.071 . . . . 1.0 112.041 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.5 ' H ' HE22 ' A' ' 12' ' ' GLN . 10.1 t -136.38 -38.35 0.68 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 111.997 -2.365 . . . . 1.0 108.986 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.74 163.48 23.76 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 123.747 0.654 . . . . 1.0 112.78 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.52 ' HG ' ' H ' ' A' ' 11' ' ' LYS . 54.5 p -70.29 -54.51 12.37 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.341 0.867 . . . . 1.0 113.341 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.52 ' H ' ' HG ' ' A' ' 10' ' ' SER . 98.8 mttt -58.44 -20.15 42.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 124.322 1.014 . . . . 1.0 111.459 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.5 HE22 ' H ' ' A' ' 8' ' ' THR . 4.9 tt0 -70.07 -31.0 68.38 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.219 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 3.9 t -80.11 -1.57 40.7 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.465 -1.243 . . . . 1.0 113.207 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.421 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 10.5 m0 -70.27 -60.4 3.42 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.406 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 87.7 Cg_endo -64.95 -44.35 10.12 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.794 2.329 . . . . 1.0 111.747 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.8 t -58.26 -45.21 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 119.736 -0.786 . . . . 1.0 110.892 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.4 t -69.98 -44.3 69.71 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -48.24 -42.06 29.31 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 122.355 1.074 . . . . 1.0 108.365 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -70.73 -47.64 58.71 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 113.114 -1.857 . . . . 1.0 112.792 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 94.9 mtp -69.19 -58.24 4.31 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 116.312 1.968 . . . . 1.0 116.312 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -102.66 -55.23 2.48 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.905 -1.043 . . . . 1.0 112.641 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.47 37.3 0.38 Allowed Glycine 0 N--CA 1.489 2.218 0 O-C-N 124.08 0.863 . . . . 1.0 111.331 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.54 115.07 22.98 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 106.548 -1.649 . . . . 1.0 106.548 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -74.46 15.36 0.67 Allowed 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.734 2.289 . . . . 1.0 112.66 -174.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.504 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 5.5 m120 -123.65 -177.13 3.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.76 0.791 . . . . 1.0 109.065 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.86 169.73 12.16 Favored Glycine 0 N--CA 1.49 2.293 0 CA-C-N 114.029 -1.441 . . . . 1.0 114.072 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 49.0 mtpt -132.21 -167.82 1.95 Allowed 'General case' 0 N--CA 1.504 2.25 0 CA-C-N 113.005 -1.597 . . . . 1.0 111.296 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.5 t -126.37 154.45 43.53 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.035 -1.839 . . . . 1.0 106.035 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.6 mtm -132.37 78.42 1.8 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.637 -1.246 . . . . 1.0 107.637 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.0 t30 28.76 52.64 0.07 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 125.835 1.959 . . . . 1.0 111.143 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 127.11 -35.49 2.83 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-O 117.019 -1.99 . . . . 1.0 116.273 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -109.23 146.01 34.93 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-N 120.853 2.326 . . . . 1.0 109.607 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -70.97 159.97 33.75 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.896 -1.047 . . . . 1.0 111.499 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.481 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 4.6 tpt180 -134.51 146.77 50.03 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 106.237 -1.764 . . . . 1.0 106.237 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.7 m -120.38 163.04 18.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.48 -1.674 . . . . 1.0 106.48 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.504 ' CD2' ' HB3' ' A' ' 25' ' ' ASN . 11.1 m-30 -114.38 178.11 4.4 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.393 -1.706 . . . . 1.0 106.393 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.506 2.35 0 O-C-N 125.117 1.511 . . . . 1.0 114.451 -179.73 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 114.073 1.138 . . . . 1.0 114.073 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -55.1 168.28 0.34 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.428 -1.715 . . . . 1.0 112.965 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.439 HG23 ' SG ' ' A' ' 33' ' ' CYS . 68.4 p -131.12 -179.95 5.64 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.078 -0.964 . . . . 1.0 112.316 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.37 -4.41 11.83 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.117 -1.856 . . . . 1.0 109.168 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.07 141.82 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 107.104 -1.443 . . . . 1.0 107.104 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -71.17 167.39 19.46 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.341 1.978 . . . . 1.0 116.341 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.2 p -139.15 177.52 7.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 124.819 1.324 . . . . 1.0 110.613 179.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.8 m -123.18 -50.11 1.92 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 104.889 -2.263 . . . . 1.0 104.889 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.05 167.85 31.79 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.581 -1.807 . . . . 1.0 108.581 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 65.4 m -46.49 -56.34 6.11 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.403 0.621 . . . . 1.0 110.19 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -48.7 -39.81 26.0 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.329 -1.305 . . . . 1.0 112.848 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -70.69 -35.21 72.67 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.846 1.308 . . . . 1.0 109.751 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 4.0 t -74.46 -12.33 60.47 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 113.653 -1.612 . . . . 1.0 113.015 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.484 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 5.0 m0 -65.9 -58.73 10.46 Favored Pre-proline 0 C--N 1.306 -1.285 0 CA-C-O 118.752 -0.642 . . . . 1.0 109.603 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -61.3 -42.86 31.89 Favored 'Trans proline' 0 N--CA 1.488 1.158 0 C-N-CA 122.567 2.178 . . . . 1.0 110.44 173.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.9 t -55.04 -44.08 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 119.335 -0.946 . . . . 1.0 110.906 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.428 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 41.2 t -70.31 -41.53 73.19 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -50.16 -43.98 52.43 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.306 -0.998 . . . . 1.0 108.306 179.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -70.85 -53.02 16.75 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 113.354 -1.748 . . . . 1.0 113.238 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.419 ' SD ' ' HB ' ' A' ' 3' ' ' THR . 20.3 ttp -55.67 -55.77 28.3 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 115.309 1.596 . . . . 1.0 115.309 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -116.13 -56.86 2.27 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 113.474 -1.693 . . . . 1.0 113.033 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.73 39.88 0.28 Allowed Glycine 0 N--CA 1.491 2.322 0 O-C-N 123.812 0.695 . . . . 1.0 111.623 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 5.5 mppt? -129.29 91.37 41.97 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 105.551 -2.018 . . . . 1.0 105.551 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -64.63 3.58 0.84 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 123.045 2.497 . . . . 1.0 113.981 -165.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.484 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 55.4 m-80 -111.62 -178.05 3.34 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.499 -1.667 . . . . 1.0 106.499 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.61 -176.03 23.98 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.269 -1.443 . . . . 1.0 114.745 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.543 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 28.5 mtpp -131.64 177.1 7.77 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 113.138 -1.531 . . . . 1.0 111.927 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.0 t -119.26 152.28 36.95 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 179.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.8 mtm -131.76 80.11 1.91 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.079 -0.964 . . . . 1.0 108.627 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.2 t30 28.73 52.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 125.586 1.804 . . . . 1.0 111.919 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.59 -31.4 4.18 Favored Glycine 0 N--CA 1.485 1.965 0 CA-C-O 116.405 -2.33 . . . . 1.0 116.912 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -115.88 141.17 48.46 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 120.795 2.297 . . . . 1.0 109.32 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.439 ' SG ' HG23 ' A' ' 3' ' ' THR . 33.1 t -71.87 160.64 32.22 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.652 -1.613 . . . . 1.0 113.517 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.557 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.2 tpt180 -133.61 146.75 51.23 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.431 -2.063 . . . . 1.0 105.431 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.3 m -117.61 164.82 14.37 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.248 -1.019 . . . . 1.0 108.248 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.529 ' CZ ' ' HG3' ' A' ' 27' ' ' LYS . 13.8 m-85 -117.63 -178.01 3.38 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.295 -1.32 . . . . 1.0 107.572 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.496 1.86 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 -179.962 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.404 0.621 . . . . 1.0 111.867 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -87.8 168.06 13.27 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.191 -0.913 . . . . 1.0 109.863 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.441 HG23 ' SG ' ' A' ' 33' ' ' CYS . 79.7 p -127.89 -173.46 2.94 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.052 0.845 . . . . 1.0 112.297 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -124.17 -7.45 7.68 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 113.403 -1.726 . . . . 1.0 110.273 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.4 t -111.54 145.34 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.498 -0.927 . . . . 1.0 108.498 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 171.02 11.68 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 116.923 2.194 . . . . 1.0 116.923 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 p -141.2 173.11 11.8 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.175 -1.375 . . . . 1.0 110.478 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.2 m -121.49 -49.49 2.14 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.854 -2.276 . . . . 1.0 104.854 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.19 169.59 33.22 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.542 -1.823 . . . . 1.0 108.542 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.6 t -43.54 -58.78 2.46 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.51 0.671 . . . . 1.0 110.521 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.26 -39.4 14.28 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 113.859 -1.519 . . . . 1.0 114.219 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -70.23 -32.66 70.62 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.066 0.936 . . . . 1.0 111.175 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 15.3 t -76.44 -12.32 60.03 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.949 -1.478 . . . . 1.0 113.111 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.407 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 6.9 m0 -66.78 -58.99 8.59 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 123.822 0.701 . . . . 1.0 109.462 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 85.3 Cg_endo -63.31 -42.88 20.32 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.883 2.389 . . . . 1.0 110.681 175.316 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.9 t -55.78 -46.45 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 C-N-CA 120.104 -0.638 . . . . 1.0 110.398 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.8 t -68.97 -42.55 76.46 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -50.48 -42.69 54.86 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.252 1.025 . . . . 1.0 108.534 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -70.65 -51.37 28.3 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.691 -1.595 . . . . 1.0 112.741 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.4 ttp -58.31 -52.41 65.7 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.026 1.121 . . . . 1.0 114.026 -179.258 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -116.86 -58.03 2.11 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.484 -1.235 . . . . 1.0 114.083 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.93 40.67 0.19 Allowed Glycine 0 N--CA 1.488 2.125 0 O-C-N 123.774 0.671 . . . . 1.0 112.501 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -127.79 103.31 21.67 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 105.694 -1.965 . . . . 1.0 105.694 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.71 10.08 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.993 2.462 . . . . 1.0 113.002 -168.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.404 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 73.5 m-80 -116.03 -176.3 2.92 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.954 -1.498 . . . . 1.0 106.954 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.406 ' HA2' ' CD1' ' A' ' 36' ' ' TYR . . . 143.44 175.98 17.05 Favored Glycine 0 N--CA 1.489 2.175 0 CA-C-N 113.994 -1.457 . . . . 1.0 113.069 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.474 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 51.8 mtpt -133.0 178.73 6.66 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 113.061 -1.57 . . . . 1.0 109.466 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -114.77 155.55 26.5 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.961 -1.496 . . . . 1.0 106.961 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 48.4 mtp -132.5 74.96 1.6 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.292 -1.373 . . . . 1.0 107.292 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 31.13 54.52 0.21 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 125.375 1.672 . . . . 1.0 110.995 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.88 -29.8 5.7 Favored Glycine 0 N--CA 1.487 2.07 0 CA-C-O 116.829 -2.095 . . . . 1.0 116.469 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.449 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 7.1 mptt -113.73 142.5 45.96 Favored 'General case' 0 C--O 1.206 -1.207 0 CA-C-N 120.387 2.093 . . . . 1.0 108.446 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.441 ' SG ' HG23 ' A' ' 3' ' ' THR . 36.4 t -71.55 160.82 32.02 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.574 -1.194 . . . . 1.0 113.216 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.581 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 5.3 tpt180 -131.6 140.12 49.34 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.274 -2.121 . . . . 1.0 105.274 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.7 m -111.74 161.55 16.18 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.116 0.96 . . . . 1.0 110.13 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.406 ' CD1' ' HA2' ' A' ' 26' ' ' GLY . 7.2 m-30 -115.88 -168.99 1.51 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 111.939 -2.391 . . . . 1.0 106.816 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 107.509 -1.293 . . . . 1.0 107.509 -179.816 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 121.746 0.784 . . . . 1.0 110.771 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -89.15 160.79 16.82 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 113.709 -1.587 . . . . 1.0 107.188 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.6 p -131.47 174.01 10.52 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 123.641 0.588 . . . . 1.0 110.72 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -125.3 32.51 5.35 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.571 -1.27 . . . . 1.0 107.571 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.1 p -111.29 134.95 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.151 -1.425 . . . . 1.0 107.151 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -70.67 140.7 51.58 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 113.454 0.909 . . . . 1.0 113.454 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.426 ' SG ' ' C ' ' A' ' 32' ' ' LYS . 2.5 p -136.21 170.41 16.06 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.063 0.935 . . . . 1.0 111.909 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.4 m -130.25 -43.19 1.18 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 112.384 -2.189 . . . . 1.0 108.516 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.19 172.08 21.59 Favored Glycine 0 N--CA 1.497 2.742 0 O-C-N 124.431 1.082 . . . . 1.0 112.411 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.1 p -70.1 -57.66 4.7 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.461 -0.869 . . . . 1.0 112.838 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -39.86 -32.79 0.17 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.82 -36.64 73.02 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 122.228 1.013 . . . . 1.0 111.031 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 41.8 t -73.6 -10.13 59.39 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.467 -1.242 . . . . 1.0 111.574 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.408 ' CD1' ' O ' ' A' ' 26' ' ' GLY . 9.8 m95 -69.94 -61.04 3.16 Favored Pre-proline 0 N--CA 1.484 1.231 0 CA-C-O 118.462 -0.78 . . . . 1.0 110.104 179.366 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -63.04 -40.42 34.05 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.771 2.314 . . . . 1.0 109.752 177.088 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.8 t -58.83 -49.77 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 123.837 0.71 . . . . 1.0 110.356 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.9 t -68.96 -34.63 75.64 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 118.946 -1.102 . . . . 1.0 109.295 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.08 -38.74 89.98 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -70.44 -52.36 22.76 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.642 -1.163 . . . . 1.0 111.035 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 73.1 mtm -61.35 -52.11 66.01 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.629 0.974 . . . . 1.0 113.629 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -111.26 -62.48 1.54 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 113.93 1.085 . . . . 1.0 113.93 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.41 43.68 0.42 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 106.922 -2.471 . . . . 1.0 106.922 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -127.82 81.94 69.33 Favored Pre-proline 0 N--CA 1.493 1.718 0 CA-C-N 113.496 -1.352 . . . . 1.0 107.584 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.7 0.18 3.23 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 123.684 2.923 . . . . 1.0 116.266 -150.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 47.0 m-80 -103.94 129.25 51.47 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 104.771 -2.307 . . . . 1.0 104.771 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 14' ' ' TRP . . . -146.82 145.86 15.14 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-N 113.958 -1.474 . . . . 1.0 110.815 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -131.46 170.51 14.59 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 106.869 -1.53 . . . . 1.0 106.869 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.3 t -107.09 150.61 26.37 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.898 -0.721 . . . . 1.0 110.691 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.3 ptm -129.18 102.77 6.61 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.916 -1.493 . . . . 1.0 108.566 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.7 p30 31.69 44.34 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 113.641 -1.618 . . . . 1.0 114.194 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.94 -28.57 6.34 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 118.592 2.197 . . . . 1.0 118.592 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 35.3 mmtp -114.99 156.64 24.72 Favored 'General case' 0 C--O 1.202 -1.419 0 CA-C-N 120.87 2.335 . . . . 1.0 111.44 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.8 t -71.87 160.27 32.86 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.155 0.978 . . . . 1.0 111.0 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.447 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.3 tpt180 -136.26 140.45 43.45 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 105.93 -1.878 . . . . 1.0 105.93 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.9 m -109.39 164.01 12.88 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.437 1.113 . . . . 1.0 113.242 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.408 ' HB2' ' HB2' ' A' ' 25' ' ' ASN . 42.9 m-85 -128.16 -160.45 1.02 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 111.931 -2.395 . . . . 1.0 108.287 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.487 1.414 0 O-C-N 125.029 1.456 . . . . 1.0 107.756 179.898 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.14 0 CA-C-O 121.199 0.523 . . . . 1.0 112.133 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -86.64 168.25 13.79 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.392 -0.822 . . . . 1.0 109.446 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.495 HG22 ' SG ' ' A' ' 33' ' ' CYS . 58.9 p -127.3 -175.41 3.43 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.71 0.767 . . . . 1.0 112.803 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -124.22 -7.21 7.66 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.05 -1.886 . . . . 1.0 110.153 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.7 t -111.64 144.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.35 170.99 11.99 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 116.515 2.042 . . . . 1.0 116.515 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.3 p -141.23 173.03 11.88 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.225 -1.352 . . . . 1.0 110.493 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.9 m -121.3 -49.51 2.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 104.758 -2.312 . . . . 1.0 104.758 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.13 169.51 33.18 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 108.625 -1.79 . . . . 1.0 108.625 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.1 t -43.29 -58.58 2.47 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.541 0.686 . . . . 1.0 110.51 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.93 -39.24 11.91 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 113.958 -1.474 . . . . 1.0 114.447 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -70.3 -33.1 71.13 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.233 1.016 . . . . 1.0 111.174 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.573 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 19.2 t -76.56 -11.55 59.89 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 113.747 -1.57 . . . . 1.0 113.075 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.408 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 7.0 m0 -67.49 -58.53 8.44 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 123.75 0.656 . . . . 1.0 109.52 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 84.6 Cg_endo -63.38 -43.07 19.23 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.816 2.344 . . . . 1.0 110.686 174.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -55.49 -47.27 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 119.844 -0.742 . . . . 1.0 110.216 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.0 t -67.75 -42.45 81.76 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.372 -0.931 . . . . 1.0 108.805 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -50.13 -42.85 51.41 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.342 1.067 . . . . 1.0 108.347 179.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -70.54 -46.25 63.93 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 113.648 -1.614 . . . . 1.0 111.151 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.4 ttp -54.03 -56.7 15.49 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 123.957 0.785 . . . . 1.0 112.641 -179.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -121.87 -57.02 1.82 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 113.385 -1.734 . . . . 1.0 114.021 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.95 43.41 0.11 Allowed Glycine 0 N--CA 1.488 2.122 0 O-C-N 124.045 0.841 . . . . 1.0 111.517 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -126.22 98.93 31.83 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 105.065 -2.198 . . . . 1.0 105.065 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.09 11.96 0.4 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 123.091 2.528 . . . . 1.0 113.218 -167.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.401 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 73.4 m-80 -116.36 -176.2 2.91 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.73 -1.581 . . . . 1.0 106.73 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.424 ' HA2' ' CD1' ' A' ' 36' ' ' TYR . . . 144.75 175.92 18.31 Favored Glycine 0 N--CA 1.49 2.254 0 CA-C-N 113.991 -1.459 . . . . 1.0 112.734 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.461 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 52.0 mtpt -133.33 177.81 7.4 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 113.165 -1.517 . . . . 1.0 109.001 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.3 t -114.89 155.99 25.83 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.769 -1.567 . . . . 1.0 106.769 179.446 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 48.8 mtp -133.01 75.17 1.61 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.29 -1.374 . . . . 1.0 107.29 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 30.95 54.44 0.19 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 125.321 1.638 . . . . 1.0 111.202 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.11 -29.69 5.68 Favored Glycine 0 N--CA 1.483 1.833 0 CA-C-O 116.916 -2.046 . . . . 1.0 116.438 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 7.1 mptt -113.97 142.49 46.09 Favored 'General case' 0 C--O 1.206 -1.218 0 CA-C-N 120.331 2.066 . . . . 1.0 108.194 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.495 ' SG ' HG22 ' A' ' 3' ' ' THR . 35.5 t -71.65 161.74 30.53 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.482 -1.236 . . . . 1.0 113.137 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.573 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 5.9 tpt180 -132.69 139.96 47.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.555 -2.017 . . . . 1.0 105.555 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.5 m -111.18 161.02 16.4 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.426 1.108 . . . . 1.0 110.778 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.424 ' CD1' ' HA2' ' A' ' 26' ' ' GLY . 6.2 m-30 -116.66 -169.0 1.55 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 111.318 -2.674 . . . . 1.0 106.722 -179.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 107.624 -1.25 . . . . 1.0 107.624 -179.863 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.88 0.371 . . . . 1.0 110.326 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -98.09 145.61 26.38 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.421 0.629 . . . . 1.0 111.088 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.9 p -132.45 171.35 13.88 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.639 -1.619 . . . . 1.0 110.687 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.58 48.79 1.03 Allowed 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.6 t -111.04 119.42 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.063 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -39.65 113.13 0.31 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.655 -1.611 . . . . 1.0 115.272 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.4 p -123.24 171.48 9.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.257 0.973 . . . . 1.0 111.149 179.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.1 p -126.18 -43.17 1.81 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 112.595 -2.093 . . . . 1.0 108.495 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.49 169.17 29.76 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 124.44 1.087 . . . . 1.0 112.29 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.9 t -54.67 -62.63 1.53 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.454 -0.873 . . . . 1.0 111.576 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -42.7 -40.13 2.67 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 115.126 1.528 . . . . 1.0 115.126 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -57.88 -31.23 66.52 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.156 0.979 . . . . 1.0 112.974 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.9 m -81.21 -3.84 53.56 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.04 -1.437 . . . . 1.0 113.553 -179.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.497 ' CG ' ' HA ' ' A' ' 25' ' ' ASN . 11.5 m0 -70.31 -59.0 4.4 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 107.826 -1.176 . . . . 1.0 107.826 179.262 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.408 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 83.6 Cg_endo -65.69 -46.45 5.15 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 122.735 2.29 . . . . 1.0 111.515 174.115 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.8 t -56.87 -44.69 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 119.276 -0.969 . . . . 1.0 110.306 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.438 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 51.8 t -68.45 -45.01 73.61 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.692 -1.203 . . . . 1.0 108.627 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -46.89 -43.18 18.61 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 107.591 -1.263 . . . . 1.0 107.591 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -70.76 -45.33 64.97 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 112.941 -1.936 . . . . 1.0 112.719 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.9 mtm -63.45 -57.96 8.59 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.678 1.362 . . . . 1.0 114.678 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -111.88 -56.34 2.4 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.387 -1.279 . . . . 1.0 113.252 -179.408 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.16 39.47 0.38 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.438 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 14.0 mptt -119.01 97.0 50.62 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 102.691 -3.078 . . . . 1.0 102.691 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -64.91 -3.48 7.07 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 123.367 2.711 . . . . 1.0 113.346 -156.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.539 ' ND2' ' H ' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -122.25 165.68 15.81 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 124.438 1.086 . . . . 1.0 109.079 179.923 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.0 168.72 41.43 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.336 -0.935 . . . . 1.0 112.444 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.571 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 27.8 mtpp -121.85 -176.64 3.38 Favored 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 115.014 -0.593 . . . . 1.0 109.575 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.8 t -127.26 156.32 42.09 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 106.263 -1.754 . . . . 1.0 106.263 179.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 71.4 mtm -136.15 77.18 1.64 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.016 -1.476 . . . . 1.0 107.016 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.1 t30 30.36 53.43 0.14 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 125.271 1.607 . . . . 1.0 111.341 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.13 -35.52 3.08 Favored Glycine 0 N--CA 1.486 2.03 0 CA-C-N 113.159 -1.837 . . . . 1.0 115.637 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' A' ' 32' ' ' LYS . 1.7 mppt? -109.48 139.78 44.04 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 119.948 1.874 . . . . 1.0 109.907 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 46.1 t -71.94 160.56 32.32 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 112.917 -1.947 . . . . 1.0 116.013 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -139.29 155.41 47.75 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.017 -1.447 . . . . 1.0 107.773 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.9 m -126.71 166.14 17.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.992 -2.225 . . . . 1.0 104.992 179.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.571 ' CZ ' ' HG3' ' A' ' 27' ' ' LYS . 89.4 m-85 -113.26 177.37 4.65 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.752 -1.203 . . . . 1.0 107.752 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.9 m . . . . . 0 N--CA 1.501 2.077 0 CA-C-O 117.404 -1.284 . . . . 1.0 111.342 179.942 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 . . . . . 0 C--O 1.216 -0.659 0 CA-C-O 120.95 0.405 . . . . 1.0 110.373 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.4 p -130.54 172.56 11.78 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.826 -1.079 . . . . 1.0 110.105 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -126.3 28.3 6.04 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.245 0.965 . . . . 1.0 109.061 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 p -115.79 155.11 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 115.152 -0.931 . . . . 1.0 109.895 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -70.8 131.95 44.59 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.508 -0.769 . . . . 1.0 112.83 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.3 p -123.55 160.31 27.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.944 0.777 . . . . 1.0 109.018 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 81.4 p -132.77 40.09 3.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.608 0.718 . . . . 1.0 110.15 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.3 163.17 13.86 Favored Glycine 0 N--CA 1.494 2.534 0 CA-C-N 114.092 -1.413 . . . . 1.0 109.8 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.4 p -43.71 -49.9 7.74 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 114.385 -0.907 . . . . 1.0 113.332 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -45.95 -50.09 15.07 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 115.102 -0.954 . . . . 1.0 113.002 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -70.99 -29.3 65.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.056 0.848 . . . . 1.0 110.692 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 26.3 t -73.97 -23.15 59.44 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.777 -1.101 . . . . 1.0 112.678 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.409 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 7.1 m0 -62.89 -58.83 14.57 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-O 118.591 -0.718 . . . . 1.0 111.949 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 90.5 Cg_endo -64.01 -41.4 23.02 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 123.121 2.548 . . . . 1.0 109.801 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.12 -45.63 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 123.96 0.788 . . . . 1.0 110.26 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 42.4 t -70.0 -43.8 70.65 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.841 -1.17 . . . . 1.0 107.841 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -48.38 -43.44 33.82 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 122.415 1.103 . . . . 1.0 108.405 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -70.82 -52.62 19.32 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 113.048 -1.887 . . . . 1.0 113.902 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 84.0 mtp -64.6 -55.97 16.92 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 115.015 1.487 . . . . 1.0 115.015 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -108.86 -57.38 2.15 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.403 1.064 . . . . 1.0 113.034 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.3 35.49 0.66 Allowed Glycine 0 N--CA 1.495 2.587 0 O-C-N 123.857 0.723 . . . . 1.0 111.332 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.548 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 13.1 mptt -122.28 90.84 49.22 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 104.484 -2.413 . . . . 1.0 104.484 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.09 -3.47 7.28 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 123.227 2.618 . . . . 1.0 113.366 -160.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.403 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 33.4 m120 -105.09 -175.93 2.93 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.032 -1.47 . . . . 1.0 107.032 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.66 -178.74 19.14 Favored Glycine 0 N--CA 1.489 2.174 0 CA-C-N 114.0 -1.454 . . . . 1.0 113.224 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -139.66 167.58 21.78 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.751 -1.225 . . . . 1.0 111.281 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 39.0 t -108.61 147.78 31.33 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.807 -0.812 . . . . 1.0 108.807 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.9 ptm -136.54 108.47 7.13 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 123.786 0.679 . . . . 1.0 110.314 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.2 t30 31.2 46.13 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.188 -1.824 . . . . 1.0 113.027 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.34 -30.42 6.02 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 119.29 2.476 . . . . 1.0 119.29 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -118.2 146.89 43.89 Favored 'General case' 0 C--O 1.205 -1.247 0 CA-C-N 120.56 2.18 . . . . 1.0 112.911 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.3 t -72.52 156.47 38.98 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 112.853 -1.976 . . . . 1.0 112.728 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.46 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 10.0 tpt180 -133.1 142.66 48.83 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 112.175 -2.284 . . . . 1.0 105.516 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.0 m -109.42 166.31 10.97 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 124.231 0.957 . . . . 1.0 109.669 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -118.37 -178.57 3.55 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 114.386 -1.279 . . . . 1.0 108.923 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 117.537 -1.22 . . . . 1.0 111.127 179.946 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.7 p90 . . . . . 0 C--O 1.217 -0.638 0 N-CA-C 112.965 0.728 . . . . 1.0 112.965 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 59.4 p -132.25 166.3 22.18 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 113.872 -1.513 . . . . 1.0 108.416 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -123.62 45.75 2.38 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.885 0.85 . . . . 1.0 109.161 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -104.78 153.17 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 114.411 -1.268 . . . . 1.0 108.975 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -70.63 117.92 12.76 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.248 1.944 . . . . 1.0 116.248 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.8 p -127.33 172.93 10.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 124.156 0.91 . . . . 1.0 109.098 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.4 m -124.11 -44.93 2.01 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 112.961 -1.927 . . . . 1.0 106.956 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.57 169.76 32.88 Favored Glycine 0 N--CA 1.494 2.555 0 CA-C-N 114.831 -1.077 . . . . 1.0 111.73 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.5 t -43.75 -57.4 3.25 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.195 -1.002 . . . . 1.0 112.076 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -41.88 -42.27 2.67 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 114.284 -1.326 . . . . 1.0 113.704 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -70.51 -41.11 73.03 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.658 1.218 . . . . 1.0 111.419 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 41.3 t -71.35 -23.53 61.93 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 113.137 -1.847 . . . . 1.0 112.309 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.452 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.2 m0 -59.15 -60.62 9.97 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 123.918 0.761 . . . . 1.0 111.876 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -63.77 -43.09 17.53 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.152 2.568 . . . . 1.0 109.738 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.77 -42.73 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 123.864 0.728 . . . . 1.0 109.966 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 51.4 m -70.27 -43.86 69.6 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -50.36 -42.24 52.85 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.333 1.063 . . . . 1.0 108.544 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -70.89 -56.39 6.36 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 113.539 -1.664 . . . . 1.0 113.42 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.7 ttm -59.19 -56.15 25.87 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 115.075 1.509 . . . . 1.0 115.075 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -106.36 -58.98 1.85 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 113.461 -1.699 . . . . 1.0 114.011 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.59 45.88 0.26 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 106.383 -2.687 . . . . 1.0 106.383 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -128.72 88.66 51.41 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 106.132 -1.803 . . . . 1.0 106.132 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -62.16 2.39 0.65 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.318 2.012 . . . . 1.0 113.67 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.452 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 8.0 m120 -113.49 -174.74 2.52 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.96 -179.08 18.38 Favored Glycine 0 N--CA 1.489 2.216 0 CA-C-N 113.659 -1.609 . . . . 1.0 110.734 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -140.96 167.92 21.04 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.863 -0.668 . . . . 1.0 110.539 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.5 t -107.75 157.49 18.08 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.52 -0.918 . . . . 1.0 108.52 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.7 mtp -132.05 81.91 1.99 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.783 -1.191 . . . . 1.0 107.783 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.1 t30 29.34 53.94 0.11 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 125.534 1.771 . . . . 1.0 111.519 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.36 -38.04 2.3 Favored Glycine 0 N--CA 1.479 1.543 0 CA-C-N 113.145 -1.843 . . . . 1.0 115.737 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -114.98 135.2 54.48 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-N 119.37 1.585 . . . . 1.0 112.711 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 15.2 t -72.07 157.61 37.47 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.796 -2.911 . . . . 1.0 114.828 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.532 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.4 tpt180 -138.11 143.49 40.41 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 112.365 -2.198 . . . . 1.0 105.938 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.6 m -119.4 160.71 21.8 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.718 -1.586 . . . . 1.0 106.718 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -110.88 -172.15 1.97 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.7 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 116.109 -1.9 . . . . 1.0 109.493 -179.702 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.2 p90 . . . . . 0 C--O 1.215 -0.759 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.431 HG21 ' SG ' ' A' ' 33' ' ' CYS . 72.8 p -128.47 177.55 6.91 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 122.132 0.968 . . . . 1.0 113.146 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -112.98 -5.93 13.77 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 112.596 -2.093 . . . . 1.0 109.319 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.2 t -112.81 140.65 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.327 -0.99 . . . . 1.0 108.327 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 25.2 pttm -71.05 167.44 19.24 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.751 1.76 . . . . 1.0 115.751 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.9 p -138.54 176.04 9.04 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 124.61 1.194 . . . . 1.0 110.716 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.3 m -125.36 -49.31 1.68 Allowed 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.256 -2.247 . . . . 1.0 105.345 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.82 170.13 29.26 Favored Glycine 0 N--CA 1.493 2.495 0 CA-C-N 114.004 -1.453 . . . . 1.0 109.764 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.0 m -51.23 -54.94 20.92 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.382 0.611 . . . . 1.0 110.661 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -49.1 -39.95 30.19 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.659 -1.155 . . . . 1.0 113.161 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -70.39 -30.71 67.67 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.255 1.026 . . . . 1.0 110.849 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.578 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 6.0 t -76.98 -10.65 59.51 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 113.568 -1.651 . . . . 1.0 112.833 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 9.9 m0 -66.86 -58.48 9.49 Favored Pre-proline 0 N--CA 1.485 1.29 0 CA-C-O 118.873 -0.584 . . . . 1.0 109.523 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.09 -48.0 9.2 Favored 'Trans proline' 0 N--CA 1.486 1.081 0 C-N-CA 122.369 2.046 . . . . 1.0 110.096 173.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 60.5 t -51.33 -40.8 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 119.997 -0.681 . . . . 1.0 110.315 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 42.8 t -70.35 -49.43 49.35 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.775 -1.17 . . . . 1.0 107.999 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -47.77 -38.23 15.18 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.205 1.002 . . . . 1.0 109.425 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -70.24 -53.99 14.65 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.309 -1.769 . . . . 1.0 111.956 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 35.7 mmt -69.82 -55.31 10.15 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 115.98 1.844 . . . . 1.0 115.98 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -102.86 -53.58 2.82 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 123.77 0.669 . . . . 1.0 112.666 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.07 35.28 0.55 Allowed Glycine 0 N--CA 1.492 2.381 0 O-C-N 123.662 0.601 . . . . 1.0 113.281 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 2.9 mptp? -127.45 131.67 23.95 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -87.3 14.36 2.43 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 122.43 2.087 . . . . 1.0 110.511 -175.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.426 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 73.4 m-80 -119.54 -177.56 3.4 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.557 -1.275 . . . . 1.0 107.557 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.24 172.76 12.76 Favored Glycine 0 N--CA 1.488 2.135 0 CA-C-N 114.13 -1.395 . . . . 1.0 114.747 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.478 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 50.4 mtpt -130.35 177.81 7.06 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 112.158 -2.021 . . . . 1.0 110.719 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 t -116.35 151.79 35.21 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.375 -1.343 . . . . 1.0 107.375 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 70.8 mtm -130.69 83.75 2.14 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.114 -1.069 . . . . 1.0 108.114 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 27.84 50.35 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 125.54 1.775 . . . . 1.0 112.851 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 126.44 -31.4 4.01 Favored Glycine 0 N--CA 1.484 1.838 0 CA-C-O 116.012 -2.549 . . . . 1.0 117.532 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -116.94 145.98 43.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 121.356 2.578 . . . . 1.0 109.491 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.431 ' SG ' HG21 ' A' ' 3' ' ' THR . 16.7 t -71.7 157.98 36.96 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.581 -1.645 . . . . 1.0 113.791 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.578 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 17.8 tpt85 -128.96 140.18 51.77 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.366 -2.197 . . . . 1.0 105.692 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.8 m -111.6 163.49 14.04 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.146 -1.057 . . . . 1.0 108.146 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.472 ' OH ' ' HG3' ' A' ' 27' ' ' LYS . 12.7 m-30 -114.26 -176.86 2.99 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 113.717 -1.583 . . . . 1.0 108.201 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 116.162 -1.875 . . . . 1.0 108.893 -179.921 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 43.9 p90 . . . . . 0 C--O 1.216 -0.687 0 CA-C-O 121.824 0.821 . . . . 1.0 113.143 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.7 p -132.18 163.47 28.48 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 113.045 -1.889 . . . . 1.0 108.158 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -126.65 52.26 1.77 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 124.003 0.814 . . . . 1.0 110.459 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -111.58 151.58 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 C-N-CA 120.001 -0.68 . . . . 1.0 109.352 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -70.21 103.17 2.27 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 114.968 1.47 . . . . 1.0 114.968 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.3 p -120.58 172.3 7.95 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.082 0.944 . . . . 1.0 109.909 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.6 t -126.22 -42.22 1.86 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 112.578 -2.101 . . . . 1.0 107.898 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.79 165.29 26.91 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 124.268 0.98 . . . . 1.0 111.542 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.0 m -47.88 -53.33 16.07 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.384 -0.908 . . . . 1.0 111.719 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' NZ ' HE22 ' A' ' 12' ' ' GLN . 10.4 mtmp? -45.19 -43.37 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.075 -1.42 . . . . 1.0 114.063 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.449 HE22 ' NZ ' ' A' ' 11' ' ' LYS . 14.4 mp0 -70.24 -32.52 70.41 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.893 0.854 . . . . 1.0 111.346 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 8.5 t -77.55 -11.5 59.86 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 113.742 -1.572 . . . . 1.0 112.331 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.446 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.0 m0 -67.6 -59.7 6.56 Favored Pre-proline 0 N--CA 1.49 1.57 0 CA-C-O 118.655 -0.688 . . . . 1.0 110.434 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -63.73 -46.98 7.82 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.59 2.194 . . . . 1.0 109.287 174.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 24.1 t -51.62 -42.08 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 123.802 0.689 . . . . 1.0 109.928 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 41.7 t -70.09 -46.05 65.69 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.31 -0.996 . . . . 1.0 108.31 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -46.76 -42.76 17.37 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.731 1.253 . . . . 1.0 108.188 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -70.62 -52.21 22.88 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 112.831 -1.986 . . . . 1.0 113.206 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -55.95 26.96 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 114.728 1.381 . . . . 1.0 114.728 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -110.82 -56.35 2.37 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.321 -1.309 . . . . 1.0 113.712 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.05 34.95 0.53 Allowed Glycine 0 N--CA 1.492 2.383 0 O-C-N 124.032 0.832 . . . . 1.0 111.132 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.471 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 13.1 mptt -124.84 99.18 35.51 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 104.292 -2.485 . . . . 1.0 104.292 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.6 14.16 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.737 2.291 . . . . 1.0 113.322 -169.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.446 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 17.9 p30 -117.03 -179.95 3.85 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.56 168.39 12.59 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.362 -1.399 . . . . 1.0 116.365 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 35.4 mtpt -123.83 171.03 9.96 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 112.55 -1.825 . . . . 1.0 109.531 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.1 t -118.42 158.57 25.06 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.539 -1.282 . . . . 1.0 107.539 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.7 mtp -134.91 79.11 1.77 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.38 -1.341 . . . . 1.0 107.38 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 28.2 51.96 0.05 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 125.598 1.811 . . . . 1.0 112.573 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.11 -37.93 2.01 Favored Glycine 0 N--CA 1.484 1.856 0 CA-C-N 112.471 -2.149 . . . . 1.0 115.258 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -114.47 139.77 49.27 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 119.46 1.63 . . . . 1.0 112.143 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 36.0 t -71.92 159.98 33.32 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 111.721 -2.49 . . . . 1.0 115.027 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.561 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 14.2 tpt180 -135.94 145.37 46.16 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 112.543 -2.117 . . . . 1.0 105.543 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.0 m -124.04 163.02 22.27 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.086 -1.82 . . . . 1.0 106.086 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.486 ' OH ' ' HG3' ' A' ' 27' ' ' LYS . 4.5 m-85 -116.57 168.27 10.33 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 105.472 -2.047 . . . . 1.0 105.472 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 N--CA 1.507 2.42 0 N-CA-C 115.34 1.607 . . . . 1.0 115.34 -179.813 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 122.101 0.953 . . . . 1.0 111.57 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.5 p -133.2 163.77 28.56 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 112.525 -2.125 . . . . 1.0 109.038 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -104.05 40.59 1.42 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.558 -0.746 . . . . 1.0 111.326 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -121.35 142.57 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 107.743 -1.206 . . . . 1.0 107.743 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 37.1 mtmm -70.72 146.44 49.86 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.412 1.634 . . . . 1.0 115.412 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.5 p -140.15 174.17 10.78 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.575 1.172 . . . . 1.0 109.807 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.5 p -122.86 -46.3 2.11 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.917 -1.947 . . . . 1.0 106.572 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.86 173.17 33.9 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.562 -1.415 . . . . 1.0 109.562 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.6 t -40.04 -59.36 1.24 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 124.521 0.777 . . . . 1.0 111.005 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -42.32 -42.32 3.1 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.061 -1.427 . . . . 1.0 113.973 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.36 -37.92 74.68 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.419 1.104 . . . . 1.0 110.005 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.612 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 10.1 t -71.51 -23.33 61.77 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.228 -1.351 . . . . 1.0 113.48 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.477 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.6 m0 -57.99 -60.62 9.46 Favored Pre-proline 0 CA--C 1.56 1.33 0 O-C-N 123.768 0.668 . . . . 1.0 111.324 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -62.38 -42.86 25.45 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 C-N-CA 122.738 2.292 . . . . 1.0 109.491 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 22.1 t -53.15 -44.44 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 123.803 0.689 . . . . 1.0 110.963 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 48.6 t -70.16 -44.76 68.16 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.948 -1.13 . . . . 1.0 107.948 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -48.49 -43.29 34.85 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.355 1.074 . . . . 1.0 108.494 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -70.86 -47.87 56.98 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 113.065 -1.879 . . . . 1.0 113.235 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 80.9 mmm -65.59 -60.2 3.16 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 114.879 1.436 . . . . 1.0 114.879 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -107.91 -56.27 2.26 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.246 -1.343 . . . . 1.0 112.855 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.18 34.83 0.61 Allowed Glycine 0 N--CA 1.493 2.485 0 O-C-N 123.92 0.762 . . . . 1.0 111.278 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 0.9 OUTLIER -121.05 86.69 42.68 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 104.563 -2.384 . . . . 1.0 104.563 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -64.49 3.18 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.141 2.561 . . . . 1.0 113.961 -163.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.477 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 32.4 m120 -111.48 -177.53 3.22 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.898 -1.89 . . . . 1.0 105.898 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.23 -172.6 24.14 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.214 -1.47 . . . . 1.0 114.222 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.593 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 60.8 mtpt -132.56 171.7 13.46 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 113.421 -1.389 . . . . 1.0 112.219 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.8 t -111.23 156.12 21.94 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 105.619 -1.993 . . . . 1.0 105.619 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 59.5 mtp -134.25 83.53 2.04 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.825 -1.176 . . . . 1.0 107.825 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 27.99 54.21 0.07 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 125.815 1.947 . . . . 1.0 110.583 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 126.34 -40.48 1.8 Allowed Glycine 0 N--CA 1.484 1.849 0 CA-C-N 112.591 -2.095 . . . . 1.0 116.441 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -116.58 147.75 41.55 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 120.554 2.177 . . . . 1.0 112.656 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 35.0 t -71.84 155.46 40.39 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.853 -2.885 . . . . 1.0 116.223 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.612 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.2 tpt180 -130.14 144.47 51.37 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 111.099 -2.773 . . . . 1.0 105.54 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.9 m -115.24 163.89 15.01 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.563 -1.643 . . . . 1.0 106.563 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.593 ' CZ ' ' HG3' ' A' ' 27' ' ' LYS . 15.3 m-85 -113.19 -179.41 3.64 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.153 -1.055 . . . . 1.0 108.153 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.8 p . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 115.928 -1.987 . . . . 1.0 110.018 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.3 p90 . . . . . 0 C--O 1.217 -0.646 0 N-CA-C 114.373 1.249 . . . . 1.0 114.373 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.3 p -132.63 171.9 13.23 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 112.901 -1.954 . . . . 1.0 109.045 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -122.99 51.54 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.992 -1.114 . . . . 1.0 107.992 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.2 t -112.67 128.72 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 115.126 -0.943 . . . . 1.0 111.418 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -39.76 102.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 118.478 2.77 . . . . 1.0 118.478 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.6 p -125.58 170.17 11.75 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.805 0.812 . . . . 1.0 109.672 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.9 t -121.98 -43.01 2.36 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 113.105 -1.861 . . . . 1.0 106.923 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.17 165.03 31.65 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.908 -1.277 . . . . 1.0 109.908 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.8 t -40.64 -59.52 1.35 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 124.727 0.898 . . . . 1.0 111.94 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -43.44 -43.39 5.26 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 113.819 -1.537 . . . . 1.0 114.618 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -70.59 -34.11 71.8 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.883 0.849 . . . . 1.0 111.121 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 7.3 t -76.24 -11.92 60.0 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.303 -1.317 . . . . 1.0 112.675 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.441 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 5.0 m0 -67.64 -58.21 8.77 Favored Pre-proline 0 N--CA 1.489 1.497 0 CA-C-O 118.605 -0.712 . . . . 1.0 110.166 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 77.0 Cg_endo -63.05 -43.1 20.52 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.936 2.424 . . . . 1.0 109.95 174.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 49.0 t -54.55 -45.05 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 119.835 -0.746 . . . . 1.0 109.829 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 54.1 t -70.13 -39.71 75.27 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.203 -1.036 . . . . 1.0 108.203 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -51.35 -43.94 61.93 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.51 1.148 . . . . 1.0 108.04 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -70.69 -57.18 4.95 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 113.663 -1.608 . . . . 1.0 113.122 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -55.25 -50.87 68.36 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 114.282 1.216 . . . . 1.0 114.282 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -112.06 -62.99 1.48 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.585 -1.643 . . . . 1.0 114.924 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.89 43.73 0.36 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 107.31 -2.316 . . . . 1.0 107.31 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 98.1 mttt -130.62 86.66 52.21 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 104.79 -2.3 . . . . 1.0 104.79 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.09 -2.66 5.98 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.55 2.833 . . . . 1.0 113.254 -160.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.441 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 34.7 m120 -104.24 -176.77 3.17 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.152 -1.425 . . . . 1.0 107.152 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.26 -176.04 21.94 Favored Glycine 0 N--CA 1.493 2.44 0 CA-C-N 114.298 -1.319 . . . . 1.0 113.259 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 53.2 mtpt -135.58 179.28 6.43 Favored 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 113.903 -1.148 . . . . 1.0 112.001 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 t -121.68 157.51 30.74 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 63.5 mtm -135.01 73.51 1.48 Allowed 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.312 -1.366 . . . . 1.0 107.312 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.1 t30 28.22 55.36 0.09 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 125.669 1.856 . . . . 1.0 111.215 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.89 -37.57 2.13 Favored Glycine 0 N--CA 1.484 1.878 0 CA-C-N 112.308 -2.224 . . . . 1.0 114.687 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -111.91 137.64 49.61 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-N 118.985 1.393 . . . . 1.0 111.607 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 45.1 t -72.13 159.6 33.86 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 112.127 -2.306 . . . . 1.0 113.449 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.563 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.6 tpt180 -135.85 147.44 48.24 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.426 -2.065 . . . . 1.0 105.426 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.9 m -122.3 162.36 21.63 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.059 -1.46 . . . . 1.0 107.059 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.47 ' OH ' ' HG3' ' A' ' 27' ' ' LYS . 16.2 m-30 -115.8 -179.03 3.53 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.4 -2.074 . . . . 1.0 105.4 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.501 2.113 0 N-CA-C 115.639 1.718 . . . . 1.0 115.639 -179.639 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--O 1.216 -0.681 0 CA-C-O 122.899 1.333 . . . . 1.0 113.313 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.3 p -133.11 160.6 36.75 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 110.902 -2.863 . . . . 1.0 107.776 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -116.06 50.4 1.04 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.063 0.852 . . . . 1.0 109.207 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.9 t -108.17 145.82 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 105.268 -2.123 . . . . 1.0 105.268 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -70.2 135.72 49.34 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.254 0.835 . . . . 1.0 113.254 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.565 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 6.0 p -130.15 160.0 35.12 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 124.887 1.367 . . . . 1.0 113.083 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.8 t -136.62 44.13 2.39 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.912 -1.494 . . . . 1.0 108.429 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.9 167.27 13.06 Favored Glycine 0 N--CA 1.495 2.606 0 CA-C-N 113.589 -1.641 . . . . 1.0 110.454 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.2 t -47.12 -62.78 1.26 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.421 0.897 . . . . 1.0 113.421 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.478 ' HD3' ' H ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -39.49 -29.18 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.262 1.949 . . . . 1.0 116.262 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.478 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 3.5 tm0? -70.62 -40.14 73.32 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 122.658 1.218 . . . . 1.0 111.398 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 70.5 m -78.4 -7.55 57.48 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.393 -1.73 . . . . 1.0 113.583 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.403 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 8.1 m95 -70.18 -57.96 5.51 Favored Pre-proline 0 C--N 1.305 -1.34 0 O-C-N 124.147 0.905 . . . . 1.0 109.34 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 98.8 Cg_endo -64.44 -45.27 9.6 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 C-N-CA 122.793 2.329 . . . . 1.0 110.343 174.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 54.6 t -55.84 -46.05 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 119.371 -0.932 . . . . 1.0 110.775 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 52.8 t -68.51 -43.26 77.2 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.938 -1.105 . . . . 1.0 109.252 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -50.36 -42.36 53.03 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -70.83 -49.23 48.56 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 113.635 -1.621 . . . . 1.0 112.971 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.2 mmm -62.93 -56.5 16.68 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.979 1.103 . . . . 1.0 113.979 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -110.82 -59.78 1.91 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.725 -1.125 . . . . 1.0 112.492 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.51 43.99 0.44 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 106.486 -2.646 . . . . 1.0 106.486 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.425 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 94.4 mttt -126.73 78.22 73.31 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 105.265 -2.124 . . . . 1.0 105.265 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -62.18 -3.48 4.04 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 123.487 2.791 . . . . 1.0 114.92 -154.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -107.11 121.25 44.11 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 104.183 -2.525 . . . . 1.0 104.183 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.16 161.7 27.88 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.788 -1.725 . . . . 1.0 108.788 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HE2' ' CE2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -127.74 176.61 7.41 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.204 -1.776 . . . . 1.0 106.204 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -109.68 161.64 15.2 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.399 -0.521 . . . . 1.0 111.027 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 64.1 mtp -136.2 88.2 2.37 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.214 -1.772 . . . . 1.0 106.214 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 30.99 48.64 0.07 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 125.121 1.513 . . . . 1.0 113.501 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.78 -35.86 3.16 Favored Glycine 0 N--CA 1.491 2.312 0 CA-C-N 113.302 -1.772 . . . . 1.0 116.504 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.67 147.65 40.6 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-N 120.108 1.954 . . . . 1.0 110.885 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 33.8 m -72.03 154.58 41.06 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 110.722 -2.944 . . . . 1.0 118.817 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.42 ' HB3' ' HG2' ' A' ' 27' ' ' LYS . 8.1 tpt180 -137.6 153.67 49.88 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 111.944 -2.389 . . . . 1.0 105.653 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.414 ' C ' ' HZ1' ' A' ' 27' ' ' LYS . 89.4 m -118.68 157.27 27.77 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 124.178 0.924 . . . . 1.0 110.678 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.523 ' CE2' ' HE2' ' A' ' 27' ' ' LYS . 49.7 m-85 -110.1 -175.86 2.84 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.042 -1.89 . . . . 1.0 108.08 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 t . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 115.852 -2.023 . . . . 1.0 108.944 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.1 t80 . . . . . 0 C--O 1.216 -0.693 0 CA-C-O 122.613 1.197 . . . . 1.0 111.598 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.3 p -147.16 166.01 28.26 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 111.702 -2.499 . . . . 1.0 109.42 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -123.57 52.47 1.42 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.463 HG21 ' SD ' ' A' ' 20' ' ' MET . 62.4 t -108.09 141.17 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-N 114.614 -1.176 . . . . 1.0 108.64 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.43 ' H ' ' HE2' ' A' ' 6' ' ' LYS . 2.0 mppt? -70.27 105.45 2.98 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 114.161 -1.382 . . . . 1.0 113.889 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.9 p -119.72 170.87 8.82 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.587 -1.188 . . . . 1.0 111.513 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -128.19 -40.81 1.63 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 112.46 -2.155 . . . . 1.0 109.064 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.1 171.3 23.16 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 124.375 1.047 . . . . 1.0 112.368 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.7 m -70.14 -58.2 4.07 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.193 -1.003 . . . . 1.0 112.355 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -44.12 -33.14 1.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.341 1.237 . . . . 1.0 114.341 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -70.19 -34.81 73.4 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.269 1.033 . . . . 1.0 111.646 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.405 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 5.5 t -77.72 -6.21 53.19 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.413 -1.721 . . . . 1.0 112.014 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.429 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 9.4 m0 -69.03 -59.96 4.76 Favored Pre-proline 0 N--CA 1.484 1.25 0 CA-C-O 118.757 -0.639 . . . . 1.0 109.456 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 94.6 Cg_endo -64.22 -46.51 7.76 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 C-N-CA 122.325 2.017 . . . . 1.0 110.421 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 70.0 t -54.29 -44.1 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.965 -0.694 . . . . 1.0 110.758 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 47.2 t -69.9 -46.22 65.9 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.381 -1.328 . . . . 1.0 107.768 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -48.92 -39.79 27.54 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 122.116 0.96 . . . . 1.0 108.987 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.15 -50.74 37.46 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.676 -1.602 . . . . 1.0 112.007 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.463 ' SD ' HG21 ' A' ' 5' ' ' VAL . 66.0 mtm -66.38 -57.45 7.41 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 115.57 1.692 . . . . 1.0 115.57 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -103.52 -55.31 2.42 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.787 -1.097 . . . . 1.0 113.76 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.14 41.14 0.31 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 75.1 mmtt -125.83 121.08 24.32 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 105.008 -2.219 . . . . 1.0 105.008 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -82.41 11.83 3.06 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.114 1.876 . . . . 1.0 110.685 -173.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -117.29 -176.86 3.09 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.385 -1.339 . . . . 1.0 107.385 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.04 143.45 3.99 Favored Glycine 0 N--CA 1.486 1.985 0 CA-C-N 113.605 -1.634 . . . . 1.0 111.47 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HG3' ' HB3' ' A' ' 34' ' ' ARG . 19.0 ptmt -123.73 172.75 8.61 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 113.569 -1.316 . . . . 1.0 107.774 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.7 t -115.61 159.72 20.93 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.699 -0.8 . . . . 1.0 110.83 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 73.2 mtm -131.01 78.47 1.84 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.41 -1.723 . . . . 1.0 107.42 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 28.48 55.63 0.1 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 125.875 1.985 . . . . 1.0 110.743 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.32 -37.14 2.52 Favored Glycine 0 N--CA 1.485 1.956 0 CA-C-N 112.586 -2.097 . . . . 1.0 115.951 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -110.66 139.65 45.75 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 119.729 1.765 . . . . 1.0 111.793 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.64 157.13 38.51 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.473 -2.148 . . . . 1.0 113.845 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.49 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 18.7 tpt85 -138.32 145.91 41.76 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 102.753 -3.054 . . . . 1.0 102.753 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -120.19 167.51 12.18 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.251 -1.018 . . . . 1.0 108.251 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -118.69 -179.0 3.67 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.096 -1.411 . . . . 1.0 108.353 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 116.389 -1.767 . . . . 1.0 109.503 -179.776 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 . . . . . 0 C--O 1.215 -0.745 0 CA-C-O 120.903 0.382 . . . . 1.0 111.114 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 p -138.31 171.97 13.59 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 114.743 -1.117 . . . . 1.0 110.137 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -131.64 40.33 3.4 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.4 -1.333 . . . . 1.0 107.4 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.9 p -114.72 155.93 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 115.122 -0.945 . . . . 1.0 110.298 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.812 ' H ' ' HZ2' ' A' ' 6' ' ' LYS . 0.2 OUTLIER -71.32 131.18 43.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 123.587 0.554 . . . . 1.0 110.207 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.475 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 30.8 p -127.6 157.33 40.5 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 120.219 -0.593 . . . . 1.0 110.741 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -137.06 42.0 2.44 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.613 -1.176 . . . . 1.0 109.646 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.75 159.88 11.24 Favored Glycine 0 N--CA 1.496 2.685 0 CA-C-N 114.293 -1.322 . . . . 1.0 111.442 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.7 p -47.35 -56.73 6.3 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.515 1.302 . . . . 1.0 114.515 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -39.69 -41.27 1.05 Allowed 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 114.291 1.219 . . . . 1.0 114.291 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -36.43 74.73 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.163 0.914 . . . . 1.0 111.394 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 73.0 m -73.26 -20.17 60.9 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.07 -0.968 . . . . 1.0 112.779 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.469 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 9.4 m0 -58.95 -62.47 5.73 Favored Pre-proline 0 CA--C 1.562 1.428 0 C-N-CA 120.321 -0.552 . . . . 1.0 110.911 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.414 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 84.7 Cg_endo -66.39 -49.84 1.65 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.883 2.389 . . . . 1.0 110.728 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 71.8 t -50.29 -42.52 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 123.648 0.593 . . . . 1.0 110.081 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 50.3 t -70.16 -47.76 60.25 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.575 -1.269 . . . . 1.0 107.575 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.425 ' HZ1' ' HD3' ' A' ' 24' ' ' PRO . 1.6 tpmt? -46.88 -40.54 14.23 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 122.196 0.998 . . . . 1.0 108.542 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -70.4 -50.94 33.38 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 113.335 -1.757 . . . . 1.0 112.107 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 56.0 mtm -70.81 -57.84 4.23 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 115.452 1.649 . . . . 1.0 115.452 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -100.6 -56.02 2.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 123.916 0.76 . . . . 1.0 112.025 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.9 39.48 0.52 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.836 -1.305 . . . . 1.0 109.836 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.573 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 38.5 mmtm -122.5 105.69 35.86 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 104.922 -2.251 . . . . 1.0 104.922 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HD3' ' HZ1' ' A' ' 18' ' ' LYS . 66.4 Cg_endo -69.94 0.65 5.47 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.258 1.972 . . . . 1.0 111.811 -171.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.469 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 5.9 m120 -119.19 -174.5 2.73 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.63 179.39 18.71 Favored Glycine 0 N--CA 1.488 2.112 0 CA-C-N 113.522 -1.672 . . . . 1.0 111.243 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HG3' ' HB3' ' A' ' 34' ' ' ARG . 11.6 ptmm? -138.31 172.51 12.79 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 114.356 -0.922 . . . . 1.0 111.197 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.9 t -107.76 160.14 15.95 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 71.5 mtm -138.96 84.8 2.03 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 108.812 -0.81 . . . . 1.0 108.812 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 25.17 55.89 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 125.975 2.047 . . . . 1.0 110.903 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.74 -42.83 1.36 Allowed Glycine 0 N--CA 1.483 1.81 0 CA-C-N 111.806 -2.452 . . . . 1.0 116.145 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -121.64 149.41 43.23 Favored 'General case' 0 C--O 1.205 -1.279 0 CA-C-O 124.46 2.076 . . . . 1.0 112.584 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 10.9 m -72.33 157.95 36.72 Favored 'General case' 0 C--N 1.285 -2.205 1 CA-C-N 108.347 -4.024 . . . . 1.0 115.199 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.465 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 2.9 tpt180 -137.73 146.34 43.58 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 111.935 -2.393 . . . . 1.0 105.35 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.2 m -117.58 163.68 16.07 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.898 -1.519 . . . . 1.0 106.898 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -116.69 175.19 5.69 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.7 m . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 C--O 1.216 -0.666 0 CA-C-O 121.538 0.685 . . . . 1.0 109.515 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.0 p -138.86 170.46 15.95 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 113.53 -1.668 . . . . 1.0 111.4 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -124.87 51.12 1.67 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.444 -1.317 . . . . 1.0 107.444 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.28 147.26 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 114.628 -1.169 . . . . 1.0 109.042 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.55 127.08 31.48 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.401 -0.818 . . . . 1.0 111.201 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.22 161.72 27.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 124.007 0.817 . . . . 1.0 111.227 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 t -135.61 42.06 2.69 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.612 -1.177 . . . . 1.0 109.403 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.66 166.52 13.34 Favored Glycine 0 N--CA 1.496 2.678 0 CA-C-N 114.061 -1.427 . . . . 1.0 111.605 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.6 t -53.71 -66.49 0.38 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 114.595 1.331 . . . . 1.0 114.595 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -39.14 -31.96 0.09 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.244 1.572 . . . . 1.0 115.244 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -70.4 -42.3 71.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 124.125 0.891 . . . . 1.0 112.439 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.465 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 4.4 t -89.38 7.79 34.04 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 117.923 -1.511 . . . . 1.0 112.978 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.464 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 2.5 m95 -70.3 -58.33 5.02 Favored Pre-proline 0 N--CA 1.482 1.171 0 N-CA-C 103.441 -2.8 . . . . 1.0 103.441 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 86.8 Cg_endo -65.37 -44.65 8.54 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 123.119 2.546 . . . . 1.0 112.429 172.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 90.7 t -58.73 -46.86 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 C-N-CA 117.633 -1.627 . . . . 1.0 110.041 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 53.2 t -64.76 -44.36 90.33 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.048 -1.061 . . . . 1.0 108.139 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -50.86 -40.17 55.55 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.287 1.042 . . . . 1.0 109.025 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -70.52 -45.78 64.88 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.894 -1.503 . . . . 1.0 111.446 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.4 mtp -61.44 -56.04 24.65 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 114.261 1.208 . . . . 1.0 114.261 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -113.39 -56.87 2.36 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.395 -1.275 . . . . 1.0 113.96 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.25 45.59 0.27 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 106.757 -2.537 . . . . 1.0 106.757 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 34.6 mmtp -125.85 89.69 51.89 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 106.053 -1.832 . . . . 1.0 106.053 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -65.57 -4.51 9.77 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.594 2.196 . . . . 1.0 113.246 -162.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -105.34 129.8 53.6 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 105.166 -2.161 . . . . 1.0 105.166 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.95 132.12 3.98 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.497 -1.841 . . . . 1.0 108.497 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -117.05 157.37 25.95 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 106.519 -1.66 . . . . 1.0 106.519 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -102.44 161.47 13.69 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.923 -0.711 . . . . 1.0 112.345 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.9 mtm -133.72 82.87 2.01 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.429 -1.714 . . . . 1.0 107.039 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 28.9 55.08 0.1 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 125.562 1.789 . . . . 1.0 111.197 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.91 -38.56 2.3 Favored Glycine 0 N--CA 1.481 1.648 0 CA-C-N 113.011 -1.904 . . . . 1.0 116.067 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -114.72 140.55 48.78 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 119.792 1.796 . . . . 1.0 112.909 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.483 ' SG ' ' N ' ' A' ' 34' ' ' ARG . 25.5 t -72.11 156.91 38.67 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 110.558 -3.019 . . . . 1.0 115.92 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.483 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 47.8 ttt-85 -136.83 146.12 45.27 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 104.106 -2.553 . . . . 1.0 104.106 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.9 m -119.22 168.58 10.75 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 123.974 0.796 . . . . 1.0 110.223 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -126.75 -165.53 1.47 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 114.421 -1.263 . . . . 1.0 111.596 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.468 -1.253 . . . . 1.0 110.278 -179.762 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 65.0 m-85 . . . . . 0 C--O 1.216 -0.664 0 CA-C-O 121.013 0.435 . . . . 1.0 110.815 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 50.2 p -134.01 169.32 17.3 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 114.491 -1.231 . . . . 1.0 109.8 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -123.59 41.36 3.49 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.369 1.081 . . . . 1.0 109.045 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.96 148.11 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.402 -1.703 . . . . 1.0 106.402 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -70.39 153.63 42.78 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.81 168.19 14.77 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 124.522 1.139 . . . . 1.0 110.553 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.5 t -142.96 32.08 1.39 Allowed 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 105.672 -1.973 . . . . 1.0 105.672 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.77 154.19 9.13 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.643 -2.183 . . . . 1.0 107.643 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.5 m -39.71 -53.08 2.24 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.182 1.178 . . . . 1.0 114.182 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -44.71 -41.26 6.66 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.442 1.645 . . . . 1.0 115.442 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -61.87 -27.69 68.98 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 119.431 -0.908 . . . . 1.0 112.687 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.1 m -77.42 -6.26 52.77 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.006 -0.997 . . . . 1.0 112.127 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.515 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 11.2 m0 -69.37 -62.57 2.51 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 108.724 -0.843 . . . . 1.0 108.724 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.515 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 94.0 Cg_endo -66.62 -42.45 9.29 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.886 2.39 . . . . 1.0 110.969 176.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.23 -45.37 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 123.962 0.789 . . . . 1.0 110.198 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 46.6 t -70.2 -44.76 68.0 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.483 -1.287 . . . . 1.0 107.765 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -47.74 -41.3 22.71 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 122.37 1.081 . . . . 1.0 108.93 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -70.86 -57.7 4.34 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 113.091 -1.868 . . . . 1.0 113.107 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.5 mmm -62.59 -54.92 32.47 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 115.928 1.825 . . . . 1.0 115.928 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -106.85 -55.91 2.26 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 114.532 -1.213 . . . . 1.0 112.998 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.84 41.05 0.27 Allowed Glycine 0 N--CA 1.492 2.426 0 O-C-N 123.467 0.48 . . . . 1.0 113.422 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.488 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 33.7 mmtp -133.58 109.55 12.24 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 107.897 -1.149 . . . . 1.0 107.897 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.27 6.79 2.05 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.989 2.459 . . . . 1.0 112.055 -175.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.1 115.19 20.75 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.588 -1.264 . . . . 1.0 107.588 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -139.41 155.25 23.98 Favored Glycine 0 N--CA 1.493 2.495 0 CA-C-N 114.195 -1.366 . . . . 1.0 114.628 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -116.46 179.7 3.93 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-N 113.882 -1.159 . . . . 1.0 108.965 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.3 t -120.29 164.28 16.54 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' LYS . 84.3 mtp -141.05 82.2 1.82 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.089 -1.819 . . . . 1.0 106.089 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.4 t30 31.79 51.77 0.19 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 125.088 1.493 . . . . 1.0 111.688 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.45 -36.42 3.16 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-O 117.463 -1.743 . . . . 1.0 115.782 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 29' ' ' MET . 35.6 mmtp -111.23 150.51 29.47 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-N 120.468 2.134 . . . . 1.0 110.811 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.5 m -71.79 163.43 27.82 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 118.72 2.859 . . . . 1.0 118.72 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.1 tpt85 -136.2 153.26 51.29 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 110.882 -2.872 . . . . 1.0 104.69 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.7 m -121.86 169.98 10.24 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.835 -1.543 . . . . 1.0 106.835 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -115.67 -172.54 2.17 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.418 -0.81 . . . . 1.0 109.63 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.2 p . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 115.89 -2.005 . . . . 1.0 110.173 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 . . . . . 0 C--O 1.215 -0.716 0 CA-C-O 121.909 0.861 . . . . 1.0 110.973 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.9 p -143.72 163.03 34.44 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 112.806 -1.997 . . . . 1.0 107.751 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -127.06 48.56 2.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 123.681 0.613 . . . . 1.0 111.086 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.29 156.68 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.641 -1.244 . . . . 1.0 107.641 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -70.31 109.99 5.02 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.133 0.79 . . . . 1.0 113.133 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.9 p -114.29 152.52 31.24 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 123.813 0.696 . . . . 1.0 110.401 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -145.72 48.52 1.24 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.57 -1.65 . . . . 1.0 108.2 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.37 125.47 2.52 Favored Glycine 0 N--CA 1.498 2.802 0 CA-C-N 114.123 -1.399 . . . . 1.0 111.472 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.3 m -39.72 -52.57 2.28 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.967 1.84 . . . . 1.0 115.967 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -40.55 -37.46 0.72 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.826 1.417 . . . . 1.0 114.826 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -61.07 -35.35 76.73 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.804 -1.089 . . . . 1.0 113.771 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.0 m -77.26 -10.95 59.74 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.338 -1.301 . . . . 1.0 112.511 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.483 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 11.3 m0 -65.7 -61.83 5.23 Favored Pre-proline 0 C--N 1.307 -1.246 0 C-N-CA 119.636 -0.825 . . . . 1.0 109.171 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.483 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 83.1 Cg_endo -67.93 -43.58 4.91 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 123.015 2.477 . . . . 1.0 111.548 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.3 t -58.35 -47.59 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 123.787 0.679 . . . . 1.0 110.733 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.549 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 46.8 t -70.32 -42.83 71.43 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.19 -1.404 . . . . 1.0 107.951 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -48.41 -41.12 28.21 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.399 1.095 . . . . 1.0 108.161 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -70.65 -51.4 28.15 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.455 -1.702 . . . . 1.0 112.107 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 32.2 ttm -58.69 -59.15 5.86 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 114.513 1.301 . . . . 1.0 114.513 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -110.63 -55.8 2.43 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.531 -1.668 . . . . 1.0 114.056 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.39 45.09 0.25 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.124 -1.99 . . . . 1.0 108.124 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.549 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 40.5 mmtm -123.74 94.68 45.71 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 105.276 -2.12 . . . . 1.0 105.276 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -64.99 -1.88 4.86 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.577 2.185 . . . . 1.0 112.489 -168.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -115.9 142.78 46.32 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 105.589 -2.004 . . . . 1.0 105.589 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.43 153.7 24.76 Favored Glycine 0 N--CA 1.489 2.17 0 CA-C-N 113.849 -1.523 . . . . 1.0 110.701 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.451 ' HG3' ' HB3' ' A' ' 34' ' ' ARG . 20.6 ptmt -131.27 176.64 8.11 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 119.253 -0.979 . . . . 1.0 109.243 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.5 t -114.16 162.3 16.7 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.108 0.48 . . . . 1.0 110.433 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.2 mtp -135.23 75.84 1.59 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.595 -1.631 . . . . 1.0 106.595 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 29.67 55.74 0.15 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 125.599 1.812 . . . . 1.0 110.89 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.18 -36.39 2.83 Favored Glycine 0 N--CA 1.483 1.806 0 CA-C-N 112.971 -1.922 . . . . 1.0 115.602 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -111.93 139.61 47.28 Favored 'General case' 0 C--O 1.206 -1.229 0 CA-C-N 119.286 1.543 . . . . 1.0 110.856 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 52.2 t -71.74 161.67 30.62 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 112.878 -1.965 . . . . 1.0 114.704 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.451 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 18.3 tpt85 -141.26 152.71 44.75 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.973 -1.467 . . . . 1.0 107.221 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.0 m -116.39 169.57 9.21 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 124.545 1.153 . . . . 1.0 109.4 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -120.07 -171.25 2.11 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.321 -1.309 . . . . 1.0 109.01 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.7 m . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 116.275 -1.821 . . . . 1.0 108.99 -179.611 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 C--O 1.216 -0.705 0 CA-C-O 121.198 0.523 . . . . 1.0 109.86 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 82.4 p -133.71 176.02 8.93 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 114.171 -1.377 . . . . 1.0 109.028 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -124.67 30.04 6.07 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 123.98 0.8 . . . . 1.0 109.382 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.48 153.37 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 115.255 -0.884 . . . . 1.0 109.311 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 62.2 pttt -71.1 155.26 40.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.988 0.805 . . . . 1.0 111.808 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.8 p -134.71 157.29 47.05 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.043 -0.663 . . . . 1.0 110.881 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.8 p -136.56 43.85 2.42 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.469 -1.241 . . . . 1.0 108.815 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.53 167.63 13.45 Favored Glycine 0 N--CA 1.494 2.564 0 CA-C-N 113.926 -1.488 . . . . 1.0 110.191 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.9 m -65.21 -59.39 4.13 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 114.46 1.282 . . . . 1.0 114.46 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -40.49 -39.23 0.97 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 114.692 1.368 . . . . 1.0 114.692 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -33.84 70.49 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 122.077 0.941 . . . . 1.0 112.806 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 60.6 m -78.36 -7.91 57.84 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.218 -1.355 . . . . 1.0 113.578 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.462 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 11.3 m95 -69.57 -60.56 3.8 Favored Pre-proline 0 C--N 1.304 -1.373 0 C-N-CA 119.554 -0.858 . . . . 1.0 108.877 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.462 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 97.6 Cg_endo -66.99 -42.92 7.37 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.891 2.394 . . . . 1.0 111.185 176.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.67 -47.9 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 123.91 0.756 . . . . 1.0 110.572 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 49.3 t -70.01 -40.61 75.14 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.702 -1.199 . . . . 1.0 108.438 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -51.41 -42.17 61.26 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.422 -0.955 . . . . 1.0 108.422 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 -70.56 -50.01 41.96 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 113.971 -1.468 . . . . 1.0 111.997 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.4 ttm -54.02 -54.59 37.04 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -122.51 -55.69 1.82 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 113.62 -1.627 . . . . 1.0 112.808 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.43 42.6 0.21 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.594 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 6.1 mptp? -120.22 92.3 47.03 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 106.409 -1.7 . . . . 1.0 106.409 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -64.82 -5.01 9.67 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.963 2.442 . . . . 1.0 113.555 -164.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -115.48 143.17 45.7 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 105.95 -1.87 . . . . 1.0 105.95 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.96 154.56 25.61 Favored Glycine 0 N--CA 1.488 2.117 0 CA-C-N 113.382 -1.735 . . . . 1.0 111.281 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HG3' ' HB3' ' A' ' 34' ' ' ARG . 20.7 ptmt -128.23 178.81 5.99 Favored 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 119.388 -0.925 . . . . 1.0 109.064 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.0 t -116.45 157.68 24.76 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 73.2 mtm -133.71 82.93 2.01 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.254 -1.758 . . . . 1.0 106.254 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 29.46 50.7 0.07 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 125.307 1.629 . . . . 1.0 112.919 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 124.96 -34.04 3.53 Favored Glycine 0 N--CA 1.483 1.777 0 CA-C-O 117.152 -1.916 . . . . 1.0 116.539 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -111.43 140.93 45.62 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 120.588 2.194 . . . . 1.0 109.817 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.1 t -71.86 158.11 36.66 Favored 'General case' 0 C--N 1.292 -1.891 0 CA-C-N 112.187 -2.279 . . . . 1.0 115.468 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.465 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 5.1 tpt180 -139.25 155.5 47.72 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.31 -1.768 . . . . 1.0 107.748 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.2 m -118.75 168.25 10.92 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 124.929 1.393 . . . . 1.0 108.338 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -118.62 -179.48 3.81 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.392 -0.822 . . . . 1.0 110.822 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.5 m . . . . . 0 N--CA 1.504 2.237 0 O-C-N 125.701 1.876 . . . . 1.0 115.684 -179.917 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 . . . . . 0 C--O 1.216 -0.671 0 CA-C-O 121.822 0.82 . . . . 1.0 110.096 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 p -141.13 165.07 28.55 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.211 -1.813 . . . . 1.0 109.825 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -125.85 55.72 1.44 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.831 -1.077 . . . . 1.0 108.776 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.68 148.32 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-N 114.672 -1.149 . . . . 1.0 108.437 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -70.1 102.57 2.09 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.853 -1.067 . . . . 1.0 110.557 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.7 p -116.24 158.61 23.07 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 124.407 1.067 . . . . 1.0 111.842 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 t -137.72 45.78 2.14 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.931 -1.486 . . . . 1.0 107.147 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.07 157.43 9.68 Favored Glycine 0 N--CA 1.494 2.522 0 CA-C-N 113.243 -1.799 . . . . 1.0 110.084 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.2 m -40.31 -49.68 2.76 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 116.148 1.906 . . . . 1.0 116.148 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.406 ' HB3' HE22 ' A' ' 12' ' ' GLN . 77.9 tttt -39.69 -31.2 0.09 Allowed 'General case' 0 C--O 1.205 -1.25 0 C-N-CA 125.577 1.551 . . . . 1.0 114.905 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.406 HE22 ' HB3' ' A' ' 11' ' ' LYS . 0.9 OUTLIER -70.15 -40.39 74.79 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.789 0.804 . . . . 1.0 113.047 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 96.1 m -70.72 -26.21 63.29 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.023 -1.444 . . . . 1.0 113.058 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -57.19 -65.79 1.57 Allowed Pre-proline 0 C--N 1.3 -1.57 0 C-N-CA 118.999 -1.08 . . . . 1.0 110.775 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -64.37 -45.84 8.7 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 122.835 2.357 . . . . 1.0 111.591 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 88.8 t -62.33 -49.01 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 124.082 0.864 . . . . 1.0 112.455 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 24.8 t -70.28 -31.94 69.51 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.973 -1.091 . . . . 1.0 108.414 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -61.52 -49.24 77.5 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.617 -0.883 . . . . 1.0 108.617 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -70.79 -38.82 73.39 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.164 -1.014 . . . . 1.0 113.236 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.0 mtp -69.64 -56.35 7.5 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 115.267 1.58 . . . . 1.0 115.267 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -106.52 -58.19 1.96 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.793 0.683 . . . . 1.0 112.091 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.55 37.62 0.58 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.821 -1.712 . . . . 1.0 108.821 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.448 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 5.0 mptp? -122.85 79.37 49.69 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 105.483 -2.043 . . . . 1.0 105.483 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -66.43 10.96 0.18 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 123.042 2.494 . . . . 1.0 113.751 -170.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -128.51 109.72 11.64 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.826 -1.175 . . . . 1.0 107.826 179.626 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.05 174.41 23.22 Favored Glycine 0 N--CA 1.492 2.384 0 CA-C-N 112.546 -2.115 . . . . 1.0 111.291 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.432 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 18.6 ptmt -132.95 171.71 13.59 Favored 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 108.891 -0.781 . . . . 1.0 108.891 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.2 t -109.27 160.23 16.3 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 120.181 -0.608 . . . . 1.0 110.019 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 56.9 mtp -132.61 76.93 1.72 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.098 -1.815 . . . . 1.0 106.098 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 30.87 55.36 0.2 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 125.606 1.816 . . . . 1.0 110.954 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.96 -35.43 3.39 Favored Glycine 0 N--CA 1.483 1.804 0 CA-C-N 113.353 -1.749 . . . . 1.0 115.815 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -112.01 137.55 49.88 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 119.315 1.557 . . . . 1.0 110.698 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 34' ' ' ARG . 39.1 t -72.18 158.31 36.13 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 117.696 2.48 . . . . 1.0 117.696 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.516 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 10.3 tpt180 -138.95 149.26 44.55 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 106.409 -1.7 . . . . 1.0 106.409 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.3 m -123.93 163.55 21.1 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 104.906 -2.257 . . . . 1.0 104.906 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -112.88 170.08 8.46 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.656 -1.609 . . . . 1.0 106.656 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.507 2.377 0 N-CA-C 116.225 1.935 . . . . 1.0 116.225 -179.902 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 . . . . . 0 C--O 1.216 -0.661 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.4 p -135.1 169.66 17.09 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 123.891 0.745 . . . . 1.0 110.894 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.405 ' H ' ' HE1' ' A' ' 20' ' ' MET . 0.7 OUTLIER -118.59 24.0 11.16 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.085 -1.416 . . . . 1.0 107.659 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.31 145.73 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.519 ' HZ2' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -71.04 163.24 27.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.277 0.985 . . . . 1.0 112.516 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.519 ' N ' ' HZ2' ' A' ' 6' ' ' LYS . 8.4 p -142.61 159.55 42.01 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 124.148 0.905 . . . . 1.0 111.353 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 p -131.89 41.02 3.31 Favored 'General case' 0 C--N 1.31 -1.116 0 O-C-N 124.465 1.103 . . . . 1.0 108.188 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.45 171.22 17.73 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.115 -1.594 . . . . 1.0 109.115 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.5 p -48.8 -60.35 2.82 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.816 0.672 . . . . 1.0 112.816 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -40.06 -39.43 0.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -70.45 -36.2 73.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.287 0.992 . . . . 1.0 112.104 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.462 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 49.0 t -76.01 -13.94 60.23 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.643 -1.617 . . . . 1.0 112.326 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.426 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 7.5 m0 -69.14 -56.2 9.09 Favored Pre-proline 0 N--CA 1.485 1.289 0 CA-C-O 118.193 -0.908 . . . . 1.0 110.695 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 90.3 Cg_endo -65.34 -42.17 13.93 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.906 2.404 . . . . 1.0 110.643 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.48 -48.45 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 123.925 0.766 . . . . 1.0 110.823 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.4 t -68.57 -44.61 74.05 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.146 -1.022 . . . . 1.0 108.915 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -52.43 -39.41 60.99 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.951 0.881 . . . . 1.0 109.081 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -70.46 -52.88 18.96 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 114.21 -1.359 . . . . 1.0 111.141 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.405 ' HE1' ' H ' ' A' ' 4' ' ' ASP . 34.4 ttm -56.07 -56.96 14.51 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.537 0.94 . . . . 1.0 113.537 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -113.07 -61.16 1.78 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 113.098 -1.864 . . . . 1.0 113.915 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.07 41.25 0.45 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 107.885 -2.086 . . . . 1.0 107.885 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 7.8 mmpt? -123.42 81.83 53.17 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 105.904 -1.887 . . . . 1.0 105.904 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -65.13 1.35 2.0 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 123.092 2.528 . . . . 1.0 114.94 -157.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 5.2 m120 -100.22 121.81 42.04 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 100.698 -3.816 . . . . 1.0 100.698 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.15 143.88 12.42 Favored Glycine 0 C--N 1.294 -1.761 0 CA-C-N 113.786 -1.552 . . . . 1.0 110.726 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.404 ' HD3' ' OH ' ' A' ' 36' ' ' TYR . 26.4 mtpp -125.77 160.3 30.13 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 106.517 -1.66 . . . . 1.0 106.517 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.9 t -101.05 157.49 16.72 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.969 -0.693 . . . . 1.0 112.629 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.4 mtm -132.3 89.88 2.72 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.527 -1.657 . . . . 1.0 106.527 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 30.34 48.31 0.05 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 125.097 1.498 . . . . 1.0 113.414 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 121.84 -31.54 4.93 Favored Glycine 0 N--CA 1.487 2.036 0 CA-C-O 117.112 -1.938 . . . . 1.0 117.912 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -113.01 142.68 45.43 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 120.719 2.259 . . . . 1.0 110.028 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 13.3 t -71.6 157.61 37.67 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.362 -1.745 . . . . 1.0 114.057 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.462 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 27.7 ttt85 -133.37 140.32 47.3 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 112.519 -2.128 . . . . 1.0 106.362 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.412 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 65.2 m -109.85 166.52 10.86 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 123.969 0.793 . . . . 1.0 112.23 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.438 ' HB2' ' HB2' ' A' ' 25' ' ' ASN . 47.4 m-85 -127.56 -165.0 1.42 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.42 -1.718 . . . . 1.0 110.774 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.4 t . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.512 -1.233 . . . . 1.0 110.004 -179.723 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.7 p90 . . . . . 0 C--O 1.218 -0.593 0 N-CA-C 109.473 -0.565 . . . . 1.0 109.473 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -124.3 173.39 8.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 124.034 0.833 . . . . 1.0 111.739 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.2 23.34 11.91 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.267 -1.788 . . . . 1.0 107.161 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -124.02 151.87 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 115.323 -0.853 . . . . 1.0 109.074 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -71.11 159.71 34.21 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.536 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.565 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 28.8 p -136.82 150.42 48.31 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.769 -0.772 . . . . 1.0 111.392 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.5 p -137.04 45.09 2.27 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.152 -1.385 . . . . 1.0 107.755 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.58 159.84 11.27 Favored Glycine 0 N--CA 1.494 2.548 0 CA-C-N 113.466 -1.697 . . . . 1.0 110.112 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.8 m -50.71 -54.47 22.95 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 113.896 1.073 . . . . 1.0 113.896 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -40.33 -36.91 0.59 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.204 1.557 . . . . 1.0 115.204 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -70.41 -34.82 72.96 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.233 -0.894 . . . . 1.0 112.432 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.5 m -73.6 -18.1 61.09 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.332 -1.304 . . . . 1.0 112.464 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.456 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 9.7 m0 -63.08 -60.88 8.51 Favored Pre-proline 0 N--CA 1.483 1.2 0 CA-C-O 118.364 -0.827 . . . . 1.0 110.887 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -65.74 -45.71 6.12 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 123.024 2.482 . . . . 1.0 111.344 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.26 -45.47 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 123.948 0.78 . . . . 1.0 111.097 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 52.7 t -70.0 -48.52 57.79 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.596 -1.261 . . . . 1.0 107.596 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -47.63 -38.87 15.63 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 122.136 0.97 . . . . 1.0 108.89 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -70.67 -58.49 3.61 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.36 -1.745 . . . . 1.0 112.433 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 70.7 mtm -68.7 -53.83 19.83 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 116.808 2.151 . . . . 1.0 116.808 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -99.01 -57.52 2.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 124.057 0.848 . . . . 1.0 112.715 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.59 34.45 0.86 Allowed Glycine 0 N--CA 1.495 2.606 0 O-C-N 123.837 0.711 . . . . 1.0 111.743 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 12.9 mptt -122.97 107.07 33.48 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 104.905 -2.257 . . . . 1.0 104.905 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.21 -4.53 13.84 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.913 2.409 . . . . 1.0 112.527 -163.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.456 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 29.3 m-80 -107.17 -171.91 1.97 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.143 -1.429 . . . . 1.0 107.143 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.35 163.94 10.44 Favored Glycine 0 N--CA 1.483 1.8 0 CA-C-N 112.302 -2.226 . . . . 1.0 110.376 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.524 ' HE2' ' CE2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -132.59 177.14 7.85 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 113.896 -1.152 . . . . 1.0 108.57 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.5 t -105.6 155.61 19.05 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.737 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 70.6 mtm -131.04 82.3 2.04 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 107.204 -1.406 . . . . 1.0 107.204 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 m120 29.49 51.38 0.08 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 125.463 1.727 . . . . 1.0 112.442 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.29 -33.84 3.53 Favored Glycine 0 N--CA 1.486 2.016 0 CA-C-N 113.082 -1.872 . . . . 1.0 116.864 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.495 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 6.2 mptt -117.43 141.34 48.46 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 120.228 2.014 . . . . 1.0 110.272 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 3.0 m -72.32 156.13 39.43 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 113.805 -1.543 . . . . 1.0 114.616 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.419 ' HB3' ' HG2' ' A' ' 27' ' ' LYS . 9.1 tpt180 -135.1 152.71 51.91 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.76 -1.941 . . . . 1.0 105.76 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.5 m -117.23 156.89 26.96 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 124.672 1.232 . . . . 1.0 110.794 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.524 ' CE2' ' HE2' ' A' ' 27' ' ' LYS . 58.1 m-85 -111.62 -179.12 3.62 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.35 -1.722 . . . . 1.0 106.35 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.2 m . . . . . 0 N--CA 1.505 2.325 0 N-CA-C 115.487 1.662 . . . . 1.0 115.487 179.837 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 . . . . . 0 C--O 1.217 -0.645 0 N-CA-C 109.818 -0.438 . . . . 1.0 109.818 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.7 p -137.05 173.37 11.77 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 115.033 -0.985 . . . . 1.0 110.395 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -131.86 34.34 3.87 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 114.72 -1.127 . . . . 1.0 108.155 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.6 p -111.08 150.86 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-N 115.053 -0.976 . . . . 1.0 110.518 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -71.13 127.46 32.64 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.096 1.147 . . . . 1.0 114.096 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.429 ' SG ' ' C ' ' A' ' 32' ' ' LYS . 30.3 p -134.9 159.37 41.63 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.837 -0.62 . . . . 1.0 109.917 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -148.02 48.64 1.06 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.621 -1.251 . . . . 1.0 107.621 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.26 153.09 7.04 Favored Glycine 0 N--CA 1.498 2.83 0 CA-C-N 113.489 -1.687 . . . . 1.0 112.145 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 65.4 p -53.62 -57.71 9.8 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 116.038 1.866 . . . . 1.0 116.038 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -39.76 -41.8 1.16 Allowed 'General case' 0 C--O 1.204 -1.298 0 C-N-CA 124.63 1.172 . . . . 1.0 113.78 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -70.69 -38.37 73.69 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.598 -1.183 . . . . 1.0 111.7 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 13.3 t -72.19 -18.1 61.88 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 113.546 -1.661 . . . . 1.0 111.369 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -64.03 -61.29 7.06 Favored Pre-proline 0 N--CA 1.486 1.341 0 CA-C-O 118.449 -0.786 . . . . 1.0 111.331 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -64.83 -42.96 13.46 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 123.054 2.503 . . . . 1.0 110.499 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 66.6 t -56.85 -45.91 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 123.928 0.767 . . . . 1.0 110.057 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.592 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 38.2 t -67.76 -45.0 76.16 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -49.31 -42.73 42.23 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.433 1.111 . . . . 1.0 108.82 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -70.48 -49.25 50.42 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 113.168 -1.833 . . . . 1.0 112.208 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.0 ttp -57.01 -57.89 10.56 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 124.265 0.978 . . . . 1.0 113.007 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -116.82 -58.61 2.05 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 113.334 -1.757 . . . . 1.0 114.073 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.04 45.71 0.21 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.033 -1.627 . . . . 1.0 109.033 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.592 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 75.0 mmtt -127.01 72.22 76.13 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 105.852 -1.907 . . . . 1.0 105.852 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -60.89 -3.47 2.86 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.738 2.959 . . . . 1.0 114.359 -163.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.4 108.09 16.42 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.616 -1.624 . . . . 1.0 106.616 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.89 172.76 23.93 Favored Glycine 0 N--CA 1.486 2.011 0 CA-C-N 111.756 -2.475 . . . . 1.0 113.454 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -131.45 169.33 16.2 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 107.979 -1.119 . . . . 1.0 107.979 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.5 t -105.69 159.7 15.78 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 120.084 -0.647 . . . . 1.0 109.505 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.1 mtm -133.68 80.66 1.88 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.712 -1.131 . . . . 1.0 107.962 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 24.96 55.84 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 126.079 2.112 . . . . 1.0 110.632 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.5 -40.87 1.58 Allowed Glycine 0 N--CA 1.483 1.827 0 CA-C-N 111.858 -2.428 . . . . 1.0 116.205 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.429 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 48.1 mtmt -118.2 144.21 45.92 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 119.598 1.699 . . . . 1.0 113.584 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.1 t -71.86 157.97 36.9 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 112.487 -2.142 . . . . 1.0 112.813 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.432 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 12.9 tpt180 -136.78 144.74 43.9 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 112.699 -2.046 . . . . 1.0 105.862 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.9 m -118.5 163.79 16.24 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 105.557 -2.016 . . . . 1.0 105.557 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -113.55 169.22 9.13 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.601 -0.888 . . . . 1.0 108.601 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.506 2.371 0 CA-C-O 116.154 -1.879 . . . . 1.0 115.788 179.992 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 . . . . . 0 C--O 1.216 -0.688 0 CA-C-O 121.837 0.827 . . . . 1.0 109.677 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.4 p -148.12 171.3 16.1 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 112.946 -1.934 . . . . 1.0 109.808 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -127.79 51.39 1.95 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.825 -1.08 . . . . 1.0 108.586 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.2 t -111.96 126.38 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.856 0.836 . . . . 1.0 110.355 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 8.6 ptpp? -39.36 110.86 0.15 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 117.438 2.384 . . . . 1.0 117.438 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.3 p -125.97 172.36 9.99 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.025 0.917 . . . . 1.0 110.409 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.0 m -123.86 -47.04 1.95 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 112.431 -2.168 . . . . 1.0 106.482 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.82 168.69 31.78 Favored Glycine 0 N--CA 1.492 2.433 0 CA-C-N 114.218 -1.355 . . . . 1.0 110.081 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -48.13 -63.72 0.99 Allowed 'General case' 0 N--CA 1.482 1.128 0 O-C-N 124.097 0.528 . . . . 1.0 111.816 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -41.09 -37.4 0.86 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.902 1.376 . . . . 1.0 114.615 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -70.59 -34.42 72.15 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 122.975 1.369 . . . . 1.0 110.51 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.448 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 14.5 t -80.83 0.96 32.65 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.35 -1.75 . . . . 1.0 111.352 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.452 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 5.5 m95 -70.05 -60.59 3.43 Favored Pre-proline 0 N--CA 1.482 1.147 0 N-CA-C 106.069 -1.826 . . . . 1.0 106.069 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.425 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 73.9 Cg_endo -61.22 -43.98 26.12 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 122.422 2.081 . . . . 1.0 110.551 174.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 91.3 t -58.2 -45.3 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 C-N-CA 118.136 -1.425 . . . . 1.0 110.677 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 40.6 t -70.29 -31.03 68.21 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.308 -0.957 . . . . 1.0 109.047 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -59.47 -50.4 74.05 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -71.14 -48.22 53.25 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 119.348 -0.941 . . . . 1.0 113.373 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -50.28 73.98 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 114.1 1.148 . . . . 1.0 114.1 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -113.16 -61.57 1.72 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.7 1.37 . . . . 1.0 114.7 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.26 41.46 0.4 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.386 -1.885 . . . . 1.0 108.386 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 63.0 mmtt -130.38 81.52 67.92 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 104.645 -2.354 . . . . 1.0 104.645 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -62.1 -0.69 1.83 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.787 2.325 . . . . 1.0 114.222 -161.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.452 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 3.8 m120 -111.97 116.4 30.53 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 101.682 -3.451 . . . . 1.0 101.682 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.88 164.98 16.87 Favored Glycine 0 N--CA 1.486 1.979 0 CA-C-N 113.32 -1.763 . . . . 1.0 111.176 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . 73.6 tttt -128.33 170.78 12.67 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.826 -1.916 . . . . 1.0 105.826 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.5 t -123.06 159.7 27.91 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.219 0.533 . . . . 1.0 109.95 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.9 mtp -133.62 71.59 1.46 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.441 -1.689 . . . . 1.0 106.441 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 30.82 53.36 0.16 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 125.311 1.632 . . . . 1.0 111.981 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 125.72 -31.87 4.02 Favored Glycine 0 N--CA 1.48 1.575 0 CA-C-N 113.317 -1.765 . . . . 1.0 115.158 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.505 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 8.3 mptt -111.12 144.16 40.7 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-N 119.299 1.55 . . . . 1.0 108.755 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.82 160.63 32.25 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 114.919 1.451 . . . . 1.0 114.919 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 20.3 tpt85 -142.72 159.23 42.64 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 104.022 -2.585 . . . . 1.0 104.022 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.9 m -128.03 169.81 13.61 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.204 0.526 . . . . 1.0 110.036 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.603 ' CZ ' ' HB2' ' A' ' 27' ' ' LYS . 11.7 m-85 -122.72 -174.3 2.89 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 109.533 -0.543 . . . . 1.0 109.533 -179.762 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.9 p90 . . . . . 0 C--O 1.216 -0.661 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.8 p -133.44 169.07 17.49 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 123.826 0.704 . . . . 1.0 110.552 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -114.86 23.79 12.3 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.361 -1.29 . . . . 1.0 107.729 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -124.29 143.18 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.347 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -71.13 161.71 30.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.192 0.932 . . . . 1.0 112.131 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.485 ' SG ' ' C ' ' A' ' 32' ' ' LYS . 11.0 p -142.12 158.76 43.37 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.955 0.784 . . . . 1.0 111.617 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.6 p -136.58 43.98 2.41 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.492 -1.231 . . . . 1.0 108.138 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.63 161.08 11.92 Favored Glycine 0 N--CA 1.494 2.56 0 CA-C-N 113.902 -1.499 . . . . 1.0 110.889 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.8 t -45.59 -58.86 3.09 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.164 -1.018 . . . . 1.0 113.594 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -40.83 -41.52 1.6 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 115.122 1.527 . . . . 1.0 115.122 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.75 -33.1 70.45 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.306 1.004 . . . . 1.0 111.995 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 41.4 t -76.55 -12.73 60.07 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 113.633 -1.621 . . . . 1.0 112.059 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.42 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 8.3 m0 -69.8 -59.38 4.6 Favored Pre-proline 0 N--CA 1.483 1.215 0 CA-C-O 118.497 -0.763 . . . . 1.0 109.645 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 72.4 Cg_endo -62.51 -43.84 20.46 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 122.826 2.351 . . . . 1.0 109.732 177.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.9 t -59.34 -46.72 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 123.946 0.779 . . . . 1.0 110.633 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 41.6 t -70.26 -31.58 69.02 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.625 -1.23 . . . . 1.0 109.724 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -63.42 -48.1 79.17 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -70.74 -44.26 67.16 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.525 -0.87 . . . . 1.0 111.843 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.4 mmm -63.93 -52.76 58.27 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 113.935 1.087 . . . . 1.0 113.935 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -110.12 -62.19 1.55 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 124.179 0.924 . . . . 1.0 112.656 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.99 42.24 0.45 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.615 -2.194 . . . . 1.0 107.615 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 48.9 mmtm -130.86 82.64 63.7 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 106.821 -1.548 . . . . 1.0 106.821 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -62.55 0.24 1.55 Allowed 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.873 2.382 . . . . 1.0 114.609 -163.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -103.08 117.06 33.73 Favored 'General case' 0 C--N 1.308 -1.224 1 N-CA-C 99.485 -4.265 . . . . 1.0 99.485 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.11 144.1 13.36 Favored Glycine 0 C--N 1.292 -1.916 0 CA-C-N 113.604 -1.635 . . . . 1.0 110.534 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HD3' ' OH ' ' A' ' 36' ' ' TYR . 43.8 mtpt -126.08 165.32 19.07 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 107.08 -1.452 . . . . 1.0 107.08 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.2 t -104.59 148.97 25.92 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 113.206 0.817 . . . . 1.0 113.206 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.3 ptp -128.97 98.53 4.97 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.354 -1.294 . . . . 1.0 108.743 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.0 t30 32.4 47.06 0.08 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 113.02 -1.9 . . . . 1.0 113.124 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.49 -26.59 8.04 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 118.686 2.234 . . . . 1.0 118.686 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.485 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 93.2 mttt -114.26 149.95 35.11 Favored 'General case' 0 C--O 1.204 -1.291 0 CA-C-N 121.167 2.483 . . . . 1.0 109.96 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.1 t -72.28 159.03 34.75 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.814 -1.085 . . . . 1.0 111.946 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.448 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 26.4 ttt85 -133.05 141.22 48.11 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 112.956 -1.929 . . . . 1.0 106.057 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -111.99 166.19 11.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 124.172 0.92 . . . . 1.0 111.743 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.414 ' OH ' ' HD3' ' A' ' 27' ' ' LYS . 40.3 m-85 -126.36 -166.25 1.55 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.175 -1.829 . . . . 1.0 110.472 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.246 -1.359 . . . . 1.0 111.232 -179.772 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.5 p90 . . . . . 0 C--O 1.217 -0.639 0 CA-C-O 120.921 0.391 . . . . 1.0 111.377 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.7 p -132.3 179.13 6.3 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.612 -1.176 . . . . 1.0 110.962 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.22 26.3 9.72 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.405 -1.27 . . . . 1.0 109.398 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.8 t -123.98 141.9 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 31.0 mmmt -71.36 148.51 46.94 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.866 1.432 . . . . 1.0 114.866 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.7 p -140.42 173.08 11.86 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.35 1.071 . . . . 1.0 112.041 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.1 t -136.38 -38.35 0.68 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 111.997 -2.365 . . . . 1.0 108.986 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.74 163.48 23.76 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 123.747 0.654 . . . . 1.0 112.78 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.5 p -70.29 -54.51 12.37 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.341 0.867 . . . . 1.0 113.341 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -58.44 -20.15 42.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 124.322 1.014 . . . . 1.0 111.459 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -70.07 -31.0 68.38 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.219 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 3.9 t -80.11 -1.57 40.7 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.465 -1.243 . . . . 1.0 113.207 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.456 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 10.5 m0 -70.27 -60.4 3.42 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 87.7 Cg_endo -64.95 -44.35 10.12 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.794 2.329 . . . . 1.0 111.747 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 78.8 t -58.26 -45.21 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 119.736 -0.786 . . . . 1.0 110.892 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.4 t -69.98 -44.3 69.71 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -48.24 -42.06 29.31 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 122.355 1.074 . . . . 1.0 108.365 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -70.73 -47.64 58.71 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 113.114 -1.857 . . . . 1.0 112.792 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 94.9 mtp -69.19 -58.24 4.31 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 116.312 1.968 . . . . 1.0 116.312 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -102.66 -55.23 2.48 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.905 -1.043 . . . . 1.0 112.641 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.47 37.3 0.38 Allowed Glycine 0 N--CA 1.489 2.218 0 O-C-N 124.08 0.863 . . . . 1.0 111.331 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.54 115.07 22.98 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 106.548 -1.649 . . . . 1.0 106.548 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -74.46 15.36 0.67 Allowed 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.734 2.289 . . . . 1.0 112.66 -174.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.56 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 5.5 m120 -123.65 -177.13 3.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.76 0.791 . . . . 1.0 109.065 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.86 169.73 12.16 Favored Glycine 0 N--CA 1.49 2.293 0 CA-C-N 114.029 -1.441 . . . . 1.0 114.072 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 49.0 mtpt -132.21 -167.82 1.95 Allowed 'General case' 0 N--CA 1.504 2.25 0 CA-C-N 113.005 -1.597 . . . . 1.0 111.296 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.5 t -126.37 154.45 43.53 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.035 -1.839 . . . . 1.0 106.035 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.6 mtm -132.37 78.42 1.8 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.637 -1.246 . . . . 1.0 107.637 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.0 t30 28.76 52.64 0.07 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 125.835 1.959 . . . . 1.0 111.143 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 127.11 -35.49 2.83 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-O 117.019 -1.99 . . . . 1.0 116.273 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -109.23 146.01 34.93 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-N 120.853 2.326 . . . . 1.0 109.607 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -70.97 159.97 33.75 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.896 -1.047 . . . . 1.0 111.499 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.481 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 4.6 tpt180 -134.51 146.77 50.03 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 106.237 -1.764 . . . . 1.0 106.237 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.7 m -120.38 163.04 18.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.48 -1.674 . . . . 1.0 106.48 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.56 ' CD2' ' HB3' ' A' ' 25' ' ' ASN . 11.1 m-30 -114.38 178.11 4.4 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.393 -1.706 . . . . 1.0 106.393 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.506 2.35 0 O-C-N 125.117 1.511 . . . . 1.0 114.451 -179.73 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.0 p90 . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 112.965 0.728 . . . . 1.0 112.965 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.53 ' HB ' ' SD ' ' A' ' 20' ' ' MET . 68.4 p -131.12 -179.95 5.64 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.078 -0.964 . . . . 1.0 112.316 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.37 -4.41 11.83 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.117 -1.856 . . . . 1.0 109.168 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.07 141.82 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 107.104 -1.443 . . . . 1.0 107.104 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -71.17 167.39 19.46 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.341 1.978 . . . . 1.0 116.341 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.2 p -139.15 177.52 7.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 124.819 1.324 . . . . 1.0 110.613 179.611 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.8 m -123.18 -50.11 1.92 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 104.889 -2.263 . . . . 1.0 104.889 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.05 167.85 31.79 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.581 -1.807 . . . . 1.0 108.581 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 65.4 m -46.49 -56.34 6.11 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.403 0.621 . . . . 1.0 110.19 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -48.7 -39.81 26.0 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.329 -1.305 . . . . 1.0 112.848 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -70.69 -35.21 72.67 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.846 1.308 . . . . 1.0 109.751 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 4.0 t -74.46 -12.33 60.47 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 113.653 -1.612 . . . . 1.0 113.015 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.51 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 5.0 m0 -65.9 -58.73 10.46 Favored Pre-proline 0 C--N 1.306 -1.285 0 CA-C-O 118.752 -0.642 . . . . 1.0 109.603 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -61.3 -42.86 31.89 Favored 'Trans proline' 0 N--CA 1.488 1.158 0 C-N-CA 122.567 2.178 . . . . 1.0 110.44 173.638 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 53.9 t -55.04 -44.08 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 119.335 -0.946 . . . . 1.0 110.906 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 41.2 t -70.31 -41.53 73.19 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -50.16 -43.98 52.43 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.306 -0.998 . . . . 1.0 108.306 179.727 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -70.85 -53.02 16.75 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 113.354 -1.748 . . . . 1.0 113.238 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.53 ' SD ' ' HB ' ' A' ' 3' ' ' THR . 20.3 ttp -55.67 -55.77 28.3 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 115.309 1.596 . . . . 1.0 115.309 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -116.13 -56.86 2.27 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 113.474 -1.693 . . . . 1.0 113.033 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.73 39.88 0.28 Allowed Glycine 0 N--CA 1.491 2.322 0 O-C-N 123.812 0.695 . . . . 1.0 111.623 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 5.5 mppt? -129.29 91.37 41.97 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 105.551 -2.018 . . . . 1.0 105.551 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -64.63 3.58 0.84 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 123.045 2.497 . . . . 1.0 113.981 -165.024 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.51 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 26.7 m120 -111.62 -178.05 3.34 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.499 -1.667 . . . . 1.0 106.499 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.61 -176.03 23.98 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.269 -1.443 . . . . 1.0 114.745 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.605 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 28.5 mtpp -131.64 177.1 7.77 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 113.138 -1.531 . . . . 1.0 111.927 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.0 t -119.26 152.28 36.95 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 179.267 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.8 mtm -131.76 80.11 1.91 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.079 -0.964 . . . . 1.0 108.627 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.2 t30 28.73 52.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 125.586 1.804 . . . . 1.0 111.919 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.59 -31.4 4.18 Favored Glycine 0 N--CA 1.485 1.965 0 CA-C-O 116.405 -2.33 . . . . 1.0 116.912 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -115.88 141.17 48.46 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 120.795 2.297 . . . . 1.0 109.32 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.465 ' SG ' HG21 ' A' ' 3' ' ' THR . 33.1 t -71.87 160.64 32.22 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.652 -1.613 . . . . 1.0 113.517 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.557 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.2 tpt180 -133.61 146.75 51.23 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.431 -2.063 . . . . 1.0 105.431 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.3 m -117.61 164.82 14.37 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.248 -1.019 . . . . 1.0 108.248 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.605 ' CZ ' ' HG3' ' A' ' 27' ' ' LYS . 13.8 m-85 -117.63 -178.01 3.38 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.295 -1.32 . . . . 1.0 107.572 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.496 1.86 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 -179.962 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.4 p90 . . . . . 0 C--O 1.216 -0.692 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.466 HG21 ' SG ' ' A' ' 33' ' ' CYS . 79.7 p -127.89 -173.46 2.94 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.052 0.845 . . . . 1.0 112.297 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -124.17 -7.45 7.68 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 113.403 -1.726 . . . . 1.0 110.273 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.4 t -111.54 145.34 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.498 -0.927 . . . . 1.0 108.498 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 171.02 11.68 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 116.923 2.194 . . . . 1.0 116.923 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 p -141.2 173.11 11.8 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.175 -1.375 . . . . 1.0 110.478 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.2 m -121.49 -49.49 2.14 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.854 -2.276 . . . . 1.0 104.854 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.19 169.59 33.22 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.542 -1.823 . . . . 1.0 108.542 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.6 t -43.54 -58.78 2.46 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.51 0.671 . . . . 1.0 110.521 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.26 -39.4 14.28 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 113.859 -1.519 . . . . 1.0 114.219 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -70.23 -32.66 70.62 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.066 0.936 . . . . 1.0 111.175 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 15.3 t -76.44 -12.32 60.03 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.949 -1.478 . . . . 1.0 113.111 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.414 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.9 m0 -66.78 -58.99 8.59 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 123.822 0.701 . . . . 1.0 109.462 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 85.3 Cg_endo -63.31 -42.88 20.32 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.883 2.389 . . . . 1.0 110.681 175.316 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 50.9 t -55.78 -46.45 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 C-N-CA 120.104 -0.638 . . . . 1.0 110.398 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.8 t -68.97 -42.55 76.46 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -50.48 -42.69 54.86 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.252 1.025 . . . . 1.0 108.534 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -70.65 -51.37 28.3 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.691 -1.595 . . . . 1.0 112.741 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.4 ttp -58.31 -52.41 65.7 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.026 1.121 . . . . 1.0 114.026 -179.258 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -116.86 -58.03 2.11 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.484 -1.235 . . . . 1.0 114.083 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.93 40.67 0.19 Allowed Glycine 0 N--CA 1.488 2.125 0 O-C-N 123.774 0.671 . . . . 1.0 112.501 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -127.79 103.31 21.67 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 105.694 -1.965 . . . . 1.0 105.694 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.71 10.08 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.993 2.462 . . . . 1.0 113.002 -168.789 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.414 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 34.0 m120 -116.03 -176.3 2.92 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.954 -1.498 . . . . 1.0 106.954 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.419 ' HA2' ' CD1' ' A' ' 36' ' ' TYR . . . 143.44 175.98 17.05 Favored Glycine 0 N--CA 1.489 2.175 0 CA-C-N 113.994 -1.457 . . . . 1.0 113.069 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.474 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 51.8 mtpt -133.0 178.73 6.66 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 113.061 -1.57 . . . . 1.0 109.466 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -114.77 155.55 26.5 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.961 -1.496 . . . . 1.0 106.961 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 48.4 mtp -132.5 74.96 1.6 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.292 -1.373 . . . . 1.0 107.292 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 31.13 54.52 0.21 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 125.375 1.672 . . . . 1.0 110.995 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.88 -29.8 5.7 Favored Glycine 0 N--CA 1.487 2.07 0 CA-C-O 116.829 -2.095 . . . . 1.0 116.469 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 7.1 mptt -113.73 142.5 45.96 Favored 'General case' 0 C--O 1.206 -1.207 0 CA-C-N 120.387 2.093 . . . . 1.0 108.446 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.466 ' SG ' HG21 ' A' ' 3' ' ' THR . 36.4 t -71.55 160.82 32.02 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.574 -1.194 . . . . 1.0 113.216 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.581 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 5.3 tpt180 -131.6 140.12 49.34 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.274 -2.121 . . . . 1.0 105.274 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.7 m -111.74 161.55 16.18 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.116 0.96 . . . . 1.0 110.13 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.419 ' CD1' ' HA2' ' A' ' 26' ' ' GLY . 7.2 m-30 -115.88 -168.99 1.51 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 111.939 -2.391 . . . . 1.0 106.816 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 107.509 -1.293 . . . . 1.0 107.509 -179.816 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 C--O 1.216 -0.693 0 N-CA-C 107.188 -1.412 . . . . 1.0 107.188 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.6 p -131.47 174.01 10.52 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 123.641 0.588 . . . . 1.0 110.72 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -125.3 32.51 5.35 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.571 -1.27 . . . . 1.0 107.571 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.1 p -111.29 134.95 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.151 -1.425 . . . . 1.0 107.151 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -70.67 140.7 51.58 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 113.454 0.909 . . . . 1.0 113.454 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.426 ' SG ' ' C ' ' A' ' 32' ' ' LYS . 2.5 p -136.21 170.41 16.06 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.063 0.935 . . . . 1.0 111.909 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.4 m -130.25 -43.19 1.18 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 112.384 -2.189 . . . . 1.0 108.516 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.19 172.08 21.59 Favored Glycine 0 N--CA 1.497 2.742 0 O-C-N 124.431 1.082 . . . . 1.0 112.411 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.1 p -70.1 -57.66 4.7 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.461 -0.869 . . . . 1.0 112.838 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -39.86 -32.79 0.17 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.82 -36.64 73.02 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 122.228 1.013 . . . . 1.0 111.031 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 41.8 t -73.6 -10.13 59.39 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.467 -1.242 . . . . 1.0 111.574 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.444 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 9.8 m95 -69.94 -61.04 3.16 Favored Pre-proline 0 N--CA 1.484 1.231 0 CA-C-O 118.462 -0.78 . . . . 1.0 110.104 179.366 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.444 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 81.8 Cg_endo -63.04 -40.42 34.05 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.771 2.314 . . . . 1.0 109.752 177.088 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.8 t -58.83 -49.77 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 123.837 0.71 . . . . 1.0 110.356 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.9 t -68.96 -34.63 75.64 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 118.946 -1.102 . . . . 1.0 109.295 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.08 -38.74 89.98 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -70.44 -52.36 22.76 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.642 -1.163 . . . . 1.0 111.035 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 73.1 mtm -61.35 -52.11 66.01 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.629 0.974 . . . . 1.0 113.629 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -111.26 -62.48 1.54 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 113.93 1.085 . . . . 1.0 113.93 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.41 43.68 0.42 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 106.922 -2.471 . . . . 1.0 106.922 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -127.82 81.94 69.33 Favored Pre-proline 0 N--CA 1.493 1.718 0 CA-C-N 113.496 -1.352 . . . . 1.0 107.584 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.7 0.18 3.23 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 123.684 2.923 . . . . 1.0 116.266 -150.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 24.7 m120 -103.94 129.25 51.47 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 104.771 -2.307 . . . . 1.0 104.771 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 14' ' ' TRP . . . -146.82 145.86 15.14 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-N 113.958 -1.474 . . . . 1.0 110.815 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -131.46 170.51 14.59 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 106.869 -1.53 . . . . 1.0 106.869 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.3 t -107.09 150.61 26.37 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.898 -0.721 . . . . 1.0 110.691 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.3 ptm -129.18 102.77 6.61 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.916 -1.493 . . . . 1.0 108.566 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.7 p30 31.69 44.34 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 113.641 -1.618 . . . . 1.0 114.194 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.94 -28.57 6.34 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 118.592 2.197 . . . . 1.0 118.592 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 35.3 mmtp -114.99 156.64 24.72 Favored 'General case' 0 C--O 1.202 -1.419 0 CA-C-N 120.87 2.335 . . . . 1.0 111.44 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.8 t -71.87 160.27 32.86 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.155 0.978 . . . . 1.0 111.0 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.447 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.3 tpt180 -136.26 140.45 43.45 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 105.93 -1.878 . . . . 1.0 105.93 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.9 m -109.39 164.01 12.88 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.437 1.113 . . . . 1.0 113.242 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.479 ' HB2' ' HB2' ' A' ' 25' ' ' ASN . 42.9 m-85 -128.16 -160.45 1.02 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 111.931 -2.395 . . . . 1.0 108.287 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.487 1.414 0 O-C-N 125.029 1.456 . . . . 1.0 107.756 179.898 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.2 p90 . . . . . 0 C--O 1.216 -0.7 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.516 HG21 ' SG ' ' A' ' 33' ' ' CYS . 58.9 p -127.3 -175.41 3.43 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.71 0.767 . . . . 1.0 112.803 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -124.22 -7.21 7.66 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.05 -1.886 . . . . 1.0 110.153 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.7 t -111.64 144.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.35 170.99 11.99 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 116.515 2.042 . . . . 1.0 116.515 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.3 p -141.23 173.03 11.88 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.225 -1.352 . . . . 1.0 110.493 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.9 m -121.3 -49.51 2.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 104.758 -2.312 . . . . 1.0 104.758 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.13 169.51 33.18 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 108.625 -1.79 . . . . 1.0 108.625 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.1 t -43.29 -58.58 2.47 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.541 0.686 . . . . 1.0 110.51 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.93 -39.24 11.91 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 113.958 -1.474 . . . . 1.0 114.447 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -70.3 -33.1 71.13 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.233 1.016 . . . . 1.0 111.174 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.573 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 19.2 t -76.56 -11.55 59.89 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 113.747 -1.57 . . . . 1.0 113.075 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.413 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 7.0 m0 -67.49 -58.53 8.44 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 123.75 0.656 . . . . 1.0 109.52 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 84.6 Cg_endo -63.38 -43.07 19.23 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.816 2.344 . . . . 1.0 110.686 174.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -55.49 -47.27 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 119.844 -0.742 . . . . 1.0 110.216 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.0 t -67.75 -42.45 81.76 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.372 -0.931 . . . . 1.0 108.805 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -50.13 -42.85 51.41 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.342 1.067 . . . . 1.0 108.347 179.655 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -70.54 -46.25 63.93 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 113.648 -1.614 . . . . 1.0 111.151 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.4 ttp -54.03 -56.7 15.49 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 123.957 0.785 . . . . 1.0 112.641 -179.388 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -121.87 -57.02 1.82 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 113.385 -1.734 . . . . 1.0 114.021 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.95 43.41 0.11 Allowed Glycine 0 N--CA 1.488 2.122 0 O-C-N 124.045 0.841 . . . . 1.0 111.517 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -126.22 98.93 31.83 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 105.065 -2.198 . . . . 1.0 105.065 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.09 11.96 0.4 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 123.091 2.528 . . . . 1.0 113.218 -167.629 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.413 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 33.5 m120 -116.36 -176.2 2.91 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.73 -1.581 . . . . 1.0 106.73 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' A' ' 36' ' ' TYR . . . 144.75 175.92 18.31 Favored Glycine 0 N--CA 1.49 2.254 0 CA-C-N 113.991 -1.459 . . . . 1.0 112.734 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.461 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 52.0 mtpt -133.33 177.81 7.4 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 113.165 -1.517 . . . . 1.0 109.001 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.3 t -114.89 155.99 25.83 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.769 -1.567 . . . . 1.0 106.769 179.446 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 48.8 mtp -133.01 75.17 1.61 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.29 -1.374 . . . . 1.0 107.29 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 30.95 54.44 0.19 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 125.321 1.638 . . . . 1.0 111.202 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.11 -29.69 5.68 Favored Glycine 0 N--CA 1.483 1.833 0 CA-C-O 116.916 -2.046 . . . . 1.0 116.438 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 7.1 mptt -113.97 142.49 46.09 Favored 'General case' 0 C--O 1.206 -1.218 0 CA-C-N 120.331 2.066 . . . . 1.0 108.194 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.516 ' SG ' HG21 ' A' ' 3' ' ' THR . 35.5 t -71.65 161.74 30.53 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.482 -1.236 . . . . 1.0 113.137 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.573 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 5.9 tpt180 -132.69 139.96 47.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.555 -2.017 . . . . 1.0 105.555 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.5 m -111.18 161.02 16.4 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.426 1.108 . . . . 1.0 110.778 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' CD1' ' HA2' ' A' ' 26' ' ' GLY . 6.2 m-30 -116.66 -169.0 1.55 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 111.318 -2.674 . . . . 1.0 106.722 -179.629 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 107.624 -1.25 . . . . 1.0 107.624 -179.863 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 35.6 p90 . . . . . 0 C--O 1.216 -0.678 0 CA-C-O 121.421 0.629 . . . . 1.0 111.088 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.9 p -132.45 171.35 13.88 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.639 -1.619 . . . . 1.0 110.687 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.58 48.79 1.03 Allowed 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.6 t -111.04 119.42 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.063 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 75.8 mmtt -39.65 113.13 0.31 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.655 -1.611 . . . . 1.0 115.272 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.4 p -123.24 171.48 9.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.257 0.973 . . . . 1.0 111.149 179.739 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.1 p -126.18 -43.17 1.81 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 112.595 -2.093 . . . . 1.0 108.495 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.49 169.17 29.76 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 124.44 1.087 . . . . 1.0 112.29 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.9 t -54.67 -62.63 1.53 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.454 -0.873 . . . . 1.0 111.576 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -42.7 -40.13 2.67 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 115.126 1.528 . . . . 1.0 115.126 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -57.88 -31.23 66.52 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.156 0.979 . . . . 1.0 112.974 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.413 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 22.9 m -81.21 -3.84 53.56 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.04 -1.437 . . . . 1.0 113.553 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.544 ' CG ' ' HA ' ' A' ' 25' ' ' ASN . 11.5 m0 -70.31 -59.0 4.4 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 107.826 -1.176 . . . . 1.0 107.826 179.262 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.464 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 83.6 Cg_endo -65.69 -46.45 5.15 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 122.735 2.29 . . . . 1.0 111.515 174.115 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 95.8 t -56.87 -44.69 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 119.276 -0.969 . . . . 1.0 110.306 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 51.8 t -68.45 -45.01 73.61 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.692 -1.203 . . . . 1.0 108.627 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -46.89 -43.18 18.61 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 107.591 -1.263 . . . . 1.0 107.591 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -70.76 -45.33 64.97 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 112.941 -1.936 . . . . 1.0 112.719 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.9 mtm -63.45 -57.96 8.59 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.678 1.362 . . . . 1.0 114.678 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -111.88 -56.34 2.4 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.387 -1.279 . . . . 1.0 113.252 -179.408 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.16 39.47 0.38 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.452 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 14.0 mptt -119.01 97.0 50.62 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 102.691 -3.078 . . . . 1.0 102.691 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -64.91 -3.48 7.07 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 123.367 2.711 . . . . 1.0 113.346 -156.495 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.544 ' HA ' ' CG ' ' A' ' 14' ' ' TRP . 8.0 p30 -122.25 165.68 15.81 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 124.438 1.086 . . . . 1.0 109.079 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.0 168.72 41.43 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.336 -0.935 . . . . 1.0 112.444 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.656 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 27.8 mtpp -121.85 -176.64 3.38 Favored 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 115.014 -0.593 . . . . 1.0 109.575 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.8 t -127.26 156.32 42.09 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 106.263 -1.754 . . . . 1.0 106.263 179.237 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 71.4 mtm -136.15 77.18 1.64 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.016 -1.476 . . . . 1.0 107.016 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.1 t30 30.36 53.43 0.14 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 125.271 1.607 . . . . 1.0 111.341 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 125.13 -35.52 3.08 Favored Glycine 0 N--CA 1.486 2.03 0 CA-C-N 113.159 -1.837 . . . . 1.0 115.637 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HD3' ' N ' ' A' ' 32' ' ' LYS . 1.7 mppt? -109.48 139.78 44.04 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 119.948 1.874 . . . . 1.0 109.907 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 46.1 t -71.94 160.56 32.32 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 112.917 -1.947 . . . . 1.0 116.013 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.453 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 9.1 tpt180 -139.29 155.41 47.75 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.017 -1.447 . . . . 1.0 107.773 179.71 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.9 m -126.71 166.14 17.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.992 -2.225 . . . . 1.0 104.992 179.327 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.656 ' CZ ' ' HG3' ' A' ' 27' ' ' LYS . 89.4 m-85 -113.26 177.37 4.65 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.752 -1.203 . . . . 1.0 107.752 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.9 m . . . . . 0 N--CA 1.501 2.077 0 CA-C-O 117.404 -1.284 . . . . 1.0 111.342 179.942 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.209 -1.063 0 N-CA-C 113.348 0.87 . . . . 1.0 113.348 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -99.31 168.5 9.98 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.624 -1.171 . . . . 1.0 110.373 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.4 p -130.54 172.56 11.78 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.826 -1.079 . . . . 1.0 110.105 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -126.3 28.3 6.04 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.245 0.965 . . . . 1.0 109.061 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 p -115.79 155.11 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 115.152 -0.931 . . . . 1.0 109.895 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -70.8 131.95 44.59 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.508 -0.769 . . . . 1.0 112.83 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.3 p -123.55 160.31 27.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.944 0.777 . . . . 1.0 109.018 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 81.4 p -132.77 40.09 3.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.608 0.718 . . . . 1.0 110.15 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.3 163.17 13.86 Favored Glycine 0 N--CA 1.494 2.534 0 CA-C-N 114.092 -1.413 . . . . 1.0 109.8 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.4 p -43.71 -49.9 7.74 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 114.385 -0.907 . . . . 1.0 113.332 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -45.95 -50.09 15.07 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 115.102 -0.954 . . . . 1.0 113.002 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -70.99 -29.3 65.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.056 0.848 . . . . 1.0 110.692 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 26.3 t -73.97 -23.15 59.44 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.777 -1.101 . . . . 1.0 112.678 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.409 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 7.1 m0 -62.89 -58.83 14.57 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-O 118.591 -0.718 . . . . 1.0 111.949 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 90.5 Cg_endo -64.01 -41.4 23.02 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 123.121 2.548 . . . . 1.0 109.801 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.12 -45.63 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 123.96 0.788 . . . . 1.0 110.26 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 42.4 t -70.0 -43.8 70.65 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.841 -1.17 . . . . 1.0 107.841 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -48.38 -43.44 33.82 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 122.415 1.103 . . . . 1.0 108.405 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -70.82 -52.62 19.32 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 113.048 -1.887 . . . . 1.0 113.902 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 84.0 mtp -64.6 -55.97 16.92 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 115.015 1.487 . . . . 1.0 115.015 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -108.86 -57.38 2.15 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.403 1.064 . . . . 1.0 113.034 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.3 35.49 0.66 Allowed Glycine 0 N--CA 1.495 2.587 0 O-C-N 123.857 0.723 . . . . 1.0 111.332 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.548 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 13.1 mptt -122.28 90.84 49.22 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 104.484 -2.413 . . . . 1.0 104.484 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.09 -3.47 7.28 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 123.227 2.618 . . . . 1.0 113.366 -160.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.403 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 33.4 m120 -105.09 -175.93 2.93 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.032 -1.47 . . . . 1.0 107.032 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.66 -178.74 19.14 Favored Glycine 0 N--CA 1.489 2.174 0 CA-C-N 114.0 -1.454 . . . . 1.0 113.224 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -139.66 167.58 21.78 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.751 -1.225 . . . . 1.0 111.281 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 39.0 t -108.61 147.78 31.33 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.807 -0.812 . . . . 1.0 108.807 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.9 ptm -136.54 108.47 7.13 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 123.786 0.679 . . . . 1.0 110.314 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.2 t30 31.2 46.13 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.188 -1.824 . . . . 1.0 113.027 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.34 -30.42 6.02 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 119.29 2.476 . . . . 1.0 119.29 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -118.2 146.89 43.89 Favored 'General case' 0 C--O 1.205 -1.247 0 CA-C-N 120.56 2.18 . . . . 1.0 112.911 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.3 t -72.52 156.47 38.98 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 112.853 -1.976 . . . . 1.0 112.728 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.46 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 10.0 tpt180 -133.1 142.66 48.83 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 112.175 -2.284 . . . . 1.0 105.516 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.0 m -109.42 166.31 10.97 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 124.231 0.957 . . . . 1.0 109.669 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -118.37 -178.57 3.55 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 114.386 -1.279 . . . . 1.0 108.923 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 117.537 -1.22 . . . . 1.0 111.127 179.946 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -94.19 156.51 16.51 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.965 0.728 . . . . 1.0 112.965 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 59.4 p -132.25 166.3 22.18 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 113.872 -1.513 . . . . 1.0 108.416 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -123.62 45.75 2.38 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.885 0.85 . . . . 1.0 109.161 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -104.78 153.17 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 114.411 -1.268 . . . . 1.0 108.975 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -70.63 117.92 12.76 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.248 1.944 . . . . 1.0 116.248 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.8 p -127.33 172.93 10.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 124.156 0.91 . . . . 1.0 109.098 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.4 m -124.11 -44.93 2.01 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 112.961 -1.927 . . . . 1.0 106.956 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.57 169.76 32.88 Favored Glycine 0 N--CA 1.494 2.555 0 CA-C-N 114.831 -1.077 . . . . 1.0 111.73 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.5 t -43.75 -57.4 3.25 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.195 -1.002 . . . . 1.0 112.076 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -41.88 -42.27 2.67 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 114.284 -1.326 . . . . 1.0 113.704 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -70.51 -41.11 73.03 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.658 1.218 . . . . 1.0 111.419 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 41.3 t -71.35 -23.53 61.93 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 113.137 -1.847 . . . . 1.0 112.309 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.452 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.2 m0 -59.15 -60.62 9.97 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 123.918 0.761 . . . . 1.0 111.876 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -63.77 -43.09 17.53 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.152 2.568 . . . . 1.0 109.738 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.77 -42.73 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 123.864 0.728 . . . . 1.0 109.966 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 51.4 m -70.27 -43.86 69.6 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -50.36 -42.24 52.85 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.333 1.063 . . . . 1.0 108.544 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -70.89 -56.39 6.36 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 113.539 -1.664 . . . . 1.0 113.42 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.7 ttm -59.19 -56.15 25.87 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 115.075 1.509 . . . . 1.0 115.075 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -106.36 -58.98 1.85 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 113.461 -1.699 . . . . 1.0 114.011 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.59 45.88 0.26 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 106.383 -2.687 . . . . 1.0 106.383 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -128.72 88.66 51.41 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 106.132 -1.803 . . . . 1.0 106.132 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -62.16 2.39 0.65 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.318 2.012 . . . . 1.0 113.67 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.452 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 8.0 m120 -113.49 -174.74 2.52 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.96 -179.08 18.38 Favored Glycine 0 N--CA 1.489 2.216 0 CA-C-N 113.659 -1.609 . . . . 1.0 110.734 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -140.96 167.92 21.04 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.863 -0.668 . . . . 1.0 110.539 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.5 t -107.75 157.49 18.08 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.52 -0.918 . . . . 1.0 108.52 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.7 mtp -132.05 81.91 1.99 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.783 -1.191 . . . . 1.0 107.783 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.1 t30 29.34 53.94 0.11 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 125.534 1.771 . . . . 1.0 111.519 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.36 -38.04 2.3 Favored Glycine 0 N--CA 1.479 1.543 0 CA-C-N 113.145 -1.843 . . . . 1.0 115.737 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -114.98 135.2 54.48 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-N 119.37 1.585 . . . . 1.0 112.711 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 15.2 t -72.07 157.61 37.47 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.796 -2.911 . . . . 1.0 114.828 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.532 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.4 tpt180 -138.11 143.49 40.41 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 112.365 -2.198 . . . . 1.0 105.938 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.6 m -119.4 160.71 21.8 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.718 -1.586 . . . . 1.0 106.718 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -110.88 -172.15 1.97 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.7 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 116.109 -1.9 . . . . 1.0 109.493 -179.702 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.907 0.384 . . . . 1.0 109.975 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -97.54 168.76 10.17 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.431 HG21 ' SG ' ' A' ' 33' ' ' CYS . 72.8 p -128.47 177.55 6.91 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 122.132 0.968 . . . . 1.0 113.146 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -112.98 -5.93 13.77 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 112.596 -2.093 . . . . 1.0 109.319 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.2 t -112.81 140.65 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.327 -0.99 . . . . 1.0 108.327 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 25.2 pttm -71.05 167.44 19.24 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.751 1.76 . . . . 1.0 115.751 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.9 p -138.54 176.04 9.04 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 124.61 1.194 . . . . 1.0 110.716 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.3 m -125.36 -49.31 1.68 Allowed 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.256 -2.247 . . . . 1.0 105.345 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.82 170.13 29.26 Favored Glycine 0 N--CA 1.493 2.495 0 CA-C-N 114.004 -1.453 . . . . 1.0 109.764 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.0 m -51.23 -54.94 20.92 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.382 0.611 . . . . 1.0 110.661 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -49.1 -39.95 30.19 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.659 -1.155 . . . . 1.0 113.161 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -70.39 -30.71 67.67 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.255 1.026 . . . . 1.0 110.849 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.578 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 6.0 t -76.98 -10.65 59.51 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 113.568 -1.651 . . . . 1.0 112.833 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 9.9 m0 -66.86 -58.48 9.49 Favored Pre-proline 0 N--CA 1.485 1.29 0 CA-C-O 118.873 -0.584 . . . . 1.0 109.523 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.09 -48.0 9.2 Favored 'Trans proline' 0 N--CA 1.486 1.081 0 C-N-CA 122.369 2.046 . . . . 1.0 110.096 173.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 60.5 t -51.33 -40.8 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 119.997 -0.681 . . . . 1.0 110.315 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 42.8 t -70.35 -49.43 49.35 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.775 -1.17 . . . . 1.0 107.999 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -47.77 -38.23 15.18 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.205 1.002 . . . . 1.0 109.425 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -70.24 -53.99 14.65 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.309 -1.769 . . . . 1.0 111.956 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 35.7 mmt -69.82 -55.31 10.15 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 115.98 1.844 . . . . 1.0 115.98 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -102.86 -53.58 2.82 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 123.77 0.669 . . . . 1.0 112.666 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.07 35.28 0.55 Allowed Glycine 0 N--CA 1.492 2.381 0 O-C-N 123.662 0.601 . . . . 1.0 113.281 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 2.9 mptp? -127.45 131.67 23.95 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -87.3 14.36 2.43 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 122.43 2.087 . . . . 1.0 110.511 -175.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.426 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 73.4 m-80 -119.54 -177.56 3.4 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.557 -1.275 . . . . 1.0 107.557 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.24 172.76 12.76 Favored Glycine 0 N--CA 1.488 2.135 0 CA-C-N 114.13 -1.395 . . . . 1.0 114.747 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.478 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 50.4 mtpt -130.35 177.81 7.06 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 112.158 -2.021 . . . . 1.0 110.719 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 t -116.35 151.79 35.21 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.375 -1.343 . . . . 1.0 107.375 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 70.8 mtm -130.69 83.75 2.14 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.114 -1.069 . . . . 1.0 108.114 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 27.84 50.35 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 125.54 1.775 . . . . 1.0 112.851 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 126.44 -31.4 4.01 Favored Glycine 0 N--CA 1.484 1.838 0 CA-C-O 116.012 -2.549 . . . . 1.0 117.532 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -116.94 145.98 43.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 121.356 2.578 . . . . 1.0 109.491 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.431 ' SG ' HG21 ' A' ' 3' ' ' THR . 16.7 t -71.7 157.98 36.96 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.581 -1.645 . . . . 1.0 113.791 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.578 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 17.8 tpt85 -128.96 140.18 51.77 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.366 -2.197 . . . . 1.0 105.692 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.8 m -111.6 163.49 14.04 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.146 -1.057 . . . . 1.0 108.146 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.472 ' OH ' ' HG3' ' A' ' 27' ' ' LYS . 12.7 m-30 -114.26 -176.86 2.99 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 113.717 -1.583 . . . . 1.0 108.201 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 116.162 -1.875 . . . . 1.0 108.893 -179.921 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PCA . . . . . 0.476 ' CD ' ' HB2' ' A' ' 35' ' ' CYS . . . . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 112.29 0.478 . . . . 1.0 112.29 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -95.27 145.19 25.25 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.824 0.821 . . . . 1.0 113.143 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.7 p -132.18 163.47 28.48 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 113.045 -1.889 . . . . 1.0 108.158 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -126.65 52.26 1.77 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 124.003 0.814 . . . . 1.0 110.459 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -111.58 151.58 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 C-N-CA 120.001 -0.68 . . . . 1.0 109.352 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -70.21 103.17 2.27 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 114.968 1.47 . . . . 1.0 114.968 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.3 p -120.58 172.3 7.95 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.082 0.944 . . . . 1.0 109.909 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.6 t -126.22 -42.22 1.86 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 112.578 -2.101 . . . . 1.0 107.898 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.79 165.29 26.91 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 124.268 0.98 . . . . 1.0 111.542 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.0 m -47.88 -53.33 16.07 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.384 -0.908 . . . . 1.0 111.719 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' NZ ' HE22 ' A' ' 12' ' ' GLN . 10.4 mtmp? -45.19 -43.37 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.075 -1.42 . . . . 1.0 114.063 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.449 HE22 ' NZ ' ' A' ' 11' ' ' LYS . 14.4 mp0 -70.24 -32.52 70.41 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.893 0.854 . . . . 1.0 111.346 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 8.5 t -77.55 -11.5 59.86 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 113.742 -1.572 . . . . 1.0 112.331 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.446 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.0 m0 -67.6 -59.7 6.56 Favored Pre-proline 0 N--CA 1.49 1.57 0 CA-C-O 118.655 -0.688 . . . . 1.0 110.434 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -63.73 -46.98 7.82 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.59 2.194 . . . . 1.0 109.287 174.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 24.1 t -51.62 -42.08 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 123.802 0.689 . . . . 1.0 109.928 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 41.7 t -70.09 -46.05 65.69 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.31 -0.996 . . . . 1.0 108.31 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -46.76 -42.76 17.37 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.731 1.253 . . . . 1.0 108.188 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -70.62 -52.21 22.88 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 112.831 -1.986 . . . . 1.0 113.206 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -55.95 26.96 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 114.728 1.381 . . . . 1.0 114.728 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -110.82 -56.35 2.37 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.321 -1.309 . . . . 1.0 113.712 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.05 34.95 0.53 Allowed Glycine 0 N--CA 1.492 2.383 0 O-C-N 124.032 0.832 . . . . 1.0 111.132 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.471 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 13.1 mptt -124.84 99.18 35.51 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 104.292 -2.485 . . . . 1.0 104.292 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.6 14.16 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.737 2.291 . . . . 1.0 113.322 -169.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.446 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 17.9 p30 -117.03 -179.95 3.85 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.56 168.39 12.59 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.362 -1.399 . . . . 1.0 116.365 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 35.4 mtpt -123.83 171.03 9.96 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 112.55 -1.825 . . . . 1.0 109.531 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.1 t -118.42 158.57 25.06 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.539 -1.282 . . . . 1.0 107.539 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.7 mtp -134.91 79.11 1.77 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.38 -1.341 . . . . 1.0 107.38 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 28.2 51.96 0.05 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 125.598 1.811 . . . . 1.0 112.573 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.11 -37.93 2.01 Favored Glycine 0 N--CA 1.484 1.856 0 CA-C-N 112.471 -2.149 . . . . 1.0 115.258 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -114.47 139.77 49.27 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 119.46 1.63 . . . . 1.0 112.143 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 36.0 t -71.92 159.98 33.32 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 111.721 -2.49 . . . . 1.0 115.027 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.561 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 14.2 tpt180 -135.94 145.37 46.16 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 112.543 -2.117 . . . . 1.0 105.543 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.476 ' HB2' ' CD ' ' A' ' 1' ' ' PCA . 71.0 m -124.04 163.02 22.27 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.086 -1.82 . . . . 1.0 106.086 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.486 ' OH ' ' HG3' ' A' ' 27' ' ' LYS . 4.5 m-85 -116.57 168.27 10.33 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 105.472 -2.047 . . . . 1.0 105.472 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 N--CA 1.507 2.42 0 N-CA-C 115.34 1.607 . . . . 1.0 115.34 -179.813 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.205 -1.267 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.86 162.09 14.52 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.101 0.953 . . . . 1.0 111.57 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.5 p -133.2 163.77 28.56 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 112.525 -2.125 . . . . 1.0 109.038 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -104.05 40.59 1.42 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.558 -0.746 . . . . 1.0 111.326 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -121.35 142.57 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 107.743 -1.206 . . . . 1.0 107.743 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 37.1 mtmm -70.72 146.44 49.86 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.412 1.634 . . . . 1.0 115.412 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.5 p -140.15 174.17 10.78 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.575 1.172 . . . . 1.0 109.807 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.5 p -122.86 -46.3 2.11 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.917 -1.947 . . . . 1.0 106.572 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.86 173.17 33.9 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.562 -1.415 . . . . 1.0 109.562 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.6 t -40.04 -59.36 1.24 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 124.521 0.777 . . . . 1.0 111.005 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -42.32 -42.32 3.1 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.061 -1.427 . . . . 1.0 113.973 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.36 -37.92 74.68 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.419 1.104 . . . . 1.0 110.005 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.612 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 10.1 t -71.51 -23.33 61.77 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.228 -1.351 . . . . 1.0 113.48 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.477 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.6 m0 -57.99 -60.62 9.46 Favored Pre-proline 0 CA--C 1.56 1.33 0 O-C-N 123.768 0.668 . . . . 1.0 111.324 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -62.38 -42.86 25.45 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 C-N-CA 122.738 2.292 . . . . 1.0 109.491 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 22.1 t -53.15 -44.44 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 123.803 0.689 . . . . 1.0 110.963 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 48.6 t -70.16 -44.76 68.16 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.948 -1.13 . . . . 1.0 107.948 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -48.49 -43.29 34.85 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.355 1.074 . . . . 1.0 108.494 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -70.86 -47.87 56.98 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 113.065 -1.879 . . . . 1.0 113.235 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 80.9 mmm -65.59 -60.2 3.16 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 114.879 1.436 . . . . 1.0 114.879 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -107.91 -56.27 2.26 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.246 -1.343 . . . . 1.0 112.855 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.18 34.83 0.61 Allowed Glycine 0 N--CA 1.493 2.485 0 O-C-N 123.92 0.762 . . . . 1.0 111.278 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 0.9 OUTLIER -121.05 86.69 42.68 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 104.563 -2.384 . . . . 1.0 104.563 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -64.49 3.18 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.141 2.561 . . . . 1.0 113.961 -163.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.477 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 32.4 m120 -111.48 -177.53 3.22 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.898 -1.89 . . . . 1.0 105.898 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.23 -172.6 24.14 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.214 -1.47 . . . . 1.0 114.222 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.593 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 60.8 mtpt -132.56 171.7 13.46 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 113.421 -1.389 . . . . 1.0 112.219 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.8 t -111.23 156.12 21.94 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 105.619 -1.993 . . . . 1.0 105.619 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 59.5 mtp -134.25 83.53 2.04 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.825 -1.176 . . . . 1.0 107.825 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 27.99 54.21 0.07 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 125.815 1.947 . . . . 1.0 110.583 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 126.34 -40.48 1.8 Allowed Glycine 0 N--CA 1.484 1.849 0 CA-C-N 112.591 -2.095 . . . . 1.0 116.441 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -116.58 147.75 41.55 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 120.554 2.177 . . . . 1.0 112.656 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 35.0 t -71.84 155.46 40.39 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.853 -2.885 . . . . 1.0 116.223 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.612 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.2 tpt180 -130.14 144.47 51.37 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 111.099 -2.773 . . . . 1.0 105.54 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.9 m -115.24 163.89 15.01 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.563 -1.643 . . . . 1.0 106.563 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.593 ' CZ ' ' HG3' ' A' ' 27' ' ' LYS . 15.3 m-85 -113.19 -179.41 3.64 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.153 -1.055 . . . . 1.0 108.153 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.8 p . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 115.928 -1.987 . . . . 1.0 110.018 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 N-CA-C 112.036 0.384 . . . . 1.0 112.036 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -85.61 146.28 26.94 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 114.373 1.249 . . . . 1.0 114.373 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.3 p -132.63 171.9 13.23 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 112.901 -1.954 . . . . 1.0 109.045 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -122.99 51.54 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.992 -1.114 . . . . 1.0 107.992 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.2 t -112.67 128.72 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 115.126 -0.943 . . . . 1.0 111.418 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -39.76 102.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 118.478 2.77 . . . . 1.0 118.478 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.6 p -125.58 170.17 11.75 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.805 0.812 . . . . 1.0 109.672 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.9 t -121.98 -43.01 2.36 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 113.105 -1.861 . . . . 1.0 106.923 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.17 165.03 31.65 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.908 -1.277 . . . . 1.0 109.908 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.8 t -40.64 -59.52 1.35 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 124.727 0.898 . . . . 1.0 111.94 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -43.44 -43.39 5.26 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 113.819 -1.537 . . . . 1.0 114.618 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -70.59 -34.11 71.8 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.883 0.849 . . . . 1.0 111.121 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 7.3 t -76.24 -11.92 60.0 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.303 -1.317 . . . . 1.0 112.675 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.441 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 5.0 m0 -67.64 -58.21 8.77 Favored Pre-proline 0 N--CA 1.489 1.497 0 CA-C-O 118.605 -0.712 . . . . 1.0 110.166 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 77.0 Cg_endo -63.05 -43.1 20.52 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.936 2.424 . . . . 1.0 109.95 174.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 49.0 t -54.55 -45.05 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 119.835 -0.746 . . . . 1.0 109.829 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 54.1 t -70.13 -39.71 75.27 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.203 -1.036 . . . . 1.0 108.203 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -51.35 -43.94 61.93 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.51 1.148 . . . . 1.0 108.04 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -70.69 -57.18 4.95 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 113.663 -1.608 . . . . 1.0 113.122 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -55.25 -50.87 68.36 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 114.282 1.216 . . . . 1.0 114.282 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -112.06 -62.99 1.48 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.585 -1.643 . . . . 1.0 114.924 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.89 43.73 0.36 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 107.31 -2.316 . . . . 1.0 107.31 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 98.1 mttt -130.62 86.66 52.21 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 104.79 -2.3 . . . . 1.0 104.79 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.09 -2.66 5.98 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.55 2.833 . . . . 1.0 113.254 -160.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.441 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 34.7 m120 -104.24 -176.77 3.17 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.152 -1.425 . . . . 1.0 107.152 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.26 -176.04 21.94 Favored Glycine 0 N--CA 1.493 2.44 0 CA-C-N 114.298 -1.319 . . . . 1.0 113.259 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 53.2 mtpt -135.58 179.28 6.43 Favored 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 113.903 -1.148 . . . . 1.0 112.001 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 t -121.68 157.51 30.74 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 63.5 mtm -135.01 73.51 1.48 Allowed 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.312 -1.366 . . . . 1.0 107.312 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.1 t30 28.22 55.36 0.09 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 125.669 1.856 . . . . 1.0 111.215 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.89 -37.57 2.13 Favored Glycine 0 N--CA 1.484 1.878 0 CA-C-N 112.308 -2.224 . . . . 1.0 114.687 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -111.91 137.64 49.61 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-N 118.985 1.393 . . . . 1.0 111.607 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 45.1 t -72.13 159.6 33.86 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 112.127 -2.306 . . . . 1.0 113.449 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.563 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.6 tpt180 -135.85 147.44 48.24 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.426 -2.065 . . . . 1.0 105.426 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.9 m -122.3 162.36 21.63 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.059 -1.46 . . . . 1.0 107.059 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.47 ' OH ' ' HG3' ' A' ' 27' ' ' LYS . 16.2 m-30 -115.8 -179.03 3.53 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.4 -2.074 . . . . 1.0 105.4 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.501 2.113 0 N-CA-C 115.639 1.718 . . . . 1.0 115.639 -179.639 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.205 -1.276 0 CA-C-O 120.502 0.191 . . . . 1.0 111.314 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -104.05 157.2 17.27 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 122.899 1.333 . . . . 1.0 113.313 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.3 p -133.11 160.6 36.75 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 110.902 -2.863 . . . . 1.0 107.776 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -116.06 50.4 1.04 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.063 0.852 . . . . 1.0 109.207 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.9 t -108.17 145.82 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 105.268 -2.123 . . . . 1.0 105.268 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -70.2 135.72 49.34 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.254 0.835 . . . . 1.0 113.254 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.565 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 6.0 p -130.15 160.0 35.12 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 124.887 1.367 . . . . 1.0 113.083 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.8 t -136.62 44.13 2.39 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.912 -1.494 . . . . 1.0 108.429 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.9 167.27 13.06 Favored Glycine 0 N--CA 1.495 2.606 0 CA-C-N 113.589 -1.641 . . . . 1.0 110.454 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.2 t -47.12 -62.78 1.26 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.421 0.897 . . . . 1.0 113.421 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.478 ' HD3' ' H ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -39.49 -29.18 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.262 1.949 . . . . 1.0 116.262 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.478 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 3.5 tm0? -70.62 -40.14 73.32 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 122.658 1.218 . . . . 1.0 111.398 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 70.5 m -78.4 -7.55 57.48 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.393 -1.73 . . . . 1.0 113.583 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.403 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 8.1 m95 -70.18 -57.96 5.51 Favored Pre-proline 0 C--N 1.305 -1.34 0 O-C-N 124.147 0.905 . . . . 1.0 109.34 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 98.8 Cg_endo -64.44 -45.27 9.6 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 C-N-CA 122.793 2.329 . . . . 1.0 110.343 174.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 54.6 t -55.84 -46.05 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 119.371 -0.932 . . . . 1.0 110.775 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 52.8 t -68.51 -43.26 77.2 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.938 -1.105 . . . . 1.0 109.252 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -50.36 -42.36 53.03 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -70.83 -49.23 48.56 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 113.635 -1.621 . . . . 1.0 112.971 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.2 mmm -62.93 -56.5 16.68 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.979 1.103 . . . . 1.0 113.979 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -110.82 -59.78 1.91 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.725 -1.125 . . . . 1.0 112.492 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.51 43.99 0.44 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 106.486 -2.646 . . . . 1.0 106.486 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.425 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 94.4 mttt -126.73 78.22 73.31 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 105.265 -2.124 . . . . 1.0 105.265 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -62.18 -3.48 4.04 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 123.487 2.791 . . . . 1.0 114.92 -154.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -107.11 121.25 44.11 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 104.183 -2.525 . . . . 1.0 104.183 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.16 161.7 27.88 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.788 -1.725 . . . . 1.0 108.788 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HE2' ' CE2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -127.74 176.61 7.41 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.204 -1.776 . . . . 1.0 106.204 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -109.68 161.64 15.2 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.399 -0.521 . . . . 1.0 111.027 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 64.1 mtp -136.2 88.2 2.37 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.214 -1.772 . . . . 1.0 106.214 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 30.99 48.64 0.07 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 125.121 1.513 . . . . 1.0 113.501 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.78 -35.86 3.16 Favored Glycine 0 N--CA 1.491 2.312 0 CA-C-N 113.302 -1.772 . . . . 1.0 116.504 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.67 147.65 40.6 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-N 120.108 1.954 . . . . 1.0 110.885 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 33.8 m -72.03 154.58 41.06 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 110.722 -2.944 . . . . 1.0 118.817 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.42 ' HB3' ' HG2' ' A' ' 27' ' ' LYS . 8.1 tpt180 -137.6 153.67 49.88 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 111.944 -2.389 . . . . 1.0 105.653 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.414 ' C ' ' HZ1' ' A' ' 27' ' ' LYS . 89.4 m -118.68 157.27 27.77 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 124.178 0.924 . . . . 1.0 110.678 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.523 ' CE2' ' HE2' ' A' ' 27' ' ' LYS . 49.7 m-85 -110.1 -175.86 2.84 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.042 -1.89 . . . . 1.0 108.08 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 t . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 115.852 -2.023 . . . . 1.0 108.944 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.187 0 N-CA-C 112.209 0.448 . . . . 1.0 112.209 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -101.81 157.46 16.83 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 122.613 1.197 . . . . 1.0 111.598 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.3 p -147.16 166.01 28.26 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 111.702 -2.499 . . . . 1.0 109.42 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -123.57 52.47 1.42 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.463 HG21 ' SD ' ' A' ' 20' ' ' MET . 62.4 t -108.09 141.17 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-N 114.614 -1.176 . . . . 1.0 108.64 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.43 ' H ' ' HE2' ' A' ' 6' ' ' LYS . 2.0 mppt? -70.27 105.45 2.98 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 114.161 -1.382 . . . . 1.0 113.889 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.9 p -119.72 170.87 8.82 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.587 -1.188 . . . . 1.0 111.513 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -128.19 -40.81 1.63 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 112.46 -2.155 . . . . 1.0 109.064 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.1 171.3 23.16 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 124.375 1.047 . . . . 1.0 112.368 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.7 m -70.14 -58.2 4.07 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.193 -1.003 . . . . 1.0 112.355 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -44.12 -33.14 1.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.341 1.237 . . . . 1.0 114.341 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -70.19 -34.81 73.4 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.269 1.033 . . . . 1.0 111.646 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.405 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 5.5 t -77.72 -6.21 53.19 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.413 -1.721 . . . . 1.0 112.014 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.429 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 9.4 m0 -69.03 -59.96 4.76 Favored Pre-proline 0 N--CA 1.484 1.25 0 CA-C-O 118.757 -0.639 . . . . 1.0 109.456 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 94.6 Cg_endo -64.22 -46.51 7.76 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 C-N-CA 122.325 2.017 . . . . 1.0 110.421 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 70.0 t -54.29 -44.1 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.965 -0.694 . . . . 1.0 110.758 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 47.2 t -69.9 -46.22 65.9 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.381 -1.328 . . . . 1.0 107.768 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -48.92 -39.79 27.54 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 122.116 0.96 . . . . 1.0 108.987 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.15 -50.74 37.46 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.676 -1.602 . . . . 1.0 112.007 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.463 ' SD ' HG21 ' A' ' 5' ' ' VAL . 66.0 mtm -66.38 -57.45 7.41 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 115.57 1.692 . . . . 1.0 115.57 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -103.52 -55.31 2.42 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.787 -1.097 . . . . 1.0 113.76 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.14 41.14 0.31 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 75.1 mmtt -125.83 121.08 24.32 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 105.008 -2.219 . . . . 1.0 105.008 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -82.41 11.83 3.06 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.114 1.876 . . . . 1.0 110.685 -173.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -117.29 -176.86 3.09 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.385 -1.339 . . . . 1.0 107.385 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.04 143.45 3.99 Favored Glycine 0 N--CA 1.486 1.985 0 CA-C-N 113.605 -1.634 . . . . 1.0 111.47 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HG3' ' HB3' ' A' ' 34' ' ' ARG . 19.0 ptmt -123.73 172.75 8.61 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 113.569 -1.316 . . . . 1.0 107.774 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.7 t -115.61 159.72 20.93 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.699 -0.8 . . . . 1.0 110.83 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 73.2 mtm -131.01 78.47 1.84 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.41 -1.723 . . . . 1.0 107.42 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 28.48 55.63 0.1 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 125.875 1.985 . . . . 1.0 110.743 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.32 -37.14 2.52 Favored Glycine 0 N--CA 1.485 1.956 0 CA-C-N 112.586 -2.097 . . . . 1.0 115.951 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -110.66 139.65 45.75 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 119.729 1.765 . . . . 1.0 111.793 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.64 157.13 38.51 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.473 -2.148 . . . . 1.0 113.845 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.49 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 18.7 tpt85 -138.32 145.91 41.76 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 102.753 -3.054 . . . . 1.0 102.753 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -120.19 167.51 12.18 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.251 -1.018 . . . . 1.0 108.251 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -118.69 -179.0 3.67 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.096 -1.411 . . . . 1.0 108.353 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 116.389 -1.767 . . . . 1.0 109.503 -179.776 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.642 0.258 . . . . 1.0 110.925 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -106.66 160.43 15.46 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 123.032 0.533 . . . . 1.0 111.114 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 p -138.31 171.97 13.59 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 114.743 -1.117 . . . . 1.0 110.137 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -131.64 40.33 3.4 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.4 -1.333 . . . . 1.0 107.4 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.9 p -114.72 155.93 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 115.122 -0.945 . . . . 1.0 110.298 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.812 ' H ' ' HZ2' ' A' ' 6' ' ' LYS . 0.2 OUTLIER -71.32 131.18 43.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 123.587 0.554 . . . . 1.0 110.207 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.475 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 30.8 p -127.6 157.33 40.5 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 120.219 -0.593 . . . . 1.0 110.741 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -137.06 42.0 2.44 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.613 -1.176 . . . . 1.0 109.646 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.75 159.88 11.24 Favored Glycine 0 N--CA 1.496 2.685 0 CA-C-N 114.293 -1.322 . . . . 1.0 111.442 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.7 p -47.35 -56.73 6.3 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.515 1.302 . . . . 1.0 114.515 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -39.69 -41.27 1.05 Allowed 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 114.291 1.219 . . . . 1.0 114.291 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -36.43 74.73 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.163 0.914 . . . . 1.0 111.394 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 73.0 m -73.26 -20.17 60.9 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.07 -0.968 . . . . 1.0 112.779 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.469 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 9.4 m0 -58.95 -62.47 5.73 Favored Pre-proline 0 CA--C 1.562 1.428 0 C-N-CA 120.321 -0.552 . . . . 1.0 110.911 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.414 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 84.7 Cg_endo -66.39 -49.84 1.65 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.883 2.389 . . . . 1.0 110.728 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 71.8 t -50.29 -42.52 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 123.648 0.593 . . . . 1.0 110.081 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 50.3 t -70.16 -47.76 60.25 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.575 -1.269 . . . . 1.0 107.575 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.425 ' HZ1' ' HD3' ' A' ' 24' ' ' PRO . 1.6 tpmt? -46.88 -40.54 14.23 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 122.196 0.998 . . . . 1.0 108.542 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -70.4 -50.94 33.38 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 113.335 -1.757 . . . . 1.0 112.107 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 56.0 mtm -70.81 -57.84 4.23 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 115.452 1.649 . . . . 1.0 115.452 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -100.6 -56.02 2.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 123.916 0.76 . . . . 1.0 112.025 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.9 39.48 0.52 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.836 -1.305 . . . . 1.0 109.836 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.573 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 38.5 mmtm -122.5 105.69 35.86 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 104.922 -2.251 . . . . 1.0 104.922 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HD3' ' HZ1' ' A' ' 18' ' ' LYS . 66.4 Cg_endo -69.94 0.65 5.47 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.258 1.972 . . . . 1.0 111.811 -171.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.469 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 5.9 m120 -119.19 -174.5 2.73 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.63 179.39 18.71 Favored Glycine 0 N--CA 1.488 2.112 0 CA-C-N 113.522 -1.672 . . . . 1.0 111.243 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HG3' ' HB3' ' A' ' 34' ' ' ARG . 11.6 ptmm? -138.31 172.51 12.79 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 114.356 -0.922 . . . . 1.0 111.197 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.9 t -107.76 160.14 15.95 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 71.5 mtm -138.96 84.8 2.03 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 108.812 -0.81 . . . . 1.0 108.812 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 25.17 55.89 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 125.975 2.047 . . . . 1.0 110.903 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.74 -42.83 1.36 Allowed Glycine 0 N--CA 1.483 1.81 0 CA-C-N 111.806 -2.452 . . . . 1.0 116.145 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -121.64 149.41 43.23 Favored 'General case' 0 C--O 1.205 -1.279 0 CA-C-O 124.46 2.076 . . . . 1.0 112.584 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 10.9 m -72.33 157.95 36.72 Favored 'General case' 0 C--N 1.285 -2.205 1 CA-C-N 108.347 -4.024 . . . . 1.0 115.199 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.465 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 2.9 tpt180 -137.73 146.34 43.58 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 111.935 -2.393 . . . . 1.0 105.35 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.2 m -117.58 163.68 16.07 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.898 -1.519 . . . . 1.0 106.898 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -116.69 175.19 5.69 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.7 m . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.223 0 N-CA-C 110.82 -0.067 . . . . 1.0 110.82 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -107.79 159.12 16.75 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.538 0.685 . . . . 1.0 109.515 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.0 p -138.86 170.46 15.95 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 113.53 -1.668 . . . . 1.0 111.4 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -124.87 51.12 1.67 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.444 -1.317 . . . . 1.0 107.444 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.28 147.26 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 114.628 -1.169 . . . . 1.0 109.042 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.55 127.08 31.48 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.401 -0.818 . . . . 1.0 111.201 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.22 161.72 27.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 124.007 0.817 . . . . 1.0 111.227 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 t -135.61 42.06 2.69 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.612 -1.177 . . . . 1.0 109.403 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.66 166.52 13.34 Favored Glycine 0 N--CA 1.496 2.678 0 CA-C-N 114.061 -1.427 . . . . 1.0 111.605 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.6 t -53.71 -66.49 0.38 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 114.595 1.331 . . . . 1.0 114.595 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -39.14 -31.96 0.09 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.244 1.572 . . . . 1.0 115.244 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -70.4 -42.3 71.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 124.125 0.891 . . . . 1.0 112.439 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.465 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 4.4 t -89.38 7.79 34.04 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 117.923 -1.511 . . . . 1.0 112.978 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.464 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 2.5 m95 -70.3 -58.33 5.02 Favored Pre-proline 0 N--CA 1.482 1.171 0 N-CA-C 103.441 -2.8 . . . . 1.0 103.441 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 86.8 Cg_endo -65.37 -44.65 8.54 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 123.119 2.546 . . . . 1.0 112.429 172.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 90.7 t -58.73 -46.86 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 C-N-CA 117.633 -1.627 . . . . 1.0 110.041 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 53.2 t -64.76 -44.36 90.33 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.048 -1.061 . . . . 1.0 108.139 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -50.86 -40.17 55.55 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.287 1.042 . . . . 1.0 109.025 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -70.52 -45.78 64.88 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.894 -1.503 . . . . 1.0 111.446 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.4 mtp -61.44 -56.04 24.65 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 114.261 1.208 . . . . 1.0 114.261 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -113.39 -56.87 2.36 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.395 -1.275 . . . . 1.0 113.96 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.25 45.59 0.27 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 106.757 -2.537 . . . . 1.0 106.757 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 34.6 mmtp -125.85 89.69 51.89 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 106.053 -1.832 . . . . 1.0 106.053 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -65.57 -4.51 9.77 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.594 2.196 . . . . 1.0 113.246 -162.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -105.34 129.8 53.6 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 105.166 -2.161 . . . . 1.0 105.166 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.95 132.12 3.98 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.497 -1.841 . . . . 1.0 108.497 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -117.05 157.37 25.95 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 106.519 -1.66 . . . . 1.0 106.519 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -102.44 161.47 13.69 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.923 -0.711 . . . . 1.0 112.345 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.9 mtm -133.72 82.87 2.01 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.429 -1.714 . . . . 1.0 107.039 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 28.9 55.08 0.1 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 125.562 1.789 . . . . 1.0 111.197 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.91 -38.56 2.3 Favored Glycine 0 N--CA 1.481 1.648 0 CA-C-N 113.011 -1.904 . . . . 1.0 116.067 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -114.72 140.55 48.78 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 119.792 1.796 . . . . 1.0 112.909 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.483 ' SG ' ' N ' ' A' ' 34' ' ' ARG . 25.5 t -72.11 156.91 38.67 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 110.558 -3.019 . . . . 1.0 115.92 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.483 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 47.8 ttt-85 -136.83 146.12 45.27 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 104.106 -2.553 . . . . 1.0 104.106 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.9 m -119.22 168.58 10.75 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 123.974 0.796 . . . . 1.0 110.223 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -126.75 -165.53 1.47 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 114.421 -1.263 . . . . 1.0 111.596 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.468 -1.253 . . . . 1.0 110.278 -179.762 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PCA . . . . . 0.447 ' CD ' ' HB2' ' A' ' 35' ' ' CYS . . . . . . . . 0 C--O 1.209 -1.034 0 N-CA-C 112.684 0.624 . . . . 1.0 112.684 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 65.0 m-85 -100.36 153.16 19.54 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.661 -0.7 . . . . 1.0 110.815 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 50.2 p -134.01 169.32 17.3 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 114.491 -1.231 . . . . 1.0 109.8 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -123.59 41.36 3.49 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.369 1.081 . . . . 1.0 109.045 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.96 148.11 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.402 -1.703 . . . . 1.0 106.402 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -70.39 153.63 42.78 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.81 168.19 14.77 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 124.522 1.139 . . . . 1.0 110.553 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.5 t -142.96 32.08 1.39 Allowed 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 105.672 -1.973 . . . . 1.0 105.672 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.77 154.19 9.13 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.643 -2.183 . . . . 1.0 107.643 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.5 m -39.71 -53.08 2.24 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.182 1.178 . . . . 1.0 114.182 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -44.71 -41.26 6.66 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.442 1.645 . . . . 1.0 115.442 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -61.87 -27.69 68.98 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 119.431 -0.908 . . . . 1.0 112.687 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.1 m -77.42 -6.26 52.77 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.006 -0.997 . . . . 1.0 112.127 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.515 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 11.2 m0 -69.37 -62.57 2.51 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 108.724 -0.843 . . . . 1.0 108.724 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.515 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 94.0 Cg_endo -66.62 -42.45 9.29 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.886 2.39 . . . . 1.0 110.969 176.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.23 -45.37 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 123.962 0.789 . . . . 1.0 110.198 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 46.6 t -70.2 -44.76 68.0 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.483 -1.287 . . . . 1.0 107.765 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -47.74 -41.3 22.71 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 122.37 1.081 . . . . 1.0 108.93 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -70.86 -57.7 4.34 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 113.091 -1.868 . . . . 1.0 113.107 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.5 mmm -62.59 -54.92 32.47 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 115.928 1.825 . . . . 1.0 115.928 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -106.85 -55.91 2.26 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 114.532 -1.213 . . . . 1.0 112.998 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.84 41.05 0.27 Allowed Glycine 0 N--CA 1.492 2.426 0 O-C-N 123.467 0.48 . . . . 1.0 113.422 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.488 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 33.7 mmtp -133.58 109.55 12.24 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 107.897 -1.149 . . . . 1.0 107.897 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.27 6.79 2.05 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.989 2.459 . . . . 1.0 112.055 -175.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.1 115.19 20.75 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.588 -1.264 . . . . 1.0 107.588 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -139.41 155.25 23.98 Favored Glycine 0 N--CA 1.493 2.495 0 CA-C-N 114.195 -1.366 . . . . 1.0 114.628 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -116.46 179.7 3.93 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-N 113.882 -1.159 . . . . 1.0 108.965 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.3 t -120.29 164.28 16.54 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' LYS . 84.3 mtp -141.05 82.2 1.82 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.089 -1.819 . . . . 1.0 106.089 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.4 t30 31.79 51.77 0.19 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 125.088 1.493 . . . . 1.0 111.688 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.45 -36.42 3.16 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-O 117.463 -1.743 . . . . 1.0 115.782 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 29' ' ' MET . 35.6 mmtp -111.23 150.51 29.47 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-N 120.468 2.134 . . . . 1.0 110.811 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.5 m -71.79 163.43 27.82 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 118.72 2.859 . . . . 1.0 118.72 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.1 tpt85 -136.2 153.26 51.29 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 110.882 -2.872 . . . . 1.0 104.69 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.447 ' HB2' ' CD ' ' A' ' 1' ' ' PCA . 69.7 m -121.86 169.98 10.24 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.835 -1.543 . . . . 1.0 106.835 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -115.67 -172.54 2.17 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.418 -0.81 . . . . 1.0 109.63 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.2 p . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 115.89 -2.005 . . . . 1.0 110.173 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PCA . . . . . 0.455 ' N ' ' HB2' ' A' ' 35' ' ' CYS . . . . . . . . 0 C--O 1.209 -1.04 0 N-CA-C 112.819 0.674 . . . . 1.0 112.819 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -101.62 151.4 22.04 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.909 0.861 . . . . 1.0 110.973 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.9 p -143.72 163.03 34.44 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 112.806 -1.997 . . . . 1.0 107.751 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -127.06 48.56 2.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 123.681 0.613 . . . . 1.0 111.086 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.29 156.68 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.641 -1.244 . . . . 1.0 107.641 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -70.31 109.99 5.02 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.133 0.79 . . . . 1.0 113.133 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.9 p -114.29 152.52 31.24 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 123.813 0.696 . . . . 1.0 110.401 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -145.72 48.52 1.24 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.57 -1.65 . . . . 1.0 108.2 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.37 125.47 2.52 Favored Glycine 0 N--CA 1.498 2.802 0 CA-C-N 114.123 -1.399 . . . . 1.0 111.472 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.3 m -39.72 -52.57 2.28 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.967 1.84 . . . . 1.0 115.967 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -40.55 -37.46 0.72 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.826 1.417 . . . . 1.0 114.826 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -61.07 -35.35 76.73 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.804 -1.089 . . . . 1.0 113.771 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.0 m -77.26 -10.95 59.74 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.338 -1.301 . . . . 1.0 112.511 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.483 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 11.3 m0 -65.7 -61.83 5.23 Favored Pre-proline 0 C--N 1.307 -1.246 0 C-N-CA 119.636 -0.825 . . . . 1.0 109.171 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.483 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 83.1 Cg_endo -67.93 -43.58 4.91 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 123.015 2.477 . . . . 1.0 111.548 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.3 t -58.35 -47.59 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 123.787 0.679 . . . . 1.0 110.733 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.549 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 46.8 t -70.32 -42.83 71.43 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.19 -1.404 . . . . 1.0 107.951 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -48.41 -41.12 28.21 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.399 1.095 . . . . 1.0 108.161 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -70.65 -51.4 28.15 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.455 -1.702 . . . . 1.0 112.107 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 32.2 ttm -58.69 -59.15 5.86 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 114.513 1.301 . . . . 1.0 114.513 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -110.63 -55.8 2.43 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.531 -1.668 . . . . 1.0 114.056 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.39 45.09 0.25 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.124 -1.99 . . . . 1.0 108.124 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.549 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 40.5 mmtm -123.74 94.68 45.71 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 105.276 -2.12 . . . . 1.0 105.276 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -64.99 -1.88 4.86 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.577 2.185 . . . . 1.0 112.489 -168.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -115.9 142.78 46.32 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 105.589 -2.004 . . . . 1.0 105.589 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.43 153.7 24.76 Favored Glycine 0 N--CA 1.489 2.17 0 CA-C-N 113.849 -1.523 . . . . 1.0 110.701 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.451 ' HG3' ' HB3' ' A' ' 34' ' ' ARG . 20.6 ptmt -131.27 176.64 8.11 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 119.253 -0.979 . . . . 1.0 109.243 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.5 t -114.16 162.3 16.7 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.108 0.48 . . . . 1.0 110.433 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.2 mtp -135.23 75.84 1.59 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.595 -1.631 . . . . 1.0 106.595 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 29.67 55.74 0.15 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 125.599 1.812 . . . . 1.0 110.89 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.18 -36.39 2.83 Favored Glycine 0 N--CA 1.483 1.806 0 CA-C-N 112.971 -1.922 . . . . 1.0 115.602 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -111.93 139.61 47.28 Favored 'General case' 0 C--O 1.206 -1.229 0 CA-C-N 119.286 1.543 . . . . 1.0 110.856 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 52.2 t -71.74 161.67 30.62 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 112.878 -1.965 . . . . 1.0 114.704 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.451 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 18.3 tpt85 -141.26 152.71 44.75 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.973 -1.467 . . . . 1.0 107.221 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.455 ' HB2' ' N ' ' A' ' 1' ' ' PCA . 49.0 m -116.39 169.57 9.21 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 124.545 1.153 . . . . 1.0 109.4 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -120.07 -171.25 2.11 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.321 -1.309 . . . . 1.0 109.01 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.7 m . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 116.275 -1.821 . . . . 1.0 108.99 -179.611 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 111.941 0.348 . . . . 1.0 111.941 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -100.2 159.33 15.2 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.198 0.523 . . . . 1.0 109.86 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 82.4 p -133.71 176.02 8.93 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 114.171 -1.377 . . . . 1.0 109.028 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -124.67 30.04 6.07 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 123.98 0.8 . . . . 1.0 109.382 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.48 153.37 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 115.255 -0.884 . . . . 1.0 109.311 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 62.2 pttt -71.1 155.26 40.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.988 0.805 . . . . 1.0 111.808 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.8 p -134.71 157.29 47.05 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.043 -0.663 . . . . 1.0 110.881 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.8 p -136.56 43.85 2.42 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.469 -1.241 . . . . 1.0 108.815 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.53 167.63 13.45 Favored Glycine 0 N--CA 1.494 2.564 0 CA-C-N 113.926 -1.488 . . . . 1.0 110.191 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.9 m -65.21 -59.39 4.13 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 114.46 1.282 . . . . 1.0 114.46 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -40.49 -39.23 0.97 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 114.692 1.368 . . . . 1.0 114.692 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -33.84 70.49 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 122.077 0.941 . . . . 1.0 112.806 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 60.6 m -78.36 -7.91 57.84 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.218 -1.355 . . . . 1.0 113.578 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.462 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 11.3 m95 -69.57 -60.56 3.8 Favored Pre-proline 0 C--N 1.304 -1.373 0 C-N-CA 119.554 -0.858 . . . . 1.0 108.877 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.462 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 97.6 Cg_endo -66.99 -42.92 7.37 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.891 2.394 . . . . 1.0 111.185 176.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.67 -47.9 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 123.91 0.756 . . . . 1.0 110.572 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 49.3 t -70.01 -40.61 75.14 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.702 -1.199 . . . . 1.0 108.438 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -51.41 -42.17 61.26 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.422 -0.955 . . . . 1.0 108.422 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 -70.56 -50.01 41.96 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 113.971 -1.468 . . . . 1.0 111.997 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.4 ttm -54.02 -54.59 37.04 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -122.51 -55.69 1.82 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 113.62 -1.627 . . . . 1.0 112.808 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.43 42.6 0.21 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.594 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 6.1 mptp? -120.22 92.3 47.03 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 106.409 -1.7 . . . . 1.0 106.409 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -64.82 -5.01 9.67 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.963 2.442 . . . . 1.0 113.555 -164.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -115.48 143.17 45.7 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 105.95 -1.87 . . . . 1.0 105.95 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.96 154.56 25.61 Favored Glycine 0 N--CA 1.488 2.117 0 CA-C-N 113.382 -1.735 . . . . 1.0 111.281 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HG3' ' HB3' ' A' ' 34' ' ' ARG . 20.7 ptmt -128.23 178.81 5.99 Favored 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 119.388 -0.925 . . . . 1.0 109.064 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.0 t -116.45 157.68 24.76 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 73.2 mtm -133.71 82.93 2.01 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.254 -1.758 . . . . 1.0 106.254 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 29.46 50.7 0.07 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 125.307 1.629 . . . . 1.0 112.919 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 124.96 -34.04 3.53 Favored Glycine 0 N--CA 1.483 1.777 0 CA-C-O 117.152 -1.916 . . . . 1.0 116.539 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -111.43 140.93 45.62 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 120.588 2.194 . . . . 1.0 109.817 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.1 t -71.86 158.11 36.66 Favored 'General case' 0 C--N 1.292 -1.891 0 CA-C-N 112.187 -2.279 . . . . 1.0 115.468 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.465 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 5.1 tpt180 -139.25 155.5 47.72 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.31 -1.768 . . . . 1.0 107.748 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.2 m -118.75 168.25 10.92 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 124.929 1.393 . . . . 1.0 108.338 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -118.62 -179.48 3.81 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.392 -0.822 . . . . 1.0 110.822 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.5 m . . . . . 0 N--CA 1.504 2.237 0 O-C-N 125.701 1.876 . . . . 1.0 115.684 -179.917 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 111.848 0.314 . . . . 1.0 111.848 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -102.56 153.73 19.8 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.822 0.82 . . . . 1.0 110.096 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 p -141.13 165.07 28.55 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.211 -1.813 . . . . 1.0 109.825 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -125.85 55.72 1.44 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.831 -1.077 . . . . 1.0 108.776 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.68 148.32 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-N 114.672 -1.149 . . . . 1.0 108.437 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -70.1 102.57 2.09 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.853 -1.067 . . . . 1.0 110.557 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.7 p -116.24 158.61 23.07 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 124.407 1.067 . . . . 1.0 111.842 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 t -137.72 45.78 2.14 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.931 -1.486 . . . . 1.0 107.147 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.07 157.43 9.68 Favored Glycine 0 N--CA 1.494 2.522 0 CA-C-N 113.243 -1.799 . . . . 1.0 110.084 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.2 m -40.31 -49.68 2.76 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 116.148 1.906 . . . . 1.0 116.148 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.406 ' HB3' HE22 ' A' ' 12' ' ' GLN . 77.9 tttt -39.69 -31.2 0.09 Allowed 'General case' 0 C--O 1.205 -1.25 0 C-N-CA 125.577 1.551 . . . . 1.0 114.905 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.406 HE22 ' HB3' ' A' ' 11' ' ' LYS . 0.9 OUTLIER -70.15 -40.39 74.79 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.789 0.804 . . . . 1.0 113.047 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 96.1 m -70.72 -26.21 63.29 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.023 -1.444 . . . . 1.0 113.058 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -57.19 -65.79 1.57 Allowed Pre-proline 0 C--N 1.3 -1.57 0 C-N-CA 118.999 -1.08 . . . . 1.0 110.775 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -64.37 -45.84 8.7 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 122.835 2.357 . . . . 1.0 111.591 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 88.8 t -62.33 -49.01 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 124.082 0.864 . . . . 1.0 112.455 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 24.8 t -70.28 -31.94 69.51 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.973 -1.091 . . . . 1.0 108.414 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -61.52 -49.24 77.5 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.617 -0.883 . . . . 1.0 108.617 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -70.79 -38.82 73.39 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.164 -1.014 . . . . 1.0 113.236 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.0 mtp -69.64 -56.35 7.5 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 115.267 1.58 . . . . 1.0 115.267 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -106.52 -58.19 1.96 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.793 0.683 . . . . 1.0 112.091 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.55 37.62 0.58 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.821 -1.712 . . . . 1.0 108.821 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.448 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 5.0 mptp? -122.85 79.37 49.69 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 105.483 -2.043 . . . . 1.0 105.483 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -66.43 10.96 0.18 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 123.042 2.494 . . . . 1.0 113.751 -170.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -128.51 109.72 11.64 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.826 -1.175 . . . . 1.0 107.826 179.626 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.05 174.41 23.22 Favored Glycine 0 N--CA 1.492 2.384 0 CA-C-N 112.546 -2.115 . . . . 1.0 111.291 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.432 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 18.6 ptmt -132.95 171.71 13.59 Favored 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 108.891 -0.781 . . . . 1.0 108.891 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.2 t -109.27 160.23 16.3 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 120.181 -0.608 . . . . 1.0 110.019 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 56.9 mtp -132.61 76.93 1.72 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.098 -1.815 . . . . 1.0 106.098 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 30.87 55.36 0.2 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 125.606 1.816 . . . . 1.0 110.954 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.96 -35.43 3.39 Favored Glycine 0 N--CA 1.483 1.804 0 CA-C-N 113.353 -1.749 . . . . 1.0 115.815 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -112.01 137.55 49.88 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 119.315 1.557 . . . . 1.0 110.698 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 34' ' ' ARG . 39.1 t -72.18 158.31 36.13 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 117.696 2.48 . . . . 1.0 117.696 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.516 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 10.3 tpt180 -138.95 149.26 44.55 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 106.409 -1.7 . . . . 1.0 106.409 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.3 m -123.93 163.55 21.1 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 104.906 -2.257 . . . . 1.0 104.906 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -112.88 170.08 8.46 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.656 -1.609 . . . . 1.0 106.656 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.507 2.377 0 N-CA-C 116.225 1.935 . . . . 1.0 116.225 -179.902 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 121.292 0.568 . . . . 1.0 111.735 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -114.61 163.81 14.89 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.4 p -135.1 169.66 17.09 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 123.891 0.745 . . . . 1.0 110.894 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.405 ' H ' ' HE1' ' A' ' 20' ' ' MET . 0.7 OUTLIER -118.59 24.0 11.16 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.085 -1.416 . . . . 1.0 107.659 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.31 145.73 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.519 ' HZ2' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -71.04 163.24 27.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.277 0.985 . . . . 1.0 112.516 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.519 ' N ' ' HZ2' ' A' ' 6' ' ' LYS . 8.4 p -142.61 159.55 42.01 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 124.148 0.905 . . . . 1.0 111.353 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 p -131.89 41.02 3.31 Favored 'General case' 0 C--N 1.31 -1.116 0 O-C-N 124.465 1.103 . . . . 1.0 108.188 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.45 171.22 17.73 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.115 -1.594 . . . . 1.0 109.115 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.5 p -48.8 -60.35 2.82 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.816 0.672 . . . . 1.0 112.816 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -40.06 -39.43 0.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -70.45 -36.2 73.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.287 0.992 . . . . 1.0 112.104 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.462 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 49.0 t -76.01 -13.94 60.23 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.643 -1.617 . . . . 1.0 112.326 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.426 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 7.5 m0 -69.14 -56.2 9.09 Favored Pre-proline 0 N--CA 1.485 1.289 0 CA-C-O 118.193 -0.908 . . . . 1.0 110.695 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 90.3 Cg_endo -65.34 -42.17 13.93 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.906 2.404 . . . . 1.0 110.643 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.48 -48.45 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 123.925 0.766 . . . . 1.0 110.823 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.4 t -68.57 -44.61 74.05 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.146 -1.022 . . . . 1.0 108.915 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -52.43 -39.41 60.99 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.951 0.881 . . . . 1.0 109.081 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -70.46 -52.88 18.96 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 114.21 -1.359 . . . . 1.0 111.141 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.405 ' HE1' ' H ' ' A' ' 4' ' ' ASP . 34.4 ttm -56.07 -56.96 14.51 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.537 0.94 . . . . 1.0 113.537 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -113.07 -61.16 1.78 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 113.098 -1.864 . . . . 1.0 113.915 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.07 41.25 0.45 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 107.885 -2.086 . . . . 1.0 107.885 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 7.8 mmpt? -123.42 81.83 53.17 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 105.904 -1.887 . . . . 1.0 105.904 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -65.13 1.35 2.0 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 123.092 2.528 . . . . 1.0 114.94 -157.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 5.2 m120 -100.22 121.81 42.04 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 100.698 -3.816 . . . . 1.0 100.698 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.15 143.88 12.42 Favored Glycine 0 C--N 1.294 -1.761 0 CA-C-N 113.786 -1.552 . . . . 1.0 110.726 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.404 ' HD3' ' OH ' ' A' ' 36' ' ' TYR . 26.4 mtpp -125.77 160.3 30.13 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 106.517 -1.66 . . . . 1.0 106.517 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.9 t -101.05 157.49 16.72 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.969 -0.693 . . . . 1.0 112.629 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.4 mtm -132.3 89.88 2.72 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.527 -1.657 . . . . 1.0 106.527 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 30.34 48.31 0.05 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 125.097 1.498 . . . . 1.0 113.414 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 121.84 -31.54 4.93 Favored Glycine 0 N--CA 1.487 2.036 0 CA-C-O 117.112 -1.938 . . . . 1.0 117.912 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -113.01 142.68 45.43 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 120.719 2.259 . . . . 1.0 110.028 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 13.3 t -71.6 157.61 37.67 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.362 -1.745 . . . . 1.0 114.057 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.462 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 27.7 ttt85 -133.37 140.32 47.3 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 112.519 -2.128 . . . . 1.0 106.362 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.412 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 65.2 m -109.85 166.52 10.86 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 123.969 0.793 . . . . 1.0 112.23 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.438 ' HB2' ' HB2' ' A' ' 25' ' ' ASN . 47.4 m-85 -127.56 -165.0 1.42 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.42 -1.718 . . . . 1.0 110.774 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.4 t . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.512 -1.233 . . . . 1.0 110.004 -179.723 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.17 0 CA-C-O 121.606 0.717 . . . . 1.0 112.552 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -84.84 171.45 12.22 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.524 -1.216 . . . . 1.0 109.473 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -124.3 173.39 8.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 124.034 0.833 . . . . 1.0 111.739 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.2 23.34 11.91 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.267 -1.788 . . . . 1.0 107.161 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -124.02 151.87 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 115.323 -0.853 . . . . 1.0 109.074 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -71.11 159.71 34.21 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.536 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.565 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 28.8 p -136.82 150.42 48.31 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.769 -0.772 . . . . 1.0 111.392 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.5 p -137.04 45.09 2.27 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.152 -1.385 . . . . 1.0 107.755 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.58 159.84 11.27 Favored Glycine 0 N--CA 1.494 2.548 0 CA-C-N 113.466 -1.697 . . . . 1.0 110.112 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.8 m -50.71 -54.47 22.95 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 113.896 1.073 . . . . 1.0 113.896 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -40.33 -36.91 0.59 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.204 1.557 . . . . 1.0 115.204 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -70.41 -34.82 72.96 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.233 -0.894 . . . . 1.0 112.432 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.5 m -73.6 -18.1 61.09 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.332 -1.304 . . . . 1.0 112.464 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.456 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 9.7 m0 -63.08 -60.88 8.51 Favored Pre-proline 0 N--CA 1.483 1.2 0 CA-C-O 118.364 -0.827 . . . . 1.0 110.887 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -65.74 -45.71 6.12 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 123.024 2.482 . . . . 1.0 111.344 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.26 -45.47 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 123.948 0.78 . . . . 1.0 111.097 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 52.7 t -70.0 -48.52 57.79 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.596 -1.261 . . . . 1.0 107.596 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -47.63 -38.87 15.63 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 122.136 0.97 . . . . 1.0 108.89 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -70.67 -58.49 3.61 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.36 -1.745 . . . . 1.0 112.433 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 70.7 mtm -68.7 -53.83 19.83 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 116.808 2.151 . . . . 1.0 116.808 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -99.01 -57.52 2.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 124.057 0.848 . . . . 1.0 112.715 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.59 34.45 0.86 Allowed Glycine 0 N--CA 1.495 2.606 0 O-C-N 123.837 0.711 . . . . 1.0 111.743 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 12.9 mptt -122.97 107.07 33.48 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 104.905 -2.257 . . . . 1.0 104.905 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.21 -4.53 13.84 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.913 2.409 . . . . 1.0 112.527 -163.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.456 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 29.3 m-80 -107.17 -171.91 1.97 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.143 -1.429 . . . . 1.0 107.143 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.35 163.94 10.44 Favored Glycine 0 N--CA 1.483 1.8 0 CA-C-N 112.302 -2.226 . . . . 1.0 110.376 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.524 ' HE2' ' CE2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -132.59 177.14 7.85 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 113.896 -1.152 . . . . 1.0 108.57 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.5 t -105.6 155.61 19.05 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.737 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 70.6 mtm -131.04 82.3 2.04 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 107.204 -1.406 . . . . 1.0 107.204 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 m120 29.49 51.38 0.08 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 125.463 1.727 . . . . 1.0 112.442 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.29 -33.84 3.53 Favored Glycine 0 N--CA 1.486 2.016 0 CA-C-N 113.082 -1.872 . . . . 1.0 116.864 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.495 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 6.2 mptt -117.43 141.34 48.46 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 120.228 2.014 . . . . 1.0 110.272 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 3.0 m -72.32 156.13 39.43 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 113.805 -1.543 . . . . 1.0 114.616 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.419 ' HB3' ' HG2' ' A' ' 27' ' ' LYS . 9.1 tpt180 -135.1 152.71 51.91 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.76 -1.941 . . . . 1.0 105.76 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.5 m -117.23 156.89 26.96 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 124.672 1.232 . . . . 1.0 110.794 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.524 ' CE2' ' HE2' ' A' ' 27' ' ' LYS . 58.1 m-85 -111.62 -179.12 3.62 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.35 -1.722 . . . . 1.0 106.35 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.2 m . . . . . 0 N--CA 1.505 2.325 0 N-CA-C 115.487 1.662 . . . . 1.0 115.487 179.837 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.444 0.64 . . . . 1.0 112.681 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -106.8 160.65 15.33 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.285 -0.87 . . . . 1.0 109.818 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.7 p -137.05 173.37 11.77 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 115.033 -0.985 . . . . 1.0 110.395 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -131.86 34.34 3.87 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 114.72 -1.127 . . . . 1.0 108.155 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.6 p -111.08 150.86 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-N 115.053 -0.976 . . . . 1.0 110.518 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -71.13 127.46 32.64 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.096 1.147 . . . . 1.0 114.096 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.429 ' SG ' ' C ' ' A' ' 32' ' ' LYS . 30.3 p -134.9 159.37 41.63 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.837 -0.62 . . . . 1.0 109.917 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -148.02 48.64 1.06 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.621 -1.251 . . . . 1.0 107.621 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.26 153.09 7.04 Favored Glycine 0 N--CA 1.498 2.83 0 CA-C-N 113.489 -1.687 . . . . 1.0 112.145 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 65.4 p -53.62 -57.71 9.8 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 116.038 1.866 . . . . 1.0 116.038 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -39.76 -41.8 1.16 Allowed 'General case' 0 C--O 1.204 -1.298 0 C-N-CA 124.63 1.172 . . . . 1.0 113.78 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -70.69 -38.37 73.69 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.598 -1.183 . . . . 1.0 111.7 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 13.3 t -72.19 -18.1 61.88 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 113.546 -1.661 . . . . 1.0 111.369 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -64.03 -61.29 7.06 Favored Pre-proline 0 N--CA 1.486 1.341 0 CA-C-O 118.449 -0.786 . . . . 1.0 111.331 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -64.83 -42.96 13.46 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 123.054 2.503 . . . . 1.0 110.499 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 66.6 t -56.85 -45.91 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 123.928 0.767 . . . . 1.0 110.057 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.592 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 38.2 t -67.76 -45.0 76.16 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -49.31 -42.73 42.23 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.433 1.111 . . . . 1.0 108.82 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -70.48 -49.25 50.42 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 113.168 -1.833 . . . . 1.0 112.208 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.0 ttp -57.01 -57.89 10.56 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 124.265 0.978 . . . . 1.0 113.007 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -116.82 -58.61 2.05 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 113.334 -1.757 . . . . 1.0 114.073 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.04 45.71 0.21 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.033 -1.627 . . . . 1.0 109.033 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.592 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 75.0 mmtt -127.01 72.22 76.13 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 105.852 -1.907 . . . . 1.0 105.852 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -60.89 -3.47 2.86 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.738 2.959 . . . . 1.0 114.359 -163.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.4 108.09 16.42 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.616 -1.624 . . . . 1.0 106.616 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.89 172.76 23.93 Favored Glycine 0 N--CA 1.486 2.011 0 CA-C-N 111.756 -2.475 . . . . 1.0 113.454 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -131.45 169.33 16.2 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 107.979 -1.119 . . . . 1.0 107.979 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.5 t -105.69 159.7 15.78 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 120.084 -0.647 . . . . 1.0 109.505 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.1 mtm -133.68 80.66 1.88 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.712 -1.131 . . . . 1.0 107.962 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 24.96 55.84 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 126.079 2.112 . . . . 1.0 110.632 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.5 -40.87 1.58 Allowed Glycine 0 N--CA 1.483 1.827 0 CA-C-N 111.858 -2.428 . . . . 1.0 116.205 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.429 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 48.1 mtmt -118.2 144.21 45.92 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 119.598 1.699 . . . . 1.0 113.584 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.1 t -71.86 157.97 36.9 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 112.487 -2.142 . . . . 1.0 112.813 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.432 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 12.9 tpt180 -136.78 144.74 43.9 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 112.699 -2.046 . . . . 1.0 105.862 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.9 m -118.5 163.79 16.24 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 105.557 -2.016 . . . . 1.0 105.557 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -113.55 169.22 9.13 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.601 -0.888 . . . . 1.0 108.601 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.506 2.371 0 CA-C-O 116.154 -1.879 . . . . 1.0 115.788 179.992 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 121.013 0.435 . . . . 1.0 111.449 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -96.01 148.72 22.36 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.837 0.827 . . . . 1.0 109.677 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.4 p -148.12 171.3 16.1 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 112.946 -1.934 . . . . 1.0 109.808 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -127.79 51.39 1.95 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.825 -1.08 . . . . 1.0 108.586 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.2 t -111.96 126.38 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.856 0.836 . . . . 1.0 110.355 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 8.6 ptpp? -39.36 110.86 0.15 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 117.438 2.384 . . . . 1.0 117.438 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.3 p -125.97 172.36 9.99 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.025 0.917 . . . . 1.0 110.409 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.0 m -123.86 -47.04 1.95 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 112.431 -2.168 . . . . 1.0 106.482 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.82 168.69 31.78 Favored Glycine 0 N--CA 1.492 2.433 0 CA-C-N 114.218 -1.355 . . . . 1.0 110.081 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -48.13 -63.72 0.99 Allowed 'General case' 0 N--CA 1.482 1.128 0 O-C-N 124.097 0.528 . . . . 1.0 111.816 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -41.09 -37.4 0.86 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.902 1.376 . . . . 1.0 114.615 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -70.59 -34.42 72.15 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 122.975 1.369 . . . . 1.0 110.51 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.448 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 14.5 t -80.83 0.96 32.65 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.35 -1.75 . . . . 1.0 111.352 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.452 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 5.5 m95 -70.05 -60.59 3.43 Favored Pre-proline 0 N--CA 1.482 1.147 0 N-CA-C 106.069 -1.826 . . . . 1.0 106.069 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.425 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 73.9 Cg_endo -61.22 -43.98 26.12 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 122.422 2.081 . . . . 1.0 110.551 174.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 91.3 t -58.2 -45.3 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 C-N-CA 118.136 -1.425 . . . . 1.0 110.677 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 40.6 t -70.29 -31.03 68.21 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.308 -0.957 . . . . 1.0 109.047 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -59.47 -50.4 74.05 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -71.14 -48.22 53.25 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 119.348 -0.941 . . . . 1.0 113.373 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -50.28 73.98 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 114.1 1.148 . . . . 1.0 114.1 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -113.16 -61.57 1.72 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.7 1.37 . . . . 1.0 114.7 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.26 41.46 0.4 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.386 -1.885 . . . . 1.0 108.386 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 63.0 mmtt -130.38 81.52 67.92 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 104.645 -2.354 . . . . 1.0 104.645 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -62.1 -0.69 1.83 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.787 2.325 . . . . 1.0 114.222 -161.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.452 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 3.8 m120 -111.97 116.4 30.53 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 101.682 -3.451 . . . . 1.0 101.682 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.88 164.98 16.87 Favored Glycine 0 N--CA 1.486 1.979 0 CA-C-N 113.32 -1.763 . . . . 1.0 111.176 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . 73.6 tttt -128.33 170.78 12.67 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.826 -1.916 . . . . 1.0 105.826 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.5 t -123.06 159.7 27.91 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.219 0.533 . . . . 1.0 109.95 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.9 mtp -133.62 71.59 1.46 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.441 -1.689 . . . . 1.0 106.441 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 30.82 53.36 0.16 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 125.311 1.632 . . . . 1.0 111.981 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 125.72 -31.87 4.02 Favored Glycine 0 N--CA 1.48 1.575 0 CA-C-N 113.317 -1.765 . . . . 1.0 115.158 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.505 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 8.3 mptt -111.12 144.16 40.7 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-N 119.299 1.55 . . . . 1.0 108.755 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.82 160.63 32.25 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 114.919 1.451 . . . . 1.0 114.919 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 20.3 tpt85 -142.72 159.23 42.64 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 104.022 -2.585 . . . . 1.0 104.022 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.9 m -128.03 169.81 13.61 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.204 0.526 . . . . 1.0 110.036 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.603 ' CZ ' ' HB2' ' A' ' 27' ' ' LYS . 11.7 m-85 -122.72 -174.3 2.89 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 109.533 -0.543 . . . . 1.0 109.533 -179.762 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.167 0 CA-C-O 121.112 0.482 . . . . 1.0 111.509 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -103.62 164.71 11.49 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.8 p -133.44 169.07 17.49 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 123.826 0.704 . . . . 1.0 110.552 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -114.86 23.79 12.3 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.361 -1.29 . . . . 1.0 107.729 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -124.29 143.18 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.347 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -71.13 161.71 30.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.192 0.932 . . . . 1.0 112.131 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.485 ' SG ' ' C ' ' A' ' 32' ' ' LYS . 11.0 p -142.12 158.76 43.37 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.955 0.784 . . . . 1.0 111.617 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.6 p -136.58 43.98 2.41 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.492 -1.231 . . . . 1.0 108.138 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.63 161.08 11.92 Favored Glycine 0 N--CA 1.494 2.56 0 CA-C-N 113.902 -1.499 . . . . 1.0 110.889 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.8 t -45.59 -58.86 3.09 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.164 -1.018 . . . . 1.0 113.594 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -40.83 -41.52 1.6 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 115.122 1.527 . . . . 1.0 115.122 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.75 -33.1 70.45 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.306 1.004 . . . . 1.0 111.995 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 41.4 t -76.55 -12.73 60.07 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 113.633 -1.621 . . . . 1.0 112.059 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.42 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 8.3 m0 -69.8 -59.38 4.6 Favored Pre-proline 0 N--CA 1.483 1.215 0 CA-C-O 118.497 -0.763 . . . . 1.0 109.645 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 72.4 Cg_endo -62.51 -43.84 20.46 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 122.826 2.351 . . . . 1.0 109.732 177.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.9 t -59.34 -46.72 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 123.946 0.779 . . . . 1.0 110.633 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 41.6 t -70.26 -31.58 69.02 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.625 -1.23 . . . . 1.0 109.724 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -63.42 -48.1 79.17 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -70.74 -44.26 67.16 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.525 -0.87 . . . . 1.0 111.843 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.4 mmm -63.93 -52.76 58.27 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 113.935 1.087 . . . . 1.0 113.935 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -110.12 -62.19 1.55 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 124.179 0.924 . . . . 1.0 112.656 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.99 42.24 0.45 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.615 -2.194 . . . . 1.0 107.615 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 48.9 mmtm -130.86 82.64 63.7 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 106.821 -1.548 . . . . 1.0 106.821 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -62.55 0.24 1.55 Allowed 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.873 2.382 . . . . 1.0 114.609 -163.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -103.08 117.06 33.73 Favored 'General case' 0 C--N 1.308 -1.224 1 N-CA-C 99.485 -4.265 . . . . 1.0 99.485 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.11 144.1 13.36 Favored Glycine 0 C--N 1.292 -1.916 0 CA-C-N 113.604 -1.635 . . . . 1.0 110.534 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HD3' ' OH ' ' A' ' 36' ' ' TYR . 43.8 mtpt -126.08 165.32 19.07 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 107.08 -1.452 . . . . 1.0 107.08 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.2 t -104.59 148.97 25.92 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 113.206 0.817 . . . . 1.0 113.206 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.3 ptp -128.97 98.53 4.97 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.354 -1.294 . . . . 1.0 108.743 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.0 t30 32.4 47.06 0.08 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 113.02 -1.9 . . . . 1.0 113.124 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.49 -26.59 8.04 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 118.686 2.234 . . . . 1.0 118.686 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.485 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 93.2 mttt -114.26 149.95 35.11 Favored 'General case' 0 C--O 1.204 -1.291 0 CA-C-N 121.167 2.483 . . . . 1.0 109.96 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.1 t -72.28 159.03 34.75 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.814 -1.085 . . . . 1.0 111.946 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.448 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 26.4 ttt85 -133.05 141.22 48.11 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 112.956 -1.929 . . . . 1.0 106.057 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -111.99 166.19 11.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 124.172 0.92 . . . . 1.0 111.743 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.414 ' OH ' ' HD3' ' A' ' 27' ' ' LYS . 40.3 m-85 -126.36 -166.25 1.55 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.175 -1.829 . . . . 1.0 110.472 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.246 -1.359 . . . . 1.0 111.232 -179.772 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 121.529 0.681 . . . . 1.0 112.837 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -92.93 165.23 12.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.901 -1.045 . . . . 1.0 111.377 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.7 p -132.3 179.13 6.3 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.612 -1.176 . . . . 1.0 110.962 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.22 26.3 9.72 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.405 -1.27 . . . . 1.0 109.398 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.8 t -123.98 141.9 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 31.0 mmmt -71.36 148.51 46.94 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.866 1.432 . . . . 1.0 114.866 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.7 p -140.42 173.08 11.86 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.35 1.071 . . . . 1.0 112.041 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.1 t -136.38 -38.35 0.68 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 111.997 -2.365 . . . . 1.0 108.986 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.74 163.48 23.76 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 123.747 0.654 . . . . 1.0 112.78 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.5 p -70.29 -54.51 12.37 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.341 0.867 . . . . 1.0 113.341 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -58.44 -20.15 42.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 124.322 1.014 . . . . 1.0 111.459 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -70.07 -31.0 68.38 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.219 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 3.9 t -80.11 -1.57 40.7 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.465 -1.243 . . . . 1.0 113.207 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.456 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 10.5 m0 -70.27 -60.4 3.42 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 87.7 Cg_endo -64.95 -44.35 10.12 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.794 2.329 . . . . 1.0 111.747 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 78.8 t -58.26 -45.21 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 119.736 -0.786 . . . . 1.0 110.892 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.4 t -69.98 -44.3 69.71 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -48.24 -42.06 29.31 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 122.355 1.074 . . . . 1.0 108.365 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -70.73 -47.64 58.71 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 113.114 -1.857 . . . . 1.0 112.792 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 94.9 mtp -69.19 -58.24 4.31 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 116.312 1.968 . . . . 1.0 116.312 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -102.66 -55.23 2.48 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.905 -1.043 . . . . 1.0 112.641 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.47 37.3 0.38 Allowed Glycine 0 N--CA 1.489 2.218 0 O-C-N 124.08 0.863 . . . . 1.0 111.331 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.54 115.07 22.98 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 106.548 -1.649 . . . . 1.0 106.548 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -74.46 15.36 0.67 Allowed 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.734 2.289 . . . . 1.0 112.66 -174.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.56 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 5.5 m120 -123.65 -177.13 3.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.76 0.791 . . . . 1.0 109.065 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.86 169.73 12.16 Favored Glycine 0 N--CA 1.49 2.293 0 CA-C-N 114.029 -1.441 . . . . 1.0 114.072 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 49.0 mtpt -132.21 -167.82 1.95 Allowed 'General case' 0 N--CA 1.504 2.25 0 CA-C-N 113.005 -1.597 . . . . 1.0 111.296 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.5 t -126.37 154.45 43.53 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.035 -1.839 . . . . 1.0 106.035 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.6 mtm -132.37 78.42 1.8 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.637 -1.246 . . . . 1.0 107.637 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.0 t30 28.76 52.64 0.07 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 125.835 1.959 . . . . 1.0 111.143 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 127.11 -35.49 2.83 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-O 117.019 -1.99 . . . . 1.0 116.273 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -109.23 146.01 34.93 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-N 120.853 2.326 . . . . 1.0 109.607 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -70.97 159.97 33.75 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.896 -1.047 . . . . 1.0 111.499 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.481 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 4.6 tpt180 -134.51 146.77 50.03 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 106.237 -1.764 . . . . 1.0 106.237 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.7 m -120.38 163.04 18.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.48 -1.674 . . . . 1.0 106.48 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.56 ' CD2' ' HB3' ' A' ' 25' ' ' ASN . 11.1 m-30 -114.38 178.11 4.4 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.393 -1.706 . . . . 1.0 106.393 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.506 2.35 0 O-C-N 125.117 1.511 . . . . 1.0 114.451 -179.73 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 114.073 1.138 . . . . 1.0 114.073 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -55.1 168.28 0.34 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.428 -1.715 . . . . 1.0 112.965 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.53 ' HB ' ' SD ' ' A' ' 20' ' ' MET . 68.4 p -131.12 -179.95 5.64 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.078 -0.964 . . . . 1.0 112.316 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.37 -4.41 11.83 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.117 -1.856 . . . . 1.0 109.168 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.07 141.82 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 107.104 -1.443 . . . . 1.0 107.104 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -71.17 167.39 19.46 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.341 1.978 . . . . 1.0 116.341 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.2 p -139.15 177.52 7.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 124.819 1.324 . . . . 1.0 110.613 179.611 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.8 m -123.18 -50.11 1.92 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 104.889 -2.263 . . . . 1.0 104.889 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.05 167.85 31.79 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.581 -1.807 . . . . 1.0 108.581 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 65.4 m -46.49 -56.34 6.11 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.403 0.621 . . . . 1.0 110.19 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -48.7 -39.81 26.0 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.329 -1.305 . . . . 1.0 112.848 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -70.69 -35.21 72.67 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.846 1.308 . . . . 1.0 109.751 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 4.0 t -74.46 -12.33 60.47 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 113.653 -1.612 . . . . 1.0 113.015 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.51 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 5.0 m0 -65.9 -58.73 10.46 Favored Pre-proline 0 C--N 1.306 -1.285 0 CA-C-O 118.752 -0.642 . . . . 1.0 109.603 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -61.3 -42.86 31.89 Favored 'Trans proline' 0 N--CA 1.488 1.158 0 C-N-CA 122.567 2.178 . . . . 1.0 110.44 173.638 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 53.9 t -55.04 -44.08 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 119.335 -0.946 . . . . 1.0 110.906 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 41.2 t -70.31 -41.53 73.19 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -50.16 -43.98 52.43 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.306 -0.998 . . . . 1.0 108.306 179.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -70.85 -53.02 16.75 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 113.354 -1.748 . . . . 1.0 113.238 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.53 ' SD ' ' HB ' ' A' ' 3' ' ' THR . 20.3 ttp -55.67 -55.77 28.3 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 115.309 1.596 . . . . 1.0 115.309 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -116.13 -56.86 2.27 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 113.474 -1.693 . . . . 1.0 113.033 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.73 39.88 0.28 Allowed Glycine 0 N--CA 1.491 2.322 0 O-C-N 123.812 0.695 . . . . 1.0 111.623 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 5.5 mppt? -129.29 91.37 41.97 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 105.551 -2.018 . . . . 1.0 105.551 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -64.63 3.58 0.84 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 123.045 2.497 . . . . 1.0 113.981 -165.024 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.51 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 26.7 m120 -111.62 -178.05 3.34 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.499 -1.667 . . . . 1.0 106.499 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.61 -176.03 23.98 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.269 -1.443 . . . . 1.0 114.745 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.605 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 28.5 mtpp -131.64 177.1 7.77 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 113.138 -1.531 . . . . 1.0 111.927 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.0 t -119.26 152.28 36.95 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 179.267 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.8 mtm -131.76 80.11 1.91 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.079 -0.964 . . . . 1.0 108.627 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.2 t30 28.73 52.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 125.586 1.804 . . . . 1.0 111.919 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.59 -31.4 4.18 Favored Glycine 0 N--CA 1.485 1.965 0 CA-C-O 116.405 -2.33 . . . . 1.0 116.912 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -115.88 141.17 48.46 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 120.795 2.297 . . . . 1.0 109.32 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.465 ' SG ' HG21 ' A' ' 3' ' ' THR . 33.1 t -71.87 160.64 32.22 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.652 -1.613 . . . . 1.0 113.517 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.557 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.2 tpt180 -133.61 146.75 51.23 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.431 -2.063 . . . . 1.0 105.431 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.3 m -117.61 164.82 14.37 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.248 -1.019 . . . . 1.0 108.248 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.605 ' CZ ' ' HG3' ' A' ' 27' ' ' LYS . 13.8 m-85 -117.63 -178.01 3.38 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.295 -1.32 . . . . 1.0 107.572 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.496 1.86 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 -179.962 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.404 0.621 . . . . 1.0 111.867 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -87.8 168.06 13.27 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.191 -0.913 . . . . 1.0 109.863 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.466 HG21 ' SG ' ' A' ' 33' ' ' CYS . 79.7 p -127.89 -173.46 2.94 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.052 0.845 . . . . 1.0 112.297 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -124.17 -7.45 7.68 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 113.403 -1.726 . . . . 1.0 110.273 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.4 t -111.54 145.34 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.498 -0.927 . . . . 1.0 108.498 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 171.02 11.68 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 116.923 2.194 . . . . 1.0 116.923 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 p -141.2 173.11 11.8 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.175 -1.375 . . . . 1.0 110.478 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.2 m -121.49 -49.49 2.14 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.854 -2.276 . . . . 1.0 104.854 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.19 169.59 33.22 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.542 -1.823 . . . . 1.0 108.542 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.6 t -43.54 -58.78 2.46 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.51 0.671 . . . . 1.0 110.521 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.26 -39.4 14.28 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 113.859 -1.519 . . . . 1.0 114.219 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -70.23 -32.66 70.62 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.066 0.936 . . . . 1.0 111.175 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 15.3 t -76.44 -12.32 60.03 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.949 -1.478 . . . . 1.0 113.111 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.414 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.9 m0 -66.78 -58.99 8.59 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 123.822 0.701 . . . . 1.0 109.462 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 85.3 Cg_endo -63.31 -42.88 20.32 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.883 2.389 . . . . 1.0 110.681 175.316 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 50.9 t -55.78 -46.45 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 C-N-CA 120.104 -0.638 . . . . 1.0 110.398 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.8 t -68.97 -42.55 76.46 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -50.48 -42.69 54.86 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.252 1.025 . . . . 1.0 108.534 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -70.65 -51.37 28.3 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.691 -1.595 . . . . 1.0 112.741 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.4 ttp -58.31 -52.41 65.7 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.026 1.121 . . . . 1.0 114.026 -179.258 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -116.86 -58.03 2.11 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.484 -1.235 . . . . 1.0 114.083 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.93 40.67 0.19 Allowed Glycine 0 N--CA 1.488 2.125 0 O-C-N 123.774 0.671 . . . . 1.0 112.501 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -127.79 103.31 21.67 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 105.694 -1.965 . . . . 1.0 105.694 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.71 10.08 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.993 2.462 . . . . 1.0 113.002 -168.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.414 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 34.0 m120 -116.03 -176.3 2.92 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.954 -1.498 . . . . 1.0 106.954 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.419 ' HA2' ' CD1' ' A' ' 36' ' ' TYR . . . 143.44 175.98 17.05 Favored Glycine 0 N--CA 1.489 2.175 0 CA-C-N 113.994 -1.457 . . . . 1.0 113.069 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.474 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 51.8 mtpt -133.0 178.73 6.66 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 113.061 -1.57 . . . . 1.0 109.466 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -114.77 155.55 26.5 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.961 -1.496 . . . . 1.0 106.961 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 48.4 mtp -132.5 74.96 1.6 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.292 -1.373 . . . . 1.0 107.292 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 31.13 54.52 0.21 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 125.375 1.672 . . . . 1.0 110.995 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.88 -29.8 5.7 Favored Glycine 0 N--CA 1.487 2.07 0 CA-C-O 116.829 -2.095 . . . . 1.0 116.469 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 7.1 mptt -113.73 142.5 45.96 Favored 'General case' 0 C--O 1.206 -1.207 0 CA-C-N 120.387 2.093 . . . . 1.0 108.446 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.466 ' SG ' HG21 ' A' ' 3' ' ' THR . 36.4 t -71.55 160.82 32.02 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.574 -1.194 . . . . 1.0 113.216 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.581 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 5.3 tpt180 -131.6 140.12 49.34 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.274 -2.121 . . . . 1.0 105.274 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.7 m -111.74 161.55 16.18 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.116 0.96 . . . . 1.0 110.13 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.419 ' CD1' ' HA2' ' A' ' 26' ' ' GLY . 7.2 m-30 -115.88 -168.99 1.51 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 111.939 -2.391 . . . . 1.0 106.816 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 107.509 -1.293 . . . . 1.0 107.509 -179.816 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 121.746 0.784 . . . . 1.0 110.771 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -89.15 160.79 16.82 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 113.709 -1.587 . . . . 1.0 107.188 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.6 p -131.47 174.01 10.52 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 123.641 0.588 . . . . 1.0 110.72 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -125.3 32.51 5.35 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.571 -1.27 . . . . 1.0 107.571 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.1 p -111.29 134.95 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.151 -1.425 . . . . 1.0 107.151 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -70.67 140.7 51.58 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 113.454 0.909 . . . . 1.0 113.454 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.426 ' SG ' ' C ' ' A' ' 32' ' ' LYS . 2.5 p -136.21 170.41 16.06 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.063 0.935 . . . . 1.0 111.909 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.4 m -130.25 -43.19 1.18 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 112.384 -2.189 . . . . 1.0 108.516 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.19 172.08 21.59 Favored Glycine 0 N--CA 1.497 2.742 0 O-C-N 124.431 1.082 . . . . 1.0 112.411 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.1 p -70.1 -57.66 4.7 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.461 -0.869 . . . . 1.0 112.838 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -39.86 -32.79 0.17 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.82 -36.64 73.02 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 122.228 1.013 . . . . 1.0 111.031 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 41.8 t -73.6 -10.13 59.39 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.467 -1.242 . . . . 1.0 111.574 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.444 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 9.8 m95 -69.94 -61.04 3.16 Favored Pre-proline 0 N--CA 1.484 1.231 0 CA-C-O 118.462 -0.78 . . . . 1.0 110.104 179.366 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.444 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 81.8 Cg_endo -63.04 -40.42 34.05 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.771 2.314 . . . . 1.0 109.752 177.088 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.8 t -58.83 -49.77 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 123.837 0.71 . . . . 1.0 110.356 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.9 t -68.96 -34.63 75.64 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 118.946 -1.102 . . . . 1.0 109.295 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.08 -38.74 89.98 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -70.44 -52.36 22.76 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.642 -1.163 . . . . 1.0 111.035 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 73.1 mtm -61.35 -52.11 66.01 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.629 0.974 . . . . 1.0 113.629 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -111.26 -62.48 1.54 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 113.93 1.085 . . . . 1.0 113.93 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.41 43.68 0.42 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 106.922 -2.471 . . . . 1.0 106.922 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -127.82 81.94 69.33 Favored Pre-proline 0 N--CA 1.493 1.718 0 CA-C-N 113.496 -1.352 . . . . 1.0 107.584 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.7 0.18 3.23 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 123.684 2.923 . . . . 1.0 116.266 -150.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 24.7 m120 -103.94 129.25 51.47 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 104.771 -2.307 . . . . 1.0 104.771 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 14' ' ' TRP . . . -146.82 145.86 15.14 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-N 113.958 -1.474 . . . . 1.0 110.815 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -131.46 170.51 14.59 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 106.869 -1.53 . . . . 1.0 106.869 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.3 t -107.09 150.61 26.37 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.898 -0.721 . . . . 1.0 110.691 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.3 ptm -129.18 102.77 6.61 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.916 -1.493 . . . . 1.0 108.566 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.7 p30 31.69 44.34 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 113.641 -1.618 . . . . 1.0 114.194 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.94 -28.57 6.34 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 118.592 2.197 . . . . 1.0 118.592 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 35.3 mmtp -114.99 156.64 24.72 Favored 'General case' 0 C--O 1.202 -1.419 0 CA-C-N 120.87 2.335 . . . . 1.0 111.44 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.8 t -71.87 160.27 32.86 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.155 0.978 . . . . 1.0 111.0 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.447 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.3 tpt180 -136.26 140.45 43.45 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 105.93 -1.878 . . . . 1.0 105.93 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.9 m -109.39 164.01 12.88 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.437 1.113 . . . . 1.0 113.242 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.479 ' HB2' ' HB2' ' A' ' 25' ' ' ASN . 42.9 m-85 -128.16 -160.45 1.02 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 111.931 -2.395 . . . . 1.0 108.287 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.487 1.414 0 O-C-N 125.029 1.456 . . . . 1.0 107.756 179.898 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.14 0 CA-C-O 121.199 0.523 . . . . 1.0 112.133 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -86.64 168.25 13.79 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.392 -0.822 . . . . 1.0 109.446 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.516 HG21 ' SG ' ' A' ' 33' ' ' CYS . 58.9 p -127.3 -175.41 3.43 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.71 0.767 . . . . 1.0 112.803 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -124.22 -7.21 7.66 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.05 -1.886 . . . . 1.0 110.153 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.7 t -111.64 144.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.35 170.99 11.99 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 116.515 2.042 . . . . 1.0 116.515 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.3 p -141.23 173.03 11.88 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.225 -1.352 . . . . 1.0 110.493 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.9 m -121.3 -49.51 2.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 104.758 -2.312 . . . . 1.0 104.758 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.13 169.51 33.18 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 108.625 -1.79 . . . . 1.0 108.625 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.1 t -43.29 -58.58 2.47 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.541 0.686 . . . . 1.0 110.51 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.93 -39.24 11.91 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 113.958 -1.474 . . . . 1.0 114.447 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -70.3 -33.1 71.13 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.233 1.016 . . . . 1.0 111.174 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.573 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 19.2 t -76.56 -11.55 59.89 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 113.747 -1.57 . . . . 1.0 113.075 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.413 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 7.0 m0 -67.49 -58.53 8.44 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 123.75 0.656 . . . . 1.0 109.52 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 84.6 Cg_endo -63.38 -43.07 19.23 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.816 2.344 . . . . 1.0 110.686 174.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -55.49 -47.27 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 119.844 -0.742 . . . . 1.0 110.216 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.0 t -67.75 -42.45 81.76 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.372 -0.931 . . . . 1.0 108.805 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -50.13 -42.85 51.41 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.342 1.067 . . . . 1.0 108.347 179.655 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -70.54 -46.25 63.93 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 113.648 -1.614 . . . . 1.0 111.151 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.4 ttp -54.03 -56.7 15.49 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 123.957 0.785 . . . . 1.0 112.641 -179.388 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -121.87 -57.02 1.82 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 113.385 -1.734 . . . . 1.0 114.021 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.95 43.41 0.11 Allowed Glycine 0 N--CA 1.488 2.122 0 O-C-N 124.045 0.841 . . . . 1.0 111.517 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -126.22 98.93 31.83 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 105.065 -2.198 . . . . 1.0 105.065 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.09 11.96 0.4 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 123.091 2.528 . . . . 1.0 113.218 -167.629 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.413 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 33.5 m120 -116.36 -176.2 2.91 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.73 -1.581 . . . . 1.0 106.73 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' A' ' 36' ' ' TYR . . . 144.75 175.92 18.31 Favored Glycine 0 N--CA 1.49 2.254 0 CA-C-N 113.991 -1.459 . . . . 1.0 112.734 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.461 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 52.0 mtpt -133.33 177.81 7.4 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 113.165 -1.517 . . . . 1.0 109.001 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.3 t -114.89 155.99 25.83 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.769 -1.567 . . . . 1.0 106.769 179.446 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 48.8 mtp -133.01 75.17 1.61 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.29 -1.374 . . . . 1.0 107.29 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 30.95 54.44 0.19 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 125.321 1.638 . . . . 1.0 111.202 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.11 -29.69 5.68 Favored Glycine 0 N--CA 1.483 1.833 0 CA-C-O 116.916 -2.046 . . . . 1.0 116.438 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 7.1 mptt -113.97 142.49 46.09 Favored 'General case' 0 C--O 1.206 -1.218 0 CA-C-N 120.331 2.066 . . . . 1.0 108.194 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.516 ' SG ' HG21 ' A' ' 3' ' ' THR . 35.5 t -71.65 161.74 30.53 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.482 -1.236 . . . . 1.0 113.137 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.573 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 5.9 tpt180 -132.69 139.96 47.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.555 -2.017 . . . . 1.0 105.555 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.5 m -111.18 161.02 16.4 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.426 1.108 . . . . 1.0 110.778 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' CD1' ' HA2' ' A' ' 26' ' ' GLY . 6.2 m-30 -116.66 -169.0 1.55 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 111.318 -2.674 . . . . 1.0 106.722 -179.629 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 107.624 -1.25 . . . . 1.0 107.624 -179.863 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.88 0.371 . . . . 1.0 110.326 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -98.09 145.61 26.38 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.421 0.629 . . . . 1.0 111.088 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.9 p -132.45 171.35 13.88 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.639 -1.619 . . . . 1.0 110.687 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.58 48.79 1.03 Allowed 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.6 t -111.04 119.42 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.063 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 75.8 mmtt -39.65 113.13 0.31 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.655 -1.611 . . . . 1.0 115.272 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.4 p -123.24 171.48 9.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.257 0.973 . . . . 1.0 111.149 179.739 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.1 p -126.18 -43.17 1.81 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 112.595 -2.093 . . . . 1.0 108.495 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.49 169.17 29.76 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 124.44 1.087 . . . . 1.0 112.29 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.9 t -54.67 -62.63 1.53 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.454 -0.873 . . . . 1.0 111.576 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -42.7 -40.13 2.67 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 115.126 1.528 . . . . 1.0 115.126 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -57.88 -31.23 66.52 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.156 0.979 . . . . 1.0 112.974 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.413 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 22.9 m -81.21 -3.84 53.56 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.04 -1.437 . . . . 1.0 113.553 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.544 ' CG ' ' HA ' ' A' ' 25' ' ' ASN . 11.5 m0 -70.31 -59.0 4.4 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 107.826 -1.176 . . . . 1.0 107.826 179.262 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.464 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 83.6 Cg_endo -65.69 -46.45 5.15 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 122.735 2.29 . . . . 1.0 111.515 174.115 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 95.8 t -56.87 -44.69 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 119.276 -0.969 . . . . 1.0 110.306 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 51.8 t -68.45 -45.01 73.61 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.692 -1.203 . . . . 1.0 108.627 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -46.89 -43.18 18.61 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 107.591 -1.263 . . . . 1.0 107.591 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -70.76 -45.33 64.97 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 112.941 -1.936 . . . . 1.0 112.719 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.9 mtm -63.45 -57.96 8.59 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.678 1.362 . . . . 1.0 114.678 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -111.88 -56.34 2.4 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.387 -1.279 . . . . 1.0 113.252 -179.408 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.16 39.47 0.38 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.452 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 14.0 mptt -119.01 97.0 50.62 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 102.691 -3.078 . . . . 1.0 102.691 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -64.91 -3.48 7.07 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 123.367 2.711 . . . . 1.0 113.346 -156.495 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.544 ' HA ' ' CG ' ' A' ' 14' ' ' TRP . 8.0 p30 -122.25 165.68 15.81 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 124.438 1.086 . . . . 1.0 109.079 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.0 168.72 41.43 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.336 -0.935 . . . . 1.0 112.444 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.656 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 27.8 mtpp -121.85 -176.64 3.38 Favored 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 115.014 -0.593 . . . . 1.0 109.575 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.8 t -127.26 156.32 42.09 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 106.263 -1.754 . . . . 1.0 106.263 179.237 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 71.4 mtm -136.15 77.18 1.64 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.016 -1.476 . . . . 1.0 107.016 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.1 t30 30.36 53.43 0.14 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 125.271 1.607 . . . . 1.0 111.341 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 125.13 -35.52 3.08 Favored Glycine 0 N--CA 1.486 2.03 0 CA-C-N 113.159 -1.837 . . . . 1.0 115.637 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HD3' ' N ' ' A' ' 32' ' ' LYS . 1.7 mppt? -109.48 139.78 44.04 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 119.948 1.874 . . . . 1.0 109.907 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 46.1 t -71.94 160.56 32.32 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 112.917 -1.947 . . . . 1.0 116.013 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.453 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 9.1 tpt180 -139.29 155.41 47.75 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.017 -1.447 . . . . 1.0 107.773 179.71 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.9 m -126.71 166.14 17.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.992 -2.225 . . . . 1.0 104.992 179.327 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.656 ' CZ ' ' HG3' ' A' ' 27' ' ' LYS . 89.4 m-85 -113.26 177.37 4.65 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.752 -1.203 . . . . 1.0 107.752 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.9 m . . . . . 0 N--CA 1.501 2.077 0 CA-C-O 117.404 -1.284 . . . . 1.0 111.342 179.942 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 . . . . . 0 C--O 1.216 -0.659 0 CA-C-O 120.95 0.405 . . . . 1.0 110.373 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.4 p -130.54 172.56 11.78 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.826 -1.079 . . . . 1.0 110.105 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -126.3 28.3 6.04 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.245 0.965 . . . . 1.0 109.061 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 p -115.79 155.11 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 115.152 -0.931 . . . . 1.0 109.895 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -70.8 131.95 44.59 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.508 -0.769 . . . . 1.0 112.83 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.3 p -123.55 160.31 27.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.944 0.777 . . . . 1.0 109.018 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 81.4 p -132.77 40.09 3.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.608 0.718 . . . . 1.0 110.15 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.3 163.17 13.86 Favored Glycine 0 N--CA 1.494 2.534 0 CA-C-N 114.092 -1.413 . . . . 1.0 109.8 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.4 p -43.71 -49.9 7.74 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 114.385 -0.907 . . . . 1.0 113.332 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -45.95 -50.09 15.07 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 115.102 -0.954 . . . . 1.0 113.002 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -70.99 -29.3 65.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.056 0.848 . . . . 1.0 110.692 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 26.3 t -73.97 -23.15 59.44 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.777 -1.101 . . . . 1.0 112.678 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.409 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 7.1 m0 -62.89 -58.83 14.57 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-O 118.591 -0.718 . . . . 1.0 111.949 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 90.5 Cg_endo -64.01 -41.4 23.02 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 123.121 2.548 . . . . 1.0 109.801 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.12 -45.63 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 123.96 0.788 . . . . 1.0 110.26 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 42.4 t -70.0 -43.8 70.65 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.841 -1.17 . . . . 1.0 107.841 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -48.38 -43.44 33.82 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 122.415 1.103 . . . . 1.0 108.405 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -70.82 -52.62 19.32 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 113.048 -1.887 . . . . 1.0 113.902 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 84.0 mtp -64.6 -55.97 16.92 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 115.015 1.487 . . . . 1.0 115.015 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -108.86 -57.38 2.15 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.403 1.064 . . . . 1.0 113.034 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.3 35.49 0.66 Allowed Glycine 0 N--CA 1.495 2.587 0 O-C-N 123.857 0.723 . . . . 1.0 111.332 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.548 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 13.1 mptt -122.28 90.84 49.22 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 104.484 -2.413 . . . . 1.0 104.484 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.09 -3.47 7.28 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 123.227 2.618 . . . . 1.0 113.366 -160.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.403 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 69.9 m-80 -105.09 -175.93 2.93 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.032 -1.47 . . . . 1.0 107.032 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.66 -178.74 19.14 Favored Glycine 0 N--CA 1.489 2.174 0 CA-C-N 114.0 -1.454 . . . . 1.0 113.224 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -139.66 167.58 21.78 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.751 -1.225 . . . . 1.0 111.281 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 39.0 t -108.61 147.78 31.33 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.807 -0.812 . . . . 1.0 108.807 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.9 ptm -136.54 108.47 7.13 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 123.786 0.679 . . . . 1.0 110.314 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.2 t30 31.2 46.13 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.188 -1.824 . . . . 1.0 113.027 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.34 -30.42 6.02 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 119.29 2.476 . . . . 1.0 119.29 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -118.2 146.89 43.89 Favored 'General case' 0 C--O 1.205 -1.247 0 CA-C-N 120.56 2.18 . . . . 1.0 112.911 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.3 t -72.52 156.47 38.98 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 112.853 -1.976 . . . . 1.0 112.728 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.46 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 10.0 tpt180 -133.1 142.66 48.83 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 112.175 -2.284 . . . . 1.0 105.516 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.0 m -109.42 166.31 10.97 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 124.231 0.957 . . . . 1.0 109.669 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -118.37 -178.57 3.55 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 114.386 -1.279 . . . . 1.0 108.923 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 117.537 -1.22 . . . . 1.0 111.127 179.946 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.7 p90 . . . . . 0 C--O 1.217 -0.638 0 N-CA-C 112.965 0.728 . . . . 1.0 112.965 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 59.4 p -132.25 166.3 22.18 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 113.872 -1.513 . . . . 1.0 108.416 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -123.62 45.75 2.38 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.885 0.85 . . . . 1.0 109.161 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -104.78 153.17 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 114.411 -1.268 . . . . 1.0 108.975 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -70.63 117.92 12.76 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.248 1.944 . . . . 1.0 116.248 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.8 p -127.33 172.93 10.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 124.156 0.91 . . . . 1.0 109.098 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.4 m -124.11 -44.93 2.01 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 112.961 -1.927 . . . . 1.0 106.956 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.57 169.76 32.88 Favored Glycine 0 N--CA 1.494 2.555 0 CA-C-N 114.831 -1.077 . . . . 1.0 111.73 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.5 t -43.75 -57.4 3.25 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.195 -1.002 . . . . 1.0 112.076 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -41.88 -42.27 2.67 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 114.284 -1.326 . . . . 1.0 113.704 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -70.51 -41.11 73.03 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.658 1.218 . . . . 1.0 111.419 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 41.3 t -71.35 -23.53 61.93 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 113.137 -1.847 . . . . 1.0 112.309 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.452 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.2 m0 -59.15 -60.62 9.97 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 123.918 0.761 . . . . 1.0 111.876 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -63.77 -43.09 17.53 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.152 2.568 . . . . 1.0 109.738 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.77 -42.73 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 123.864 0.728 . . . . 1.0 109.966 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 51.4 m -70.27 -43.86 69.6 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -50.36 -42.24 52.85 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.333 1.063 . . . . 1.0 108.544 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -70.89 -56.39 6.36 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 113.539 -1.664 . . . . 1.0 113.42 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.7 ttm -59.19 -56.15 25.87 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 115.075 1.509 . . . . 1.0 115.075 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -106.36 -58.98 1.85 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 113.461 -1.699 . . . . 1.0 114.011 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.59 45.88 0.26 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 106.383 -2.687 . . . . 1.0 106.383 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -128.72 88.66 51.41 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 106.132 -1.803 . . . . 1.0 106.132 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -62.16 2.39 0.65 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.318 2.012 . . . . 1.0 113.67 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.452 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 8.0 m120 -113.49 -174.74 2.52 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.96 -179.08 18.38 Favored Glycine 0 N--CA 1.489 2.216 0 CA-C-N 113.659 -1.609 . . . . 1.0 110.734 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -140.96 167.92 21.04 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.863 -0.668 . . . . 1.0 110.539 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.5 t -107.75 157.49 18.08 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.52 -0.918 . . . . 1.0 108.52 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.7 mtp -132.05 81.91 1.99 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.783 -1.191 . . . . 1.0 107.783 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.1 t30 29.34 53.94 0.11 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 125.534 1.771 . . . . 1.0 111.519 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.36 -38.04 2.3 Favored Glycine 0 N--CA 1.479 1.543 0 CA-C-N 113.145 -1.843 . . . . 1.0 115.737 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -114.98 135.2 54.48 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-N 119.37 1.585 . . . . 1.0 112.711 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 15.2 t -72.07 157.61 37.47 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.796 -2.911 . . . . 1.0 114.828 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.532 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.4 tpt180 -138.11 143.49 40.41 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 112.365 -2.198 . . . . 1.0 105.938 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.6 m -119.4 160.71 21.8 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.718 -1.586 . . . . 1.0 106.718 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -110.88 -172.15 1.97 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.7 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 116.109 -1.9 . . . . 1.0 109.493 -179.702 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.2 p90 . . . . . 0 C--O 1.215 -0.759 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.431 HG21 ' SG ' ' A' ' 33' ' ' CYS . 72.8 p -128.47 177.55 6.91 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 122.132 0.968 . . . . 1.0 113.146 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -112.98 -5.93 13.77 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 112.596 -2.093 . . . . 1.0 109.319 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.2 t -112.81 140.65 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.327 -0.99 . . . . 1.0 108.327 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 25.2 pttm -71.05 167.44 19.24 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.751 1.76 . . . . 1.0 115.751 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.9 p -138.54 176.04 9.04 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 124.61 1.194 . . . . 1.0 110.716 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.3 m -125.36 -49.31 1.68 Allowed 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.256 -2.247 . . . . 1.0 105.345 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.82 170.13 29.26 Favored Glycine 0 N--CA 1.493 2.495 0 CA-C-N 114.004 -1.453 . . . . 1.0 109.764 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.0 m -51.23 -54.94 20.92 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.382 0.611 . . . . 1.0 110.661 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -49.1 -39.95 30.19 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.659 -1.155 . . . . 1.0 113.161 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -70.39 -30.71 67.67 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.255 1.026 . . . . 1.0 110.849 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.578 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 6.0 t -76.98 -10.65 59.51 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 113.568 -1.651 . . . . 1.0 112.833 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 9.9 m0 -66.86 -58.48 9.49 Favored Pre-proline 0 N--CA 1.485 1.29 0 CA-C-O 118.873 -0.584 . . . . 1.0 109.523 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.09 -48.0 9.2 Favored 'Trans proline' 0 N--CA 1.486 1.081 0 C-N-CA 122.369 2.046 . . . . 1.0 110.096 173.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 60.5 t -51.33 -40.8 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 119.997 -0.681 . . . . 1.0 110.315 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 42.8 t -70.35 -49.43 49.35 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.775 -1.17 . . . . 1.0 107.999 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -47.77 -38.23 15.18 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.205 1.002 . . . . 1.0 109.425 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -70.24 -53.99 14.65 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.309 -1.769 . . . . 1.0 111.956 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 35.7 mmt -69.82 -55.31 10.15 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 115.98 1.844 . . . . 1.0 115.98 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -102.86 -53.58 2.82 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 123.77 0.669 . . . . 1.0 112.666 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.07 35.28 0.55 Allowed Glycine 0 N--CA 1.492 2.381 0 O-C-N 123.662 0.601 . . . . 1.0 113.281 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 2.9 mptp? -127.45 131.67 23.95 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -87.3 14.36 2.43 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 122.43 2.087 . . . . 1.0 110.511 -175.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.426 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 73.4 m-80 -119.54 -177.56 3.4 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.557 -1.275 . . . . 1.0 107.557 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.24 172.76 12.76 Favored Glycine 0 N--CA 1.488 2.135 0 CA-C-N 114.13 -1.395 . . . . 1.0 114.747 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.478 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 50.4 mtpt -130.35 177.81 7.06 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 112.158 -2.021 . . . . 1.0 110.719 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 t -116.35 151.79 35.21 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.375 -1.343 . . . . 1.0 107.375 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 70.8 mtm -130.69 83.75 2.14 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.114 -1.069 . . . . 1.0 108.114 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 27.84 50.35 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 125.54 1.775 . . . . 1.0 112.851 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 126.44 -31.4 4.01 Favored Glycine 0 N--CA 1.484 1.838 0 CA-C-O 116.012 -2.549 . . . . 1.0 117.532 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -116.94 145.98 43.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 121.356 2.578 . . . . 1.0 109.491 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.431 ' SG ' HG21 ' A' ' 3' ' ' THR . 16.7 t -71.7 157.98 36.96 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.581 -1.645 . . . . 1.0 113.791 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.578 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 17.8 tpt85 -128.96 140.18 51.77 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.366 -2.197 . . . . 1.0 105.692 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.8 m -111.6 163.49 14.04 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.146 -1.057 . . . . 1.0 108.146 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.472 ' OH ' ' HG3' ' A' ' 27' ' ' LYS . 12.7 m-30 -114.26 -176.86 2.99 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 113.717 -1.583 . . . . 1.0 108.201 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 116.162 -1.875 . . . . 1.0 108.893 -179.921 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 43.9 p90 . . . . . 0 C--O 1.216 -0.687 0 CA-C-O 121.824 0.821 . . . . 1.0 113.143 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.7 p -132.18 163.47 28.48 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 113.045 -1.889 . . . . 1.0 108.158 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -126.65 52.26 1.77 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 124.003 0.814 . . . . 1.0 110.459 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -111.58 151.58 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 C-N-CA 120.001 -0.68 . . . . 1.0 109.352 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -70.21 103.17 2.27 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 114.968 1.47 . . . . 1.0 114.968 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.3 p -120.58 172.3 7.95 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.082 0.944 . . . . 1.0 109.909 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.6 t -126.22 -42.22 1.86 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 112.578 -2.101 . . . . 1.0 107.898 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.79 165.29 26.91 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 124.268 0.98 . . . . 1.0 111.542 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.0 m -47.88 -53.33 16.07 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.384 -0.908 . . . . 1.0 111.719 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' NZ ' HE22 ' A' ' 12' ' ' GLN . 10.4 mtmp? -45.19 -43.37 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.075 -1.42 . . . . 1.0 114.063 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.449 HE22 ' NZ ' ' A' ' 11' ' ' LYS . 14.4 mp0 -70.24 -32.52 70.41 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.893 0.854 . . . . 1.0 111.346 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 8.5 t -77.55 -11.5 59.86 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 113.742 -1.572 . . . . 1.0 112.331 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.446 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.0 m0 -67.6 -59.7 6.56 Favored Pre-proline 0 N--CA 1.49 1.57 0 CA-C-O 118.655 -0.688 . . . . 1.0 110.434 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -63.73 -46.98 7.82 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.59 2.194 . . . . 1.0 109.287 174.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 24.1 t -51.62 -42.08 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 123.802 0.689 . . . . 1.0 109.928 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 41.7 t -70.09 -46.05 65.69 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.31 -0.996 . . . . 1.0 108.31 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -46.76 -42.76 17.37 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.731 1.253 . . . . 1.0 108.188 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -70.62 -52.21 22.88 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 112.831 -1.986 . . . . 1.0 113.206 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -55.95 26.96 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 114.728 1.381 . . . . 1.0 114.728 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -110.82 -56.35 2.37 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.321 -1.309 . . . . 1.0 113.712 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.05 34.95 0.53 Allowed Glycine 0 N--CA 1.492 2.383 0 O-C-N 124.032 0.832 . . . . 1.0 111.132 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.471 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 13.1 mptt -124.84 99.18 35.51 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 104.292 -2.485 . . . . 1.0 104.292 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.6 14.16 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.737 2.291 . . . . 1.0 113.322 -169.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.446 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 17.9 p30 -117.03 -179.95 3.85 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.56 168.39 12.59 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.362 -1.399 . . . . 1.0 116.365 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 35.4 mtpt -123.83 171.03 9.96 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 112.55 -1.825 . . . . 1.0 109.531 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.1 t -118.42 158.57 25.06 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.539 -1.282 . . . . 1.0 107.539 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.7 mtp -134.91 79.11 1.77 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.38 -1.341 . . . . 1.0 107.38 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.6 p30 28.2 51.96 0.05 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 125.598 1.811 . . . . 1.0 112.573 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.11 -37.93 2.01 Favored Glycine 0 N--CA 1.484 1.856 0 CA-C-N 112.471 -2.149 . . . . 1.0 115.258 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -114.47 139.77 49.27 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 119.46 1.63 . . . . 1.0 112.143 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 36.0 t -71.92 159.98 33.32 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 111.721 -2.49 . . . . 1.0 115.027 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.561 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 14.2 tpt180 -135.94 145.37 46.16 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 112.543 -2.117 . . . . 1.0 105.543 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.0 m -124.04 163.02 22.27 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.086 -1.82 . . . . 1.0 106.086 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.486 ' OH ' ' HG3' ' A' ' 27' ' ' LYS . 4.5 m-85 -116.57 168.27 10.33 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 105.472 -2.047 . . . . 1.0 105.472 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 N--CA 1.507 2.42 0 N-CA-C 115.34 1.607 . . . . 1.0 115.34 -179.813 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 122.101 0.953 . . . . 1.0 111.57 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.5 p -133.2 163.77 28.56 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 112.525 -2.125 . . . . 1.0 109.038 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -104.05 40.59 1.42 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.558 -0.746 . . . . 1.0 111.326 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -121.35 142.57 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 107.743 -1.206 . . . . 1.0 107.743 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 37.1 mtmm -70.72 146.44 49.86 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.412 1.634 . . . . 1.0 115.412 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.5 p -140.15 174.17 10.78 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.575 1.172 . . . . 1.0 109.807 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.5 p -122.86 -46.3 2.11 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.917 -1.947 . . . . 1.0 106.572 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.86 173.17 33.9 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.562 -1.415 . . . . 1.0 109.562 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.6 t -40.04 -59.36 1.24 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 124.521 0.777 . . . . 1.0 111.005 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -42.32 -42.32 3.1 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.061 -1.427 . . . . 1.0 113.973 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.36 -37.92 74.68 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.419 1.104 . . . . 1.0 110.005 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.612 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 10.1 t -71.51 -23.33 61.77 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.228 -1.351 . . . . 1.0 113.48 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.477 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.6 m0 -57.99 -60.62 9.46 Favored Pre-proline 0 CA--C 1.56 1.33 0 O-C-N 123.768 0.668 . . . . 1.0 111.324 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -62.38 -42.86 25.45 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 C-N-CA 122.738 2.292 . . . . 1.0 109.491 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 22.1 t -53.15 -44.44 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 123.803 0.689 . . . . 1.0 110.963 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 48.6 t -70.16 -44.76 68.16 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.948 -1.13 . . . . 1.0 107.948 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -48.49 -43.29 34.85 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.355 1.074 . . . . 1.0 108.494 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -70.86 -47.87 56.98 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 113.065 -1.879 . . . . 1.0 113.235 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 80.9 mmm -65.59 -60.2 3.16 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 114.879 1.436 . . . . 1.0 114.879 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -107.91 -56.27 2.26 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.246 -1.343 . . . . 1.0 112.855 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.18 34.83 0.61 Allowed Glycine 0 N--CA 1.493 2.485 0 O-C-N 123.92 0.762 . . . . 1.0 111.278 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 0.9 OUTLIER -121.05 86.69 42.68 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 104.563 -2.384 . . . . 1.0 104.563 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -64.49 3.18 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.141 2.561 . . . . 1.0 113.961 -163.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.477 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 66.8 m-80 -111.48 -177.53 3.22 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.898 -1.89 . . . . 1.0 105.898 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.23 -172.6 24.14 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.214 -1.47 . . . . 1.0 114.222 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.593 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 60.8 mtpt -132.56 171.7 13.46 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 113.421 -1.389 . . . . 1.0 112.219 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.8 t -111.23 156.12 21.94 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 105.619 -1.993 . . . . 1.0 105.619 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 59.5 mtp -134.25 83.53 2.04 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.825 -1.176 . . . . 1.0 107.825 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 27.99 54.21 0.07 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 125.815 1.947 . . . . 1.0 110.583 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 126.34 -40.48 1.8 Allowed Glycine 0 N--CA 1.484 1.849 0 CA-C-N 112.591 -2.095 . . . . 1.0 116.441 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -116.58 147.75 41.55 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 120.554 2.177 . . . . 1.0 112.656 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 35.0 t -71.84 155.46 40.39 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.853 -2.885 . . . . 1.0 116.223 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.612 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.2 tpt180 -130.14 144.47 51.37 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 111.099 -2.773 . . . . 1.0 105.54 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.9 m -115.24 163.89 15.01 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.563 -1.643 . . . . 1.0 106.563 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.593 ' CZ ' ' HG3' ' A' ' 27' ' ' LYS . 15.3 m-85 -113.19 -179.41 3.64 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.153 -1.055 . . . . 1.0 108.153 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.8 p . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 115.928 -1.987 . . . . 1.0 110.018 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.3 p90 . . . . . 0 C--O 1.217 -0.646 0 N-CA-C 114.373 1.249 . . . . 1.0 114.373 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.3 p -132.63 171.9 13.23 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 112.901 -1.954 . . . . 1.0 109.045 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -122.99 51.54 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.992 -1.114 . . . . 1.0 107.992 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.2 t -112.67 128.72 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 115.126 -0.943 . . . . 1.0 111.418 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -39.76 102.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 118.478 2.77 . . . . 1.0 118.478 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.6 p -125.58 170.17 11.75 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.805 0.812 . . . . 1.0 109.672 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.9 t -121.98 -43.01 2.36 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 113.105 -1.861 . . . . 1.0 106.923 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.17 165.03 31.65 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.908 -1.277 . . . . 1.0 109.908 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.8 t -40.64 -59.52 1.35 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 124.727 0.898 . . . . 1.0 111.94 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -43.44 -43.39 5.26 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 113.819 -1.537 . . . . 1.0 114.618 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -70.59 -34.11 71.8 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.883 0.849 . . . . 1.0 111.121 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 7.3 t -76.24 -11.92 60.0 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.303 -1.317 . . . . 1.0 112.675 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.441 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 5.0 m0 -67.64 -58.21 8.77 Favored Pre-proline 0 N--CA 1.489 1.497 0 CA-C-O 118.605 -0.712 . . . . 1.0 110.166 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 77.0 Cg_endo -63.05 -43.1 20.52 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.936 2.424 . . . . 1.0 109.95 174.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 49.0 t -54.55 -45.05 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 119.835 -0.746 . . . . 1.0 109.829 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 54.1 t -70.13 -39.71 75.27 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.203 -1.036 . . . . 1.0 108.203 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -51.35 -43.94 61.93 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.51 1.148 . . . . 1.0 108.04 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -70.69 -57.18 4.95 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 113.663 -1.608 . . . . 1.0 113.122 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -55.25 -50.87 68.36 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 114.282 1.216 . . . . 1.0 114.282 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -112.06 -62.99 1.48 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.585 -1.643 . . . . 1.0 114.924 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.89 43.73 0.36 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 107.31 -2.316 . . . . 1.0 107.31 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 98.1 mttt -130.62 86.66 52.21 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 104.79 -2.3 . . . . 1.0 104.79 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.09 -2.66 5.98 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.55 2.833 . . . . 1.0 113.254 -160.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.441 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 71.9 m-80 -104.24 -176.77 3.17 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.152 -1.425 . . . . 1.0 107.152 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.26 -176.04 21.94 Favored Glycine 0 N--CA 1.493 2.44 0 CA-C-N 114.298 -1.319 . . . . 1.0 113.259 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 53.2 mtpt -135.58 179.28 6.43 Favored 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 113.903 -1.148 . . . . 1.0 112.001 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 t -121.68 157.51 30.74 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 63.5 mtm -135.01 73.51 1.48 Allowed 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.312 -1.366 . . . . 1.0 107.312 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.1 t30 28.22 55.36 0.09 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 125.669 1.856 . . . . 1.0 111.215 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.89 -37.57 2.13 Favored Glycine 0 N--CA 1.484 1.878 0 CA-C-N 112.308 -2.224 . . . . 1.0 114.687 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -111.91 137.64 49.61 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-N 118.985 1.393 . . . . 1.0 111.607 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 45.1 t -72.13 159.6 33.86 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 112.127 -2.306 . . . . 1.0 113.449 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.563 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.6 tpt180 -135.85 147.44 48.24 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.426 -2.065 . . . . 1.0 105.426 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.9 m -122.3 162.36 21.63 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.059 -1.46 . . . . 1.0 107.059 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.47 ' OH ' ' HG3' ' A' ' 27' ' ' LYS . 16.2 m-30 -115.8 -179.03 3.53 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.4 -2.074 . . . . 1.0 105.4 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.501 2.113 0 N-CA-C 115.639 1.718 . . . . 1.0 115.639 -179.639 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--O 1.216 -0.681 0 CA-C-O 122.899 1.333 . . . . 1.0 113.313 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.3 p -133.11 160.6 36.75 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 110.902 -2.863 . . . . 1.0 107.776 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -116.06 50.4 1.04 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.063 0.852 . . . . 1.0 109.207 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.9 t -108.17 145.82 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 105.268 -2.123 . . . . 1.0 105.268 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -70.2 135.72 49.34 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.254 0.835 . . . . 1.0 113.254 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.565 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 6.0 p -130.15 160.0 35.12 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 124.887 1.367 . . . . 1.0 113.083 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.8 t -136.62 44.13 2.39 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.912 -1.494 . . . . 1.0 108.429 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.9 167.27 13.06 Favored Glycine 0 N--CA 1.495 2.606 0 CA-C-N 113.589 -1.641 . . . . 1.0 110.454 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.2 t -47.12 -62.78 1.26 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.421 0.897 . . . . 1.0 113.421 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.478 ' HD3' ' H ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -39.49 -29.18 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.262 1.949 . . . . 1.0 116.262 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.478 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 3.5 tm0? -70.62 -40.14 73.32 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 122.658 1.218 . . . . 1.0 111.398 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 70.5 m -78.4 -7.55 57.48 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.393 -1.73 . . . . 1.0 113.583 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.403 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 8.1 m95 -70.18 -57.96 5.51 Favored Pre-proline 0 C--N 1.305 -1.34 0 O-C-N 124.147 0.905 . . . . 1.0 109.34 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 98.8 Cg_endo -64.44 -45.27 9.6 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 C-N-CA 122.793 2.329 . . . . 1.0 110.343 174.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 54.6 t -55.84 -46.05 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 119.371 -0.932 . . . . 1.0 110.775 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 52.8 t -68.51 -43.26 77.2 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.938 -1.105 . . . . 1.0 109.252 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -50.36 -42.36 53.03 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -70.83 -49.23 48.56 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 113.635 -1.621 . . . . 1.0 112.971 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.2 mmm -62.93 -56.5 16.68 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.979 1.103 . . . . 1.0 113.979 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -110.82 -59.78 1.91 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.725 -1.125 . . . . 1.0 112.492 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.51 43.99 0.44 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 106.486 -2.646 . . . . 1.0 106.486 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.425 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 94.4 mttt -126.73 78.22 73.31 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 105.265 -2.124 . . . . 1.0 105.265 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -62.18 -3.48 4.04 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 123.487 2.791 . . . . 1.0 114.92 -154.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -107.11 121.25 44.11 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 104.183 -2.525 . . . . 1.0 104.183 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.16 161.7 27.88 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.788 -1.725 . . . . 1.0 108.788 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HE2' ' CE2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -127.74 176.61 7.41 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.204 -1.776 . . . . 1.0 106.204 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -109.68 161.64 15.2 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.399 -0.521 . . . . 1.0 111.027 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 64.1 mtp -136.2 88.2 2.37 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.214 -1.772 . . . . 1.0 106.214 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.1 p30 30.99 48.64 0.07 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 125.121 1.513 . . . . 1.0 113.501 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.78 -35.86 3.16 Favored Glycine 0 N--CA 1.491 2.312 0 CA-C-N 113.302 -1.772 . . . . 1.0 116.504 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.67 147.65 40.6 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-N 120.108 1.954 . . . . 1.0 110.885 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 33.8 m -72.03 154.58 41.06 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 110.722 -2.944 . . . . 1.0 118.817 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.42 ' HB3' ' HG2' ' A' ' 27' ' ' LYS . 8.1 tpt180 -137.6 153.67 49.88 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 111.944 -2.389 . . . . 1.0 105.653 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.414 ' C ' ' HZ1' ' A' ' 27' ' ' LYS . 89.4 m -118.68 157.27 27.77 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 124.178 0.924 . . . . 1.0 110.678 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.523 ' CE2' ' HE2' ' A' ' 27' ' ' LYS . 49.7 m-85 -110.1 -175.86 2.84 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.042 -1.89 . . . . 1.0 108.08 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 t . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 115.852 -2.023 . . . . 1.0 108.944 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.1 t80 . . . . . 0 C--O 1.216 -0.693 0 CA-C-O 122.613 1.197 . . . . 1.0 111.598 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.3 p -147.16 166.01 28.26 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 111.702 -2.499 . . . . 1.0 109.42 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -123.57 52.47 1.42 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.463 HG21 ' SD ' ' A' ' 20' ' ' MET . 62.4 t -108.09 141.17 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-N 114.614 -1.176 . . . . 1.0 108.64 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.43 ' H ' ' HE2' ' A' ' 6' ' ' LYS . 2.0 mppt? -70.27 105.45 2.98 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 114.161 -1.382 . . . . 1.0 113.889 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.9 p -119.72 170.87 8.82 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.587 -1.188 . . . . 1.0 111.513 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -128.19 -40.81 1.63 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 112.46 -2.155 . . . . 1.0 109.064 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.1 171.3 23.16 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 124.375 1.047 . . . . 1.0 112.368 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.7 m -70.14 -58.2 4.07 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.193 -1.003 . . . . 1.0 112.355 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -44.12 -33.14 1.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.341 1.237 . . . . 1.0 114.341 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -70.19 -34.81 73.4 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.269 1.033 . . . . 1.0 111.646 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.405 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 5.5 t -77.72 -6.21 53.19 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.413 -1.721 . . . . 1.0 112.014 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.429 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 9.4 m0 -69.03 -59.96 4.76 Favored Pre-proline 0 N--CA 1.484 1.25 0 CA-C-O 118.757 -0.639 . . . . 1.0 109.456 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 94.6 Cg_endo -64.22 -46.51 7.76 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 C-N-CA 122.325 2.017 . . . . 1.0 110.421 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 70.0 t -54.29 -44.1 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.965 -0.694 . . . . 1.0 110.758 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 47.2 t -69.9 -46.22 65.9 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.381 -1.328 . . . . 1.0 107.768 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -48.92 -39.79 27.54 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 122.116 0.96 . . . . 1.0 108.987 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.15 -50.74 37.46 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.676 -1.602 . . . . 1.0 112.007 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.463 ' SD ' HG21 ' A' ' 5' ' ' VAL . 66.0 mtm -66.38 -57.45 7.41 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 115.57 1.692 . . . . 1.0 115.57 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -103.52 -55.31 2.42 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.787 -1.097 . . . . 1.0 113.76 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.14 41.14 0.31 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 75.1 mmtt -125.83 121.08 24.32 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 105.008 -2.219 . . . . 1.0 105.008 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -82.41 11.83 3.06 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.114 1.876 . . . . 1.0 110.685 -173.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -117.29 -176.86 3.09 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.385 -1.339 . . . . 1.0 107.385 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.04 143.45 3.99 Favored Glycine 0 N--CA 1.486 1.985 0 CA-C-N 113.605 -1.634 . . . . 1.0 111.47 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HG3' ' HB3' ' A' ' 34' ' ' ARG . 19.0 ptmt -123.73 172.75 8.61 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 113.569 -1.316 . . . . 1.0 107.774 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.7 t -115.61 159.72 20.93 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.699 -0.8 . . . . 1.0 110.83 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 73.2 mtm -131.01 78.47 1.84 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.41 -1.723 . . . . 1.0 107.42 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 28.48 55.63 0.1 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 125.875 1.985 . . . . 1.0 110.743 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.32 -37.14 2.52 Favored Glycine 0 N--CA 1.485 1.956 0 CA-C-N 112.586 -2.097 . . . . 1.0 115.951 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -110.66 139.65 45.75 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 119.729 1.765 . . . . 1.0 111.793 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.64 157.13 38.51 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.473 -2.148 . . . . 1.0 113.845 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.49 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 18.7 tpt85 -138.32 145.91 41.76 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 102.753 -3.054 . . . . 1.0 102.753 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -120.19 167.51 12.18 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.251 -1.018 . . . . 1.0 108.251 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -118.69 -179.0 3.67 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.096 -1.411 . . . . 1.0 108.353 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 116.389 -1.767 . . . . 1.0 109.503 -179.776 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 . . . . . 0 C--O 1.215 -0.745 0 CA-C-O 120.903 0.382 . . . . 1.0 111.114 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 p -138.31 171.97 13.59 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 114.743 -1.117 . . . . 1.0 110.137 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -131.64 40.33 3.4 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.4 -1.333 . . . . 1.0 107.4 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.9 p -114.72 155.93 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 115.122 -0.945 . . . . 1.0 110.298 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.812 ' H ' ' HZ2' ' A' ' 6' ' ' LYS . 0.2 OUTLIER -71.32 131.18 43.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 123.587 0.554 . . . . 1.0 110.207 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.475 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 30.8 p -127.6 157.33 40.5 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 120.219 -0.593 . . . . 1.0 110.741 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -137.06 42.0 2.44 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.613 -1.176 . . . . 1.0 109.646 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.75 159.88 11.24 Favored Glycine 0 N--CA 1.496 2.685 0 CA-C-N 114.293 -1.322 . . . . 1.0 111.442 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.7 p -47.35 -56.73 6.3 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.515 1.302 . . . . 1.0 114.515 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -39.69 -41.27 1.05 Allowed 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 114.291 1.219 . . . . 1.0 114.291 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -36.43 74.73 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.163 0.914 . . . . 1.0 111.394 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 73.0 m -73.26 -20.17 60.9 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.07 -0.968 . . . . 1.0 112.779 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.469 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 9.4 m0 -58.95 -62.47 5.73 Favored Pre-proline 0 CA--C 1.562 1.428 0 C-N-CA 120.321 -0.552 . . . . 1.0 110.911 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.414 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 84.7 Cg_endo -66.39 -49.84 1.65 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.883 2.389 . . . . 1.0 110.728 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 71.8 t -50.29 -42.52 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 123.648 0.593 . . . . 1.0 110.081 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 50.3 t -70.16 -47.76 60.25 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.575 -1.269 . . . . 1.0 107.575 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.425 ' HZ1' ' HD3' ' A' ' 24' ' ' PRO . 1.6 tpmt? -46.88 -40.54 14.23 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 122.196 0.998 . . . . 1.0 108.542 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -70.4 -50.94 33.38 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 113.335 -1.757 . . . . 1.0 112.107 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 56.0 mtm -70.81 -57.84 4.23 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 115.452 1.649 . . . . 1.0 115.452 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -100.6 -56.02 2.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 123.916 0.76 . . . . 1.0 112.025 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.9 39.48 0.52 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.836 -1.305 . . . . 1.0 109.836 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.573 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 38.5 mmtm -122.5 105.69 35.86 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 104.922 -2.251 . . . . 1.0 104.922 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HD3' ' HZ1' ' A' ' 18' ' ' LYS . 66.4 Cg_endo -69.94 0.65 5.47 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.258 1.972 . . . . 1.0 111.811 -171.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.469 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 5.9 m120 -119.19 -174.5 2.73 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.63 179.39 18.71 Favored Glycine 0 N--CA 1.488 2.112 0 CA-C-N 113.522 -1.672 . . . . 1.0 111.243 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HG3' ' HB3' ' A' ' 34' ' ' ARG . 11.6 ptmm? -138.31 172.51 12.79 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 114.356 -0.922 . . . . 1.0 111.197 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.9 t -107.76 160.14 15.95 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 71.5 mtm -138.96 84.8 2.03 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 108.812 -0.81 . . . . 1.0 108.812 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 25.17 55.89 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 125.975 2.047 . . . . 1.0 110.903 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.74 -42.83 1.36 Allowed Glycine 0 N--CA 1.483 1.81 0 CA-C-N 111.806 -2.452 . . . . 1.0 116.145 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -121.64 149.41 43.23 Favored 'General case' 0 C--O 1.205 -1.279 0 CA-C-O 124.46 2.076 . . . . 1.0 112.584 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 10.9 m -72.33 157.95 36.72 Favored 'General case' 0 C--N 1.285 -2.205 1 CA-C-N 108.347 -4.024 . . . . 1.0 115.199 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.465 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 2.9 tpt180 -137.73 146.34 43.58 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 111.935 -2.393 . . . . 1.0 105.35 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.2 m -117.58 163.68 16.07 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.898 -1.519 . . . . 1.0 106.898 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -116.69 175.19 5.69 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.7 m . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 C--O 1.216 -0.666 0 CA-C-O 121.538 0.685 . . . . 1.0 109.515 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.0 p -138.86 170.46 15.95 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 113.53 -1.668 . . . . 1.0 111.4 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -124.87 51.12 1.67 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.444 -1.317 . . . . 1.0 107.444 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.28 147.26 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 114.628 -1.169 . . . . 1.0 109.042 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.55 127.08 31.48 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.401 -0.818 . . . . 1.0 111.201 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.22 161.72 27.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 124.007 0.817 . . . . 1.0 111.227 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 t -135.61 42.06 2.69 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.612 -1.177 . . . . 1.0 109.403 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.66 166.52 13.34 Favored Glycine 0 N--CA 1.496 2.678 0 CA-C-N 114.061 -1.427 . . . . 1.0 111.605 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.6 t -53.71 -66.49 0.38 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 114.595 1.331 . . . . 1.0 114.595 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -39.14 -31.96 0.09 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.244 1.572 . . . . 1.0 115.244 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -70.4 -42.3 71.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 124.125 0.891 . . . . 1.0 112.439 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.465 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 4.4 t -89.38 7.79 34.04 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 117.923 -1.511 . . . . 1.0 112.978 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.464 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 2.5 m95 -70.3 -58.33 5.02 Favored Pre-proline 0 N--CA 1.482 1.171 0 N-CA-C 103.441 -2.8 . . . . 1.0 103.441 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 86.8 Cg_endo -65.37 -44.65 8.54 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 123.119 2.546 . . . . 1.0 112.429 172.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 90.7 t -58.73 -46.86 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 C-N-CA 117.633 -1.627 . . . . 1.0 110.041 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 53.2 t -64.76 -44.36 90.33 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.048 -1.061 . . . . 1.0 108.139 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -50.86 -40.17 55.55 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.287 1.042 . . . . 1.0 109.025 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -70.52 -45.78 64.88 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.894 -1.503 . . . . 1.0 111.446 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.4 mtp -61.44 -56.04 24.65 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 114.261 1.208 . . . . 1.0 114.261 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -113.39 -56.87 2.36 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.395 -1.275 . . . . 1.0 113.96 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.25 45.59 0.27 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 106.757 -2.537 . . . . 1.0 106.757 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 34.6 mmtp -125.85 89.69 51.89 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 106.053 -1.832 . . . . 1.0 106.053 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -65.57 -4.51 9.77 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.594 2.196 . . . . 1.0 113.246 -162.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -105.34 129.8 53.6 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 105.166 -2.161 . . . . 1.0 105.166 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.95 132.12 3.98 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.497 -1.841 . . . . 1.0 108.497 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -117.05 157.37 25.95 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 106.519 -1.66 . . . . 1.0 106.519 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -102.44 161.47 13.69 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.923 -0.711 . . . . 1.0 112.345 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.9 mtm -133.72 82.87 2.01 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.429 -1.714 . . . . 1.0 107.039 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 28.9 55.08 0.1 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 125.562 1.789 . . . . 1.0 111.197 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.91 -38.56 2.3 Favored Glycine 0 N--CA 1.481 1.648 0 CA-C-N 113.011 -1.904 . . . . 1.0 116.067 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -114.72 140.55 48.78 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 119.792 1.796 . . . . 1.0 112.909 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.483 ' SG ' ' N ' ' A' ' 34' ' ' ARG . 25.5 t -72.11 156.91 38.67 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 110.558 -3.019 . . . . 1.0 115.92 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.483 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 47.8 ttt-85 -136.83 146.12 45.27 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 104.106 -2.553 . . . . 1.0 104.106 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.9 m -119.22 168.58 10.75 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 123.974 0.796 . . . . 1.0 110.223 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -126.75 -165.53 1.47 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 114.421 -1.263 . . . . 1.0 111.596 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.468 -1.253 . . . . 1.0 110.278 -179.762 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 65.0 m-85 . . . . . 0 C--O 1.216 -0.664 0 CA-C-O 121.013 0.435 . . . . 1.0 110.815 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 50.2 p -134.01 169.32 17.3 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 114.491 -1.231 . . . . 1.0 109.8 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -123.59 41.36 3.49 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.369 1.081 . . . . 1.0 109.045 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.96 148.11 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.402 -1.703 . . . . 1.0 106.402 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -70.39 153.63 42.78 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.81 168.19 14.77 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 124.522 1.139 . . . . 1.0 110.553 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.5 t -142.96 32.08 1.39 Allowed 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 105.672 -1.973 . . . . 1.0 105.672 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.77 154.19 9.13 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.643 -2.183 . . . . 1.0 107.643 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.5 m -39.71 -53.08 2.24 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.182 1.178 . . . . 1.0 114.182 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -44.71 -41.26 6.66 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.442 1.645 . . . . 1.0 115.442 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -61.87 -27.69 68.98 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 119.431 -0.908 . . . . 1.0 112.687 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.1 m -77.42 -6.26 52.77 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.006 -0.997 . . . . 1.0 112.127 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.515 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 11.2 m0 -69.37 -62.57 2.51 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 108.724 -0.843 . . . . 1.0 108.724 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.515 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 94.0 Cg_endo -66.62 -42.45 9.29 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.886 2.39 . . . . 1.0 110.969 176.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.23 -45.37 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 123.962 0.789 . . . . 1.0 110.198 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 46.6 t -70.2 -44.76 68.0 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.483 -1.287 . . . . 1.0 107.765 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -47.74 -41.3 22.71 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 122.37 1.081 . . . . 1.0 108.93 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -70.86 -57.7 4.34 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 113.091 -1.868 . . . . 1.0 113.107 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.5 mmm -62.59 -54.92 32.47 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 115.928 1.825 . . . . 1.0 115.928 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -106.85 -55.91 2.26 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 114.532 -1.213 . . . . 1.0 112.998 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.84 41.05 0.27 Allowed Glycine 0 N--CA 1.492 2.426 0 O-C-N 123.467 0.48 . . . . 1.0 113.422 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.488 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 33.7 mmtp -133.58 109.55 12.24 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 107.897 -1.149 . . . . 1.0 107.897 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.27 6.79 2.05 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.989 2.459 . . . . 1.0 112.055 -175.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.1 115.19 20.75 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.588 -1.264 . . . . 1.0 107.588 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -139.41 155.25 23.98 Favored Glycine 0 N--CA 1.493 2.495 0 CA-C-N 114.195 -1.366 . . . . 1.0 114.628 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -116.46 179.7 3.93 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-N 113.882 -1.159 . . . . 1.0 108.965 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.3 t -120.29 164.28 16.54 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' LYS . 84.3 mtp -141.05 82.2 1.82 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.089 -1.819 . . . . 1.0 106.089 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.4 t30 31.79 51.77 0.19 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 125.088 1.493 . . . . 1.0 111.688 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.45 -36.42 3.16 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-O 117.463 -1.743 . . . . 1.0 115.782 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 29' ' ' MET . 35.6 mmtp -111.23 150.51 29.47 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-N 120.468 2.134 . . . . 1.0 110.811 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.5 m -71.79 163.43 27.82 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 118.72 2.859 . . . . 1.0 118.72 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.1 tpt85 -136.2 153.26 51.29 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 110.882 -2.872 . . . . 1.0 104.69 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.7 m -121.86 169.98 10.24 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.835 -1.543 . . . . 1.0 106.835 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -115.67 -172.54 2.17 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.418 -0.81 . . . . 1.0 109.63 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.2 p . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 115.89 -2.005 . . . . 1.0 110.173 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 . . . . . 0 C--O 1.215 -0.716 0 CA-C-O 121.909 0.861 . . . . 1.0 110.973 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.9 p -143.72 163.03 34.44 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 112.806 -1.997 . . . . 1.0 107.751 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -127.06 48.56 2.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 123.681 0.613 . . . . 1.0 111.086 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.29 156.68 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.641 -1.244 . . . . 1.0 107.641 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -70.31 109.99 5.02 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.133 0.79 . . . . 1.0 113.133 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.9 p -114.29 152.52 31.24 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 123.813 0.696 . . . . 1.0 110.401 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -145.72 48.52 1.24 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.57 -1.65 . . . . 1.0 108.2 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.37 125.47 2.52 Favored Glycine 0 N--CA 1.498 2.802 0 CA-C-N 114.123 -1.399 . . . . 1.0 111.472 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.3 m -39.72 -52.57 2.28 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.967 1.84 . . . . 1.0 115.967 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -40.55 -37.46 0.72 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.826 1.417 . . . . 1.0 114.826 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -61.07 -35.35 76.73 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.804 -1.089 . . . . 1.0 113.771 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.0 m -77.26 -10.95 59.74 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.338 -1.301 . . . . 1.0 112.511 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.483 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 11.3 m0 -65.7 -61.83 5.23 Favored Pre-proline 0 C--N 1.307 -1.246 0 C-N-CA 119.636 -0.825 . . . . 1.0 109.171 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.483 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 83.1 Cg_endo -67.93 -43.58 4.91 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 123.015 2.477 . . . . 1.0 111.548 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.3 t -58.35 -47.59 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 123.787 0.679 . . . . 1.0 110.733 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.549 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 46.8 t -70.32 -42.83 71.43 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.19 -1.404 . . . . 1.0 107.951 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -48.41 -41.12 28.21 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.399 1.095 . . . . 1.0 108.161 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -70.65 -51.4 28.15 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.455 -1.702 . . . . 1.0 112.107 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 32.2 ttm -58.69 -59.15 5.86 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 114.513 1.301 . . . . 1.0 114.513 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -110.63 -55.8 2.43 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.531 -1.668 . . . . 1.0 114.056 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.39 45.09 0.25 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.124 -1.99 . . . . 1.0 108.124 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.549 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 40.5 mmtm -123.74 94.68 45.71 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 105.276 -2.12 . . . . 1.0 105.276 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -64.99 -1.88 4.86 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.577 2.185 . . . . 1.0 112.489 -168.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -115.9 142.78 46.32 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 105.589 -2.004 . . . . 1.0 105.589 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.43 153.7 24.76 Favored Glycine 0 N--CA 1.489 2.17 0 CA-C-N 113.849 -1.523 . . . . 1.0 110.701 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.451 ' HG3' ' HB3' ' A' ' 34' ' ' ARG . 20.6 ptmt -131.27 176.64 8.11 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 119.253 -0.979 . . . . 1.0 109.243 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.5 t -114.16 162.3 16.7 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.108 0.48 . . . . 1.0 110.433 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.2 mtp -135.23 75.84 1.59 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.595 -1.631 . . . . 1.0 106.595 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 29.67 55.74 0.15 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 125.599 1.812 . . . . 1.0 110.89 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.18 -36.39 2.83 Favored Glycine 0 N--CA 1.483 1.806 0 CA-C-N 112.971 -1.922 . . . . 1.0 115.602 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -111.93 139.61 47.28 Favored 'General case' 0 C--O 1.206 -1.229 0 CA-C-N 119.286 1.543 . . . . 1.0 110.856 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 52.2 t -71.74 161.67 30.62 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 112.878 -1.965 . . . . 1.0 114.704 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.451 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 18.3 tpt85 -141.26 152.71 44.75 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.973 -1.467 . . . . 1.0 107.221 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.0 m -116.39 169.57 9.21 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 124.545 1.153 . . . . 1.0 109.4 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -120.07 -171.25 2.11 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.321 -1.309 . . . . 1.0 109.01 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.7 m . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 116.275 -1.821 . . . . 1.0 108.99 -179.611 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 C--O 1.216 -0.705 0 CA-C-O 121.198 0.523 . . . . 1.0 109.86 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 82.4 p -133.71 176.02 8.93 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 114.171 -1.377 . . . . 1.0 109.028 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -124.67 30.04 6.07 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 123.98 0.8 . . . . 1.0 109.382 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.48 153.37 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 115.255 -0.884 . . . . 1.0 109.311 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 62.2 pttt -71.1 155.26 40.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.988 0.805 . . . . 1.0 111.808 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.8 p -134.71 157.29 47.05 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.043 -0.663 . . . . 1.0 110.881 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.8 p -136.56 43.85 2.42 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.469 -1.241 . . . . 1.0 108.815 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.53 167.63 13.45 Favored Glycine 0 N--CA 1.494 2.564 0 CA-C-N 113.926 -1.488 . . . . 1.0 110.191 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.9 m -65.21 -59.39 4.13 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 114.46 1.282 . . . . 1.0 114.46 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -40.49 -39.23 0.97 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 114.692 1.368 . . . . 1.0 114.692 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -33.84 70.49 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 122.077 0.941 . . . . 1.0 112.806 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 60.6 m -78.36 -7.91 57.84 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.218 -1.355 . . . . 1.0 113.578 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.462 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 11.3 m95 -69.57 -60.56 3.8 Favored Pre-proline 0 C--N 1.304 -1.373 0 C-N-CA 119.554 -0.858 . . . . 1.0 108.877 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.462 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 97.6 Cg_endo -66.99 -42.92 7.37 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.891 2.394 . . . . 1.0 111.185 176.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.67 -47.9 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 123.91 0.756 . . . . 1.0 110.572 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 49.3 t -70.01 -40.61 75.14 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.702 -1.199 . . . . 1.0 108.438 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -51.41 -42.17 61.26 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.422 -0.955 . . . . 1.0 108.422 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 -70.56 -50.01 41.96 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 113.971 -1.468 . . . . 1.0 111.997 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.4 ttm -54.02 -54.59 37.04 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -122.51 -55.69 1.82 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 113.62 -1.627 . . . . 1.0 112.808 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.43 42.6 0.21 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.594 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 6.1 mptp? -120.22 92.3 47.03 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 106.409 -1.7 . . . . 1.0 106.409 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -64.82 -5.01 9.67 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.963 2.442 . . . . 1.0 113.555 -164.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -115.48 143.17 45.7 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 105.95 -1.87 . . . . 1.0 105.95 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.96 154.56 25.61 Favored Glycine 0 N--CA 1.488 2.117 0 CA-C-N 113.382 -1.735 . . . . 1.0 111.281 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HG3' ' HB3' ' A' ' 34' ' ' ARG . 20.7 ptmt -128.23 178.81 5.99 Favored 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 119.388 -0.925 . . . . 1.0 109.064 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.0 t -116.45 157.68 24.76 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 73.2 mtm -133.71 82.93 2.01 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.254 -1.758 . . . . 1.0 106.254 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 29.46 50.7 0.07 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 125.307 1.629 . . . . 1.0 112.919 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 124.96 -34.04 3.53 Favored Glycine 0 N--CA 1.483 1.777 0 CA-C-O 117.152 -1.916 . . . . 1.0 116.539 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -111.43 140.93 45.62 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 120.588 2.194 . . . . 1.0 109.817 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.1 t -71.86 158.11 36.66 Favored 'General case' 0 C--N 1.292 -1.891 0 CA-C-N 112.187 -2.279 . . . . 1.0 115.468 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.465 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 5.1 tpt180 -139.25 155.5 47.72 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.31 -1.768 . . . . 1.0 107.748 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.2 m -118.75 168.25 10.92 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 124.929 1.393 . . . . 1.0 108.338 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -118.62 -179.48 3.81 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.392 -0.822 . . . . 1.0 110.822 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.5 m . . . . . 0 N--CA 1.504 2.237 0 O-C-N 125.701 1.876 . . . . 1.0 115.684 -179.917 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 . . . . . 0 C--O 1.216 -0.671 0 CA-C-O 121.822 0.82 . . . . 1.0 110.096 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 p -141.13 165.07 28.55 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.211 -1.813 . . . . 1.0 109.825 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -125.85 55.72 1.44 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.831 -1.077 . . . . 1.0 108.776 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.68 148.32 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-N 114.672 -1.149 . . . . 1.0 108.437 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -70.1 102.57 2.09 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.853 -1.067 . . . . 1.0 110.557 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.7 p -116.24 158.61 23.07 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 124.407 1.067 . . . . 1.0 111.842 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 t -137.72 45.78 2.14 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.931 -1.486 . . . . 1.0 107.147 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.07 157.43 9.68 Favored Glycine 0 N--CA 1.494 2.522 0 CA-C-N 113.243 -1.799 . . . . 1.0 110.084 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.2 m -40.31 -49.68 2.76 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 116.148 1.906 . . . . 1.0 116.148 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -39.69 -31.2 0.09 Allowed 'General case' 0 C--O 1.205 -1.25 0 C-N-CA 125.577 1.551 . . . . 1.0 114.905 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -70.15 -40.39 74.79 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.789 0.804 . . . . 1.0 113.047 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 96.1 m -70.72 -26.21 63.29 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.023 -1.444 . . . . 1.0 113.058 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -57.19 -65.79 1.57 Allowed Pre-proline 0 C--N 1.3 -1.57 0 C-N-CA 118.999 -1.08 . . . . 1.0 110.775 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -64.37 -45.84 8.7 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 122.835 2.357 . . . . 1.0 111.591 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 88.8 t -62.33 -49.01 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 124.082 0.864 . . . . 1.0 112.455 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 24.8 t -70.28 -31.94 69.51 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.973 -1.091 . . . . 1.0 108.414 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -61.52 -49.24 77.5 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.617 -0.883 . . . . 1.0 108.617 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -70.79 -38.82 73.39 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.164 -1.014 . . . . 1.0 113.236 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.0 mtp -69.64 -56.35 7.5 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 115.267 1.58 . . . . 1.0 115.267 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -106.52 -58.19 1.96 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.793 0.683 . . . . 1.0 112.091 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.55 37.62 0.58 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.821 -1.712 . . . . 1.0 108.821 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.448 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 5.0 mptp? -122.85 79.37 49.69 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 105.483 -2.043 . . . . 1.0 105.483 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -66.43 10.96 0.18 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 123.042 2.494 . . . . 1.0 113.751 -170.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -128.51 109.72 11.64 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.826 -1.175 . . . . 1.0 107.826 179.626 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.05 174.41 23.22 Favored Glycine 0 N--CA 1.492 2.384 0 CA-C-N 112.546 -2.115 . . . . 1.0 111.291 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.432 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 18.6 ptmt -132.95 171.71 13.59 Favored 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 108.891 -0.781 . . . . 1.0 108.891 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.2 t -109.27 160.23 16.3 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 120.181 -0.608 . . . . 1.0 110.019 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 56.9 mtp -132.61 76.93 1.72 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.098 -1.815 . . . . 1.0 106.098 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 30.87 55.36 0.2 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 125.606 1.816 . . . . 1.0 110.954 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.96 -35.43 3.39 Favored Glycine 0 N--CA 1.483 1.804 0 CA-C-N 113.353 -1.749 . . . . 1.0 115.815 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -112.01 137.55 49.88 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 119.315 1.557 . . . . 1.0 110.698 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 34' ' ' ARG . 39.1 t -72.18 158.31 36.13 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 117.696 2.48 . . . . 1.0 117.696 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.516 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 10.3 tpt180 -138.95 149.26 44.55 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 106.409 -1.7 . . . . 1.0 106.409 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.3 m -123.93 163.55 21.1 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 104.906 -2.257 . . . . 1.0 104.906 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -112.88 170.08 8.46 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.656 -1.609 . . . . 1.0 106.656 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.507 2.377 0 N-CA-C 116.225 1.935 . . . . 1.0 116.225 -179.902 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 . . . . . 0 C--O 1.216 -0.661 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.4 p -135.1 169.66 17.09 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 123.891 0.745 . . . . 1.0 110.894 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.405 ' H ' ' HE1' ' A' ' 20' ' ' MET . 0.7 OUTLIER -118.59 24.0 11.16 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.085 -1.416 . . . . 1.0 107.659 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.31 145.73 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.519 ' HZ2' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -71.04 163.24 27.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.277 0.985 . . . . 1.0 112.516 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.519 ' N ' ' HZ2' ' A' ' 6' ' ' LYS . 8.4 p -142.61 159.55 42.01 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 124.148 0.905 . . . . 1.0 111.353 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 p -131.89 41.02 3.31 Favored 'General case' 0 C--N 1.31 -1.116 0 O-C-N 124.465 1.103 . . . . 1.0 108.188 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.45 171.22 17.73 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.115 -1.594 . . . . 1.0 109.115 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.5 p -48.8 -60.35 2.82 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.816 0.672 . . . . 1.0 112.816 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -40.06 -39.43 0.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -70.45 -36.2 73.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.287 0.992 . . . . 1.0 112.104 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.462 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 49.0 t -76.01 -13.94 60.23 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.643 -1.617 . . . . 1.0 112.326 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.426 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 7.5 m0 -69.14 -56.2 9.09 Favored Pre-proline 0 N--CA 1.485 1.289 0 CA-C-O 118.193 -0.908 . . . . 1.0 110.695 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 90.3 Cg_endo -65.34 -42.17 13.93 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.906 2.404 . . . . 1.0 110.643 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.48 -48.45 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 123.925 0.766 . . . . 1.0 110.823 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.4 t -68.57 -44.61 74.05 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.146 -1.022 . . . . 1.0 108.915 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -52.43 -39.41 60.99 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.951 0.881 . . . . 1.0 109.081 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -70.46 -52.88 18.96 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 114.21 -1.359 . . . . 1.0 111.141 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.405 ' HE1' ' H ' ' A' ' 4' ' ' ASP . 34.4 ttm -56.07 -56.96 14.51 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.537 0.94 . . . . 1.0 113.537 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -113.07 -61.16 1.78 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 113.098 -1.864 . . . . 1.0 113.915 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.07 41.25 0.45 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 107.885 -2.086 . . . . 1.0 107.885 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 7.8 mmpt? -123.42 81.83 53.17 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 105.904 -1.887 . . . . 1.0 105.904 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -65.13 1.35 2.0 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 123.092 2.528 . . . . 1.0 114.94 -157.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 5.2 m120 -100.22 121.81 42.04 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 100.698 -3.816 . . . . 1.0 100.698 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.15 143.88 12.42 Favored Glycine 0 C--N 1.294 -1.761 0 CA-C-N 113.786 -1.552 . . . . 1.0 110.726 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.404 ' HD3' ' OH ' ' A' ' 36' ' ' TYR . 26.4 mtpp -125.77 160.3 30.13 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 106.517 -1.66 . . . . 1.0 106.517 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.9 t -101.05 157.49 16.72 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.969 -0.693 . . . . 1.0 112.629 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.4 mtm -132.3 89.88 2.72 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.527 -1.657 . . . . 1.0 106.527 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 30.34 48.31 0.05 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 125.097 1.498 . . . . 1.0 113.414 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 121.84 -31.54 4.93 Favored Glycine 0 N--CA 1.487 2.036 0 CA-C-O 117.112 -1.938 . . . . 1.0 117.912 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -113.01 142.68 45.43 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 120.719 2.259 . . . . 1.0 110.028 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 13.3 t -71.6 157.61 37.67 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.362 -1.745 . . . . 1.0 114.057 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.462 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 27.7 ttt85 -133.37 140.32 47.3 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 112.519 -2.128 . . . . 1.0 106.362 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.412 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 65.2 m -109.85 166.52 10.86 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 123.969 0.793 . . . . 1.0 112.23 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.438 ' HB2' ' HB2' ' A' ' 25' ' ' ASN . 47.4 m-85 -127.56 -165.0 1.42 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.42 -1.718 . . . . 1.0 110.774 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.4 t . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.512 -1.233 . . . . 1.0 110.004 -179.723 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.7 p90 . . . . . 0 C--O 1.218 -0.593 0 N-CA-C 109.473 -0.565 . . . . 1.0 109.473 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -124.3 173.39 8.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 124.034 0.833 . . . . 1.0 111.739 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.2 23.34 11.91 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.267 -1.788 . . . . 1.0 107.161 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -124.02 151.87 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 115.323 -0.853 . . . . 1.0 109.074 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -71.11 159.71 34.21 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.536 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.565 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 28.8 p -136.82 150.42 48.31 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.769 -0.772 . . . . 1.0 111.392 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.5 p -137.04 45.09 2.27 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.152 -1.385 . . . . 1.0 107.755 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.58 159.84 11.27 Favored Glycine 0 N--CA 1.494 2.548 0 CA-C-N 113.466 -1.697 . . . . 1.0 110.112 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.8 m -50.71 -54.47 22.95 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 113.896 1.073 . . . . 1.0 113.896 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -40.33 -36.91 0.59 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.204 1.557 . . . . 1.0 115.204 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -70.41 -34.82 72.96 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.233 -0.894 . . . . 1.0 112.432 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.5 m -73.6 -18.1 61.09 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.332 -1.304 . . . . 1.0 112.464 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.456 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 9.7 m0 -63.08 -60.88 8.51 Favored Pre-proline 0 N--CA 1.483 1.2 0 CA-C-O 118.364 -0.827 . . . . 1.0 110.887 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -65.74 -45.71 6.12 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 123.024 2.482 . . . . 1.0 111.344 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.26 -45.47 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 123.948 0.78 . . . . 1.0 111.097 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 52.7 t -70.0 -48.52 57.79 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.596 -1.261 . . . . 1.0 107.596 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -47.63 -38.87 15.63 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 122.136 0.97 . . . . 1.0 108.89 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -70.67 -58.49 3.61 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.36 -1.745 . . . . 1.0 112.433 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 70.7 mtm -68.7 -53.83 19.83 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 116.808 2.151 . . . . 1.0 116.808 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -99.01 -57.52 2.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 124.057 0.848 . . . . 1.0 112.715 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.59 34.45 0.86 Allowed Glycine 0 N--CA 1.495 2.606 0 O-C-N 123.837 0.711 . . . . 1.0 111.743 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 12.9 mptt -122.97 107.07 33.48 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 104.905 -2.257 . . . . 1.0 104.905 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.21 -4.53 13.84 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.913 2.409 . . . . 1.0 112.527 -163.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.456 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 29.3 m-80 -107.17 -171.91 1.97 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.143 -1.429 . . . . 1.0 107.143 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.35 163.94 10.44 Favored Glycine 0 N--CA 1.483 1.8 0 CA-C-N 112.302 -2.226 . . . . 1.0 110.376 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.524 ' HE2' ' CE2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -132.59 177.14 7.85 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 113.896 -1.152 . . . . 1.0 108.57 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.5 t -105.6 155.61 19.05 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.737 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 70.6 mtm -131.04 82.3 2.04 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 107.204 -1.406 . . . . 1.0 107.204 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 m120 29.49 51.38 0.08 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 125.463 1.727 . . . . 1.0 112.442 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.29 -33.84 3.53 Favored Glycine 0 N--CA 1.486 2.016 0 CA-C-N 113.082 -1.872 . . . . 1.0 116.864 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.495 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 6.2 mptt -117.43 141.34 48.46 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 120.228 2.014 . . . . 1.0 110.272 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 3.0 m -72.32 156.13 39.43 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 113.805 -1.543 . . . . 1.0 114.616 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.419 ' HB3' ' HG2' ' A' ' 27' ' ' LYS . 9.1 tpt180 -135.1 152.71 51.91 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.76 -1.941 . . . . 1.0 105.76 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.5 m -117.23 156.89 26.96 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 124.672 1.232 . . . . 1.0 110.794 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.524 ' CE2' ' HE2' ' A' ' 27' ' ' LYS . 58.1 m-85 -111.62 -179.12 3.62 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.35 -1.722 . . . . 1.0 106.35 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.2 m . . . . . 0 N--CA 1.505 2.325 0 N-CA-C 115.487 1.662 . . . . 1.0 115.487 179.837 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 . . . . . 0 C--O 1.217 -0.645 0 N-CA-C 109.818 -0.438 . . . . 1.0 109.818 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.7 p -137.05 173.37 11.77 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 115.033 -0.985 . . . . 1.0 110.395 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -131.86 34.34 3.87 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 114.72 -1.127 . . . . 1.0 108.155 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.6 p -111.08 150.86 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-N 115.053 -0.976 . . . . 1.0 110.518 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -71.13 127.46 32.64 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.096 1.147 . . . . 1.0 114.096 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.429 ' SG ' ' C ' ' A' ' 32' ' ' LYS . 30.3 p -134.9 159.37 41.63 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.837 -0.62 . . . . 1.0 109.917 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -148.02 48.64 1.06 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.621 -1.251 . . . . 1.0 107.621 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.26 153.09 7.04 Favored Glycine 0 N--CA 1.498 2.83 0 CA-C-N 113.489 -1.687 . . . . 1.0 112.145 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 65.4 p -53.62 -57.71 9.8 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 116.038 1.866 . . . . 1.0 116.038 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -39.76 -41.8 1.16 Allowed 'General case' 0 C--O 1.204 -1.298 0 C-N-CA 124.63 1.172 . . . . 1.0 113.78 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -70.69 -38.37 73.69 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.598 -1.183 . . . . 1.0 111.7 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 13.3 t -72.19 -18.1 61.88 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 113.546 -1.661 . . . . 1.0 111.369 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -64.03 -61.29 7.06 Favored Pre-proline 0 N--CA 1.486 1.341 0 CA-C-O 118.449 -0.786 . . . . 1.0 111.331 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -64.83 -42.96 13.46 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 123.054 2.503 . . . . 1.0 110.499 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 66.6 t -56.85 -45.91 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 123.928 0.767 . . . . 1.0 110.057 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.592 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 38.2 t -67.76 -45.0 76.16 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -49.31 -42.73 42.23 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.433 1.111 . . . . 1.0 108.82 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -70.48 -49.25 50.42 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 113.168 -1.833 . . . . 1.0 112.208 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.0 ttp -57.01 -57.89 10.56 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 124.265 0.978 . . . . 1.0 113.007 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -116.82 -58.61 2.05 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 113.334 -1.757 . . . . 1.0 114.073 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.04 45.71 0.21 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.033 -1.627 . . . . 1.0 109.033 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.592 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 75.0 mmtt -127.01 72.22 76.13 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 105.852 -1.907 . . . . 1.0 105.852 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -60.89 -3.47 2.86 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.738 2.959 . . . . 1.0 114.359 -163.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.4 108.09 16.42 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.616 -1.624 . . . . 1.0 106.616 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.89 172.76 23.93 Favored Glycine 0 N--CA 1.486 2.011 0 CA-C-N 111.756 -2.475 . . . . 1.0 113.454 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -131.45 169.33 16.2 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 107.979 -1.119 . . . . 1.0 107.979 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.5 t -105.69 159.7 15.78 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 120.084 -0.647 . . . . 1.0 109.505 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.1 mtm -133.68 80.66 1.88 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.712 -1.131 . . . . 1.0 107.962 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 24.96 55.84 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 126.079 2.112 . . . . 1.0 110.632 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.5 -40.87 1.58 Allowed Glycine 0 N--CA 1.483 1.827 0 CA-C-N 111.858 -2.428 . . . . 1.0 116.205 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.429 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 48.1 mtmt -118.2 144.21 45.92 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 119.598 1.699 . . . . 1.0 113.584 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.1 t -71.86 157.97 36.9 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 112.487 -2.142 . . . . 1.0 112.813 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.432 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 12.9 tpt180 -136.78 144.74 43.9 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 112.699 -2.046 . . . . 1.0 105.862 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.9 m -118.5 163.79 16.24 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 105.557 -2.016 . . . . 1.0 105.557 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -113.55 169.22 9.13 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.601 -0.888 . . . . 1.0 108.601 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.506 2.371 0 CA-C-O 116.154 -1.879 . . . . 1.0 115.788 179.992 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 . . . . . 0 C--O 1.216 -0.688 0 CA-C-O 121.837 0.827 . . . . 1.0 109.677 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.4 p -148.12 171.3 16.1 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 112.946 -1.934 . . . . 1.0 109.808 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -127.79 51.39 1.95 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.825 -1.08 . . . . 1.0 108.586 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.2 t -111.96 126.38 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.856 0.836 . . . . 1.0 110.355 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 8.6 ptpp? -39.36 110.86 0.15 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 117.438 2.384 . . . . 1.0 117.438 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.3 p -125.97 172.36 9.99 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.025 0.917 . . . . 1.0 110.409 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.0 m -123.86 -47.04 1.95 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 112.431 -2.168 . . . . 1.0 106.482 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.82 168.69 31.78 Favored Glycine 0 N--CA 1.492 2.433 0 CA-C-N 114.218 -1.355 . . . . 1.0 110.081 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -48.13 -63.72 0.99 Allowed 'General case' 0 N--CA 1.482 1.128 0 O-C-N 124.097 0.528 . . . . 1.0 111.816 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -41.09 -37.4 0.86 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.902 1.376 . . . . 1.0 114.615 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -70.59 -34.42 72.15 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 122.975 1.369 . . . . 1.0 110.51 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.448 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 14.5 t -80.83 0.96 32.65 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.35 -1.75 . . . . 1.0 111.352 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.452 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 5.5 m95 -70.05 -60.59 3.43 Favored Pre-proline 0 N--CA 1.482 1.147 0 N-CA-C 106.069 -1.826 . . . . 1.0 106.069 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.425 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 73.9 Cg_endo -61.22 -43.98 26.12 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 122.422 2.081 . . . . 1.0 110.551 174.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 91.3 t -58.2 -45.3 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 C-N-CA 118.136 -1.425 . . . . 1.0 110.677 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 40.6 t -70.29 -31.03 68.21 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.308 -0.957 . . . . 1.0 109.047 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -59.47 -50.4 74.05 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -71.14 -48.22 53.25 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 119.348 -0.941 . . . . 1.0 113.373 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -50.28 73.98 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 114.1 1.148 . . . . 1.0 114.1 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -113.16 -61.57 1.72 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.7 1.37 . . . . 1.0 114.7 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.26 41.46 0.4 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.386 -1.885 . . . . 1.0 108.386 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 63.0 mmtt -130.38 81.52 67.92 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 104.645 -2.354 . . . . 1.0 104.645 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -62.1 -0.69 1.83 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.787 2.325 . . . . 1.0 114.222 -161.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.452 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 3.8 m120 -111.97 116.4 30.53 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 101.682 -3.451 . . . . 1.0 101.682 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.88 164.98 16.87 Favored Glycine 0 N--CA 1.486 1.979 0 CA-C-N 113.32 -1.763 . . . . 1.0 111.176 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . 73.6 tttt -128.33 170.78 12.67 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.826 -1.916 . . . . 1.0 105.826 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.5 t -123.06 159.7 27.91 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.219 0.533 . . . . 1.0 109.95 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.9 mtp -133.62 71.59 1.46 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.441 -1.689 . . . . 1.0 106.441 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 30.82 53.36 0.16 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 125.311 1.632 . . . . 1.0 111.981 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 125.72 -31.87 4.02 Favored Glycine 0 N--CA 1.48 1.575 0 CA-C-N 113.317 -1.765 . . . . 1.0 115.158 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.505 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 8.3 mptt -111.12 144.16 40.7 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-N 119.299 1.55 . . . . 1.0 108.755 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.82 160.63 32.25 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 114.919 1.451 . . . . 1.0 114.919 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 20.3 tpt85 -142.72 159.23 42.64 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 104.022 -2.585 . . . . 1.0 104.022 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.9 m -128.03 169.81 13.61 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.204 0.526 . . . . 1.0 110.036 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.603 ' CZ ' ' HB2' ' A' ' 27' ' ' LYS . 11.7 m-85 -122.72 -174.3 2.89 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 109.533 -0.543 . . . . 1.0 109.533 -179.762 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.9 p90 . . . . . 0 C--O 1.216 -0.661 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.8 p -133.44 169.07 17.49 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 123.826 0.704 . . . . 1.0 110.552 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -114.86 23.79 12.3 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.361 -1.29 . . . . 1.0 107.729 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -124.29 143.18 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.347 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -71.13 161.71 30.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.192 0.932 . . . . 1.0 112.131 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.485 ' SG ' ' C ' ' A' ' 32' ' ' LYS . 11.0 p -142.12 158.76 43.37 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.955 0.784 . . . . 1.0 111.617 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.6 p -136.58 43.98 2.41 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.492 -1.231 . . . . 1.0 108.138 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.63 161.08 11.92 Favored Glycine 0 N--CA 1.494 2.56 0 CA-C-N 113.902 -1.499 . . . . 1.0 110.889 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.8 t -45.59 -58.86 3.09 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.164 -1.018 . . . . 1.0 113.594 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -40.83 -41.52 1.6 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 115.122 1.527 . . . . 1.0 115.122 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.75 -33.1 70.45 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.306 1.004 . . . . 1.0 111.995 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 41.4 t -76.55 -12.73 60.07 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 113.633 -1.621 . . . . 1.0 112.059 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.42 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 8.3 m0 -69.8 -59.38 4.6 Favored Pre-proline 0 N--CA 1.483 1.215 0 CA-C-O 118.497 -0.763 . . . . 1.0 109.645 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 72.4 Cg_endo -62.51 -43.84 20.46 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 122.826 2.351 . . . . 1.0 109.732 177.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.9 t -59.34 -46.72 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 123.946 0.779 . . . . 1.0 110.633 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 41.6 t -70.26 -31.58 69.02 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.625 -1.23 . . . . 1.0 109.724 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -63.42 -48.1 79.17 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -70.74 -44.26 67.16 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.525 -0.87 . . . . 1.0 111.843 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.4 mmm -63.93 -52.76 58.27 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 113.935 1.087 . . . . 1.0 113.935 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -110.12 -62.19 1.55 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 124.179 0.924 . . . . 1.0 112.656 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.99 42.24 0.45 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.615 -2.194 . . . . 1.0 107.615 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 48.9 mmtm -130.86 82.64 63.7 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 106.821 -1.548 . . . . 1.0 106.821 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -62.55 0.24 1.55 Allowed 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.873 2.382 . . . . 1.0 114.609 -163.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -103.08 117.06 33.73 Favored 'General case' 0 C--N 1.308 -1.224 1 N-CA-C 99.485 -4.265 . . . . 1.0 99.485 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.11 144.1 13.36 Favored Glycine 0 C--N 1.292 -1.916 0 CA-C-N 113.604 -1.635 . . . . 1.0 110.534 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HD3' ' OH ' ' A' ' 36' ' ' TYR . 43.8 mtpt -126.08 165.32 19.07 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 107.08 -1.452 . . . . 1.0 107.08 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.2 t -104.59 148.97 25.92 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 113.206 0.817 . . . . 1.0 113.206 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.3 ptp -128.97 98.53 4.97 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.354 -1.294 . . . . 1.0 108.743 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.0 t30 32.4 47.06 0.08 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 113.02 -1.9 . . . . 1.0 113.124 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.49 -26.59 8.04 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 118.686 2.234 . . . . 1.0 118.686 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.485 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 93.2 mttt -114.26 149.95 35.11 Favored 'General case' 0 C--O 1.204 -1.291 0 CA-C-N 121.167 2.483 . . . . 1.0 109.96 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.1 t -72.28 159.03 34.75 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.814 -1.085 . . . . 1.0 111.946 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.448 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 26.4 ttt85 -133.05 141.22 48.11 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 112.956 -1.929 . . . . 1.0 106.057 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -111.99 166.19 11.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 124.172 0.92 . . . . 1.0 111.743 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.414 ' OH ' ' HD3' ' A' ' 27' ' ' LYS . 40.3 m-85 -126.36 -166.25 1.55 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.175 -1.829 . . . . 1.0 110.472 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.246 -1.359 . . . . 1.0 111.232 -179.772 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.5 p90 . . . . . 0 C--O 1.217 -0.639 0 CA-C-O 120.921 0.391 . . . . 1.0 111.377 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.7 p -132.3 179.13 6.3 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.612 -1.176 . . . . 1.0 110.962 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.22 26.3 9.72 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.405 -1.27 . . . . 1.0 109.398 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.8 t -123.98 141.9 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 31.0 mmmt -71.36 148.51 46.94 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.866 1.432 . . . . 1.0 114.866 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.7 p -140.42 173.08 11.86 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.35 1.071 . . . . 1.0 112.041 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.548 ' H ' HE22 ' A' ' 12' ' ' GLN . 10.1 t -136.38 -38.35 0.68 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 111.997 -2.365 . . . . 1.0 108.986 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.74 163.48 23.76 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 123.747 0.654 . . . . 1.0 112.78 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.5 p -70.29 -54.51 12.37 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.341 0.867 . . . . 1.0 113.341 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -58.44 -20.15 42.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 124.322 1.014 . . . . 1.0 111.459 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.548 HE22 ' H ' ' A' ' 8' ' ' THR . 4.9 tt0 -70.07 -31.0 68.38 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.219 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 3.9 t -80.11 -1.57 40.7 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.465 -1.243 . . . . 1.0 113.207 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.456 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 10.5 m0 -70.27 -60.4 3.42 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 87.7 Cg_endo -64.95 -44.35 10.12 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.794 2.329 . . . . 1.0 111.747 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 78.8 t -58.26 -45.21 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 119.736 -0.786 . . . . 1.0 110.892 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.4 t -69.98 -44.3 69.71 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -48.24 -42.06 29.31 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 122.355 1.074 . . . . 1.0 108.365 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -70.73 -47.64 58.71 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 113.114 -1.857 . . . . 1.0 112.792 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 94.9 mtp -69.19 -58.24 4.31 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 116.312 1.968 . . . . 1.0 116.312 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -102.66 -55.23 2.48 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.905 -1.043 . . . . 1.0 112.641 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.47 37.3 0.38 Allowed Glycine 0 N--CA 1.489 2.218 0 O-C-N 124.08 0.863 . . . . 1.0 111.331 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.54 115.07 22.98 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 106.548 -1.649 . . . . 1.0 106.548 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -74.46 15.36 0.67 Allowed 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.734 2.289 . . . . 1.0 112.66 -174.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.56 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 5.5 m120 -123.65 -177.13 3.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.76 0.791 . . . . 1.0 109.065 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.86 169.73 12.16 Favored Glycine 0 N--CA 1.49 2.293 0 CA-C-N 114.029 -1.441 . . . . 1.0 114.072 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 49.0 mtpt -132.21 -167.82 1.95 Allowed 'General case' 0 N--CA 1.504 2.25 0 CA-C-N 113.005 -1.597 . . . . 1.0 111.296 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.5 t -126.37 154.45 43.53 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.035 -1.839 . . . . 1.0 106.035 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.6 mtm -132.37 78.42 1.8 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.637 -1.246 . . . . 1.0 107.637 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.0 t30 28.76 52.64 0.07 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 125.835 1.959 . . . . 1.0 111.143 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 127.11 -35.49 2.83 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-O 117.019 -1.99 . . . . 1.0 116.273 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -109.23 146.01 34.93 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-N 120.853 2.326 . . . . 1.0 109.607 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -70.97 159.97 33.75 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.896 -1.047 . . . . 1.0 111.499 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.481 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 4.6 tpt180 -134.51 146.77 50.03 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 106.237 -1.764 . . . . 1.0 106.237 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.7 m -120.38 163.04 18.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.48 -1.674 . . . . 1.0 106.48 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.56 ' CD2' ' HB3' ' A' ' 25' ' ' ASN . 11.1 m-30 -114.38 178.11 4.4 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.393 -1.706 . . . . 1.0 106.393 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.506 2.35 0 O-C-N 125.117 1.511 . . . . 1.0 114.451 -179.73 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.0 p90 . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 112.965 0.728 . . . . 1.0 112.965 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.53 ' HB ' ' SD ' ' A' ' 20' ' ' MET . 68.4 p -131.12 -179.95 5.64 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.078 -0.964 . . . . 1.0 112.316 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.37 -4.41 11.83 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.117 -1.856 . . . . 1.0 109.168 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.07 141.82 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 107.104 -1.443 . . . . 1.0 107.104 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -71.17 167.39 19.46 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.341 1.978 . . . . 1.0 116.341 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.2 p -139.15 177.52 7.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 124.819 1.324 . . . . 1.0 110.613 179.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.8 m -123.18 -50.11 1.92 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 104.889 -2.263 . . . . 1.0 104.889 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.05 167.85 31.79 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.581 -1.807 . . . . 1.0 108.581 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 65.4 m -46.49 -56.34 6.11 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.403 0.621 . . . . 1.0 110.19 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -48.7 -39.81 26.0 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.329 -1.305 . . . . 1.0 112.848 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -70.69 -35.21 72.67 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.846 1.308 . . . . 1.0 109.751 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 4.0 t -74.46 -12.33 60.47 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 113.653 -1.612 . . . . 1.0 113.015 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.51 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 5.0 m0 -65.9 -58.73 10.46 Favored Pre-proline 0 C--N 1.306 -1.285 0 CA-C-O 118.752 -0.642 . . . . 1.0 109.603 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -61.3 -42.86 31.89 Favored 'Trans proline' 0 N--CA 1.488 1.158 0 C-N-CA 122.567 2.178 . . . . 1.0 110.44 173.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 53.9 t -55.04 -44.08 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 119.335 -0.946 . . . . 1.0 110.906 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 41.2 t -70.31 -41.53 73.19 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -50.16 -43.98 52.43 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.306 -0.998 . . . . 1.0 108.306 179.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -70.85 -53.02 16.75 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 113.354 -1.748 . . . . 1.0 113.238 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.53 ' SD ' ' HB ' ' A' ' 3' ' ' THR . 20.3 ttp -55.67 -55.77 28.3 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 115.309 1.596 . . . . 1.0 115.309 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -116.13 -56.86 2.27 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 113.474 -1.693 . . . . 1.0 113.033 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.73 39.88 0.28 Allowed Glycine 0 N--CA 1.491 2.322 0 O-C-N 123.812 0.695 . . . . 1.0 111.623 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 5.5 mppt? -129.29 91.37 41.97 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 105.551 -2.018 . . . . 1.0 105.551 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -64.63 3.58 0.84 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 123.045 2.497 . . . . 1.0 113.981 -165.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.51 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 55.4 m-80 -111.62 -178.05 3.34 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.499 -1.667 . . . . 1.0 106.499 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.61 -176.03 23.98 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.269 -1.443 . . . . 1.0 114.745 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.605 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 28.5 mtpp -131.64 177.1 7.77 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 113.138 -1.531 . . . . 1.0 111.927 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.0 t -119.26 152.28 36.95 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 179.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.8 mtm -131.76 80.11 1.91 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.079 -0.964 . . . . 1.0 108.627 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.2 t30 28.73 52.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 125.586 1.804 . . . . 1.0 111.919 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.59 -31.4 4.18 Favored Glycine 0 N--CA 1.485 1.965 0 CA-C-O 116.405 -2.33 . . . . 1.0 116.912 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -115.88 141.17 48.46 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 120.795 2.297 . . . . 1.0 109.32 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.465 ' SG ' HG21 ' A' ' 3' ' ' THR . 33.1 t -71.87 160.64 32.22 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.652 -1.613 . . . . 1.0 113.517 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.557 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.2 tpt180 -133.61 146.75 51.23 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.431 -2.063 . . . . 1.0 105.431 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.3 m -117.61 164.82 14.37 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.248 -1.019 . . . . 1.0 108.248 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.605 ' CZ ' ' HG3' ' A' ' 27' ' ' LYS . 13.8 m-85 -117.63 -178.01 3.38 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.295 -1.32 . . . . 1.0 107.572 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.496 1.86 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 -179.962 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.4 p90 . . . . . 0 C--O 1.216 -0.692 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.466 HG21 ' SG ' ' A' ' 33' ' ' CYS . 79.7 p -127.89 -173.46 2.94 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.052 0.845 . . . . 1.0 112.297 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -124.17 -7.45 7.68 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 113.403 -1.726 . . . . 1.0 110.273 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.4 t -111.54 145.34 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.498 -0.927 . . . . 1.0 108.498 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 171.02 11.68 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 116.923 2.194 . . . . 1.0 116.923 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 p -141.2 173.11 11.8 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.175 -1.375 . . . . 1.0 110.478 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.2 m -121.49 -49.49 2.14 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.854 -2.276 . . . . 1.0 104.854 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.19 169.59 33.22 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.542 -1.823 . . . . 1.0 108.542 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.6 t -43.54 -58.78 2.46 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.51 0.671 . . . . 1.0 110.521 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.26 -39.4 14.28 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 113.859 -1.519 . . . . 1.0 114.219 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -70.23 -32.66 70.62 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.066 0.936 . . . . 1.0 111.175 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 15.3 t -76.44 -12.32 60.03 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.949 -1.478 . . . . 1.0 113.111 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.414 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.9 m0 -66.78 -58.99 8.59 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 123.822 0.701 . . . . 1.0 109.462 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 85.3 Cg_endo -63.31 -42.88 20.32 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.883 2.389 . . . . 1.0 110.681 175.316 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 50.9 t -55.78 -46.45 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 C-N-CA 120.104 -0.638 . . . . 1.0 110.398 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.8 t -68.97 -42.55 76.46 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -50.48 -42.69 54.86 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.252 1.025 . . . . 1.0 108.534 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -70.65 -51.37 28.3 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.691 -1.595 . . . . 1.0 112.741 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.4 ttp -58.31 -52.41 65.7 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.026 1.121 . . . . 1.0 114.026 -179.258 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -116.86 -58.03 2.11 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.484 -1.235 . . . . 1.0 114.083 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.93 40.67 0.19 Allowed Glycine 0 N--CA 1.488 2.125 0 O-C-N 123.774 0.671 . . . . 1.0 112.501 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -127.79 103.31 21.67 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 105.694 -1.965 . . . . 1.0 105.694 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.71 10.08 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.993 2.462 . . . . 1.0 113.002 -168.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.414 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 73.5 m-80 -116.03 -176.3 2.92 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.954 -1.498 . . . . 1.0 106.954 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.419 ' HA2' ' CD1' ' A' ' 36' ' ' TYR . . . 143.44 175.98 17.05 Favored Glycine 0 N--CA 1.489 2.175 0 CA-C-N 113.994 -1.457 . . . . 1.0 113.069 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.474 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 51.8 mtpt -133.0 178.73 6.66 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 113.061 -1.57 . . . . 1.0 109.466 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -114.77 155.55 26.5 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.961 -1.496 . . . . 1.0 106.961 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 48.4 mtp -132.5 74.96 1.6 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.292 -1.373 . . . . 1.0 107.292 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 31.13 54.52 0.21 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 125.375 1.672 . . . . 1.0 110.995 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.88 -29.8 5.7 Favored Glycine 0 N--CA 1.487 2.07 0 CA-C-O 116.829 -2.095 . . . . 1.0 116.469 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 7.1 mptt -113.73 142.5 45.96 Favored 'General case' 0 C--O 1.206 -1.207 0 CA-C-N 120.387 2.093 . . . . 1.0 108.446 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.466 ' SG ' HG21 ' A' ' 3' ' ' THR . 36.4 t -71.55 160.82 32.02 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.574 -1.194 . . . . 1.0 113.216 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.581 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 5.3 tpt180 -131.6 140.12 49.34 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.274 -2.121 . . . . 1.0 105.274 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.7 m -111.74 161.55 16.18 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.116 0.96 . . . . 1.0 110.13 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.419 ' CD1' ' HA2' ' A' ' 26' ' ' GLY . 7.2 m-30 -115.88 -168.99 1.51 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 111.939 -2.391 . . . . 1.0 106.816 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 107.509 -1.293 . . . . 1.0 107.509 -179.816 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 C--O 1.216 -0.693 0 N-CA-C 107.188 -1.412 . . . . 1.0 107.188 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.6 p -131.47 174.01 10.52 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 123.641 0.588 . . . . 1.0 110.72 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -125.3 32.51 5.35 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.571 -1.27 . . . . 1.0 107.571 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.1 p -111.29 134.95 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.151 -1.425 . . . . 1.0 107.151 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -70.67 140.7 51.58 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 113.454 0.909 . . . . 1.0 113.454 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.426 ' SG ' ' C ' ' A' ' 32' ' ' LYS . 2.5 p -136.21 170.41 16.06 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.063 0.935 . . . . 1.0 111.909 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.4 m -130.25 -43.19 1.18 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 112.384 -2.189 . . . . 1.0 108.516 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.19 172.08 21.59 Favored Glycine 0 N--CA 1.497 2.742 0 O-C-N 124.431 1.082 . . . . 1.0 112.411 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.1 p -70.1 -57.66 4.7 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.461 -0.869 . . . . 1.0 112.838 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -39.86 -32.79 0.17 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.82 -36.64 73.02 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 122.228 1.013 . . . . 1.0 111.031 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 41.8 t -73.6 -10.13 59.39 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.467 -1.242 . . . . 1.0 111.574 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.444 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 9.8 m95 -69.94 -61.04 3.16 Favored Pre-proline 0 N--CA 1.484 1.231 0 CA-C-O 118.462 -0.78 . . . . 1.0 110.104 179.366 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.444 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 81.8 Cg_endo -63.04 -40.42 34.05 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.771 2.314 . . . . 1.0 109.752 177.088 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.8 t -58.83 -49.77 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 123.837 0.71 . . . . 1.0 110.356 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.9 t -68.96 -34.63 75.64 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 118.946 -1.102 . . . . 1.0 109.295 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.08 -38.74 89.98 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -70.44 -52.36 22.76 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.642 -1.163 . . . . 1.0 111.035 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 73.1 mtm -61.35 -52.11 66.01 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.629 0.974 . . . . 1.0 113.629 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -111.26 -62.48 1.54 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 113.93 1.085 . . . . 1.0 113.93 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.41 43.68 0.42 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 106.922 -2.471 . . . . 1.0 106.922 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -127.82 81.94 69.33 Favored Pre-proline 0 N--CA 1.493 1.718 0 CA-C-N 113.496 -1.352 . . . . 1.0 107.584 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.7 0.18 3.23 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 123.684 2.923 . . . . 1.0 116.266 -150.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 47.0 m-80 -103.94 129.25 51.47 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 104.771 -2.307 . . . . 1.0 104.771 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 14' ' ' TRP . . . -146.82 145.86 15.14 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-N 113.958 -1.474 . . . . 1.0 110.815 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -131.46 170.51 14.59 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 106.869 -1.53 . . . . 1.0 106.869 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.3 t -107.09 150.61 26.37 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.898 -0.721 . . . . 1.0 110.691 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.3 ptm -129.18 102.77 6.61 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.916 -1.493 . . . . 1.0 108.566 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.7 p30 31.69 44.34 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 113.641 -1.618 . . . . 1.0 114.194 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.94 -28.57 6.34 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 118.592 2.197 . . . . 1.0 118.592 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 35.3 mmtp -114.99 156.64 24.72 Favored 'General case' 0 C--O 1.202 -1.419 0 CA-C-N 120.87 2.335 . . . . 1.0 111.44 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.8 t -71.87 160.27 32.86 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.155 0.978 . . . . 1.0 111.0 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.447 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.3 tpt180 -136.26 140.45 43.45 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 105.93 -1.878 . . . . 1.0 105.93 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.9 m -109.39 164.01 12.88 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.437 1.113 . . . . 1.0 113.242 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.479 ' HB2' ' HB2' ' A' ' 25' ' ' ASN . 42.9 m-85 -128.16 -160.45 1.02 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 111.931 -2.395 . . . . 1.0 108.287 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.487 1.414 0 O-C-N 125.029 1.456 . . . . 1.0 107.756 179.898 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.2 p90 . . . . . 0 C--O 1.216 -0.7 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.516 HG21 ' SG ' ' A' ' 33' ' ' CYS . 58.9 p -127.3 -175.41 3.43 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.71 0.767 . . . . 1.0 112.803 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -124.22 -7.21 7.66 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.05 -1.886 . . . . 1.0 110.153 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.7 t -111.64 144.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.35 170.99 11.99 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 116.515 2.042 . . . . 1.0 116.515 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.3 p -141.23 173.03 11.88 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.225 -1.352 . . . . 1.0 110.493 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.9 m -121.3 -49.51 2.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 104.758 -2.312 . . . . 1.0 104.758 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.13 169.51 33.18 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 108.625 -1.79 . . . . 1.0 108.625 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.1 t -43.29 -58.58 2.47 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.541 0.686 . . . . 1.0 110.51 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.93 -39.24 11.91 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 113.958 -1.474 . . . . 1.0 114.447 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -70.3 -33.1 71.13 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.233 1.016 . . . . 1.0 111.174 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.573 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 19.2 t -76.56 -11.55 59.89 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 113.747 -1.57 . . . . 1.0 113.075 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.413 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 7.0 m0 -67.49 -58.53 8.44 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 123.75 0.656 . . . . 1.0 109.52 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 84.6 Cg_endo -63.38 -43.07 19.23 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.816 2.344 . . . . 1.0 110.686 174.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -55.49 -47.27 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 119.844 -0.742 . . . . 1.0 110.216 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.0 t -67.75 -42.45 81.76 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.372 -0.931 . . . . 1.0 108.805 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -50.13 -42.85 51.41 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.342 1.067 . . . . 1.0 108.347 179.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -70.54 -46.25 63.93 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 113.648 -1.614 . . . . 1.0 111.151 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.4 ttp -54.03 -56.7 15.49 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 123.957 0.785 . . . . 1.0 112.641 -179.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -121.87 -57.02 1.82 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 113.385 -1.734 . . . . 1.0 114.021 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.95 43.41 0.11 Allowed Glycine 0 N--CA 1.488 2.122 0 O-C-N 124.045 0.841 . . . . 1.0 111.517 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -126.22 98.93 31.83 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 105.065 -2.198 . . . . 1.0 105.065 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.09 11.96 0.4 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 123.091 2.528 . . . . 1.0 113.218 -167.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.413 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 73.4 m-80 -116.36 -176.2 2.91 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.73 -1.581 . . . . 1.0 106.73 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' A' ' 36' ' ' TYR . . . 144.75 175.92 18.31 Favored Glycine 0 N--CA 1.49 2.254 0 CA-C-N 113.991 -1.459 . . . . 1.0 112.734 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.461 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 52.0 mtpt -133.33 177.81 7.4 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 113.165 -1.517 . . . . 1.0 109.001 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.3 t -114.89 155.99 25.83 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.769 -1.567 . . . . 1.0 106.769 179.446 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 48.8 mtp -133.01 75.17 1.61 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.29 -1.374 . . . . 1.0 107.29 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 30.95 54.44 0.19 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 125.321 1.638 . . . . 1.0 111.202 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.11 -29.69 5.68 Favored Glycine 0 N--CA 1.483 1.833 0 CA-C-O 116.916 -2.046 . . . . 1.0 116.438 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 7.1 mptt -113.97 142.49 46.09 Favored 'General case' 0 C--O 1.206 -1.218 0 CA-C-N 120.331 2.066 . . . . 1.0 108.194 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.516 ' SG ' HG21 ' A' ' 3' ' ' THR . 35.5 t -71.65 161.74 30.53 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.482 -1.236 . . . . 1.0 113.137 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.573 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 5.9 tpt180 -132.69 139.96 47.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.555 -2.017 . . . . 1.0 105.555 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.5 m -111.18 161.02 16.4 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.426 1.108 . . . . 1.0 110.778 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' CD1' ' HA2' ' A' ' 26' ' ' GLY . 6.2 m-30 -116.66 -169.0 1.55 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 111.318 -2.674 . . . . 1.0 106.722 -179.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 107.624 -1.25 . . . . 1.0 107.624 -179.863 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 35.6 p90 . . . . . 0 C--O 1.216 -0.678 0 CA-C-O 121.421 0.629 . . . . 1.0 111.088 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.9 p -132.45 171.35 13.88 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.639 -1.619 . . . . 1.0 110.687 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.58 48.79 1.03 Allowed 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.6 t -111.04 119.42 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.063 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 75.8 mmtt -39.65 113.13 0.31 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.655 -1.611 . . . . 1.0 115.272 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.4 p -123.24 171.48 9.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.257 0.973 . . . . 1.0 111.149 179.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.1 p -126.18 -43.17 1.81 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 112.595 -2.093 . . . . 1.0 108.495 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.49 169.17 29.76 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 124.44 1.087 . . . . 1.0 112.29 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.9 t -54.67 -62.63 1.53 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.454 -0.873 . . . . 1.0 111.576 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -42.7 -40.13 2.67 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 115.126 1.528 . . . . 1.0 115.126 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -57.88 -31.23 66.52 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.156 0.979 . . . . 1.0 112.974 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.413 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 22.9 m -81.21 -3.84 53.56 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.04 -1.437 . . . . 1.0 113.553 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.544 ' CG ' ' HA ' ' A' ' 25' ' ' ASN . 11.5 m0 -70.31 -59.0 4.4 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 107.826 -1.176 . . . . 1.0 107.826 179.262 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.464 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 83.6 Cg_endo -65.69 -46.45 5.15 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 122.735 2.29 . . . . 1.0 111.515 174.115 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 95.8 t -56.87 -44.69 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 119.276 -0.969 . . . . 1.0 110.306 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 51.8 t -68.45 -45.01 73.61 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.692 -1.203 . . . . 1.0 108.627 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -46.89 -43.18 18.61 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 107.591 -1.263 . . . . 1.0 107.591 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -70.76 -45.33 64.97 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 112.941 -1.936 . . . . 1.0 112.719 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.9 mtm -63.45 -57.96 8.59 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.678 1.362 . . . . 1.0 114.678 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -111.88 -56.34 2.4 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.387 -1.279 . . . . 1.0 113.252 -179.408 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.16 39.47 0.38 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.452 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 14.0 mptt -119.01 97.0 50.62 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 102.691 -3.078 . . . . 1.0 102.691 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -64.91 -3.48 7.07 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 123.367 2.711 . . . . 1.0 113.346 -156.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.59 HD22 ' H ' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -122.25 165.68 15.81 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 124.438 1.086 . . . . 1.0 109.079 179.923 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.0 168.72 41.43 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.336 -0.935 . . . . 1.0 112.444 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.656 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 27.8 mtpp -121.85 -176.64 3.38 Favored 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 115.014 -0.593 . . . . 1.0 109.575 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.8 t -127.26 156.32 42.09 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 106.263 -1.754 . . . . 1.0 106.263 179.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 71.4 mtm -136.15 77.18 1.64 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.016 -1.476 . . . . 1.0 107.016 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.1 t30 30.36 53.43 0.14 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 125.271 1.607 . . . . 1.0 111.341 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 125.13 -35.52 3.08 Favored Glycine 0 N--CA 1.486 2.03 0 CA-C-N 113.159 -1.837 . . . . 1.0 115.637 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HD3' ' N ' ' A' ' 32' ' ' LYS . 1.7 mppt? -109.48 139.78 44.04 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 119.948 1.874 . . . . 1.0 109.907 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 46.1 t -71.94 160.56 32.32 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 112.917 -1.947 . . . . 1.0 116.013 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.453 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 9.1 tpt180 -139.29 155.41 47.75 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.017 -1.447 . . . . 1.0 107.773 179.71 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.9 m -126.71 166.14 17.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.992 -2.225 . . . . 1.0 104.992 179.327 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.656 ' CZ ' ' HG3' ' A' ' 27' ' ' LYS . 89.4 m-85 -113.26 177.37 4.65 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.752 -1.203 . . . . 1.0 107.752 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.9 m . . . . . 0 N--CA 1.501 2.077 0 CA-C-O 117.404 -1.284 . . . . 1.0 111.342 179.942 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.209 -1.063 0 N-CA-C 113.348 0.87 . . . . 1.0 113.348 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -99.31 168.5 9.98 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.624 -1.171 . . . . 1.0 110.373 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.4 p -130.54 172.56 11.78 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.826 -1.079 . . . . 1.0 110.105 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -126.3 28.3 6.04 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.245 0.965 . . . . 1.0 109.061 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 p -115.79 155.11 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 115.152 -0.931 . . . . 1.0 109.895 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -70.8 131.95 44.59 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.508 -0.769 . . . . 1.0 112.83 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.3 p -123.55 160.31 27.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.944 0.777 . . . . 1.0 109.018 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 81.4 p -132.77 40.09 3.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.608 0.718 . . . . 1.0 110.15 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.3 163.17 13.86 Favored Glycine 0 N--CA 1.494 2.534 0 CA-C-N 114.092 -1.413 . . . . 1.0 109.8 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.4 p -43.71 -49.9 7.74 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 114.385 -0.907 . . . . 1.0 113.332 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -45.95 -50.09 15.07 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 115.102 -0.954 . . . . 1.0 113.002 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -70.99 -29.3 65.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.056 0.848 . . . . 1.0 110.692 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 26.3 t -73.97 -23.15 59.44 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.777 -1.101 . . . . 1.0 112.678 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.409 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 7.1 m0 -62.89 -58.83 14.57 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-O 118.591 -0.718 . . . . 1.0 111.949 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 90.5 Cg_endo -64.01 -41.4 23.02 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 123.121 2.548 . . . . 1.0 109.801 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.12 -45.63 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 123.96 0.788 . . . . 1.0 110.26 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 42.4 t -70.0 -43.8 70.65 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.841 -1.17 . . . . 1.0 107.841 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -48.38 -43.44 33.82 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 122.415 1.103 . . . . 1.0 108.405 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -70.82 -52.62 19.32 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 113.048 -1.887 . . . . 1.0 113.902 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 84.0 mtp -64.6 -55.97 16.92 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 115.015 1.487 . . . . 1.0 115.015 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -108.86 -57.38 2.15 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.403 1.064 . . . . 1.0 113.034 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.3 35.49 0.66 Allowed Glycine 0 N--CA 1.495 2.587 0 O-C-N 123.857 0.723 . . . . 1.0 111.332 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.548 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 13.1 mptt -122.28 90.84 49.22 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 104.484 -2.413 . . . . 1.0 104.484 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.09 -3.47 7.28 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 123.227 2.618 . . . . 1.0 113.366 -160.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.403 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 69.9 m-80 -105.09 -175.93 2.93 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.032 -1.47 . . . . 1.0 107.032 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.66 -178.74 19.14 Favored Glycine 0 N--CA 1.489 2.174 0 CA-C-N 114.0 -1.454 . . . . 1.0 113.224 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -139.66 167.58 21.78 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.751 -1.225 . . . . 1.0 111.281 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 39.0 t -108.61 147.78 31.33 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.807 -0.812 . . . . 1.0 108.807 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.9 ptm -136.54 108.47 7.13 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 123.786 0.679 . . . . 1.0 110.314 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.2 t30 31.2 46.13 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.188 -1.824 . . . . 1.0 113.027 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.34 -30.42 6.02 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 119.29 2.476 . . . . 1.0 119.29 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -118.2 146.89 43.89 Favored 'General case' 0 C--O 1.205 -1.247 0 CA-C-N 120.56 2.18 . . . . 1.0 112.911 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.3 t -72.52 156.47 38.98 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 112.853 -1.976 . . . . 1.0 112.728 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.46 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 10.0 tpt180 -133.1 142.66 48.83 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 112.175 -2.284 . . . . 1.0 105.516 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.0 m -109.42 166.31 10.97 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 124.231 0.957 . . . . 1.0 109.669 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -118.37 -178.57 3.55 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 114.386 -1.279 . . . . 1.0 108.923 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 117.537 -1.22 . . . . 1.0 111.127 179.946 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -94.19 156.51 16.51 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.965 0.728 . . . . 1.0 112.965 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 59.4 p -132.25 166.3 22.18 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 113.872 -1.513 . . . . 1.0 108.416 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -123.62 45.75 2.38 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.885 0.85 . . . . 1.0 109.161 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -104.78 153.17 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 114.411 -1.268 . . . . 1.0 108.975 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -70.63 117.92 12.76 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.248 1.944 . . . . 1.0 116.248 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.8 p -127.33 172.93 10.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 124.156 0.91 . . . . 1.0 109.098 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.4 m -124.11 -44.93 2.01 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 112.961 -1.927 . . . . 1.0 106.956 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.57 169.76 32.88 Favored Glycine 0 N--CA 1.494 2.555 0 CA-C-N 114.831 -1.077 . . . . 1.0 111.73 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 42.5 t -43.75 -57.4 3.25 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.195 -1.002 . . . . 1.0 112.076 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -41.88 -42.27 2.67 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 114.284 -1.326 . . . . 1.0 113.704 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -70.51 -41.11 73.03 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.658 1.218 . . . . 1.0 111.419 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 41.3 t -71.35 -23.53 61.93 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 113.137 -1.847 . . . . 1.0 112.309 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.452 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.2 m0 -59.15 -60.62 9.97 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 123.918 0.761 . . . . 1.0 111.876 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -63.77 -43.09 17.53 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.152 2.568 . . . . 1.0 109.738 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.77 -42.73 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 123.864 0.728 . . . . 1.0 109.966 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 51.4 m -70.27 -43.86 69.6 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -50.36 -42.24 52.85 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.333 1.063 . . . . 1.0 108.544 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -70.89 -56.39 6.36 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 113.539 -1.664 . . . . 1.0 113.42 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.7 ttm -59.19 -56.15 25.87 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 115.075 1.509 . . . . 1.0 115.075 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -106.36 -58.98 1.85 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 113.461 -1.699 . . . . 1.0 114.011 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.59 45.88 0.26 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 106.383 -2.687 . . . . 1.0 106.383 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -128.72 88.66 51.41 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 106.132 -1.803 . . . . 1.0 106.132 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -62.16 2.39 0.65 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.318 2.012 . . . . 1.0 113.67 -173.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.452 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 8.0 m120 -113.49 -174.74 2.52 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.96 -179.08 18.38 Favored Glycine 0 N--CA 1.489 2.216 0 CA-C-N 113.659 -1.609 . . . . 1.0 110.734 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -140.96 167.92 21.04 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.863 -0.668 . . . . 1.0 110.539 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.5 t -107.75 157.49 18.08 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.52 -0.918 . . . . 1.0 108.52 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.7 mtp -132.05 81.91 1.99 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.783 -1.191 . . . . 1.0 107.783 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.1 t30 29.34 53.94 0.11 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 125.534 1.771 . . . . 1.0 111.519 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.36 -38.04 2.3 Favored Glycine 0 N--CA 1.479 1.543 0 CA-C-N 113.145 -1.843 . . . . 1.0 115.737 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -114.98 135.2 54.48 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-N 119.37 1.585 . . . . 1.0 112.711 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 15.2 t -72.07 157.61 37.47 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.796 -2.911 . . . . 1.0 114.828 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.532 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.4 tpt180 -138.11 143.49 40.41 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 112.365 -2.198 . . . . 1.0 105.938 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.6 m -119.4 160.71 21.8 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.718 -1.586 . . . . 1.0 106.718 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -110.88 -172.15 1.97 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.7 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 116.109 -1.9 . . . . 1.0 109.493 -179.702 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.907 0.384 . . . . 1.0 109.975 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -97.54 168.76 10.17 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.431 HG21 ' SG ' ' A' ' 33' ' ' CYS . 72.8 p -128.47 177.55 6.91 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 122.132 0.968 . . . . 1.0 113.146 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -112.98 -5.93 13.77 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 112.596 -2.093 . . . . 1.0 109.319 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.2 t -112.81 140.65 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.327 -0.99 . . . . 1.0 108.327 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 25.2 pttm -71.05 167.44 19.24 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.751 1.76 . . . . 1.0 115.751 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.9 p -138.54 176.04 9.04 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 124.61 1.194 . . . . 1.0 110.716 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.3 m -125.36 -49.31 1.68 Allowed 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.256 -2.247 . . . . 1.0 105.345 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.82 170.13 29.26 Favored Glycine 0 N--CA 1.493 2.495 0 CA-C-N 114.004 -1.453 . . . . 1.0 109.764 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.0 m -51.23 -54.94 20.92 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.382 0.611 . . . . 1.0 110.661 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -49.1 -39.95 30.19 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.659 -1.155 . . . . 1.0 113.161 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -70.39 -30.71 67.67 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.255 1.026 . . . . 1.0 110.849 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.578 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 6.0 t -76.98 -10.65 59.51 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 113.568 -1.651 . . . . 1.0 112.833 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 9.9 m0 -66.86 -58.48 9.49 Favored Pre-proline 0 N--CA 1.485 1.29 0 CA-C-O 118.873 -0.584 . . . . 1.0 109.523 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.09 -48.0 9.2 Favored 'Trans proline' 0 N--CA 1.486 1.081 0 C-N-CA 122.369 2.046 . . . . 1.0 110.096 173.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 60.5 t -51.33 -40.8 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 119.997 -0.681 . . . . 1.0 110.315 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 42.8 t -70.35 -49.43 49.35 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.775 -1.17 . . . . 1.0 107.999 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -47.77 -38.23 15.18 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.205 1.002 . . . . 1.0 109.425 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -70.24 -53.99 14.65 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.309 -1.769 . . . . 1.0 111.956 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 35.7 mmt -69.82 -55.31 10.15 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 115.98 1.844 . . . . 1.0 115.98 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -102.86 -53.58 2.82 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 123.77 0.669 . . . . 1.0 112.666 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.07 35.28 0.55 Allowed Glycine 0 N--CA 1.492 2.381 0 O-C-N 123.662 0.601 . . . . 1.0 113.281 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 2.9 mptp? -127.45 131.67 23.95 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -87.3 14.36 2.43 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 122.43 2.087 . . . . 1.0 110.511 -175.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.426 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 73.4 m-80 -119.54 -177.56 3.4 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.557 -1.275 . . . . 1.0 107.557 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.24 172.76 12.76 Favored Glycine 0 N--CA 1.488 2.135 0 CA-C-N 114.13 -1.395 . . . . 1.0 114.747 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.478 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 50.4 mtpt -130.35 177.81 7.06 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 112.158 -2.021 . . . . 1.0 110.719 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 t -116.35 151.79 35.21 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.375 -1.343 . . . . 1.0 107.375 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 70.8 mtm -130.69 83.75 2.14 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.114 -1.069 . . . . 1.0 108.114 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 27.84 50.35 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 125.54 1.775 . . . . 1.0 112.851 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 126.44 -31.4 4.01 Favored Glycine 0 N--CA 1.484 1.838 0 CA-C-O 116.012 -2.549 . . . . 1.0 117.532 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -116.94 145.98 43.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 121.356 2.578 . . . . 1.0 109.491 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.431 ' SG ' HG21 ' A' ' 3' ' ' THR . 16.7 t -71.7 157.98 36.96 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.581 -1.645 . . . . 1.0 113.791 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.578 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 17.8 tpt85 -128.96 140.18 51.77 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.366 -2.197 . . . . 1.0 105.692 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 69.8 m -111.6 163.49 14.04 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.146 -1.057 . . . . 1.0 108.146 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.472 ' OH ' ' HG3' ' A' ' 27' ' ' LYS . 12.7 m-30 -114.26 -176.86 2.99 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 113.717 -1.583 . . . . 1.0 108.201 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 116.162 -1.875 . . . . 1.0 108.893 -179.921 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . 0.476 ' CD ' ' HB2' ' A' ' 35' ' ' CYS . . . . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 112.29 0.478 . . . . 1.0 112.29 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -95.27 145.19 25.25 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.824 0.821 . . . . 1.0 113.143 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.7 p -132.18 163.47 28.48 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 113.045 -1.889 . . . . 1.0 108.158 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -126.65 52.26 1.77 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 124.003 0.814 . . . . 1.0 110.459 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -111.58 151.58 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 C-N-CA 120.001 -0.68 . . . . 1.0 109.352 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -70.21 103.17 2.27 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 114.968 1.47 . . . . 1.0 114.968 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.3 p -120.58 172.3 7.95 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.082 0.944 . . . . 1.0 109.909 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.6 t -126.22 -42.22 1.86 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 112.578 -2.101 . . . . 1.0 107.898 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.79 165.29 26.91 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 124.268 0.98 . . . . 1.0 111.542 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.0 m -47.88 -53.33 16.07 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.384 -0.908 . . . . 1.0 111.719 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' NZ ' HE22 ' A' ' 12' ' ' GLN . 10.4 mtmp? -45.19 -43.37 10.04 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.075 -1.42 . . . . 1.0 114.063 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.449 HE22 ' NZ ' ' A' ' 11' ' ' LYS . 14.4 mp0 -70.24 -32.52 70.41 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.893 0.854 . . . . 1.0 111.346 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 8.5 t -77.55 -11.5 59.86 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 113.742 -1.572 . . . . 1.0 112.331 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.446 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.0 m0 -67.6 -59.7 6.56 Favored Pre-proline 0 N--CA 1.49 1.57 0 CA-C-O 118.655 -0.688 . . . . 1.0 110.434 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -63.73 -46.98 7.82 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.59 2.194 . . . . 1.0 109.287 174.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 24.1 t -51.62 -42.08 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 123.802 0.689 . . . . 1.0 109.928 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 41.7 t -70.09 -46.05 65.69 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.31 -0.996 . . . . 1.0 108.31 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -46.76 -42.76 17.37 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.731 1.253 . . . . 1.0 108.188 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -70.62 -52.21 22.88 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 112.831 -1.986 . . . . 1.0 113.206 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -55.95 26.96 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 114.728 1.381 . . . . 1.0 114.728 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -110.82 -56.35 2.37 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.321 -1.309 . . . . 1.0 113.712 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.05 34.95 0.53 Allowed Glycine 0 N--CA 1.492 2.383 0 O-C-N 124.032 0.832 . . . . 1.0 111.132 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.471 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 13.1 mptt -124.84 99.18 35.51 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 104.292 -2.485 . . . . 1.0 104.292 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.6 14.16 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.737 2.291 . . . . 1.0 113.322 -169.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.446 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 17.9 p30 -117.03 -179.95 3.85 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.56 168.39 12.59 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.362 -1.399 . . . . 1.0 116.365 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 35.4 mtpt -123.83 171.03 9.96 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 112.55 -1.825 . . . . 1.0 109.531 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.1 t -118.42 158.57 25.06 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.539 -1.282 . . . . 1.0 107.539 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.7 mtp -134.91 79.11 1.77 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.38 -1.341 . . . . 1.0 107.38 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.6 p30 28.2 51.96 0.05 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 125.598 1.811 . . . . 1.0 112.573 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.11 -37.93 2.01 Favored Glycine 0 N--CA 1.484 1.856 0 CA-C-N 112.471 -2.149 . . . . 1.0 115.258 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -114.47 139.77 49.27 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 119.46 1.63 . . . . 1.0 112.143 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 36.0 t -71.92 159.98 33.32 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 111.721 -2.49 . . . . 1.0 115.027 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.561 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 14.2 tpt180 -135.94 145.37 46.16 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 112.543 -2.117 . . . . 1.0 105.543 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.476 ' HB2' ' CD ' ' A' ' 1' ' ' PCA . 71.0 m -124.04 163.02 22.27 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 106.086 -1.82 . . . . 1.0 106.086 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.486 ' OH ' ' HG3' ' A' ' 27' ' ' LYS . 4.5 m-85 -116.57 168.27 10.33 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 105.472 -2.047 . . . . 1.0 105.472 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 N--CA 1.507 2.42 0 N-CA-C 115.34 1.607 . . . . 1.0 115.34 -179.813 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.205 -1.267 0 N-CA-C 112.725 0.639 . . . . 1.0 112.725 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.86 162.09 14.52 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.101 0.953 . . . . 1.0 111.57 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.5 p -133.2 163.77 28.56 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 112.525 -2.125 . . . . 1.0 109.038 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -104.05 40.59 1.42 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.558 -0.746 . . . . 1.0 111.326 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -121.35 142.57 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 107.743 -1.206 . . . . 1.0 107.743 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 37.1 mtmm -70.72 146.44 49.86 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.412 1.634 . . . . 1.0 115.412 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.5 p -140.15 174.17 10.78 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.575 1.172 . . . . 1.0 109.807 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.5 p -122.86 -46.3 2.11 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.917 -1.947 . . . . 1.0 106.572 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.86 173.17 33.9 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.562 -1.415 . . . . 1.0 109.562 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.6 t -40.04 -59.36 1.24 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 124.521 0.777 . . . . 1.0 111.005 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -42.32 -42.32 3.1 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.061 -1.427 . . . . 1.0 113.973 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.36 -37.92 74.68 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 122.419 1.104 . . . . 1.0 110.005 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.612 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 10.1 t -71.51 -23.33 61.77 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.228 -1.351 . . . . 1.0 113.48 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.477 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.6 m0 -57.99 -60.62 9.46 Favored Pre-proline 0 CA--C 1.56 1.33 0 O-C-N 123.768 0.668 . . . . 1.0 111.324 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -62.38 -42.86 25.45 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 C-N-CA 122.738 2.292 . . . . 1.0 109.491 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 22.1 t -53.15 -44.44 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 123.803 0.689 . . . . 1.0 110.963 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 48.6 t -70.16 -44.76 68.16 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.948 -1.13 . . . . 1.0 107.948 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -48.49 -43.29 34.85 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 122.355 1.074 . . . . 1.0 108.494 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -70.86 -47.87 56.98 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 113.065 -1.879 . . . . 1.0 113.235 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 80.9 mmm -65.59 -60.2 3.16 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 114.879 1.436 . . . . 1.0 114.879 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -107.91 -56.27 2.26 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.246 -1.343 . . . . 1.0 112.855 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.18 34.83 0.61 Allowed Glycine 0 N--CA 1.493 2.485 0 O-C-N 123.92 0.762 . . . . 1.0 111.278 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 0.9 OUTLIER -121.05 86.69 42.68 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 104.563 -2.384 . . . . 1.0 104.563 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -64.49 3.18 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.141 2.561 . . . . 1.0 113.961 -163.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.477 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 66.8 m-80 -111.48 -177.53 3.22 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 105.898 -1.89 . . . . 1.0 105.898 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.23 -172.6 24.14 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.214 -1.47 . . . . 1.0 114.222 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.593 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 60.8 mtpt -132.56 171.7 13.46 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 113.421 -1.389 . . . . 1.0 112.219 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.8 t -111.23 156.12 21.94 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 105.619 -1.993 . . . . 1.0 105.619 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 59.5 mtp -134.25 83.53 2.04 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.825 -1.176 . . . . 1.0 107.825 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 27.99 54.21 0.07 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 125.815 1.947 . . . . 1.0 110.583 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 126.34 -40.48 1.8 Allowed Glycine 0 N--CA 1.484 1.849 0 CA-C-N 112.591 -2.095 . . . . 1.0 116.441 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -116.58 147.75 41.55 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 120.554 2.177 . . . . 1.0 112.656 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 35.0 t -71.84 155.46 40.39 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 110.853 -2.885 . . . . 1.0 116.223 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.612 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.2 tpt180 -130.14 144.47 51.37 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 111.099 -2.773 . . . . 1.0 105.54 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.9 m -115.24 163.89 15.01 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.563 -1.643 . . . . 1.0 106.563 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.593 ' CZ ' ' HG3' ' A' ' 27' ' ' LYS . 15.3 m-85 -113.19 -179.41 3.64 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.153 -1.055 . . . . 1.0 108.153 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.8 p . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 115.928 -1.987 . . . . 1.0 110.018 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 N-CA-C 112.036 0.384 . . . . 1.0 112.036 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -85.61 146.28 26.94 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 114.373 1.249 . . . . 1.0 114.373 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.3 p -132.63 171.9 13.23 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 112.901 -1.954 . . . . 1.0 109.045 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -122.99 51.54 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.992 -1.114 . . . . 1.0 107.992 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.2 t -112.67 128.72 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 115.126 -0.943 . . . . 1.0 111.418 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -39.76 102.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 118.478 2.77 . . . . 1.0 118.478 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.6 p -125.58 170.17 11.75 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.805 0.812 . . . . 1.0 109.672 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.9 t -121.98 -43.01 2.36 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 113.105 -1.861 . . . . 1.0 106.923 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.17 165.03 31.65 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.908 -1.277 . . . . 1.0 109.908 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.8 t -40.64 -59.52 1.35 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 124.727 0.898 . . . . 1.0 111.94 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -43.44 -43.39 5.26 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 113.819 -1.537 . . . . 1.0 114.618 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -70.59 -34.11 71.8 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.883 0.849 . . . . 1.0 111.121 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 7.3 t -76.24 -11.92 60.0 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.303 -1.317 . . . . 1.0 112.675 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.441 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 5.0 m0 -67.64 -58.21 8.77 Favored Pre-proline 0 N--CA 1.489 1.497 0 CA-C-O 118.605 -0.712 . . . . 1.0 110.166 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 77.0 Cg_endo -63.05 -43.1 20.52 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.936 2.424 . . . . 1.0 109.95 174.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 49.0 t -54.55 -45.05 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 119.835 -0.746 . . . . 1.0 109.829 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 54.1 t -70.13 -39.71 75.27 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.203 -1.036 . . . . 1.0 108.203 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -51.35 -43.94 61.93 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.51 1.148 . . . . 1.0 108.04 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -70.69 -57.18 4.95 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 113.663 -1.608 . . . . 1.0 113.122 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -55.25 -50.87 68.36 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 114.282 1.216 . . . . 1.0 114.282 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -112.06 -62.99 1.48 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.585 -1.643 . . . . 1.0 114.924 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.89 43.73 0.36 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 107.31 -2.316 . . . . 1.0 107.31 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 98.1 mttt -130.62 86.66 52.21 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 104.79 -2.3 . . . . 1.0 104.79 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.09 -2.66 5.98 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.55 2.833 . . . . 1.0 113.254 -160.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.441 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 71.9 m-80 -104.24 -176.77 3.17 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.152 -1.425 . . . . 1.0 107.152 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.26 -176.04 21.94 Favored Glycine 0 N--CA 1.493 2.44 0 CA-C-N 114.298 -1.319 . . . . 1.0 113.259 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 53.2 mtpt -135.58 179.28 6.43 Favored 'General case' 0 N--CA 1.505 2.275 0 CA-C-N 113.903 -1.148 . . . . 1.0 112.001 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.5 t -121.68 157.51 30.74 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.243 -1.021 . . . . 1.0 108.243 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 63.5 mtm -135.01 73.51 1.48 Allowed 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.312 -1.366 . . . . 1.0 107.312 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.1 t30 28.22 55.36 0.09 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 125.669 1.856 . . . . 1.0 111.215 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.89 -37.57 2.13 Favored Glycine 0 N--CA 1.484 1.878 0 CA-C-N 112.308 -2.224 . . . . 1.0 114.687 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -111.91 137.64 49.61 Favored 'General case' 0 C--O 1.204 -1.309 0 CA-C-N 118.985 1.393 . . . . 1.0 111.607 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 45.1 t -72.13 159.6 33.86 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 112.127 -2.306 . . . . 1.0 113.449 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.563 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.6 tpt180 -135.85 147.44 48.24 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 105.426 -2.065 . . . . 1.0 105.426 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.9 m -122.3 162.36 21.63 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.059 -1.46 . . . . 1.0 107.059 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.47 ' OH ' ' HG3' ' A' ' 27' ' ' LYS . 16.2 m-30 -115.8 -179.03 3.53 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.4 -2.074 . . . . 1.0 105.4 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.501 2.113 0 N-CA-C 115.639 1.718 . . . . 1.0 115.639 -179.639 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.205 -1.276 0 CA-C-O 120.502 0.191 . . . . 1.0 111.314 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -104.05 157.2 17.27 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 122.899 1.333 . . . . 1.0 113.313 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.3 p -133.11 160.6 36.75 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 110.902 -2.863 . . . . 1.0 107.776 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -116.06 50.4 1.04 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.063 0.852 . . . . 1.0 109.207 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.9 t -108.17 145.82 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 105.268 -2.123 . . . . 1.0 105.268 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -70.2 135.72 49.34 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.254 0.835 . . . . 1.0 113.254 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.565 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 6.0 p -130.15 160.0 35.12 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 124.887 1.367 . . . . 1.0 113.083 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.8 t -136.62 44.13 2.39 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.912 -1.494 . . . . 1.0 108.429 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.9 167.27 13.06 Favored Glycine 0 N--CA 1.495 2.606 0 CA-C-N 113.589 -1.641 . . . . 1.0 110.454 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.2 t -47.12 -62.78 1.26 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.421 0.897 . . . . 1.0 113.421 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.478 ' HD3' ' H ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -39.49 -29.18 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.262 1.949 . . . . 1.0 116.262 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.478 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 3.5 tm0? -70.62 -40.14 73.32 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 122.658 1.218 . . . . 1.0 111.398 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 70.5 m -78.4 -7.55 57.48 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.393 -1.73 . . . . 1.0 113.583 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.403 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 8.1 m95 -70.18 -57.96 5.51 Favored Pre-proline 0 C--N 1.305 -1.34 0 O-C-N 124.147 0.905 . . . . 1.0 109.34 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 98.8 Cg_endo -64.44 -45.27 9.6 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 C-N-CA 122.793 2.329 . . . . 1.0 110.343 174.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 54.6 t -55.84 -46.05 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 119.371 -0.932 . . . . 1.0 110.775 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 52.8 t -68.51 -43.26 77.2 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.938 -1.105 . . . . 1.0 109.252 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -50.36 -42.36 53.03 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -70.83 -49.23 48.56 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 113.635 -1.621 . . . . 1.0 112.971 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.2 mmm -62.93 -56.5 16.68 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.979 1.103 . . . . 1.0 113.979 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -110.82 -59.78 1.91 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.725 -1.125 . . . . 1.0 112.492 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.51 43.99 0.44 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 106.486 -2.646 . . . . 1.0 106.486 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.425 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 94.4 mttt -126.73 78.22 73.31 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 105.265 -2.124 . . . . 1.0 105.265 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -62.18 -3.48 4.04 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 123.487 2.791 . . . . 1.0 114.92 -154.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -107.11 121.25 44.11 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 104.183 -2.525 . . . . 1.0 104.183 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.16 161.7 27.88 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.788 -1.725 . . . . 1.0 108.788 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HE2' ' CE2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -127.74 176.61 7.41 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.204 -1.776 . . . . 1.0 106.204 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.1 t -109.68 161.64 15.2 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.399 -0.521 . . . . 1.0 111.027 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 64.1 mtp -136.2 88.2 2.37 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.214 -1.772 . . . . 1.0 106.214 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.1 p30 30.99 48.64 0.07 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 125.121 1.513 . . . . 1.0 113.501 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.78 -35.86 3.16 Favored Glycine 0 N--CA 1.491 2.312 0 CA-C-N 113.302 -1.772 . . . . 1.0 116.504 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.67 147.65 40.6 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-N 120.108 1.954 . . . . 1.0 110.885 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 33.8 m -72.03 154.58 41.06 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 110.722 -2.944 . . . . 1.0 118.817 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.42 ' HB3' ' HG2' ' A' ' 27' ' ' LYS . 8.1 tpt180 -137.6 153.67 49.88 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 111.944 -2.389 . . . . 1.0 105.653 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.414 ' C ' ' HZ1' ' A' ' 27' ' ' LYS . 89.4 m -118.68 157.27 27.77 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 124.178 0.924 . . . . 1.0 110.678 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.523 ' CE2' ' HE2' ' A' ' 27' ' ' LYS . 49.7 m-85 -110.1 -175.86 2.84 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.042 -1.89 . . . . 1.0 108.08 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 t . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 115.852 -2.023 . . . . 1.0 108.944 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.187 0 N-CA-C 112.209 0.448 . . . . 1.0 112.209 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -101.81 157.46 16.83 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 122.613 1.197 . . . . 1.0 111.598 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.3 p -147.16 166.01 28.26 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 111.702 -2.499 . . . . 1.0 109.42 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -123.57 52.47 1.42 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.463 HG21 ' SD ' ' A' ' 20' ' ' MET . 62.4 t -108.09 141.17 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-N 114.614 -1.176 . . . . 1.0 108.64 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.43 ' H ' ' HE2' ' A' ' 6' ' ' LYS . 2.0 mppt? -70.27 105.45 2.98 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 114.161 -1.382 . . . . 1.0 113.889 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.9 p -119.72 170.87 8.82 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.587 -1.188 . . . . 1.0 111.513 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -128.19 -40.81 1.63 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 112.46 -2.155 . . . . 1.0 109.064 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.1 171.3 23.16 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 124.375 1.047 . . . . 1.0 112.368 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.7 m -70.14 -58.2 4.07 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.193 -1.003 . . . . 1.0 112.355 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -44.12 -33.14 1.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.341 1.237 . . . . 1.0 114.341 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -70.19 -34.81 73.4 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.269 1.033 . . . . 1.0 111.646 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.405 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 5.5 t -77.72 -6.21 53.19 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.413 -1.721 . . . . 1.0 112.014 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.429 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 9.4 m0 -69.03 -59.96 4.76 Favored Pre-proline 0 N--CA 1.484 1.25 0 CA-C-O 118.757 -0.639 . . . . 1.0 109.456 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 94.6 Cg_endo -64.22 -46.51 7.76 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 C-N-CA 122.325 2.017 . . . . 1.0 110.421 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 70.0 t -54.29 -44.1 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.965 -0.694 . . . . 1.0 110.758 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 47.2 t -69.9 -46.22 65.9 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.381 -1.328 . . . . 1.0 107.768 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -48.92 -39.79 27.54 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 122.116 0.96 . . . . 1.0 108.987 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.15 -50.74 37.46 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.676 -1.602 . . . . 1.0 112.007 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.463 ' SD ' HG21 ' A' ' 5' ' ' VAL . 66.0 mtm -66.38 -57.45 7.41 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 115.57 1.692 . . . . 1.0 115.57 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -103.52 -55.31 2.42 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.787 -1.097 . . . . 1.0 113.76 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.14 41.14 0.31 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.333 -1.107 . . . . 1.0 110.333 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 75.1 mmtt -125.83 121.08 24.32 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 105.008 -2.219 . . . . 1.0 105.008 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -82.41 11.83 3.06 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.114 1.876 . . . . 1.0 110.685 -173.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -117.29 -176.86 3.09 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.385 -1.339 . . . . 1.0 107.385 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.04 143.45 3.99 Favored Glycine 0 N--CA 1.486 1.985 0 CA-C-N 113.605 -1.634 . . . . 1.0 111.47 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HG3' ' HB3' ' A' ' 34' ' ' ARG . 19.0 ptmt -123.73 172.75 8.61 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 113.569 -1.316 . . . . 1.0 107.774 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.7 t -115.61 159.72 20.93 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.699 -0.8 . . . . 1.0 110.83 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 73.2 mtm -131.01 78.47 1.84 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.41 -1.723 . . . . 1.0 107.42 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 28.48 55.63 0.1 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 125.875 1.985 . . . . 1.0 110.743 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.32 -37.14 2.52 Favored Glycine 0 N--CA 1.485 1.956 0 CA-C-N 112.586 -2.097 . . . . 1.0 115.951 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -110.66 139.65 45.75 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 119.729 1.765 . . . . 1.0 111.793 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.64 157.13 38.51 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.473 -2.148 . . . . 1.0 113.845 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.49 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 18.7 tpt85 -138.32 145.91 41.76 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 102.753 -3.054 . . . . 1.0 102.753 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -120.19 167.51 12.18 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.251 -1.018 . . . . 1.0 108.251 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -118.69 -179.0 3.67 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.096 -1.411 . . . . 1.0 108.353 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 116.389 -1.767 . . . . 1.0 109.503 -179.776 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.642 0.258 . . . . 1.0 110.925 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -106.66 160.43 15.46 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 123.032 0.533 . . . . 1.0 111.114 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 p -138.31 171.97 13.59 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 114.743 -1.117 . . . . 1.0 110.137 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -131.64 40.33 3.4 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.4 -1.333 . . . . 1.0 107.4 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.9 p -114.72 155.93 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 115.122 -0.945 . . . . 1.0 110.298 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.812 ' H ' ' HZ2' ' A' ' 6' ' ' LYS . 0.2 OUTLIER -71.32 131.18 43.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 123.587 0.554 . . . . 1.0 110.207 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.475 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 30.8 p -127.6 157.33 40.5 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 120.219 -0.593 . . . . 1.0 110.741 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -137.06 42.0 2.44 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.613 -1.176 . . . . 1.0 109.646 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.75 159.88 11.24 Favored Glycine 0 N--CA 1.496 2.685 0 CA-C-N 114.293 -1.322 . . . . 1.0 111.442 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.7 p -47.35 -56.73 6.3 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.515 1.302 . . . . 1.0 114.515 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -39.69 -41.27 1.05 Allowed 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 114.291 1.219 . . . . 1.0 114.291 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -36.43 74.73 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.163 0.914 . . . . 1.0 111.394 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 73.0 m -73.26 -20.17 60.9 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.07 -0.968 . . . . 1.0 112.779 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.469 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 9.4 m0 -58.95 -62.47 5.73 Favored Pre-proline 0 CA--C 1.562 1.428 0 C-N-CA 120.321 -0.552 . . . . 1.0 110.911 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.414 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 84.7 Cg_endo -66.39 -49.84 1.65 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.883 2.389 . . . . 1.0 110.728 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 71.8 t -50.29 -42.52 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 123.648 0.593 . . . . 1.0 110.081 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 50.3 t -70.16 -47.76 60.25 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.575 -1.269 . . . . 1.0 107.575 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.425 ' HZ1' ' HD3' ' A' ' 24' ' ' PRO . 1.6 tpmt? -46.88 -40.54 14.23 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 122.196 0.998 . . . . 1.0 108.542 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -70.4 -50.94 33.38 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 113.335 -1.757 . . . . 1.0 112.107 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 56.0 mtm -70.81 -57.84 4.23 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 115.452 1.649 . . . . 1.0 115.452 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -100.6 -56.02 2.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 123.916 0.76 . . . . 1.0 112.025 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.9 39.48 0.52 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.836 -1.305 . . . . 1.0 109.836 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.573 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 38.5 mmtm -122.5 105.69 35.86 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 104.922 -2.251 . . . . 1.0 104.922 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HD3' ' HZ1' ' A' ' 18' ' ' LYS . 66.4 Cg_endo -69.94 0.65 5.47 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.258 1.972 . . . . 1.0 111.811 -171.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.469 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 5.9 m120 -119.19 -174.5 2.73 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.63 179.39 18.71 Favored Glycine 0 N--CA 1.488 2.112 0 CA-C-N 113.522 -1.672 . . . . 1.0 111.243 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HG3' ' HB3' ' A' ' 34' ' ' ARG . 11.6 ptmm? -138.31 172.51 12.79 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 114.356 -0.922 . . . . 1.0 111.197 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.9 t -107.76 160.14 15.95 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.716 -0.846 . . . . 1.0 108.716 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 71.5 mtm -138.96 84.8 2.03 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 108.812 -0.81 . . . . 1.0 108.812 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 25.17 55.89 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 125.975 2.047 . . . . 1.0 110.903 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.74 -42.83 1.36 Allowed Glycine 0 N--CA 1.483 1.81 0 CA-C-N 111.806 -2.452 . . . . 1.0 116.145 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -121.64 149.41 43.23 Favored 'General case' 0 C--O 1.205 -1.279 0 CA-C-O 124.46 2.076 . . . . 1.0 112.584 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 10.9 m -72.33 157.95 36.72 Favored 'General case' 0 C--N 1.285 -2.205 1 CA-C-N 108.347 -4.024 . . . . 1.0 115.199 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.465 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 2.9 tpt180 -137.73 146.34 43.58 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 111.935 -2.393 . . . . 1.0 105.35 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.2 m -117.58 163.68 16.07 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.898 -1.519 . . . . 1.0 106.898 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -116.69 175.19 5.69 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.7 m . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 108.58 -0.896 . . . . 1.0 108.58 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.223 0 N-CA-C 110.82 -0.067 . . . . 1.0 110.82 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -107.79 159.12 16.75 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.538 0.685 . . . . 1.0 109.515 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.0 p -138.86 170.46 15.95 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 113.53 -1.668 . . . . 1.0 111.4 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -124.87 51.12 1.67 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.444 -1.317 . . . . 1.0 107.444 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.28 147.26 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 114.628 -1.169 . . . . 1.0 109.042 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.55 127.08 31.48 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.401 -0.818 . . . . 1.0 111.201 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.22 161.72 27.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 124.007 0.817 . . . . 1.0 111.227 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 t -135.61 42.06 2.69 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.612 -1.177 . . . . 1.0 109.403 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.66 166.52 13.34 Favored Glycine 0 N--CA 1.496 2.678 0 CA-C-N 114.061 -1.427 . . . . 1.0 111.605 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.6 t -53.71 -66.49 0.38 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 114.595 1.331 . . . . 1.0 114.595 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -39.14 -31.96 0.09 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.244 1.572 . . . . 1.0 115.244 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -70.4 -42.3 71.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 124.125 0.891 . . . . 1.0 112.439 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.465 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 4.4 t -89.38 7.79 34.04 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 117.923 -1.511 . . . . 1.0 112.978 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.464 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 2.5 m95 -70.3 -58.33 5.02 Favored Pre-proline 0 N--CA 1.482 1.171 0 N-CA-C 103.441 -2.8 . . . . 1.0 103.441 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 86.8 Cg_endo -65.37 -44.65 8.54 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 123.119 2.546 . . . . 1.0 112.429 172.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 90.7 t -58.73 -46.86 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 C-N-CA 117.633 -1.627 . . . . 1.0 110.041 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 53.2 t -64.76 -44.36 90.33 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.048 -1.061 . . . . 1.0 108.139 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -50.86 -40.17 55.55 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.287 1.042 . . . . 1.0 109.025 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -70.52 -45.78 64.88 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.894 -1.503 . . . . 1.0 111.446 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.4 mtp -61.44 -56.04 24.65 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 114.261 1.208 . . . . 1.0 114.261 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -113.39 -56.87 2.36 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.395 -1.275 . . . . 1.0 113.96 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.25 45.59 0.27 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 106.757 -2.537 . . . . 1.0 106.757 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 34.6 mmtp -125.85 89.69 51.89 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 106.053 -1.832 . . . . 1.0 106.053 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -65.57 -4.51 9.77 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.594 2.196 . . . . 1.0 113.246 -162.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -105.34 129.8 53.6 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 105.166 -2.161 . . . . 1.0 105.166 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.95 132.12 3.98 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.497 -1.841 . . . . 1.0 108.497 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -117.05 157.37 25.95 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 106.519 -1.66 . . . . 1.0 106.519 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -102.44 161.47 13.69 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.923 -0.711 . . . . 1.0 112.345 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.9 mtm -133.72 82.87 2.01 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.429 -1.714 . . . . 1.0 107.039 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 28.9 55.08 0.1 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 125.562 1.789 . . . . 1.0 111.197 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.91 -38.56 2.3 Favored Glycine 0 N--CA 1.481 1.648 0 CA-C-N 113.011 -1.904 . . . . 1.0 116.067 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -114.72 140.55 48.78 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 119.792 1.796 . . . . 1.0 112.909 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.483 ' SG ' ' N ' ' A' ' 34' ' ' ARG . 25.5 t -72.11 156.91 38.67 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 110.558 -3.019 . . . . 1.0 115.92 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.483 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 47.8 ttt-85 -136.83 146.12 45.27 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 104.106 -2.553 . . . . 1.0 104.106 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.9 m -119.22 168.58 10.75 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 123.974 0.796 . . . . 1.0 110.223 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -126.75 -165.53 1.47 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 114.421 -1.263 . . . . 1.0 111.596 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.468 -1.253 . . . . 1.0 110.278 -179.762 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . 0.447 ' CD ' ' HB2' ' A' ' 35' ' ' CYS . . . . . . . . 0 C--O 1.209 -1.034 0 N-CA-C 112.684 0.624 . . . . 1.0 112.684 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 65.0 m-85 -100.36 153.16 19.54 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.661 -0.7 . . . . 1.0 110.815 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 50.2 p -134.01 169.32 17.3 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 114.491 -1.231 . . . . 1.0 109.8 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -123.59 41.36 3.49 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.369 1.081 . . . . 1.0 109.045 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.96 148.11 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.402 -1.703 . . . . 1.0 106.402 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -70.39 153.63 42.78 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.81 168.19 14.77 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 124.522 1.139 . . . . 1.0 110.553 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.5 t -142.96 32.08 1.39 Allowed 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 105.672 -1.973 . . . . 1.0 105.672 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.77 154.19 9.13 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.643 -2.183 . . . . 1.0 107.643 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.5 m -39.71 -53.08 2.24 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.182 1.178 . . . . 1.0 114.182 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -44.71 -41.26 6.66 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.442 1.645 . . . . 1.0 115.442 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -61.87 -27.69 68.98 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 119.431 -0.908 . . . . 1.0 112.687 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.1 m -77.42 -6.26 52.77 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.006 -0.997 . . . . 1.0 112.127 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.515 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 11.2 m0 -69.37 -62.57 2.51 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 108.724 -0.843 . . . . 1.0 108.724 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.515 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 94.0 Cg_endo -66.62 -42.45 9.29 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.886 2.39 . . . . 1.0 110.969 176.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.23 -45.37 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 123.962 0.789 . . . . 1.0 110.198 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 46.6 t -70.2 -44.76 68.0 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.483 -1.287 . . . . 1.0 107.765 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -47.74 -41.3 22.71 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 122.37 1.081 . . . . 1.0 108.93 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -70.86 -57.7 4.34 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 113.091 -1.868 . . . . 1.0 113.107 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 77.5 mmm -62.59 -54.92 32.47 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 115.928 1.825 . . . . 1.0 115.928 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -106.85 -55.91 2.26 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 114.532 -1.213 . . . . 1.0 112.998 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.84 41.05 0.27 Allowed Glycine 0 N--CA 1.492 2.426 0 O-C-N 123.467 0.48 . . . . 1.0 113.422 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.488 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 33.7 mmtp -133.58 109.55 12.24 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 107.897 -1.149 . . . . 1.0 107.897 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.27 6.79 2.05 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.989 2.459 . . . . 1.0 112.055 -175.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.1 115.19 20.75 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.588 -1.264 . . . . 1.0 107.588 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -139.41 155.25 23.98 Favored Glycine 0 N--CA 1.493 2.495 0 CA-C-N 114.195 -1.366 . . . . 1.0 114.628 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -116.46 179.7 3.93 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-N 113.882 -1.159 . . . . 1.0 108.965 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.3 t -120.29 164.28 16.54 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' LYS . 84.3 mtp -141.05 82.2 1.82 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.089 -1.819 . . . . 1.0 106.089 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.4 t30 31.79 51.77 0.19 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 125.088 1.493 . . . . 1.0 111.688 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.45 -36.42 3.16 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-O 117.463 -1.743 . . . . 1.0 115.782 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 29' ' ' MET . 35.6 mmtp -111.23 150.51 29.47 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-N 120.468 2.134 . . . . 1.0 110.811 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.5 m -71.79 163.43 27.82 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 118.72 2.859 . . . . 1.0 118.72 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.1 tpt85 -136.2 153.26 51.29 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 110.882 -2.872 . . . . 1.0 104.69 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.447 ' HB2' ' CD ' ' A' ' 1' ' ' PCA . 69.7 m -121.86 169.98 10.24 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.835 -1.543 . . . . 1.0 106.835 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -115.67 -172.54 2.17 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.418 -0.81 . . . . 1.0 109.63 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.2 p . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 115.89 -2.005 . . . . 1.0 110.173 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . 0.455 ' N ' ' HB2' ' A' ' 35' ' ' CYS . . . . . . . . 0 C--O 1.209 -1.04 0 N-CA-C 112.819 0.674 . . . . 1.0 112.819 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -101.62 151.4 22.04 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.909 0.861 . . . . 1.0 110.973 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.9 p -143.72 163.03 34.44 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 112.806 -1.997 . . . . 1.0 107.751 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -127.06 48.56 2.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 123.681 0.613 . . . . 1.0 111.086 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.29 156.68 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.641 -1.244 . . . . 1.0 107.641 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -70.31 109.99 5.02 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.133 0.79 . . . . 1.0 113.133 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.9 p -114.29 152.52 31.24 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 123.813 0.696 . . . . 1.0 110.401 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -145.72 48.52 1.24 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.57 -1.65 . . . . 1.0 108.2 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.37 125.47 2.52 Favored Glycine 0 N--CA 1.498 2.802 0 CA-C-N 114.123 -1.399 . . . . 1.0 111.472 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.3 m -39.72 -52.57 2.28 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.967 1.84 . . . . 1.0 115.967 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -40.55 -37.46 0.72 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.826 1.417 . . . . 1.0 114.826 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -61.07 -35.35 76.73 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.804 -1.089 . . . . 1.0 113.771 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.0 m -77.26 -10.95 59.74 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.338 -1.301 . . . . 1.0 112.511 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.483 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 11.3 m0 -65.7 -61.83 5.23 Favored Pre-proline 0 C--N 1.307 -1.246 0 C-N-CA 119.636 -0.825 . . . . 1.0 109.171 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.483 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 83.1 Cg_endo -67.93 -43.58 4.91 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 123.015 2.477 . . . . 1.0 111.548 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.3 t -58.35 -47.59 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 123.787 0.679 . . . . 1.0 110.733 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.549 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 46.8 t -70.32 -42.83 71.43 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.19 -1.404 . . . . 1.0 107.951 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -48.41 -41.12 28.21 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.399 1.095 . . . . 1.0 108.161 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -70.65 -51.4 28.15 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.455 -1.702 . . . . 1.0 112.107 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 32.2 ttm -58.69 -59.15 5.86 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 114.513 1.301 . . . . 1.0 114.513 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -110.63 -55.8 2.43 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.531 -1.668 . . . . 1.0 114.056 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.39 45.09 0.25 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.124 -1.99 . . . . 1.0 108.124 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.549 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 40.5 mmtm -123.74 94.68 45.71 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 105.276 -2.12 . . . . 1.0 105.276 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -64.99 -1.88 4.86 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.577 2.185 . . . . 1.0 112.489 -168.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -115.9 142.78 46.32 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 105.589 -2.004 . . . . 1.0 105.589 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.43 153.7 24.76 Favored Glycine 0 N--CA 1.489 2.17 0 CA-C-N 113.849 -1.523 . . . . 1.0 110.701 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.451 ' HG3' ' HB3' ' A' ' 34' ' ' ARG . 20.6 ptmt -131.27 176.64 8.11 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 119.253 -0.979 . . . . 1.0 109.243 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.5 t -114.16 162.3 16.7 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.108 0.48 . . . . 1.0 110.433 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.2 mtp -135.23 75.84 1.59 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.595 -1.631 . . . . 1.0 106.595 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 29.67 55.74 0.15 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 125.599 1.812 . . . . 1.0 110.89 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.18 -36.39 2.83 Favored Glycine 0 N--CA 1.483 1.806 0 CA-C-N 112.971 -1.922 . . . . 1.0 115.602 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -111.93 139.61 47.28 Favored 'General case' 0 C--O 1.206 -1.229 0 CA-C-N 119.286 1.543 . . . . 1.0 110.856 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 52.2 t -71.74 161.67 30.62 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 112.878 -1.965 . . . . 1.0 114.704 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.451 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 18.3 tpt85 -141.26 152.71 44.75 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.973 -1.467 . . . . 1.0 107.221 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.455 ' HB2' ' N ' ' A' ' 1' ' ' PCA . 49.0 m -116.39 169.57 9.21 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 124.545 1.153 . . . . 1.0 109.4 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -120.07 -171.25 2.11 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.321 -1.309 . . . . 1.0 109.01 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.7 m . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 116.275 -1.821 . . . . 1.0 108.99 -179.611 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 111.941 0.348 . . . . 1.0 111.941 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -100.2 159.33 15.2 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.198 0.523 . . . . 1.0 109.86 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 82.4 p -133.71 176.02 8.93 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 114.171 -1.377 . . . . 1.0 109.028 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -124.67 30.04 6.07 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 123.98 0.8 . . . . 1.0 109.382 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.48 153.37 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 115.255 -0.884 . . . . 1.0 109.311 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 62.2 pttt -71.1 155.26 40.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.988 0.805 . . . . 1.0 111.808 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.8 p -134.71 157.29 47.05 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.043 -0.663 . . . . 1.0 110.881 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.8 p -136.56 43.85 2.42 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.469 -1.241 . . . . 1.0 108.815 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.53 167.63 13.45 Favored Glycine 0 N--CA 1.494 2.564 0 CA-C-N 113.926 -1.488 . . . . 1.0 110.191 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.9 m -65.21 -59.39 4.13 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 114.46 1.282 . . . . 1.0 114.46 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -40.49 -39.23 0.97 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 114.692 1.368 . . . . 1.0 114.692 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -33.84 70.49 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 122.077 0.941 . . . . 1.0 112.806 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 60.6 m -78.36 -7.91 57.84 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.218 -1.355 . . . . 1.0 113.578 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.462 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 11.3 m95 -69.57 -60.56 3.8 Favored Pre-proline 0 C--N 1.304 -1.373 0 C-N-CA 119.554 -0.858 . . . . 1.0 108.877 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.462 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 97.6 Cg_endo -66.99 -42.92 7.37 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.891 2.394 . . . . 1.0 111.185 176.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.67 -47.9 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 123.91 0.756 . . . . 1.0 110.572 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 49.3 t -70.01 -40.61 75.14 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.702 -1.199 . . . . 1.0 108.438 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -51.41 -42.17 61.26 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.422 -0.955 . . . . 1.0 108.422 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 -70.56 -50.01 41.96 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 113.971 -1.468 . . . . 1.0 111.997 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.4 ttm -54.02 -54.59 37.04 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -122.51 -55.69 1.82 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 113.62 -1.627 . . . . 1.0 112.808 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.43 42.6 0.21 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.594 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 6.1 mptp? -120.22 92.3 47.03 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 106.409 -1.7 . . . . 1.0 106.409 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -64.82 -5.01 9.67 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.963 2.442 . . . . 1.0 113.555 -164.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -115.48 143.17 45.7 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 105.95 -1.87 . . . . 1.0 105.95 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.96 154.56 25.61 Favored Glycine 0 N--CA 1.488 2.117 0 CA-C-N 113.382 -1.735 . . . . 1.0 111.281 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HG3' ' HB3' ' A' ' 34' ' ' ARG . 20.7 ptmt -128.23 178.81 5.99 Favored 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 119.388 -0.925 . . . . 1.0 109.064 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.0 t -116.45 157.68 24.76 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 73.2 mtm -133.71 82.93 2.01 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.254 -1.758 . . . . 1.0 106.254 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 29.46 50.7 0.07 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 125.307 1.629 . . . . 1.0 112.919 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 124.96 -34.04 3.53 Favored Glycine 0 N--CA 1.483 1.777 0 CA-C-O 117.152 -1.916 . . . . 1.0 116.539 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -111.43 140.93 45.62 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 120.588 2.194 . . . . 1.0 109.817 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.1 t -71.86 158.11 36.66 Favored 'General case' 0 C--N 1.292 -1.891 0 CA-C-N 112.187 -2.279 . . . . 1.0 115.468 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.465 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 5.1 tpt180 -139.25 155.5 47.72 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.31 -1.768 . . . . 1.0 107.748 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.2 m -118.75 168.25 10.92 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 124.929 1.393 . . . . 1.0 108.338 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -118.62 -179.48 3.81 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.392 -0.822 . . . . 1.0 110.822 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.5 m . . . . . 0 N--CA 1.504 2.237 0 O-C-N 125.701 1.876 . . . . 1.0 115.684 -179.917 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 111.848 0.314 . . . . 1.0 111.848 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -102.56 153.73 19.8 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.822 0.82 . . . . 1.0 110.096 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 p -141.13 165.07 28.55 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.211 -1.813 . . . . 1.0 109.825 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -125.85 55.72 1.44 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.831 -1.077 . . . . 1.0 108.776 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.68 148.32 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-N 114.672 -1.149 . . . . 1.0 108.437 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -70.1 102.57 2.09 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.853 -1.067 . . . . 1.0 110.557 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.7 p -116.24 158.61 23.07 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 124.407 1.067 . . . . 1.0 111.842 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 t -137.72 45.78 2.14 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.931 -1.486 . . . . 1.0 107.147 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.07 157.43 9.68 Favored Glycine 0 N--CA 1.494 2.522 0 CA-C-N 113.243 -1.799 . . . . 1.0 110.084 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.2 m -40.31 -49.68 2.76 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 116.148 1.906 . . . . 1.0 116.148 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -39.69 -31.2 0.09 Allowed 'General case' 0 C--O 1.205 -1.25 0 C-N-CA 125.577 1.551 . . . . 1.0 114.905 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -70.15 -40.39 74.79 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.789 0.804 . . . . 1.0 113.047 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 96.1 m -70.72 -26.21 63.29 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.023 -1.444 . . . . 1.0 113.058 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -57.19 -65.79 1.57 Allowed Pre-proline 0 C--N 1.3 -1.57 0 C-N-CA 118.999 -1.08 . . . . 1.0 110.775 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -64.37 -45.84 8.7 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 122.835 2.357 . . . . 1.0 111.591 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 88.8 t -62.33 -49.01 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 124.082 0.864 . . . . 1.0 112.455 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 24.8 t -70.28 -31.94 69.51 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.973 -1.091 . . . . 1.0 108.414 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -61.52 -49.24 77.5 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.617 -0.883 . . . . 1.0 108.617 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -70.79 -38.82 73.39 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.164 -1.014 . . . . 1.0 113.236 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.0 mtp -69.64 -56.35 7.5 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 115.267 1.58 . . . . 1.0 115.267 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -106.52 -58.19 1.96 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.793 0.683 . . . . 1.0 112.091 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.55 37.62 0.58 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.821 -1.712 . . . . 1.0 108.821 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.448 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 5.0 mptp? -122.85 79.37 49.69 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 105.483 -2.043 . . . . 1.0 105.483 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -66.43 10.96 0.18 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 123.042 2.494 . . . . 1.0 113.751 -170.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -128.51 109.72 11.64 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.826 -1.175 . . . . 1.0 107.826 179.626 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.05 174.41 23.22 Favored Glycine 0 N--CA 1.492 2.384 0 CA-C-N 112.546 -2.115 . . . . 1.0 111.291 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.432 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 18.6 ptmt -132.95 171.71 13.59 Favored 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 108.891 -0.781 . . . . 1.0 108.891 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.2 t -109.27 160.23 16.3 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 120.181 -0.608 . . . . 1.0 110.019 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 56.9 mtp -132.61 76.93 1.72 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.098 -1.815 . . . . 1.0 106.098 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 30.87 55.36 0.2 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 125.606 1.816 . . . . 1.0 110.954 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.96 -35.43 3.39 Favored Glycine 0 N--CA 1.483 1.804 0 CA-C-N 113.353 -1.749 . . . . 1.0 115.815 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -112.01 137.55 49.88 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 119.315 1.557 . . . . 1.0 110.698 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 34' ' ' ARG . 39.1 t -72.18 158.31 36.13 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 117.696 2.48 . . . . 1.0 117.696 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.516 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 10.3 tpt180 -138.95 149.26 44.55 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 106.409 -1.7 . . . . 1.0 106.409 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.3 m -123.93 163.55 21.1 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 104.906 -2.257 . . . . 1.0 104.906 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -112.88 170.08 8.46 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.656 -1.609 . . . . 1.0 106.656 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.507 2.377 0 N-CA-C 116.225 1.935 . . . . 1.0 116.225 -179.902 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 121.292 0.568 . . . . 1.0 111.735 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -114.61 163.81 14.89 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.4 p -135.1 169.66 17.09 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 123.891 0.745 . . . . 1.0 110.894 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.405 ' H ' ' HE1' ' A' ' 20' ' ' MET . 0.7 OUTLIER -118.59 24.0 11.16 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.085 -1.416 . . . . 1.0 107.659 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.31 145.73 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.519 ' HZ2' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -71.04 163.24 27.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.277 0.985 . . . . 1.0 112.516 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.519 ' N ' ' HZ2' ' A' ' 6' ' ' LYS . 8.4 p -142.61 159.55 42.01 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 124.148 0.905 . . . . 1.0 111.353 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 p -131.89 41.02 3.31 Favored 'General case' 0 C--N 1.31 -1.116 0 O-C-N 124.465 1.103 . . . . 1.0 108.188 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.45 171.22 17.73 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.115 -1.594 . . . . 1.0 109.115 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.5 p -48.8 -60.35 2.82 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.816 0.672 . . . . 1.0 112.816 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -40.06 -39.43 0.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -70.45 -36.2 73.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.287 0.992 . . . . 1.0 112.104 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.462 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 49.0 t -76.01 -13.94 60.23 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 113.643 -1.617 . . . . 1.0 112.326 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.426 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 7.5 m0 -69.14 -56.2 9.09 Favored Pre-proline 0 N--CA 1.485 1.289 0 CA-C-O 118.193 -0.908 . . . . 1.0 110.695 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 90.3 Cg_endo -65.34 -42.17 13.93 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.906 2.404 . . . . 1.0 110.643 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.48 -48.45 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 123.925 0.766 . . . . 1.0 110.823 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.4 t -68.57 -44.61 74.05 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.146 -1.022 . . . . 1.0 108.915 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -52.43 -39.41 60.99 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.951 0.881 . . . . 1.0 109.081 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -70.46 -52.88 18.96 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 114.21 -1.359 . . . . 1.0 111.141 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.405 ' HE1' ' H ' ' A' ' 4' ' ' ASP . 34.4 ttm -56.07 -56.96 14.51 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.537 0.94 . . . . 1.0 113.537 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -113.07 -61.16 1.78 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 113.098 -1.864 . . . . 1.0 113.915 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.07 41.25 0.45 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 107.885 -2.086 . . . . 1.0 107.885 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 7.8 mmpt? -123.42 81.83 53.17 Favored Pre-proline 0 N--CA 1.494 1.726 0 N-CA-C 105.904 -1.887 . . . . 1.0 105.904 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -65.13 1.35 2.0 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 123.092 2.528 . . . . 1.0 114.94 -157.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 5.2 m120 -100.22 121.81 42.04 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 100.698 -3.816 . . . . 1.0 100.698 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.15 143.88 12.42 Favored Glycine 0 C--N 1.294 -1.761 0 CA-C-N 113.786 -1.552 . . . . 1.0 110.726 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.404 ' HD3' ' OH ' ' A' ' 36' ' ' TYR . 26.4 mtpp -125.77 160.3 30.13 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 106.517 -1.66 . . . . 1.0 106.517 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.9 t -101.05 157.49 16.72 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.969 -0.693 . . . . 1.0 112.629 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.4 mtm -132.3 89.88 2.72 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.527 -1.657 . . . . 1.0 106.527 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 30.34 48.31 0.05 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 125.097 1.498 . . . . 1.0 113.414 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 121.84 -31.54 4.93 Favored Glycine 0 N--CA 1.487 2.036 0 CA-C-O 117.112 -1.938 . . . . 1.0 117.912 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -113.01 142.68 45.43 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 120.719 2.259 . . . . 1.0 110.028 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 13.3 t -71.6 157.61 37.67 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.362 -1.745 . . . . 1.0 114.057 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.462 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 27.7 ttt85 -133.37 140.32 47.3 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 112.519 -2.128 . . . . 1.0 106.362 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.412 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 65.2 m -109.85 166.52 10.86 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 123.969 0.793 . . . . 1.0 112.23 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.438 ' HB2' ' HB2' ' A' ' 25' ' ' ASN . 47.4 m-85 -127.56 -165.0 1.42 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.42 -1.718 . . . . 1.0 110.774 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.4 t . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.512 -1.233 . . . . 1.0 110.004 -179.723 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.17 0 CA-C-O 121.606 0.717 . . . . 1.0 112.552 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -84.84 171.45 12.22 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.524 -1.216 . . . . 1.0 109.473 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.5 p -124.3 173.39 8.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 124.034 0.833 . . . . 1.0 111.739 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.2 23.34 11.91 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.267 -1.788 . . . . 1.0 107.161 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -124.02 151.87 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 115.323 -0.853 . . . . 1.0 109.074 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -71.11 159.71 34.21 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.536 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.565 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 28.8 p -136.82 150.42 48.31 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.769 -0.772 . . . . 1.0 111.392 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.5 p -137.04 45.09 2.27 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.152 -1.385 . . . . 1.0 107.755 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.58 159.84 11.27 Favored Glycine 0 N--CA 1.494 2.548 0 CA-C-N 113.466 -1.697 . . . . 1.0 110.112 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.8 m -50.71 -54.47 22.95 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 113.896 1.073 . . . . 1.0 113.896 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -40.33 -36.91 0.59 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 115.204 1.557 . . . . 1.0 115.204 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -70.41 -34.82 72.96 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.233 -0.894 . . . . 1.0 112.432 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.5 m -73.6 -18.1 61.09 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.332 -1.304 . . . . 1.0 112.464 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.456 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 9.7 m0 -63.08 -60.88 8.51 Favored Pre-proline 0 N--CA 1.483 1.2 0 CA-C-O 118.364 -0.827 . . . . 1.0 110.887 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -65.74 -45.71 6.12 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 123.024 2.482 . . . . 1.0 111.344 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.26 -45.47 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 123.948 0.78 . . . . 1.0 111.097 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 52.7 t -70.0 -48.52 57.79 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.596 -1.261 . . . . 1.0 107.596 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -47.63 -38.87 15.63 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 122.136 0.97 . . . . 1.0 108.89 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -70.67 -58.49 3.61 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.36 -1.745 . . . . 1.0 112.433 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 70.7 mtm -68.7 -53.83 19.83 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 116.808 2.151 . . . . 1.0 116.808 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -99.01 -57.52 2.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 124.057 0.848 . . . . 1.0 112.715 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.59 34.45 0.86 Allowed Glycine 0 N--CA 1.495 2.606 0 O-C-N 123.837 0.711 . . . . 1.0 111.743 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 12.9 mptt -122.97 107.07 33.48 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 104.905 -2.257 . . . . 1.0 104.905 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.21 -4.53 13.84 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.913 2.409 . . . . 1.0 112.527 -163.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.456 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 29.3 m-80 -107.17 -171.91 1.97 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.143 -1.429 . . . . 1.0 107.143 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.35 163.94 10.44 Favored Glycine 0 N--CA 1.483 1.8 0 CA-C-N 112.302 -2.226 . . . . 1.0 110.376 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.524 ' HE2' ' CE2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -132.59 177.14 7.85 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 113.896 -1.152 . . . . 1.0 108.57 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.5 t -105.6 155.61 19.05 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.737 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 70.6 mtm -131.04 82.3 2.04 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 107.204 -1.406 . . . . 1.0 107.204 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.3 m120 29.49 51.38 0.08 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 125.463 1.727 . . . . 1.0 112.442 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.29 -33.84 3.53 Favored Glycine 0 N--CA 1.486 2.016 0 CA-C-N 113.082 -1.872 . . . . 1.0 116.864 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.495 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 6.2 mptt -117.43 141.34 48.46 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 120.228 2.014 . . . . 1.0 110.272 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 3.0 m -72.32 156.13 39.43 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 113.805 -1.543 . . . . 1.0 114.616 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.419 ' HB3' ' HG2' ' A' ' 27' ' ' LYS . 9.1 tpt180 -135.1 152.71 51.91 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.76 -1.941 . . . . 1.0 105.76 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.5 m -117.23 156.89 26.96 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 124.672 1.232 . . . . 1.0 110.794 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.524 ' CE2' ' HE2' ' A' ' 27' ' ' LYS . 58.1 m-85 -111.62 -179.12 3.62 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.35 -1.722 . . . . 1.0 106.35 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.2 m . . . . . 0 N--CA 1.505 2.325 0 N-CA-C 115.487 1.662 . . . . 1.0 115.487 179.837 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.444 0.64 . . . . 1.0 112.681 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -106.8 160.65 15.33 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.285 -0.87 . . . . 1.0 109.818 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.7 p -137.05 173.37 11.77 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 115.033 -0.985 . . . . 1.0 110.395 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -131.86 34.34 3.87 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 114.72 -1.127 . . . . 1.0 108.155 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.6 p -111.08 150.86 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-N 115.053 -0.976 . . . . 1.0 110.518 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -71.13 127.46 32.64 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.096 1.147 . . . . 1.0 114.096 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.429 ' SG ' ' C ' ' A' ' 32' ' ' LYS . 30.3 p -134.9 159.37 41.63 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.837 -0.62 . . . . 1.0 109.917 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -148.02 48.64 1.06 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.621 -1.251 . . . . 1.0 107.621 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.26 153.09 7.04 Favored Glycine 0 N--CA 1.498 2.83 0 CA-C-N 113.489 -1.687 . . . . 1.0 112.145 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 65.4 p -53.62 -57.71 9.8 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 116.038 1.866 . . . . 1.0 116.038 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -39.76 -41.8 1.16 Allowed 'General case' 0 C--O 1.204 -1.298 0 C-N-CA 124.63 1.172 . . . . 1.0 113.78 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -70.69 -38.37 73.69 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.598 -1.183 . . . . 1.0 111.7 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 13.3 t -72.19 -18.1 61.88 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 113.546 -1.661 . . . . 1.0 111.369 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -64.03 -61.29 7.06 Favored Pre-proline 0 N--CA 1.486 1.341 0 CA-C-O 118.449 -0.786 . . . . 1.0 111.331 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -64.83 -42.96 13.46 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 123.054 2.503 . . . . 1.0 110.499 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 66.6 t -56.85 -45.91 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 123.928 0.767 . . . . 1.0 110.057 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.592 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 38.2 t -67.76 -45.0 76.16 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -49.31 -42.73 42.23 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.433 1.111 . . . . 1.0 108.82 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -70.48 -49.25 50.42 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 113.168 -1.833 . . . . 1.0 112.208 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.0 ttp -57.01 -57.89 10.56 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 124.265 0.978 . . . . 1.0 113.007 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -116.82 -58.61 2.05 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 113.334 -1.757 . . . . 1.0 114.073 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.04 45.71 0.21 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.033 -1.627 . . . . 1.0 109.033 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.592 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 75.0 mmtt -127.01 72.22 76.13 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 105.852 -1.907 . . . . 1.0 105.852 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -60.89 -3.47 2.86 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.738 2.959 . . . . 1.0 114.359 -163.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.4 108.09 16.42 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.616 -1.624 . . . . 1.0 106.616 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.89 172.76 23.93 Favored Glycine 0 N--CA 1.486 2.011 0 CA-C-N 111.756 -2.475 . . . . 1.0 113.454 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -131.45 169.33 16.2 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 107.979 -1.119 . . . . 1.0 107.979 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.5 t -105.69 159.7 15.78 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 120.084 -0.647 . . . . 1.0 109.505 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.1 mtm -133.68 80.66 1.88 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.712 -1.131 . . . . 1.0 107.962 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 24.96 55.84 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 126.079 2.112 . . . . 1.0 110.632 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.5 -40.87 1.58 Allowed Glycine 0 N--CA 1.483 1.827 0 CA-C-N 111.858 -2.428 . . . . 1.0 116.205 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.429 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 48.1 mtmt -118.2 144.21 45.92 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 119.598 1.699 . . . . 1.0 113.584 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.1 t -71.86 157.97 36.9 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 112.487 -2.142 . . . . 1.0 112.813 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.432 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 12.9 tpt180 -136.78 144.74 43.9 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 112.699 -2.046 . . . . 1.0 105.862 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.9 m -118.5 163.79 16.24 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 105.557 -2.016 . . . . 1.0 105.557 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -113.55 169.22 9.13 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.601 -0.888 . . . . 1.0 108.601 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.506 2.371 0 CA-C-O 116.154 -1.879 . . . . 1.0 115.788 179.992 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 121.013 0.435 . . . . 1.0 111.449 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -96.01 148.72 22.36 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.837 0.827 . . . . 1.0 109.677 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.4 p -148.12 171.3 16.1 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 112.946 -1.934 . . . . 1.0 109.808 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -127.79 51.39 1.95 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.825 -1.08 . . . . 1.0 108.586 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.2 t -111.96 126.38 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.856 0.836 . . . . 1.0 110.355 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 8.6 ptpp? -39.36 110.86 0.15 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 117.438 2.384 . . . . 1.0 117.438 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.3 p -125.97 172.36 9.99 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.025 0.917 . . . . 1.0 110.409 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.0 m -123.86 -47.04 1.95 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 112.431 -2.168 . . . . 1.0 106.482 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.82 168.69 31.78 Favored Glycine 0 N--CA 1.492 2.433 0 CA-C-N 114.218 -1.355 . . . . 1.0 110.081 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 m -48.13 -63.72 0.99 Allowed 'General case' 0 N--CA 1.482 1.128 0 O-C-N 124.097 0.528 . . . . 1.0 111.816 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -41.09 -37.4 0.86 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.902 1.376 . . . . 1.0 114.615 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -70.59 -34.42 72.15 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 122.975 1.369 . . . . 1.0 110.51 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.448 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 14.5 t -80.83 0.96 32.65 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.35 -1.75 . . . . 1.0 111.352 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.452 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 5.5 m95 -70.05 -60.59 3.43 Favored Pre-proline 0 N--CA 1.482 1.147 0 N-CA-C 106.069 -1.826 . . . . 1.0 106.069 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.425 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 73.9 Cg_endo -61.22 -43.98 26.12 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 122.422 2.081 . . . . 1.0 110.551 174.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 91.3 t -58.2 -45.3 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 C-N-CA 118.136 -1.425 . . . . 1.0 110.677 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 40.6 t -70.29 -31.03 68.21 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.308 -0.957 . . . . 1.0 109.047 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -59.47 -50.4 74.05 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -71.14 -48.22 53.25 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 119.348 -0.941 . . . . 1.0 113.373 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -50.28 73.98 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 114.1 1.148 . . . . 1.0 114.1 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -113.16 -61.57 1.72 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.7 1.37 . . . . 1.0 114.7 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.26 41.46 0.4 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.386 -1.885 . . . . 1.0 108.386 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 63.0 mmtt -130.38 81.52 67.92 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 104.645 -2.354 . . . . 1.0 104.645 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -62.1 -0.69 1.83 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.787 2.325 . . . . 1.0 114.222 -161.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.452 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 3.8 m120 -111.97 116.4 30.53 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 101.682 -3.451 . . . . 1.0 101.682 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.88 164.98 16.87 Favored Glycine 0 N--CA 1.486 1.979 0 CA-C-N 113.32 -1.763 . . . . 1.0 111.176 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . 73.6 tttt -128.33 170.78 12.67 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.826 -1.916 . . . . 1.0 105.826 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.5 t -123.06 159.7 27.91 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.219 0.533 . . . . 1.0 109.95 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.9 mtp -133.62 71.59 1.46 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 106.441 -1.689 . . . . 1.0 106.441 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 30.82 53.36 0.16 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 125.311 1.632 . . . . 1.0 111.981 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 125.72 -31.87 4.02 Favored Glycine 0 N--CA 1.48 1.575 0 CA-C-N 113.317 -1.765 . . . . 1.0 115.158 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.505 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 8.3 mptt -111.12 144.16 40.7 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-N 119.299 1.55 . . . . 1.0 108.755 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.82 160.63 32.25 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 114.919 1.451 . . . . 1.0 114.919 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 20.3 tpt85 -142.72 159.23 42.64 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 104.022 -2.585 . . . . 1.0 104.022 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.9 m -128.03 169.81 13.61 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.204 0.526 . . . . 1.0 110.036 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.603 ' CZ ' ' HB2' ' A' ' 27' ' ' LYS . 11.7 m-85 -122.72 -174.3 2.89 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 109.533 -0.543 . . . . 1.0 109.533 -179.762 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.167 0 CA-C-O 121.112 0.482 . . . . 1.0 111.509 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -103.62 164.71 11.49 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.8 p -133.44 169.07 17.49 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 123.826 0.704 . . . . 1.0 110.552 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -114.86 23.79 12.3 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.361 -1.29 . . . . 1.0 107.729 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -124.29 143.18 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.347 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -71.13 161.71 30.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.192 0.932 . . . . 1.0 112.131 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.485 ' SG ' ' C ' ' A' ' 32' ' ' LYS . 11.0 p -142.12 158.76 43.37 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 123.955 0.784 . . . . 1.0 111.617 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.6 p -136.58 43.98 2.41 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.492 -1.231 . . . . 1.0 108.138 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.63 161.08 11.92 Favored Glycine 0 N--CA 1.494 2.56 0 CA-C-N 113.902 -1.499 . . . . 1.0 110.889 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.8 t -45.59 -58.86 3.09 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.164 -1.018 . . . . 1.0 113.594 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -40.83 -41.52 1.6 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 115.122 1.527 . . . . 1.0 115.122 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.75 -33.1 70.45 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.306 1.004 . . . . 1.0 111.995 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 41.4 t -76.55 -12.73 60.07 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 113.633 -1.621 . . . . 1.0 112.059 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.42 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 8.3 m0 -69.8 -59.38 4.6 Favored Pre-proline 0 N--CA 1.483 1.215 0 CA-C-O 118.497 -0.763 . . . . 1.0 109.645 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 72.4 Cg_endo -62.51 -43.84 20.46 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 122.826 2.351 . . . . 1.0 109.732 177.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.9 t -59.34 -46.72 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 123.946 0.779 . . . . 1.0 110.633 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 41.6 t -70.26 -31.58 69.02 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.625 -1.23 . . . . 1.0 109.724 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -63.42 -48.1 79.17 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -70.74 -44.26 67.16 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.525 -0.87 . . . . 1.0 111.843 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.4 mmm -63.93 -52.76 58.27 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 113.935 1.087 . . . . 1.0 113.935 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -110.12 -62.19 1.55 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 124.179 0.924 . . . . 1.0 112.656 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.99 42.24 0.45 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.615 -2.194 . . . . 1.0 107.615 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 48.9 mmtm -130.86 82.64 63.7 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 106.821 -1.548 . . . . 1.0 106.821 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -62.55 0.24 1.55 Allowed 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.873 2.382 . . . . 1.0 114.609 -163.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -103.08 117.06 33.73 Favored 'General case' 0 C--N 1.308 -1.224 1 N-CA-C 99.485 -4.265 . . . . 1.0 99.485 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.11 144.1 13.36 Favored Glycine 0 C--N 1.292 -1.916 0 CA-C-N 113.604 -1.635 . . . . 1.0 110.534 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HD3' ' OH ' ' A' ' 36' ' ' TYR . 43.8 mtpt -126.08 165.32 19.07 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 107.08 -1.452 . . . . 1.0 107.08 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.2 t -104.59 148.97 25.92 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 113.206 0.817 . . . . 1.0 113.206 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.3 ptp -128.97 98.53 4.97 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.354 -1.294 . . . . 1.0 108.743 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.0 t30 32.4 47.06 0.08 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 113.02 -1.9 . . . . 1.0 113.124 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.49 -26.59 8.04 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 118.686 2.234 . . . . 1.0 118.686 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.485 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 93.2 mttt -114.26 149.95 35.11 Favored 'General case' 0 C--O 1.204 -1.291 0 CA-C-N 121.167 2.483 . . . . 1.0 109.96 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.1 t -72.28 159.03 34.75 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.814 -1.085 . . . . 1.0 111.946 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.448 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 26.4 ttt85 -133.05 141.22 48.11 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 112.956 -1.929 . . . . 1.0 106.057 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -111.99 166.19 11.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 124.172 0.92 . . . . 1.0 111.743 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.414 ' OH ' ' HD3' ' A' ' 27' ' ' LYS . 40.3 m-85 -126.36 -166.25 1.55 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.175 -1.829 . . . . 1.0 110.472 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.246 -1.359 . . . . 1.0 111.232 -179.772 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 121.529 0.681 . . . . 1.0 112.837 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -92.93 165.23 12.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.901 -1.045 . . . . 1.0 111.377 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.7 p -132.3 179.13 6.3 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.612 -1.176 . . . . 1.0 110.962 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.22 26.3 9.72 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.405 -1.27 . . . . 1.0 109.398 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.8 t -123.98 141.9 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 31.0 mmmt -71.36 148.51 46.94 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.866 1.432 . . . . 1.0 114.866 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.7 p -140.42 173.08 11.86 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.35 1.071 . . . . 1.0 112.041 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.548 ' H ' HE22 ' A' ' 12' ' ' GLN . 10.1 t -136.38 -38.35 0.68 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 111.997 -2.365 . . . . 1.0 108.986 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.74 163.48 23.76 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 123.747 0.654 . . . . 1.0 112.78 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.5 p -70.29 -54.51 12.37 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.341 0.867 . . . . 1.0 113.341 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -58.44 -20.15 42.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 124.322 1.014 . . . . 1.0 111.459 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.548 HE22 ' H ' ' A' ' 8' ' ' THR . 4.9 tt0 -70.07 -31.0 68.38 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.293 -0.867 . . . . 1.0 110.219 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 3.9 t -80.11 -1.57 40.7 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.465 -1.243 . . . . 1.0 113.207 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.456 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 10.5 m0 -70.27 -60.4 3.42 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 87.7 Cg_endo -64.95 -44.35 10.12 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.794 2.329 . . . . 1.0 111.747 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 78.8 t -58.26 -45.21 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 119.736 -0.786 . . . . 1.0 110.892 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.4 t -69.98 -44.3 69.71 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -48.24 -42.06 29.31 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 122.355 1.074 . . . . 1.0 108.365 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -70.73 -47.64 58.71 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 113.114 -1.857 . . . . 1.0 112.792 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 94.9 mtp -69.19 -58.24 4.31 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 116.312 1.968 . . . . 1.0 116.312 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -102.66 -55.23 2.48 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 114.905 -1.043 . . . . 1.0 112.641 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.47 37.3 0.38 Allowed Glycine 0 N--CA 1.489 2.218 0 O-C-N 124.08 0.863 . . . . 1.0 111.331 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.54 115.07 22.98 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 106.548 -1.649 . . . . 1.0 106.548 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -74.46 15.36 0.67 Allowed 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.734 2.289 . . . . 1.0 112.66 -174.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.56 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 5.5 m120 -123.65 -177.13 3.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.76 0.791 . . . . 1.0 109.065 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.86 169.73 12.16 Favored Glycine 0 N--CA 1.49 2.293 0 CA-C-N 114.029 -1.441 . . . . 1.0 114.072 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 49.0 mtpt -132.21 -167.82 1.95 Allowed 'General case' 0 N--CA 1.504 2.25 0 CA-C-N 113.005 -1.597 . . . . 1.0 111.296 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.5 t -126.37 154.45 43.53 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.035 -1.839 . . . . 1.0 106.035 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.6 mtm -132.37 78.42 1.8 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.637 -1.246 . . . . 1.0 107.637 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.0 t30 28.76 52.64 0.07 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 125.835 1.959 . . . . 1.0 111.143 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 127.11 -35.49 2.83 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-O 117.019 -1.99 . . . . 1.0 116.273 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -109.23 146.01 34.93 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-N 120.853 2.326 . . . . 1.0 109.607 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -70.97 159.97 33.75 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.896 -1.047 . . . . 1.0 111.499 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.481 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 4.6 tpt180 -134.51 146.77 50.03 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 106.237 -1.764 . . . . 1.0 106.237 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.7 m -120.38 163.04 18.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.48 -1.674 . . . . 1.0 106.48 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.56 ' CD2' ' HB3' ' A' ' 25' ' ' ASN . 11.1 m-30 -114.38 178.11 4.4 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.393 -1.706 . . . . 1.0 106.393 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.506 2.35 0 O-C-N 125.117 1.511 . . . . 1.0 114.451 -179.73 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 114.073 1.138 . . . . 1.0 114.073 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -55.1 168.28 0.34 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 113.428 -1.715 . . . . 1.0 112.965 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.53 ' HB ' ' SD ' ' A' ' 20' ' ' MET . 68.4 p -131.12 -179.95 5.64 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.078 -0.964 . . . . 1.0 112.316 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.37 -4.41 11.83 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.117 -1.856 . . . . 1.0 109.168 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.07 141.82 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 107.104 -1.443 . . . . 1.0 107.104 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -71.17 167.39 19.46 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.341 1.978 . . . . 1.0 116.341 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.2 p -139.15 177.52 7.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 124.819 1.324 . . . . 1.0 110.613 179.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.8 m -123.18 -50.11 1.92 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 104.889 -2.263 . . . . 1.0 104.889 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.05 167.85 31.79 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.581 -1.807 . . . . 1.0 108.581 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 65.4 m -46.49 -56.34 6.11 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.403 0.621 . . . . 1.0 110.19 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -48.7 -39.81 26.0 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.329 -1.305 . . . . 1.0 112.848 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -70.69 -35.21 72.67 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.846 1.308 . . . . 1.0 109.751 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 4.0 t -74.46 -12.33 60.47 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 113.653 -1.612 . . . . 1.0 113.015 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.51 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 5.0 m0 -65.9 -58.73 10.46 Favored Pre-proline 0 C--N 1.306 -1.285 0 CA-C-O 118.752 -0.642 . . . . 1.0 109.603 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -61.3 -42.86 31.89 Favored 'Trans proline' 0 N--CA 1.488 1.158 0 C-N-CA 122.567 2.178 . . . . 1.0 110.44 173.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 53.9 t -55.04 -44.08 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 119.335 -0.946 . . . . 1.0 110.906 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 41.2 t -70.31 -41.53 73.19 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -50.16 -43.98 52.43 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.306 -0.998 . . . . 1.0 108.306 179.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -70.85 -53.02 16.75 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 113.354 -1.748 . . . . 1.0 113.238 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.53 ' SD ' ' HB ' ' A' ' 3' ' ' THR . 20.3 ttp -55.67 -55.77 28.3 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 115.309 1.596 . . . . 1.0 115.309 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -116.13 -56.86 2.27 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 113.474 -1.693 . . . . 1.0 113.033 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.73 39.88 0.28 Allowed Glycine 0 N--CA 1.491 2.322 0 O-C-N 123.812 0.695 . . . . 1.0 111.623 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 5.5 mppt? -129.29 91.37 41.97 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 105.551 -2.018 . . . . 1.0 105.551 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -64.63 3.58 0.84 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 123.045 2.497 . . . . 1.0 113.981 -165.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.51 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 55.4 m-80 -111.62 -178.05 3.34 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.499 -1.667 . . . . 1.0 106.499 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.61 -176.03 23.98 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.269 -1.443 . . . . 1.0 114.745 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.605 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 28.5 mtpp -131.64 177.1 7.77 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 113.138 -1.531 . . . . 1.0 111.927 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.0 t -119.26 152.28 36.95 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 179.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.8 mtm -131.76 80.11 1.91 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.079 -0.964 . . . . 1.0 108.627 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.2 t30 28.73 52.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 125.586 1.804 . . . . 1.0 111.919 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.59 -31.4 4.18 Favored Glycine 0 N--CA 1.485 1.965 0 CA-C-O 116.405 -2.33 . . . . 1.0 116.912 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -115.88 141.17 48.46 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 120.795 2.297 . . . . 1.0 109.32 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.465 ' SG ' HG21 ' A' ' 3' ' ' THR . 33.1 t -71.87 160.64 32.22 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.652 -1.613 . . . . 1.0 113.517 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.557 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.2 tpt180 -133.61 146.75 51.23 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.431 -2.063 . . . . 1.0 105.431 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.3 m -117.61 164.82 14.37 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.248 -1.019 . . . . 1.0 108.248 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.605 ' CZ ' ' HG3' ' A' ' 27' ' ' LYS . 13.8 m-85 -117.63 -178.01 3.38 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.295 -1.32 . . . . 1.0 107.572 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.496 1.86 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 -179.962 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.404 0.621 . . . . 1.0 111.867 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -87.8 168.06 13.27 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.191 -0.913 . . . . 1.0 109.863 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.466 HG21 ' SG ' ' A' ' 33' ' ' CYS . 79.7 p -127.89 -173.46 2.94 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.052 0.845 . . . . 1.0 112.297 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -124.17 -7.45 7.68 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 113.403 -1.726 . . . . 1.0 110.273 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.4 t -111.54 145.34 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.498 -0.927 . . . . 1.0 108.498 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 171.02 11.68 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 116.923 2.194 . . . . 1.0 116.923 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 p -141.2 173.11 11.8 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.175 -1.375 . . . . 1.0 110.478 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.2 m -121.49 -49.49 2.14 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.854 -2.276 . . . . 1.0 104.854 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.19 169.59 33.22 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.542 -1.823 . . . . 1.0 108.542 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.6 t -43.54 -58.78 2.46 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.51 0.671 . . . . 1.0 110.521 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.26 -39.4 14.28 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 113.859 -1.519 . . . . 1.0 114.219 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -70.23 -32.66 70.62 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.066 0.936 . . . . 1.0 111.175 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 15.3 t -76.44 -12.32 60.03 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.949 -1.478 . . . . 1.0 113.111 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.414 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 6.9 m0 -66.78 -58.99 8.59 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 123.822 0.701 . . . . 1.0 109.462 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 85.3 Cg_endo -63.31 -42.88 20.32 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.883 2.389 . . . . 1.0 110.681 175.316 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 50.9 t -55.78 -46.45 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 C-N-CA 120.104 -0.638 . . . . 1.0 110.398 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.8 t -68.97 -42.55 76.46 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -50.48 -42.69 54.86 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.252 1.025 . . . . 1.0 108.534 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -70.65 -51.37 28.3 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 113.691 -1.595 . . . . 1.0 112.741 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.4 ttp -58.31 -52.41 65.7 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.026 1.121 . . . . 1.0 114.026 -179.258 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -116.86 -58.03 2.11 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.484 -1.235 . . . . 1.0 114.083 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.93 40.67 0.19 Allowed Glycine 0 N--CA 1.488 2.125 0 O-C-N 123.774 0.671 . . . . 1.0 112.501 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -127.79 103.31 21.67 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 105.694 -1.965 . . . . 1.0 105.694 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.71 10.08 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.993 2.462 . . . . 1.0 113.002 -168.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.414 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 73.5 m-80 -116.03 -176.3 2.92 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.954 -1.498 . . . . 1.0 106.954 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.419 ' HA2' ' CD1' ' A' ' 36' ' ' TYR . . . 143.44 175.98 17.05 Favored Glycine 0 N--CA 1.489 2.175 0 CA-C-N 113.994 -1.457 . . . . 1.0 113.069 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.474 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 51.8 mtpt -133.0 178.73 6.66 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 113.061 -1.57 . . . . 1.0 109.466 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.4 t -114.77 155.55 26.5 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.961 -1.496 . . . . 1.0 106.961 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 48.4 mtp -132.5 74.96 1.6 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.292 -1.373 . . . . 1.0 107.292 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 31.13 54.52 0.21 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 125.375 1.672 . . . . 1.0 110.995 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.88 -29.8 5.7 Favored Glycine 0 N--CA 1.487 2.07 0 CA-C-O 116.829 -2.095 . . . . 1.0 116.469 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 7.1 mptt -113.73 142.5 45.96 Favored 'General case' 0 C--O 1.206 -1.207 0 CA-C-N 120.387 2.093 . . . . 1.0 108.446 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.466 ' SG ' HG21 ' A' ' 3' ' ' THR . 36.4 t -71.55 160.82 32.02 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.574 -1.194 . . . . 1.0 113.216 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.581 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 5.3 tpt180 -131.6 140.12 49.34 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.274 -2.121 . . . . 1.0 105.274 179.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.7 m -111.74 161.55 16.18 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.116 0.96 . . . . 1.0 110.13 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.419 ' CD1' ' HA2' ' A' ' 26' ' ' GLY . 7.2 m-30 -115.88 -168.99 1.51 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 111.939 -2.391 . . . . 1.0 106.816 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 107.509 -1.293 . . . . 1.0 107.509 -179.816 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 121.746 0.784 . . . . 1.0 110.771 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -89.15 160.79 16.82 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 113.709 -1.587 . . . . 1.0 107.188 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.6 p -131.47 174.01 10.52 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 123.641 0.588 . . . . 1.0 110.72 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -125.3 32.51 5.35 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.571 -1.27 . . . . 1.0 107.571 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.1 p -111.29 134.95 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.151 -1.425 . . . . 1.0 107.151 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -70.67 140.7 51.58 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 113.454 0.909 . . . . 1.0 113.454 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.426 ' SG ' ' C ' ' A' ' 32' ' ' LYS . 2.5 p -136.21 170.41 16.06 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.063 0.935 . . . . 1.0 111.909 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.4 m -130.25 -43.19 1.18 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 112.384 -2.189 . . . . 1.0 108.516 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.19 172.08 21.59 Favored Glycine 0 N--CA 1.497 2.742 0 O-C-N 124.431 1.082 . . . . 1.0 112.411 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 59.1 p -70.1 -57.66 4.7 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.461 -0.869 . . . . 1.0 112.838 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -39.86 -32.79 0.17 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.82 -36.64 73.02 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 122.228 1.013 . . . . 1.0 111.031 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 41.8 t -73.6 -10.13 59.39 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.467 -1.242 . . . . 1.0 111.574 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.444 ' HB2' ' CD ' ' A' ' 15' ' ' PRO . 9.8 m95 -69.94 -61.04 3.16 Favored Pre-proline 0 N--CA 1.484 1.231 0 CA-C-O 118.462 -0.78 . . . . 1.0 110.104 179.366 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.444 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 81.8 Cg_endo -63.04 -40.42 34.05 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.771 2.314 . . . . 1.0 109.752 177.088 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.8 t -58.83 -49.77 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 123.837 0.71 . . . . 1.0 110.356 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.9 t -68.96 -34.63 75.64 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 118.946 -1.102 . . . . 1.0 109.295 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.08 -38.74 89.98 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -70.44 -52.36 22.76 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.642 -1.163 . . . . 1.0 111.035 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 73.1 mtm -61.35 -52.11 66.01 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.629 0.974 . . . . 1.0 113.629 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -111.26 -62.48 1.54 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 113.93 1.085 . . . . 1.0 113.93 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 121.41 43.68 0.42 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 106.922 -2.471 . . . . 1.0 106.922 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -127.82 81.94 69.33 Favored Pre-proline 0 N--CA 1.493 1.718 0 CA-C-N 113.496 -1.352 . . . . 1.0 107.584 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.7 0.18 3.23 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 123.684 2.923 . . . . 1.0 116.266 -150.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 36' ' ' TYR . 47.0 m-80 -103.94 129.25 51.47 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 104.771 -2.307 . . . . 1.0 104.771 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 14' ' ' TRP . . . -146.82 145.86 15.14 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-N 113.958 -1.474 . . . . 1.0 110.815 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -131.46 170.51 14.59 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 106.869 -1.53 . . . . 1.0 106.869 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.3 t -107.09 150.61 26.37 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.898 -0.721 . . . . 1.0 110.691 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.3 ptm -129.18 102.77 6.61 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.916 -1.493 . . . . 1.0 108.566 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.7 p30 31.69 44.34 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 113.641 -1.618 . . . . 1.0 114.194 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.94 -28.57 6.34 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 118.592 2.197 . . . . 1.0 118.592 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 35.3 mmtp -114.99 156.64 24.72 Favored 'General case' 0 C--O 1.202 -1.419 0 CA-C-N 120.87 2.335 . . . . 1.0 111.44 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.8 t -71.87 160.27 32.86 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.155 0.978 . . . . 1.0 111.0 179.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.447 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 9.3 tpt180 -136.26 140.45 43.45 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 105.93 -1.878 . . . . 1.0 105.93 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.9 m -109.39 164.01 12.88 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.437 1.113 . . . . 1.0 113.242 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.479 ' HB2' ' HB2' ' A' ' 25' ' ' ASN . 42.9 m-85 -128.16 -160.45 1.02 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 111.931 -2.395 . . . . 1.0 108.287 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.487 1.414 0 O-C-N 125.029 1.456 . . . . 1.0 107.756 179.898 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.14 0 CA-C-O 121.199 0.523 . . . . 1.0 112.133 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -86.64 168.25 13.79 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.392 -0.822 . . . . 1.0 109.446 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.516 HG21 ' SG ' ' A' ' 33' ' ' CYS . 58.9 p -127.3 -175.41 3.43 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.71 0.767 . . . . 1.0 112.803 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -124.22 -7.21 7.66 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.05 -1.886 . . . . 1.0 110.153 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.7 t -111.64 144.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.35 170.99 11.99 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 116.515 2.042 . . . . 1.0 116.515 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.3 p -141.23 173.03 11.88 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.225 -1.352 . . . . 1.0 110.493 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.9 m -121.3 -49.51 2.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 104.758 -2.312 . . . . 1.0 104.758 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.13 169.51 33.18 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 108.625 -1.79 . . . . 1.0 108.625 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.1 t -43.29 -58.58 2.47 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.541 0.686 . . . . 1.0 110.51 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.93 -39.24 11.91 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 113.958 -1.474 . . . . 1.0 114.447 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -70.3 -33.1 71.13 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.233 1.016 . . . . 1.0 111.174 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.573 ' SG ' ' O ' ' A' ' 34' ' ' ARG . 19.2 t -76.56 -11.55 59.89 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 113.747 -1.57 . . . . 1.0 113.075 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.413 ' CD2' ' HA ' ' A' ' 25' ' ' ASN . 7.0 m0 -67.49 -58.53 8.44 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 123.75 0.656 . . . . 1.0 109.52 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 14' ' ' TRP . 84.6 Cg_endo -63.38 -43.07 19.23 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.816 2.344 . . . . 1.0 110.686 174.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -55.49 -47.27 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 C-N-CA 119.844 -0.742 . . . . 1.0 110.216 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.0 t -67.75 -42.45 81.76 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.372 -0.931 . . . . 1.0 108.805 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -50.13 -42.85 51.41 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.342 1.067 . . . . 1.0 108.347 179.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -70.54 -46.25 63.93 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 113.648 -1.614 . . . . 1.0 111.151 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.4 ttp -54.03 -56.7 15.49 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 123.957 0.785 . . . . 1.0 112.641 -179.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -121.87 -57.02 1.82 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 113.385 -1.734 . . . . 1.0 114.021 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.95 43.41 0.11 Allowed Glycine 0 N--CA 1.488 2.122 0 O-C-N 124.045 0.841 . . . . 1.0 111.517 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -126.22 98.93 31.83 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 105.065 -2.198 . . . . 1.0 105.065 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.09 11.96 0.4 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 123.091 2.528 . . . . 1.0 113.218 -167.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.413 ' HA ' ' CD2' ' A' ' 14' ' ' TRP . 73.4 m-80 -116.36 -176.2 2.91 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.73 -1.581 . . . . 1.0 106.73 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' A' ' 36' ' ' TYR . . . 144.75 175.92 18.31 Favored Glycine 0 N--CA 1.49 2.254 0 CA-C-N 113.991 -1.459 . . . . 1.0 112.734 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.461 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 52.0 mtpt -133.33 177.81 7.4 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 113.165 -1.517 . . . . 1.0 109.001 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.3 t -114.89 155.99 25.83 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.769 -1.567 . . . . 1.0 106.769 179.446 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 48.8 mtp -133.01 75.17 1.61 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.29 -1.374 . . . . 1.0 107.29 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 30.95 54.44 0.19 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 125.321 1.638 . . . . 1.0 111.202 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.11 -29.69 5.68 Favored Glycine 0 N--CA 1.483 1.833 0 CA-C-O 116.916 -2.046 . . . . 1.0 116.438 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 7.1 mptt -113.97 142.49 46.09 Favored 'General case' 0 C--O 1.206 -1.218 0 CA-C-N 120.331 2.066 . . . . 1.0 108.194 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.516 ' SG ' HG21 ' A' ' 3' ' ' THR . 35.5 t -71.65 161.74 30.53 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.482 -1.236 . . . . 1.0 113.137 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.573 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 5.9 tpt180 -132.69 139.96 47.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.555 -2.017 . . . . 1.0 105.555 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.5 m -111.18 161.02 16.4 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.426 1.108 . . . . 1.0 110.778 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' CD1' ' HA2' ' A' ' 26' ' ' GLY . 6.2 m-30 -116.66 -169.0 1.55 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 111.318 -2.674 . . . . 1.0 106.722 -179.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 107.624 -1.25 . . . . 1.0 107.624 -179.863 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.88 0.371 . . . . 1.0 110.326 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -98.09 145.61 26.38 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.421 0.629 . . . . 1.0 111.088 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.9 p -132.45 171.35 13.88 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.639 -1.619 . . . . 1.0 110.687 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.58 48.79 1.03 Allowed 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.6 t -111.04 119.42 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.063 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 75.8 mmtt -39.65 113.13 0.31 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.655 -1.611 . . . . 1.0 115.272 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.4 p -123.24 171.48 9.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.257 0.973 . . . . 1.0 111.149 179.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.1 p -126.18 -43.17 1.81 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 112.595 -2.093 . . . . 1.0 108.495 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.49 169.17 29.76 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 124.44 1.087 . . . . 1.0 112.29 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.9 t -54.67 -62.63 1.53 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.454 -0.873 . . . . 1.0 111.576 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -42.7 -40.13 2.67 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 115.126 1.528 . . . . 1.0 115.126 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -57.88 -31.23 66.52 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.156 0.979 . . . . 1.0 112.974 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.413 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 22.9 m -81.21 -3.84 53.56 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.04 -1.437 . . . . 1.0 113.553 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.544 ' CG ' ' HA ' ' A' ' 25' ' ' ASN . 11.5 m0 -70.31 -59.0 4.4 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 107.826 -1.176 . . . . 1.0 107.826 179.262 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.464 ' CD ' ' HB2' ' A' ' 14' ' ' TRP . 83.6 Cg_endo -65.69 -46.45 5.15 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 122.735 2.29 . . . . 1.0 111.515 174.115 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 95.8 t -56.87 -44.69 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 119.276 -0.969 . . . . 1.0 110.306 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 23' ' ' LYS . 51.8 t -68.45 -45.01 73.61 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.692 -1.203 . . . . 1.0 108.627 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -46.89 -43.18 18.61 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 107.591 -1.263 . . . . 1.0 107.591 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -70.76 -45.33 64.97 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 112.941 -1.936 . . . . 1.0 112.719 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.9 mtm -63.45 -57.96 8.59 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.678 1.362 . . . . 1.0 114.678 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -111.88 -56.34 2.4 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.387 -1.279 . . . . 1.0 113.252 -179.408 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.16 39.47 0.38 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.858 -1.297 . . . . 1.0 109.858 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.452 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 14.0 mptt -119.01 97.0 50.62 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 102.691 -3.078 . . . . 1.0 102.691 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -64.91 -3.48 7.07 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 123.367 2.711 . . . . 1.0 113.346 -156.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.59 HD22 ' H ' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -122.25 165.68 15.81 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 124.438 1.086 . . . . 1.0 109.079 179.923 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.0 168.72 41.43 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.336 -0.935 . . . . 1.0 112.444 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.656 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 27.8 mtpp -121.85 -176.64 3.38 Favored 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 115.014 -0.593 . . . . 1.0 109.575 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.8 t -127.26 156.32 42.09 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 106.263 -1.754 . . . . 1.0 106.263 179.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 71.4 mtm -136.15 77.18 1.64 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.016 -1.476 . . . . 1.0 107.016 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.1 t30 30.36 53.43 0.14 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 125.271 1.607 . . . . 1.0 111.341 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 125.13 -35.52 3.08 Favored Glycine 0 N--CA 1.486 2.03 0 CA-C-N 113.159 -1.837 . . . . 1.0 115.637 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HD3' ' N ' ' A' ' 32' ' ' LYS . 1.7 mppt? -109.48 139.78 44.04 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 119.948 1.874 . . . . 1.0 109.907 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 46.1 t -71.94 160.56 32.32 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 112.917 -1.947 . . . . 1.0 116.013 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.453 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 9.1 tpt180 -139.29 155.41 47.75 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.017 -1.447 . . . . 1.0 107.773 179.71 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.9 m -126.71 166.14 17.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.992 -2.225 . . . . 1.0 104.992 179.327 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.656 ' CZ ' ' HG3' ' A' ' 27' ' ' LYS . 89.4 m-85 -113.26 177.37 4.65 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.752 -1.203 . . . . 1.0 107.752 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.9 m . . . . . 0 N--CA 1.501 2.077 0 CA-C-O 117.404 -1.284 . . . . 1.0 111.342 179.942 . . . . . . . . 0 0 . 1 stop_ save_